tag:blogger.com,1999:blog-56868962247592674462024-03-27T06:45:43.019-07:00Breast Cancer Community NewsNYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comBlogger26125tag:blogger.com,1999:blog-5686896224759267446.post-58137926707063128482024-03-15T22:35:00.000-07:002024-03-27T06:45:10.259-07:00HONORING HEWLETT HOUSE & GERI BARISH- LONG ISLAND'S LEGEND IN CANCER CAREGIVING!<p></p><div style="text-align: justify;"><p><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgegtFLseVSPGveuwBaOou4tS_3vYZhJDESibqPrsqFNKT9bdBwRMF2US_KyjHy0SKb6IwomKP0Y9KCWKUZWBGKcKjrumGTGiE6VRf9xK6l1w5uv91tgRdnF5ByBrtTN3G805G99cRpbIGLl8x91pz2dkKS_RpaNxDcF2tEQfd50HQ3_kttLJLaTv7KlvYt/s4000/20240221_135932.jpg" style="clear: right; display: inline; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="3000" data-original-width="4000" height="173" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgegtFLseVSPGveuwBaOou4tS_3vYZhJDESibqPrsqFNKT9bdBwRMF2US_KyjHy0SKb6IwomKP0Y9KCWKUZWBGKcKjrumGTGiE6VRf9xK6l1w5uv91tgRdnF5ByBrtTN3G805G99cRpbIGLl8x91pz2dkKS_RpaNxDcF2tEQfd50HQ3_kttLJLaTv7KlvYt/w232-h173/20240221_135932.jpg" width="232" /></a></p>Introduction</div><div style="text-align: justify;">In a recent interview with Long Island cancer support advocate, Ms. Geri Barish shares her uncompromising passion for her life’s work. As co-founder of Hewlett House, Ms. Barish established a well-loved community learning resource center for cancer patients and their families. She and her staff have been serving the local community for over 28 years and have served tens of thousands of cancer patients and their families.</div><div style="text-align: justify;"><br /></div><p></p><p></p><p></p><div style="text-align: justify;">INTERVIEW with Geri Barish</div><div style="text-align: justify;">“Hewlett House is all about human connection: since its opening in 2000, it has become a safe haven for cancer patients and their families.” Their patients come together to network and receive accurate information in a comfortable home environment. The Hewlett House facilitates discussions that help patients come to terms with their cancer and treatments, all while maintaining strict HIPAA standards of privacy. Their services rely primarily on the generosity of our supporters and local communities.</div><p></p><p style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiW1KIlc5WJylKUVquKa8TJIA0bhwZb4Nkrvta6DPxqo0B_89YZhYyQjDPuDXtjm0oObodnIAz5GM_w-sdITmYu2VeSCjZc3wOinRhIQRXognmXmk29N_S9pyhhTZ1sTTYOjJITHgheddkTUfyCcokZzBlH2cPk44xtOX5jn4He-TDMmoGu1u3Ki7CK_N2I/s4000/20240221_130854.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="4000" data-original-width="3000" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiW1KIlc5WJylKUVquKa8TJIA0bhwZb4Nkrvta6DPxqo0B_89YZhYyQjDPuDXtjm0oObodnIAz5GM_w-sdITmYu2VeSCjZc3wOinRhIQRXognmXmk29N_S9pyhhTZ1sTTYOjJITHgheddkTUfyCcokZzBlH2cPk44xtOX5jn4He-TDMmoGu1u3Ki7CK_N2I/s320/20240221_130854.jpg" width="240" /></a></div>I'm a five time cancer survivor and was originally diagnosed with breast cancer at 38. I see people with cancer all the time and if I knew then what I know now, maybe I could have helped so many more. What I say all the time is “you have to be screened! Cancer starts young.” It doesn't start at 50 and 60 and 70. It's not just an old person's disease. <p></p><div style="text-align: justify;">CANCER STARTS EARLIER</div><div style="text-align: justify;">I'm fighting right now for younger women to be screened – and to know their history. We have too many young women in their twenties getting breast cancer. Our last meeting had 27 new patients, mostly under 31, either breast cancer survivors or still in treatment. I think that's pretty serious. When they come down with breast cancer, it's often very aggressive because they weren’t screened and didn’t know their history. I am advocating to push for younger women to know their history and to get screened.</div><p></p><p></p><div style="text-align: justify;">Part of this advocacy is addressing the need for people to get ultrasounds, and insurance isn’t always covering it. When the doctor writes a prescription it should be adhered to. So when you go for an ultrasound it is often out of pocket, $3-$400. It is outrageous. Because of this, we just put together a bill with New York State Senator Steven D. Rhoads that would require Breast Cancer ultrasounds to be covered.</div><p></p><p style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiBFX735ysAcYy4CQ3YkP6JaSmn3yJF0XAvFXixYXj69oTb_4hg8Vc_xUuBY5bHDec12QHAwxN8L5cVuB8pJz7i7YqB42Qt1WVrU9GvAUMKTrb2RSzofhhJOwfHaUBd4TTcq4anPztknsoY7fxMkhXRx4Cev3Xn0hmq9djOUjQ_mwd-XvzP2ru9_2qKvS1n/s1820/geri.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="1820" data-original-width="1304" height="127" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiBFX735ysAcYy4CQ3YkP6JaSmn3yJF0XAvFXixYXj69oTb_4hg8Vc_xUuBY5bHDec12QHAwxN8L5cVuB8pJz7i7YqB42Qt1WVrU9GvAUMKTrb2RSzofhhJOwfHaUBd4TTcq4anPztknsoY7fxMkhXRx4Cev3Xn0hmq9djOUjQ_mwd-XvzP2ru9_2qKvS1n/w91-h127/geri.jpg" width="91" /></a></div>Starting next week I am doing a radio program about exploring “what does early detection really mean?” … and what is the age group? I'm out there really pushing for younger and younger women to go to their doctor to be screened. If you feel something, if you know there's a history in your family, whether it's prostate cancer or another kind of cancer, you need to speak to your doctor. We're just seeing too many young people get cancer across the board. <p></p><p style="text-align: justify;"><br /></p><div class="separator" style="clear: both; text-align: center;"><a href="https://photos.app.goo.gl/vKDu2X2LtYDSVjWy8" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="255" data-original-width="773" height="199" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjR72eeml77dvKwbYLB67C9h_SPFJJ5x_GLQghLPySiWPsAn6MyDKa0rRx273DrOJb4wysOmR8LIdu5WK4Fz1Zlrm7CTOqhSJm9hmfMNirHQsQVxNK5XN-usc0dv1wLXkC98HJsK4aA8FCzbiZm_s7NM3OWDBdDpKohhHl69BForKRvB7elvfrp_z-dEQzT/w597-h199/film.jpg" width="597" /></a></div><div class="separator" style="clear: both; text-align: center;"><br /></div><br /><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiv0iH3lUautqK9fY2-z8s-a5v6ngqR6ERK2Y5Chbu-AmqyrCgijRFm9ZYJGTsckx4jfBLxJsjTCpVX8ie3wXxoL8QlNRw8aD7HZR6FmRP5Hjr4UWDgswEWU-4qV6kP-WsPLp4lbnxtxLdJmI0CTqUklDGM4zBHV2sMED2m8x2PfARpYdqDr1_DL8NLbA9F/s587/HOUSE-PICTURE.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><br /><br /></a></div><div style="text-align: justify;">THE HOUSE BUILT FROM LOVE</div><div style="text-align: justify;">The Hewlett House itself is a national landmark that was deeded to the Hewlett-Woodmere school district for educational purposes. Unfortunately the house had fallen into neglect and disrepair. County executive Bruce Blakeman had worked with me on cancer issues and thought I could have use for this building for our cancer patient support initiatives. He arranged for the legislature to buy the house for a dollar, and we took it over with major support from caring volunteers. We converted this 387 years old house into our patient haven. (See photo tour of the Hewlett House.)</div><p></p><p style="text-align: justify;">We started out as breast cancer support, but today Hewlett House services all kinds of cancer patients. We see men, women, children and we have served over 37,000 people since we opened our doors. All services are free and we work with all hospitals. </p><p style="text-align: justify;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjIsrY7bD923sxzJj2K1Cu71PyRNjlN3Q-5Y5YKbvduI037UrhBdY8EaofLECaW-NqZkyT9hyE_War62WqmxUHoXB3vPewbSBAtMUsGAMsP-v4r6tyWHydR8Q8vjZYeD2L3anqZlx0ToV7sBTe_3Ac-TfWui7B6dJn7IBwtnQWPz9t9iKQh4qfFv0v2i8cQ/s4000/20240221_135546.jpg" style="clear: right; display: inline; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="3000" data-original-width="4000" height="240" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjIsrY7bD923sxzJj2K1Cu71PyRNjlN3Q-5Y5YKbvduI037UrhBdY8EaofLECaW-NqZkyT9hyE_War62WqmxUHoXB3vPewbSBAtMUsGAMsP-v4r6tyWHydR8Q8vjZYeD2L3anqZlx0ToV7sBTe_3Ac-TfWui7B6dJn7IBwtnQWPz9t9iKQh4qfFv0v2i8cQ/s320/20240221_135546.jpg" width="320" /></a>I sit on the advisory board for cancer at Mount Sinai Hospital and I'm a special assistant to the Commissioner of Health of Nassau County. I work for the health department. I also sit on the Medical Society board for Nassau County. My outreach goes everywhere - it doesn't stop at the front door of Hewlett house.</p><p></p><div style="text-align: justify;">A PERSONAL CRUSADE – REFLECTING ON HEREDITY & “A LONG WAY TO GO”</div><div style="text-align: justify;">For me, this all started when my son had cancer. In 1974 my son Michael was diagnosed with Hodgkin's disease, at the age of 13. In 1986, a week before he died, I was diagnosed with breast cancer at the age of 38. I remember coughing one night and I put my hand to my chest. I felt something hard and round like a pea. It was towards my clavicle. I thought, “God, I wonder what that was?” I was so involved with my son that I didn't even think about it. Looking back, my mother had died from breast cancer and I wasn’t making the connection. I was more concerned about Michael. Then I went to the doctor and he said, “no, it's very hard – let's try taking a biopsy”. Lo and behold, it turned out to be cancer. The day I was supposed to start radiation was the same day as his funeral. </div><p></p><p></p><p style="text-align: justify;">That was in 1986, and the breast cancer recurred in 1987. I had skin cancer in 1990. I had breast cancer again in 1993. In 2015 I had lung cancer. I just keep going because of my son. I made him a promise and I'm writing a book right now— it’s called “I made him a promise”. He asked me “what did I do wrong, why do I have cancer”. I said “you did nothing wrong”, and I promised him I’d find out why. I'm not going to stop. We've come very far and there's still a long way to go.</p><p style="text-align: justify;"><br /></p><p></p><div style="text-align: justify;">ENVIRONMENTAL MISSION</div><div style="text-align: justify;">Our location allows us to work well with the five boroughs. We also work with a group of young women across the United States called the BREASTIES, all under 32. We had meetings a few times a year to discuss environmental impacts on cancer cases. </div><p></p><p style="text-align: justify;">We got together as an organization in the late eighties, when Long Island had a very high rate of breast cancer. We started talking about having an environmental study. We got together with Susan Love and we helped to start the National Breast Cancer Coalition in Washington. We marched and we met many people and we started asking questions. I met with the surgeon general asking the NCI for a $5M budget for an in-depth environmental study of Long Island due to the prevalent cases of breast cancer. It is an island with the most open waste sites. The study would need about $5 million. We were directed to Senator Al D'Amato and Congressman Peter King. They helped start our five year in-depth environmental study on water, pesticides, chemicals, and much more. It became known as the Long Island Breast Cancer Study Project.</p><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhzCPXjC44YLbHXyNSMuoe6xHRBniE_-GQuh6Y2eWBJIuI4yQ2q7_BUX9jNWuef1XW_gIF8vJ51BR5wbbyurIVztGCE8o4AJX3te7Ad9AX2m1LNTnXfD3oqTkE_KZU4_Lgpr_InWOXyTMwMMCW3DA74lkYcav2ujXflPkKGTTjvDcQLz3epXJrT6M_6Gtyl/s154/W.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="154" data-original-width="154" height="98" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhzCPXjC44YLbHXyNSMuoe6xHRBniE_-GQuh6Y2eWBJIuI4yQ2q7_BUX9jNWuef1XW_gIF8vJ51BR5wbbyurIVztGCE8o4AJX3te7Ad9AX2m1LNTnXfD3oqTkE_KZU4_Lgpr_InWOXyTMwMMCW3DA74lkYcav2ujXflPkKGTTjvDcQLz3epXJrT6M_6Gtyl/w98-h98/W.jpg" width="98" /></a></div>THE WOMEN'S HEALTH COLLABORATIVE gives special thanks to Ms. Geri Barish for a lifetime of generosity, endless support and loving care for all those who have entered the doorway of the Hewlett House- and for the many who call on her for help and resources while battling debilitating diseases. Since 1990, the mission of Hewlett House is to support cancer patients at every stage of treatment. Ms. Barish and all her volunteers manage this special community resource center that provides all services without charge. They pride themselves in providing patrons with the highest-quality information and guiding them throughout their battle with cancer. Every patron is treated like family and given full access to educational materials, 24/7 peer-to-peer support systems, and a network of cancer survivors and doctors. Hewlett House is open to those fighting cancer and their families. A variety of free services are available, including yoga, meditation and tai chi classes, support groups, wigs, bathing suits, bras and informational services. For more information, visit: <a href="https://hewlett-house.org/">https://hewlett-house.org/</a> or call 516.374.2385</div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><div><hr /><br /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgHOYgLZJKC4rL5liapoY2A5TiyRF80GXj9vQlGSNJ2hF6oBV-Ywdp6qKWOEWCWmmHi-MTHySXUJ0OR46KGxk0RcCasqQX9is6uWUD-E9LkLzDX-fJQ2SuYjlkFqGiLzIppjE6EvOh_YTZDu4nLf2ZaC3kWaM4XOo9sV7P9QtHl8s5ZQQj34XGi-nKgytmD/s182/EXTRA1.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="48" data-original-width="182" height="38" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgHOYgLZJKC4rL5liapoY2A5TiyRF80GXj9vQlGSNJ2hF6oBV-Ywdp6qKWOEWCWmmHi-MTHySXUJ0OR46KGxk0RcCasqQX9is6uWUD-E9LkLzDX-fJQ2SuYjlkFqGiLzIppjE6EvOh_YTZDu4nLf2ZaC3kWaM4XOo9sV7P9QtHl8s5ZQQj34XGi-nKgytmD/w145-h38/EXTRA1.jpg" width="145" /></a></div><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; text-align: left;"><a href="https://360healthalert.blogspot.com/2024/02/the-real-cause-and-effect-of.html"><br /></a><div class="separator" style="clear: both; text-align: center;"><a href="https://360healthalert.blogspot.com/2024/02/the-real-cause-and-effect-of.html"></a><a href="https://360healthalert.blogspot.com/2024/02/the-real-cause-and-effect-of.html" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="257" data-original-width="257" height="108" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgDsnj8xaOaZwtK1UQKB4_oZmRAahEc5148OOYPDv6rmrvLpGJeTCJgmm_S3d8A39UIpTCaVS4jVQmo60wc9LG6x2TtiP_JKAJOAFkyGIbumj9nELEnSvpz1UDT_Hwi30ab2Ufv1orAPewzgxe1dsXPiQX52dlIrYwLvHKHCzn3gL5gdVaD9yah1PVh2sXX/w108-h108/1.jpg" width="108" /></a></div>A COMPLEX INTERACTION & ENVIRONMENTAL TOXICANTS<br />By: <a href="https://robertaklinemd.com/">Dr. Roberta Kline</a><br />Not everyone who is exposed to environmental chemicals will develop disease or cancer. The outcome for each individual is the result of a complex interplay of their genetic predispositions, epigenetics, and environmental exposures over their lifetime. We all have biological processes to clear many different chemical substances from our bodies. How well these systems function can be affected by many factors, including genetics and epigenetics, along with a person’s health and nutrition status, exposure level, and even stress. The more suboptimal these are, the higher a person’s risk for consequences to their health from environmental toxins.</div><div class="separator" style="clear: both; text-align: left;"><br /></div></div><div><br /></div><div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://balance-longevity.blogspot.com/2024/03/cancer-predisposition-heredity-gene.html" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="216" data-original-width="216" height="109" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjP-9EgqpQMuJo9MQh2o5qTeGYVxdvKldFLyhY4WXztFt5s7Z6b5G52izt5DfyY_4Z1OpHYFnoTH-MA3MHGZkJdL0zjBn-iTYNUiB7LqCP_cK2hRVC9VczPST2pMchlHTRa5BT0Uet3RnYdZuH4fRNy368tpVqqEmV6W_K-J3ZPoXxRVb6sMXvStGkGxEx1/w109-h109/5.jpg" width="109" /></a></div><a href="https://balance-longevity.blogspot.com/2024/03/cancer-predisposition-heredity-gene.html">CANCER PREDISPOSITION, HEREDITY & GENE TESTING</a></div><div>NYCRA NEWS- Genetic Predisposition (with Special Video PSA by Dr. R. Kline)</div><div>By definition, diseases like CANCER are not directly hereditary. Unlike genetic traits and characteristics passed down to children like blood type and eye color, chronic diseases like cancer are recognized to be contracted through the environment (external impact). However, as cancer is a form of genetic mutation, genetic changes that increase the risk of cancer CAN be passed down or inherited. </div></div><div><br /></div><div><div><br /></div></div><div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://meetourcrusaders.blogspot.com/2024/02/musicians-for-cancer-causes-part-1.html" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1314" data-original-width="1314" height="111" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgXNyTIUqiwbvndC7_HHfzwJT1nrWFkVaWZ9phDizBPa1ng4XNeQMKhyGwbK4vm8SFlNL467h7njsc_E7fTTKXre8kvnOGMaldowOZvhwoPMsycaN3UNrOVgDG0PciP6HHD0KDpQgZp_AeWWn6g5xjjKQcIhp9pnneny_61yOBGi82iJZ_MrslkfOjOceCq/w111-h111/mu.jpg" width="111" /></a></div><a href="https://meetourcrusaders.blogspot.com/2024/02/musicians-for-cancer-causes-part-1.html">MAKING OF A CANCER MUSICFEST: </a></div><div>An interview with <a href="https://www.areyoudense.org/">Joe Cappello (Co-founder of the Are You Dense? Foundation)</a></div><div>Many organizations fundraise through golf club outings and things like that. We thought to do better- by bringing families together under one roof for a memorable night of "joyful noise". The concept of the Musicfest is an event that we started producing 15 years ago as a fundraiser to support the Are You Dense? mission. For many years, we have done legislative work while bringing awareness and education to the public about the cancer concerns linked to Dense Breast Tissue. The Musicfest was our largest finance producer and we need it every year. It's very exciting to have bands from all over the country come in to perform-- both well-known and not-so well-known groups. </div><div><br /></div><div><br /></div><div><hr /></div><div><br /></div><div></div></div><div><div><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_cW7iDDVgVSX67vV-RU1CCr0jCKpf_SgqwGJWS2_FSymjDKodeG09QyLoGiixfbMMXDRLvbDqxuaiy-hXO7y4wXnrWlTru0CumXO5aP0MZzSYv7lZeZsqZkh_o2xVeDUPHYxoVmi_TzO6S7bZC64Xoh1rqbN71k_0jnfQuRMoOb8unv2gQUMSq8Lj08WG/s362/editorial.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: center;"><img border="0" data-original-height="80" data-original-width="362" height="39" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj_cW7iDDVgVSX67vV-RU1CCr0jCKpf_SgqwGJWS2_FSymjDKodeG09QyLoGiixfbMMXDRLvbDqxuaiy-hXO7y4wXnrWlTru0CumXO5aP0MZzSYv7lZeZsqZkh_o2xVeDUPHYxoVmi_TzO6S7bZC64Xoh1rqbN71k_0jnfQuRMoOb8unv2gQUMSq8Lj08WG/w177-h39/editorial.jpg" width="177" /></a><span style="font-size: large;"></span></div><div><span style="font-size: large;"><br /></span></div><div><span style="font-size: large;"><br /></span></div><div><span style="font-size: large;"><br /></span></div><div><span style="font-size: large;">WE ALL NEED MENTORS</span></div><div>By: <a href="https://lennardgettz.com/">Lennard Gettz</a></div><div><div class="separator" style="clear: both; text-align: center;"><br /></div>I had the pleasure of finally meeting the legendary GERI BARISH and THE HEWLETT HOUSE. After one phone interview, Geri's commitment to advocacy and resource giving sparked a unique level of curiosity about her work to see her magical HOUSE on East Rockaway Road for myself - and I'm so glad I did. From the front steps to every room inside the hallowed house, the love and compassion was literally sprinkled everywhere. Geri's historical tour included some of the most heartwarming highlights about some of the individuals who lovingly called this place a second home - including those whose lives were cut short by the dreaded disease. As the director of the <a href="https://nycranews.com/">NY Cancer Resource Alliance</a> & <a href="https://healthscannyc.org/faces.html">Firefighters Against Cancer & Exposures</a> (as well as being a fellow Long Islander), I have always known about Geri's work going as far back as 2001. Admittedly, I never thought my level of philanthropy could ever compare to her achievements or her unending level of commitment. But having finally met her, I was almost reduced to tears having personally felt Geri's brand of kindness and leadership to help ANYONE in need. As a 5-time cancer survivor herself, Geri understands the emotional tolls and the need for resources that a sufferer undergoes. There is truly no limit to her will to share and give and help. At long last, I join the many voices of appreciation and gratitude for Geri Barish - the ultimate role model for altruism, benevolence and moxy for making a difference! She wins the lifetime 'cats' pajamas' award for "amazingness"!</div><div><br /></div><div><br /></div><div>This feature is sponsored in part by:</div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjusQW-y-5Vn_Qc1UY0dk2kfggs13QCBI0UizL38Cgttp1irouYyLOVMiu5galPYjbGhuki5mibx2nru3-OC9tJwlnM1iEDkm3MB6npX3Cha4Aw1VOAw7WtFt8owHw3C6lBCx6yB6or_mb6uKSGs16z5ZAFxg7jSXJt8UhyqPqlL_tib1u1VlL4eaFomb6I/s986/logos.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="282" data-original-width="986" height="153" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjusQW-y-5Vn_Qc1UY0dk2kfggs13QCBI0UizL38Cgttp1irouYyLOVMiu5galPYjbGhuki5mibx2nru3-OC9tJwlnM1iEDkm3MB6npX3Cha4Aw1VOAw7WtFt8owHw3C6lBCx6yB6or_mb6uKSGs16z5ZAFxg7jSXJt8UhyqPqlL_tib1u1VlL4eaFomb6I/w530-h153/logos.jpg" width="530" /></a></div></div></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><span style="font-size: x-small;"><br /></span></div><div style="text-align: justify;"><span style="font-size: x-small;"><br /></span></div><div style="text-align: justify;"><span style="font-size: x-small;"><br /></span></div><div style="text-align: justify;"><span style="font-size: x-small;"><br /></span></div><div style="text-align: justify;"><span style="font-size: x-small;"><br /></span></div><div style="text-align: justify;"><span style="font-size: x-small;"><br /></span></div><div style="text-align: justify;"><span style="font-size: x-small;"><br /></span></div><div style="text-align: justify;"><span style="font-size: x-small;"><br /></span></div><div style="text-align: justify;"><span style="font-size: x-small;"><br /></span></div><div style="text-align: justify;"><span style="font-size: x-small;"><br /></span></div><div style="text-align: justify;"><span style="font-size: x-small;"><br /></span></div><div style="text-align: justify;"><span style="font-size: x-small;">Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and The AngioFoundation). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.</span></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-34603418887084509292024-02-28T21:15:00.000-08:002024-02-29T04:51:06.096-08:00A QUANTITIATIVE ANALYSIS & IDENTIFYING THE KILLING CANCER<p>Written & produced by: Dr. Robert Bard</p><p>INTRODUCTION<br />I'm a radiologist subspecializing in ultrasound imaging, and I've been doing breast scanning for over 35 years. We have advanced radiology from x-rays to ultrasound to MRI and beyond. Reports are now promoting certain cancers should be considered as chronic diseases instead of "killing" cancers. We have known this for the past 30+ years that some cancers are dormant and while cancers are actively lethal. </p><p>We've learned that some breast cancers are low-aggressive (but we need to continually watch them) or perhaps call for less aggressive treatment. We've also learned that certain cancers may surprise us; they do not follow the expected guidelines due to continung mutation. An example of this is the new findings of breast cancer cases in younger and younger ages (ie. 19 to 22 years old), and this age limit continues to get lower and lower. </p><p style="text-align: center;"><iframe allow="autoplay; fullscreen; picture-in-picture" frameborder="0" height="338" src="https://player.vimeo.com/video/917780414?badge=0&autopause=0&player_id=0&app_id=58479" title="PART1-RLB-ONLY" width="600"></iframe></p><p>The same thing goes with breast cancers in men; five years ago, the count it used to be 1% of the population of cases, and now it's risen to 2% of the breast cancer population. We're finding more of it, partly thanks to better imaging access and partly because of improved awareness. </p><p>Imaging innovations not only offers better detection but once we have the image, we can see if this is a "killing cancer" or not. The simplest technique and most basic technique is to use blood flow imaging. If we find many tumor vessels, "tumor's bad". If the tumor has only a few tumor vessels, tumor is "not so bad". More importantly, if you're treating a tumor and it goes from less to more, the treatment is not working. So we have a way of monitoring treatment in real time. </p><p><br /></p><p>PRESENTATION:</p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://breastcancernyc.com/9.html" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img alt="" data-original-height="601" data-original-width="879" height="248" src="https://blogger.googleusercontent.com/img/a/AVvXsEjcuUGMY9obcGAjQ_FJLJ9zWf8sa8Ji0IjqzdFpeoKpVC2MvCdEMname1AYOSYjM7r4_iLJgWtcGpJ51PRASB6fhcQXuK_LAww66gZuiijnHvSGwiItne6kZZNgBlDJ_CaMMT0MNz44FydT55eN_NVFsyDY32C-pYTJIbj4mtZ0B7lkKH4C5zCp6eCXYy2P=w362-h248" width="362" /></a></div>Slide 1- shows a mass under the arm that is measured externally and internally. We employed 3D Doppler blood flow (for PreOp scan or prediagnostic scan) to find out where the cancer is and focus on that. We target before, during, and after treatment scan points. The slide also shows the blood flow readings- showing very few tumor vessels, which is a good sign. This indicates our new ways of targeting tumor aggressiveness. <div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://breastcancernyc.com/7.html" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="331" data-original-width="879" height="138" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi482ZOCEYY4H9y58dBgcE6wPC8fqcJp4-FwGSkyB9zosPTYsWUMgQ_7KUNsac5kLxcvgKg_v_ZJ4dYdtVhgA5V8mLPV3HNXrGQjEjMtFQk9tIYe7hsuFEoMbw4pldPhwlmc2QTXpsTEzkqyk7DwEv-SFSkiRsFNq2QyEViTltMCO5rKLmMqpXA43odisAc/w366-h138/7.jpg" width="366" /></a></div>Slide 2 shows a gland, allowing us to determine whether it is normal or abnormal. Clinically, this was a fatty tumor 'cause it was smooth and, and moved. But if you look carefully, it was not a breast cancer metastasis, but it was a, a primary cancer of the glands or the the bloodstream, which is useful. But again, it's radioactivity, it's isotopes. It, uh, takes a long time and it's expensive. <p></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://breastcancernyc.com/13.html" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><br /><img border="0" data-original-height="422" data-original-width="879" height="176" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjGvs-DeVeU0mcZ5hT55FBPJE4uQA7ABtScQS2j3bTa_gtASK7mkDTrCJtxDiJLJ7qguc98N_bARQdx_MN7K3ESuusWkcfcL38yB9mGXsTnqNzTr-KVqP1iHu2Q6RQaXQhWw3lC_eBko3E9jAFRXPkJKhfNWpr_Jb5glEQtSjQuMBmXmSJUvhffBHIzVMbr/w366-h176/13.jpg" width="366" /></a></div>Slide 3- shows a mass and then we have a color on the far right slide, which is new for us because it's not a blood flow technology. This is elastography. When you feel a cancer, it's often hard like a piece of rock, whether it's in the breast, the prostate, the in the neck. And this is a non-invasive way of looking at tumors. It's called elastography because it shows the elastic nature of tumors. So if a tumor is rock hard, it's highly inelastic, and if it's soft, it's more elastic. <p></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjroM-gQn4PkzggaHUpaolLyVBQtA8pYxxYTGpcx4nDcJo_zKMyAfDOjhBEGHU6PT79ryVec_7lBPHsA2IojLp1qqFF0Hv1-JtnSr0VXYi_jdZnGe5Yc03zwQujgsqLSFBRnrUs4huXY096Yk2hDFvtY3pUIwUnszuOxPy6fPhe0QgqvLOZ9HwRFAPWeTdN/s3243/dreamstime_xl_40799127.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="2466" data-original-width="3243" height="243" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjroM-gQn4PkzggaHUpaolLyVBQtA8pYxxYTGpcx4nDcJo_zKMyAfDOjhBEGHU6PT79ryVec_7lBPHsA2IojLp1qqFF0Hv1-JtnSr0VXYi_jdZnGe5Yc03zwQujgsqLSFBRnrUs4huXY096Yk2hDFvtY3pUIwUnszuOxPy6fPhe0QgqvLOZ9HwRFAPWeTdN/s320/dreamstime_xl_40799127.jpg" width="320" /></a></div>And this is a quantitative technology that's used globally for the last 15 years. So we now have ways of seeing what a tumor is, where it is. And globally, people are deciding whether or not to biopsy a breast if there's nothing showing up by an ultrasound or ELAs that looks suspicious. And the Doppler blood flow is, looks, uh, either low grade or benign. So this is a, a filter which is just being recognized by the insurance companies and paid for now to decide whether the biopsy or not. Also, if the tumor is hard, like the, the vessels going into it and it becomes soft with few vessels and less elastic or less, uh, red in it on the gram, we have the ability to say that the treatment is working non aggressively without doing biopsies to see if it's gotten better or worse. <p></p><p>So we're learning that biopsies can be hit or miss in the getting. They can be hit or miss in the sectioning. They can get the hit or miss in the interpretation at the end. Sorry to say that this is a problem, but you have to realize that the reason we went to advanced imaging is because it's safe, it's quick, it's repeatable without needles. Using the imaging, which I repeat is done globally now, to avoid biopsies and to avoid re-biopsying lesions to see if the treatment is working with the blood flow technology. The 3D Doppler, the advanced equipment will show you where the tumor is, what's happening to it. And once you see the blood vessels, you also have other options. For example, in if you have blood vessels feeding a tumor, now you can stick a catheter in the artery that's feeding the tumor and destroy the whole tumor by blocking the blood supply. </p><p></p><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: right;"><tbody><tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhPqhXyXKOMeISDxY6Tdtl4cSX0OtdVlUh05ethkNV7de5NS5hJbAxDPmxWdsJsxA6dkPihiqYJP_96g49TvCPZtHCsGiJLH9vkqRhfcJqjZNGCERxnrVOmAkp5SkeaVs7HONaul0X5-VmHZ-rpjHqiQgSrSjxs1GOjnTNPucUgYlEoSMiSslwrtbiWEd8M/s1947/dreamstime_m_60996794.jpg" style="clear: right; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><i><img border="0" data-original-height="1947" data-original-width="1540" height="274" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhPqhXyXKOMeISDxY6Tdtl4cSX0OtdVlUh05ethkNV7de5NS5hJbAxDPmxWdsJsxA6dkPihiqYJP_96g49TvCPZtHCsGiJLH9vkqRhfcJqjZNGCERxnrVOmAkp5SkeaVs7HONaul0X5-VmHZ-rpjHqiQgSrSjxs1GOjnTNPucUgYlEoSMiSslwrtbiWEd8M/w217-h274/dreamstime_m_60996794.jpg" width="217" /></i></a></td></tr><tr><td class="tr-caption" style="text-align: center;"><i>Needle Biopsy (sample)</i></td></tr></tbody></table>It's called infarct the tumor- used also in treating fibroids. Now we're treating certain cancers. You just kill the blood supply to the tumor if you know where it is. So these are options that weren't available before and are being accepted by medical community. For example, if there's a tumor in the breast, we look at the tumor, but then what next? The patient is sitting in front of you. So you may want to look under the arm to see if it's spread. And of course if you find it's metastasized to lymph nodes under the arm, you may say, and again, the patient's right in front of you, where else could it spread? Because treatment of disease that's only in the glands is different from treatment of cancers that spread to the well to the lymph nodes in the body or to the uh, liver for example. <p></p><p>So it's a completely different approach. So then we ask the patient to lie down, put the probe over the lymph nodes over the aorta, the main blood vessel in the midline, and then we check the liver and then the other areas that can be affected. We can also look at the ribs to see if there's erosion of the bone by tumors, which commonly wind up in the rib cage. So we can do all of this at the same time. The patient is in front of us. </p><p><br /></p><p></p><hr /><p></p><p>ROBERT L. BARD, MD is internationally recognized in the field of 3D DOPPLER ULTRASOUND IMAGING to detect cancers (in organs including the breast, prostate, skin, thyroid, melanoma and other areas). As a certified diagnostic radiologist, Dr. Bard evolved his practice to pursue non-invasive 3D imaging with ultrasound, MRI and laser technologies. He is also passionate about conducting educational presentations and publishing in International Medical Journals. He holds Board certification from the American Board of Radiology (1974) and Fellowship in the American Society of Lasers in Medicine and Surgery (2014). <a href="https://drrobertbard.com/">https://drrobertbard.com/</a></p></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-60367155312880432282024-01-26T10:25:00.000-08:002024-01-30T03:43:30.000-08:0027 Year Old Stage 3 Breast Cancer Victim Survived - Despite of Docs Who MISDIAGNOSED!<p><iframe allow="autoplay; fullscreen; picture-in-picture" frameborder="0" height="338" src="https://player.vimeo.com/video/886262775?badge=0&autopause=0&player_id=0&app_id=58479" title="Interview #5: Jaime (Cancer Survivor)" width="600"></iframe> </p><p>The Women's Health Collaborative and EARLIER DETECTION advocate Alexandra Fiederlein interviewed breast cancer survivor Jamie Butera about her journey to getting checked to save her own life. When her own doctor said, "You're Way to Young for it to be Breast Cancer"- Jamie's instincts told her different. By 'demanding' the right screening and tests, she found that she had Stage 3 breast cancer. "Be your own advocate, get the answers you deserve... if I didn't seek answers when I did, I would only have had 2 months to live!"</p><p><br /></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhjanm8EzMm3fXE0KxWoj6Td9oE_qL9ANC6OfXcesqAthp8SeQLA6hj5drtuHhYL_RLAXSh8O-K11G2wfqaX9wAi6jhbqYW7wD3Lutj0fHdIOw3Di9BBU2G5zYFwLnuns2BbXbOv5P5tSNAgEfVXOrcMAFQEJObtqnCFgrs2XWzW_OUDpwrz38YV7DOQvKD/s766/scr2.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="442" data-original-width="766" height="66" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhjanm8EzMm3fXE0KxWoj6Td9oE_qL9ANC6OfXcesqAthp8SeQLA6hj5drtuHhYL_RLAXSh8O-K11G2wfqaX9wAi6jhbqYW7wD3Lutj0fHdIOw3Di9BBU2G5zYFwLnuns2BbXbOv5P5tSNAgEfVXOrcMAFQEJObtqnCFgrs2XWzW_OUDpwrz38YV7DOQvKD/w115-h66/scr2.jpg" width="115" /></a></div>INTRODUCTION<br />FACT: Cancer does not discriminate. And this includes healthy people, people that are physically fit and active and young women. In general, young people think they're bulletproof. Well, you are not! You look at the camera as one of the young people, but you're one of the smartest generation young people and say, "take it from me. Young people can get cancer just like older people."<p></p><p>In the case of Jamie, I'm glad she was proactive enough to follow her gut - instead of doctors who guess wrong! Jamie is a survivor of stage three breast cancer and is a supporter of earlier diagnosis. Jamie's strength is an inspiration for many, and her story is a reminder of how women should be advocates for their health because their lives depend on it. Jamie is also the owner and operator of a full service WIG Salon called the Wig Nook located in Las Vegas, Nevada. Her services play a special focus on cancer patient survivors and those struggling with alopecia. And Jamie is also an active member of the Hidden Angel Cancer Support Group. </p><p><br /></p><p><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhX2u7VxL2JtCUrKx3cuDuM_J8KDKQQr25ftsWIJ7uPPqb18LxuyizypFXKQi9yoBp4tn1qoUyAkcOe3gh6Fp2p4k8VASdRlztKqiohQT8o7HVQKLGldf94CFSYSwSWUj_L0LTTg8uw_CChfFFbcEFZDjx6wBn6-u7xsCJh0hInJA096TJ6aYry35ytn2Ef/s568/Jaime.jpg" style="clear: left; display: inline; float: left; margin-bottom: 1em; margin-right: 1em; text-align: center;"><img border="0" data-original-height="568" data-original-width="338" height="162" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhX2u7VxL2JtCUrKx3cuDuM_J8KDKQQr25ftsWIJ7uPPqb18LxuyizypFXKQi9yoBp4tn1qoUyAkcOe3gh6Fp2p4k8VASdRlztKqiohQT8o7HVQKLGldf94CFSYSwSWUj_L0LTTg8uw_CChfFFbcEFZDjx6wBn6-u7xsCJh0hInJA096TJ6aYry35ytn2Ef/w96-h162/Jaime.jpg" width="96" /></a>JAMIE'S TRANSCRIPT<br />In the year 2015, I was diagnosed with a stage three breast cancer on my right breast. It was a triple negative. When I did my own research, it just really means it tested negative on three aspects of tests with (I believe) estrogen. </p><p>It all started when I found a lump in my right breast. It was a very small lump, about the size of a grape. When I initially felt the lump, I went to an ER and saw a doctor there. They told me that they don't really deal with that... I have to go see my gynecologist- who told me that it could be an infection of a milk duct because I was way too young for it to be cancer. So she told me I shouldn't be concerned at all! She told me I shouldn't be concerned at all. I'm way too young. So she put me on antibiotics to see how that would go.</p><p>I feel if I didn't follow my intuition or demand answers (since I found this lump), I wouldn't be here today because records have shown when we're younger, they don't really take it as seriously. I would say be your own advocate! Get the answers you deserve because there is always a cause. If you have a lump, obviously there is a cause for it. So even if they tell you otherwise, keep asking and keep digging for answers. Find out the cause of this lump and more importantly, find out what it really is!</p><p>So from my understanding, this was an aggressive kind of cancer- so I started chemo right away right after I got diagnosed. It took them about two months before my being initially diagnosed because they didn't really think I had the breast cancer because I was very young (I was 27 at the time). By the time I was diagnosed, I started with intense chemotherapy then followed by radiation then surgery. Seven years later, I'm still cancer free. </p><p>SURVIVOR'S ADVOCACY<br />Years later, after my diagnosis, I chose to go public and be really open with my diagnosis. I put my story on social media. I let people see me without my hair. I didn't want someone to go through the same thing I went through or someone to possibly die because they weren't diagnosed early enough because they were too young. U</p><p>I host the Hidden Angel Cancer Support Group so people don't feel alone with this cancer. It made me feel really good to speak to survivors at the time when I was going through it myself. I feel like being involved with cancer support groups help you to see (especially survivors) that if somebody else has survived this, I too can survive it!</p><p></p><hr /><p></p><p><br /></p><p>SURVIVOR TURNED RESOURCE FOR PATIENTS & SURVIVORS<br /></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiwcxLBWwvmV0eXqdU3uuroKOjQJg0-f2Ri49to0Oc7Krv9Dc19Z1RSVfRxxsx7R6cYEUiHrc4b6rTQLkbLihx9CN4tClItmEObRJzqLTU8f4Z_aOXEMIgotfYMv2qTDMLydemYjTPepWAjwukUVGik8tQ5RPu67OgVN2zuxIdcjuEUPUJEsdELdY_taMZj/s421/IMG_4907_JPG.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="421" data-original-width="389" height="198" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiwcxLBWwvmV0eXqdU3uuroKOjQJg0-f2Ri49to0Oc7Krv9Dc19Z1RSVfRxxsx7R6cYEUiHrc4b6rTQLkbLihx9CN4tClItmEObRJzqLTU8f4Z_aOXEMIgotfYMv2qTDMLydemYjTPepWAjwukUVGik8tQ5RPu67OgVN2zuxIdcjuEUPUJEsdELdY_taMZj/w183-h198/IMG_4907_JPG.jpg" width="183" /></a></div>Another wig salon opening in Vegas? Well the Wig Nook is not just any new salon. The Wig Nook by Jaime is full service to all wig designs and fittings but thoughtfully designed from one survivor to another. While we offer a large wig selection, custom fitting and cuts, steaming and cleaning, we offer the comfort and care of someone who "has been there and back" as a cancer survivor and is dedicated to a comfortable and inviting setting for our clients. <p></p><p>The Wig Nook offers other board licensed expertise in Hair Extensions and Hair Styling to all your needs. We are proud to announce that we offer Nail Service to our list of services. With all these exciting professional services, we want you to Meet me at the Nook! At The Wig Nook, we pride ourselves to have a true connection with our clients. As a Stage 3 Breast Cancer survivor, owner and lead stylist Jaime Butera is dedicated to provide specialized wig services with the care that a cancer survivor is looking for and deserves. She offers various hair services including the highest quality wig services</p><div><br /></div><div><hr /><p></p><div style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: justify;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBv2182EGB6jHc5n-ghsD0_nYqvRCRUL7Xa9XR7RanDvIIe0IvbD5X2jwoTK4OTtNyzrIywrascF2UEw7aboeVwrb_ZSOAzoEfG7jeS9O_rYYvz5AZrXu5XjKoSqGyWKefp3Tjt2zceeFuX2KPG5SmPk95hA_MQEHIsu7pd8B-w_ty5Y6KeAnze4EuMADl/s932/Untitled-1.jpg" style="clear: left; color: #a900ee; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="527" data-original-width="932" height="91" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBv2182EGB6jHc5n-ghsD0_nYqvRCRUL7Xa9XR7RanDvIIe0IvbD5X2jwoTK4OTtNyzrIywrascF2UEw7aboeVwrb_ZSOAzoEfG7jeS9O_rYYvz5AZrXu5XjKoSqGyWKefp3Tjt2zceeFuX2KPG5SmPk95hA_MQEHIsu7pd8B-w_ty5Y6KeAnze4EuMADl/w160-h91/Untitled-1.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="160" /></a></div>WHAT ABOUT IF YOU'RE TOO YOUNG FOR A MAMMOGRAM? I went to my doctor for a lump I felt in my breast and she gave me a response that set off red flags: "don't worry about it". Being a researcher involved in breast density and breast cancer, I knew that I had to take action; I was fortunate enough to have my breast ultrasound training with Dr. Robert Bard (cancer imaging specialist, NYC) upcoming in the next week. Dr. Bard showed me how to use the ultrasound to help me find two benign tumors in my breasts, and it was there that he reported that I have dense breasts. Had I not taken action in getting screened at the young age of 22, I would have never known that I should be getting screened via ultrasound every 6 months (because having dense breasts puts me at a higher risk for breast cancer), nor would I have known that I had benign breast tumors. </div><div style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: justify;"><br /></div><div style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: justify;">- ALEXANDRA FIEDERLEIN, 22</div><div style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: justify;">Cancer Researcher/ Graduate- Molloy Univ.</div></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-7083730048033292592023-12-16T12:42:00.000-08:002023-12-16T13:09:47.967-08:00PATHOLOGICAL VIEWS OF DENSE BREAST TISSUE <p><span style="font-family: arial;">Written by: <a href="https://drrobertbard.com/">Dr. Robert L. Bard</a> (12/2023)<br />Edited by: <a href="https://painhealersgroup.org/network.html">Carmen Regallo-Dewitt</a></span></p><p><span style="font-family: arial;">Decades since the advent of breast scanning technology, innovations in non-invasive diagnostic imaging provide new options in the field of early detection. A mammogram can show how dense your breasts are including how low or high in density. However, over-compression artificially lowers the radiographic density.</span></p><div class="separator" style="clear: both; text-align: left;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjq8cApIA0F9bVmjfwGr_Uma-MQBTiqrTcGlTw6PgLQ-KCN0D2qKAC1orPV9tb3JhNMtsIVVKxnOltTaUUGOsTWtzK97DO1g3rEOkL7-WshIGX1bFMoDK9qW5pA7zOIzFv2X1Ap7wC_SV81HIySwxDUoOFOlihGmN9EDly1XMKBhtDifhDwDqF75chkLIZI/s1964/3.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><span style="font-family: arial;"><img border="0" data-original-height="480" data-original-width="1964" height="159" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjq8cApIA0F9bVmjfwGr_Uma-MQBTiqrTcGlTw6PgLQ-KCN0D2qKAC1orPV9tb3JhNMtsIVVKxnOltTaUUGOsTWtzK97DO1g3rEOkL7-WshIGX1bFMoDK9qW5pA7zOIzFv2X1Ap7wC_SV81HIySwxDUoOFOlihGmN9EDly1XMKBhtDifhDwDqF75chkLIZI/w652-h159/3.jpg" width="652" /></span></a></div><span style="font-family: arial;"><br /></span><p><span style="font-family: arial;"><br /></span></p><p><span style="font-family: arial;"> [Image 1] in this standard mammogram, a dense breast is presented side by side. The white shaped “V” that comes down the top center are the pectoral muscles of the chest wall. On the far outside, the white line is the skin outline of the breast. This is the dermal tissue causing the white line viewed enface. Radiologists always study this for any indication of inflammatory disease of the skin or inflammatory breast cancer, which manifests itself in skin thickening. Between the center wedge and the skin outline, you will find homogeneous cloudy areas with patchy black spaces within as an example of dense breast tissue. </span></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhbR1Mn5NXEtdV9mjJhd0PJp9zZ_TAFxAoz_z3mgC8SClIqigpZYi6_LLTOpC7ml6J9faMwLgAD4RQTVqE9ICtupQDcQw6Z-l9S-b3sHl3zMagrOVyx3lSwiBnNjf783Hy6SOh05nlzF6gdP9O1aFMFISFJtkqjMIWT0PofXm3ABYnsgdVcNAyw2NHAA_70/s624/brca.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><span style="font-family: arial;"><img border="0" data-original-height="425" data-original-width="624" height="218" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhbR1Mn5NXEtdV9mjJhd0PJp9zZ_TAFxAoz_z3mgC8SClIqigpZYi6_LLTOpC7ml6J9faMwLgAD4RQTVqE9ICtupQDcQw6Z-l9S-b3sHl3zMagrOVyx3lSwiBnNjf783Hy6SOh05nlzF6gdP9O1aFMFISFJtkqjMIWT0PofXm3ABYnsgdVcNAyw2NHAA_70/s320/brca.jpg" width="320" /></span></a></div><span style="font-family: arial;">Usually, dense breast tissue appears white on a mammogram. We must identify them as one of two forms of breast density; one is called FIBROCYSTIC or fibrous [Image 2] which is homogeneously white. Occasionally you can see a branching of blood vessels, dilated ducts or a streak of fat inside the dense breast tissue. This is the most common type of dense breast tissue and generally seen in the over 40 population.</span><p></p><p><span style="font-family: arial;">[Image 3] Another example of a dense breast shows the difference between homogeneous white versus the whitish area. This is filled with dark, wormy looking structures, which are the breast glands called GLANDULAR tissue. This kind secretes milk and its glands are often dilated. Both Fibrous and Glandular may appear similar under a mammogram as highly dense areas, but they look completely different under an ultrasound scan. </span></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjSOgle-zLXpf8thoFdxkmwIp_Mra6AtWSEIlYOVHZTjZf2OJuIBiQoYiXlQuSd5ZfP0mLBnt0_Z2WL-n2cybiWBWwDqd6xeI5seFqHM-7GZiQT6pa19Kezx1umSbIdOs3LDyFX3H2-nBv5TflzPsAOoWAK9JcipfQTdWWt3fHJQtEbRNzZLIprd_Wk_ZTH/s1017/ela.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: right;"><span style="font-family: arial;"><img border="0" data-original-height="498" data-original-width="1017" height="157" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjSOgle-zLXpf8thoFdxkmwIp_Mra6AtWSEIlYOVHZTjZf2OJuIBiQoYiXlQuSd5ZfP0mLBnt0_Z2WL-n2cybiWBWwDqd6xeI5seFqHM-7GZiQT6pa19Kezx1umSbIdOs3LDyFX3H2-nBv5TflzPsAOoWAK9JcipfQTdWWt3fHJQtEbRNzZLIprd_Wk_ZTH/s320/ela.jpg" width="320" /></span></a></div><span style="font-family: arial;">Through ultrasound, we can check for tumors easily through fibrotic dense breasts because it stands out as a black region (or a black hole) within the white area. As shown in Image 3, a black hole could get lost, making it more difficult to image this type of dense breast. In this case, a solution is the use of elastography [Image 4], which offers visual confirmation as indicated by color data. Elastography can measure tissue density (its hardness or elasticity) within the glandular breast tissue. </span><p></p><p><span style="font-family: arial;">This tissue type is more common in the under-40 age group and is associated with other glandular proliferation such as endometriosis and is reportedly linked to dermal inflammation. In published reports, comparative studies between FIBROUS and GLANDULAR breast tissue studies remain limited. We are observing (especially in the younger age groups) expanding reviews of these types of tissue density aligned with the rates of breast cancer to confirm the rate of malignancy in tissue alteration from normal.</span></p><p><span style="font-family: arial;"><br /></span></p><div><div class="separator" style="clear: both; color: #444444; text-align: center;"><span style="font-family: arial;"><br /></span></div><div class="separator" style="clear: both; color: #444444; text-align: center;"><div style="text-align: justify;"><span style="font-family: arial;"><br /></span></div><div style="text-align: justify;"><div class="MsoNormalCxSpFirst"><table border="2" cellpadding="10" cellspacing="0" style="text-align: justify;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; color: #444444; font-weight: bold; text-align: center;"><span style="font-family: arial;"><br /></span></div></div><div><span style="color: #444444; font-family: arial;"><div><b><div style="text-align: left;"><b><span>TRIBUTE TO A GLOBAL CRUSADER</span></b><div class="separator" style="clear: both; text-align: center;"><a href="https://www.youtube.com/watch?v=ht4UpoY-BnQ" style="clear: right; color: #0043ee; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="544" data-original-width="974" height="157" src="https://1.bp.blogspot.com/-jbm88Nc3MbU/YPpd0QALrfI/AAAAAAAARTM/96r_xNR5WT8vPYKUAfLaZ6dEjVntTTBIgCLcBGAsYHQ/w281-h157/7b03b9f1-ea1d-4885-b14d-923629c94c54.jpg" style="background: rgb(255, 255, 255); border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="281" /></a></div></div></b>(<a href="https://www.youtube.com/watch?v=ht4UpoY-BnQ" style="color: #0043ee; text-decoration-line: none;">Play Video-L)</a> The NY Cancer Resource Alliance gives loving tribute to Dr. Nancy Cappello, co-founder of "Are You Dense" and chief crusader of the mission to bring change to the protocols and standards of Early Detection. Her organization embarked in a global advocacy project to win legislation for dense breast scanning and to bring awareness to the need for better technologies and imaging interpretation. Today, her loving husband Joe continues her unending fight to save more lives through awareness, advocacy and her crusade for change. (Also see below to read her full story in our ORG SPOTLIGHT section)</div><div><br /></div></span></div></td></tr></tbody></table></div><div class="MsoNormalCxSpFirst" style="text-align: left;"></div></div></div><div class="separator" style="clear: both; color: #444444; text-align: center;"><span style="font-family: arial;"><br /></span></div><div class="separator" style="clear: both; color: #444444; text-align: center;"><div class="MsoNormalCxSpFirst"><div class="separator" style="clear: both;"><span style="font-family: arial;"><br /></span></div><div style="text-align: justify;"><h3 class="post-title entry-title" itemprop="name" style="background-color: white; color: #222222; font-feature-settings: normal; font-kerning: auto; font-optical-sizing: auto; font-stretch: normal; font-variant-alternates: normal; font-variant-east-asian: normal; font-variant-numeric: normal; font-variant-position: normal; font-variation-settings: normal; font-weight: normal; line-height: normal; margin: 0.75em 0px 0px; position: relative; text-align: start;"><span style="font-family: arial; font-size: large;">Epigenetic Research Notes: Profiling the Dense Breast Paradigm (part 1)</span></h3><div class="post-header" style="background-color: white; color: #222222; line-height: 1.6; margin: 0px 0px 1.5em; text-align: start;"><div class="post-header-line-1"></div></div><div class="post-body entry-content" id="post-body-31166069214326345" itemprop="description articleBody" style="background-color: white; color: #222222; line-height: 1.4; position: relative; text-align: start; width: 660px;"><p><span style="font-family: arial;"> Coursework (Part 1) w<span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif">ritten by: </span><a href="https://robertaklinemd.com/" style="color: #2288bb; text-decoration-line: none;">Dr. Roberta Kline</a><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif">. </span></span></p><div class="post-body entry-content" id="post-body-5157246929809960258" itemprop="description articleBody" style="line-height: 1.4; position: relative; width: 660px;"><p></p><p></p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif"><span style="font-family: arial;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh9mXNAKFEd85vCObnWJ_JCE0i5e8qiH-8Kq-96togium3g4bI9Oe5vfTwIgg8iyRqQj0zp6ZNuoUdUAaiPOFhHoNBdxqR_JQ3_H8m8jq0TB2DslP_mKDfWePM4kwIwpID2cv9lj8Xa2ukWM7pqQ5Zr0xxiwy9BDomif56CKJ0Lki1Fk8JC1e58acJc6Ntf/s1222/book-kline.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="744" data-original-width="1222" height="265" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh9mXNAKFEd85vCObnWJ_JCE0i5e8qiH-8Kq-96togium3g4bI9Oe5vfTwIgg8iyRqQj0zp6ZNuoUdUAaiPOFhHoNBdxqR_JQ3_H8m8jq0TB2DslP_mKDfWePM4kwIwpID2cv9lj8Xa2ukWM7pqQ5Zr0xxiwy9BDomif56CKJ0Lki1Fk8JC1e58acJc6Ntf/w435-h265/book-kline.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="435" /></a></div><br />As an Ob-Gyn physician and genomics specialist, I have spent the better part of 10 years translating research in the genomic and gene expression areas into clinically usable information for healthcare professionals. One of the biggest challenges we face when connecting research with patient care is the long delay in the translation process and dissemination of the information. It often takes 10 to 20 years for information (validated findings) that comes out of research to be applied in clinical practice. These delays result in many lost opportunities to provide better care for our patients. This is one of the reasons why I'm really passionate about accelerating this process and making it easier for clinicians and their patients to take advantage of cutting-edge information and new technologies. </span></span></div><div class="post-body entry-content" id="post-body-5157246929809960258" itemprop="description articleBody" style="line-height: 1.4; position: relative; width: 660px;"><span style="font-family: arial;"><br /></span></div><div class="post-body entry-content" id="post-body-5157246929809960258" itemprop="description articleBody" style="line-height: 1.4; position: relative; width: 660px;"><span style="font-family: arial;"><b><div class="separator" style="clear: both; text-align: center;"><a href="https://breastcancerblognews.blogspot.com/2023/12/epigenetic-research-notes-profiling.html" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="308" data-original-width="431" height="116" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEijjxsVWyYOVQcoO1gP2wYZEIrc5kZz8TUOM0YwBnRWUFgk1BQJmSEbAJNA4ibMFSz4U36BExEmbchSdzlouUCzieFVDSvkpiCySoYx3CQ82ba9Xv1fJTj6dl1AOKEuvSMqG_wshbqrqYUkx1lzxJ_YjYyXLhDZR5Z55HbkMegWHvV00BBD5YZVPM-RW4VR/w162-h116/wee.jpg" width="162" /></a></div>LINKING DENSE BREAST WITH BREAST CANCER</b><br />We have known for a very long time that there is an increased risk of breast cancer for women who have dense breasts. Until recently, the research has been lagging in terms of what's the molecular mechanism, why do dense breasts present an increased risk of breast cancer? Without this knowledge, we can’t address the root causes, and are left with a lot of trial and error based on incomplete understanding. <a href="https://breastcancerblognews.blogspot.com/2023/12/epigenetic-research-notes-profiling.html">(see complete report)</a></span></div></div></div><div><span style="color: black; font-family: arial; text-align: left;"><br /></span></div><div><span style="color: black; font-family: arial; text-align: left;"><br /></span></div><div><span style="color: black; font-family: arial; text-align: left;"><div class="MsoNormalCxSpFirst" style="font-family: "Times New Roman";"><div style="text-align: justify;"><hr /><p></p></div></div><div class="separator" style="clear: both; font-family: "Times New Roman"; text-align: center;"></div></span></div></div></div></div><div><span style="font-family: arial;"><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;"><span style="font-size: large;"><a href="https://wellnesstechnews.blogspot.com/2023/11/advocates-journal-where-are-we-with.html">LIVING WITH ENDOMETRIOSIS:</a></span><br />From an interview with MJ Smith</p><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://wellnesstechnews.blogspot.com/2023/11/advocates-journal-where-are-we-with.html" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="372" data-original-width="686" height="174" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhTgj96E6Y9QIL0sq1soZAnpaZQHD4tmSuVhC2XWAWo6RqYnxI7BCFJWhK-HNVlORsx6qNtohXv0H2qAzGc9ycNKhN8FaR-7gnMpwpogymSCWX8ws0qu0atXhEUPU40rcYsS7XVNCRPtBkVRBz6_OI-yZYXEHgy89_tUnZapzQQdgiujz8ZU8Ar5SutRErz/s320/MJ.jpg" width="320" /></a></div>My personal and professional missions are both in women's health. By day, I work for a breast AI company focused on helping radiologists find breast cancers on mammograms. I chose this path because I believe in advancing causes that support women's health simply because women are core members of our culture and our families. I have had two family members, both maternal aunts, who died of breast cancer, - one at the age of 36, and an the other at the age of 52.<p></p><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;">Advocacy for Endometriosis is directly related to my personal journey. Growing up with endometriosis since puberty, I've been to the emergency department probably over 20 times for pain or pelvic pain related conditions. The pain had me flat on my back for days at a time or falling out of bed with pain. I drove myself to a Planned Parenthood in Minnesota where I grew up and was prescribed birth control to manage it well into my twenties. Despite the hormonal treatments, I still had a series of episodes. </p><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;"><a href="https://wellnesstechnews.blogspot.com/2023/11/advocates-journal-where-are-we-with.html" style="clear: left; color: #3367d6; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="3000" data-original-width="4000" height="231" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi0c2di7r5dCUGUngVxQQK2Y83pLTpYULBjM3ByXXDuyc1PNExT_VQ4YHMFve69jdC9IwyOhnFijkkB-EkwQOYbgzKqFuVi0OqoDldALqIZC4ubZ9zwqjfwqz56D5n0OrSOnALpjm_2XCxUnsDOzgFJ_eDFBmPmqBHiIu1CKZb3ZgXdOSVcBjGYc6njCw/w306-h231/shutterstock_2268244097.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="306" /></a>Endometriosis is the uterine tissue that grows and implants itself outside of the uterus. Going through that pain is the result of a complex process, resulting in swelling and bleeding inside the interstitial spaces of my body. Women who have endometriosis also often develop painful cysts on their ovaries. </p><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;">I think the biggest reason you see women in the ER is pelvic pain. Women with chronic pelvic pain (which is often what endometriosis causes) are underserved by the healthcare community because we're constantly complaining of pelvic pain. The ER is not where you want treatment because you see a different doctor every time you get admitted. With emergency imaging, you usually get a pelvic ultrasound where cysts can show up and they're quick to assume that you have a cyst, or a cyst has burst and this is why you're uncomfortable. I think now you can do a pelvic MRI with contrast media- but it's still not enough to offer a definitive diagnosis. (<a href="https://wellnesstechnews.blogspot.com/2023/11/advocates-journal-where-are-we-with.html">See complete report</a>)</p><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;"><br /></p></span></div><div><div class="MsoNormalCxSpFirst"><div style="text-align: justify;"><hr /><p></p></div></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj6T4YqmyEawEsw1JywBb6OO2b8srSPaRSsEmBTPIVMqncEZplpoM1zAguiXey-IvaEBWbM3b41-EFEez6st8K18rSJ90YwiZnREYkpV8BC1SoHPIOiWJbGgdr-0pU-GSYGE0ESQizWiumpt9QOe7TIAgIUZwJkL-Z5JZNMbGVG7PKHWzIk_4ZDOgAkvq6N/s182/EXTRA1.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="48" data-original-width="182" height="37" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj6T4YqmyEawEsw1JywBb6OO2b8srSPaRSsEmBTPIVMqncEZplpoM1zAguiXey-IvaEBWbM3b41-EFEez6st8K18rSJ90YwiZnREYkpV8BC1SoHPIOiWJbGgdr-0pU-GSYGE0ESQizWiumpt9QOe7TIAgIUZwJkL-Z5JZNMbGVG7PKHWzIk_4ZDOgAkvq6N/w139-h37/EXTRA1.jpg" width="139" /></a></div><br /><p style="text-align: justify;"><br /></p><div><div class="separator" style="clear: both; text-align: justify;"><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-nhYKSycK9HY/YPBBiz9kT4I/AAAAAAAARQ0/hZBcbRGgdpkeas9QODPtZnjsTHe8N7Q_gCLcBGAsYHQ/s1100/INSERT2.jpg" style="clear: right; color: #0043ee; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><span style="font-family: arial;"><img border="0" data-original-height="706" data-original-width="1100" height="300" src="https://1.bp.blogspot.com/-nhYKSycK9HY/YPBBiz9kT4I/AAAAAAAARQ0/hZBcbRGgdpkeas9QODPtZnjsTHe8N7Q_gCLcBGAsYHQ/w468-h300/INSERT2.jpg" style="background: rgb(255, 255, 255); border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="468" /></span></a></div><span style="font-family: arial;">Decades since the advent of breast scanning technology, innovations in non-invasive diagnostic imaging provide new options in the field of early detection. These technologies directly align with breast density screening (and are part of the Bard Breast Density Diagnostic Program).</span></div></div><div><p></p><p></p><div style="text-align: justify;"><br /></div><p style="text-align: justify;"><span style="font-family: arial;"><br /></span></p><p style="text-align: justify;"><span style="font-family: arial;"><br /></span></p><p style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEip-H14UnsIvfI0JUWuDrakSdp18ndgUDGyA_1J-x-3nD3b4oePzgQbwEJKnPLTyBg9x6uW5vIh5tPDoxmEYnLnLpwtwyhVuf7UVVsHB8HXhQbH5m0Q-iElkux7VTrziu1CzJD6w1q7SXXSjxR-N3wVsTf5ztIWQ0mnr5BBLM60dQzAeLxQLnVb3Xj4O2xZ/s621/wee.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="94" data-original-width="621" height="102" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEip-H14UnsIvfI0JUWuDrakSdp18ndgUDGyA_1J-x-3nD3b4oePzgQbwEJKnPLTyBg9x6uW5vIh5tPDoxmEYnLnLpwtwyhVuf7UVVsHB8HXhQbH5m0Q-iElkux7VTrziu1CzJD6w1q7SXXSjxR-N3wVsTf5ztIWQ0mnr5BBLM60dQzAeLxQLnVb3Xj4O2xZ/w681-h102/wee.jpg" width="681" /></a></div><br /><span style="font-family: arial;"><br /></span><p></p><div class="MsoNormalCxSpFirst"><div style="text-align: justify;"><hr /><p></p></div></div><p style="text-align: justify;"><span style="font-family: arial;"></span></p><div class="separator" style="clear: both; text-align: center;"><div><br /></div></div><div style="background-color: white; color: #222222; font-family: Tinos; text-align: justify;"><span style="font-family: arial;">CONTRIBUTORS</span></div><div style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;"><div class="separator" style="clear: both; text-align: center;"><span style="color: #444444; text-align: start;"><div style="text-align: justify;"><i><div><span style="font-family: times;"><br /></span><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiapg5j-9tONExlbEM1BwZct2gpXl85jPXiSdRb8hGAskemnIfZth4eDXwHnD23Z1F6Fpf_T05yfANVXbtzC82XgoN09NJm64kQGHNpV09ifHQEBtotcDRNmZydJe4lUqVyrAX2K-55ctLFfgfh9ixN0B3fUlmVd_t_ZO8rDTdNsUTkrpcJeTie4Lit1w/s69/BARD.jpg" style="clear: left; color: #2288bb; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><span style="font-family: times;"><img border="0" data-original-height="69" data-original-width="69" height="69" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiapg5j-9tONExlbEM1BwZct2gpXl85jPXiSdRb8hGAskemnIfZth4eDXwHnD23Z1F6Fpf_T05yfANVXbtzC82XgoN09NJm64kQGHNpV09ifHQEBtotcDRNmZydJe4lUqVyrAX2K-55ctLFfgfh9ixN0B3fUlmVd_t_ZO8rDTdNsUTkrpcJeTie4Lit1w/s1600/BARD.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="69" /></span></a></div><span style="font-family: times;">ROBERT L. BARD, MD (Diagnostic Imaging Specialist)</span></div></div><div><span style="font-family: times;">Having paved the way for the study of various cancers both clinically and academically, Dr. Robert Bard co-founded the 9/11 CancerScan program to bring additional diagnostic support to all first responders from Ground Zero. His main practice in midtown, NYC (Bard Diagnostic Imaging- www.CancerScan.com) uses the latest in digital Imaging technology has been also used to help guide biopsies and in many cases, even replicate much of the same reports of a clinical invasive biopsy. His most recent program is dedicated to the reporting of mental health diagnostic and innovative solutions including the use of modern neuromagnetic technologies and protocols in his MEDTECH REVIEWS program. </span></div><div><span style="font-family: times;"><br /></span></div><div><br /></div><div><div><div class="separator" style="clear: both; font-family: arial; text-align: center;"><br /></div><div class="separator" style="clear: both; font-family: arial; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgoRViR40CZmyfdlib8IRe9ZurvPS4jh9ko24-2fZh1SdQ6tP95iriOaHyzVhGj76pKpA2S2IlgEJ0DOu6u3cLlXJHO1HI9H-K09wtbKcpiA5i-JNSS6Em0IzN1kOxKtSxwqMzJKfmqjOFg194WBq9b0zjMrptUDeT2D79z82_96XUSbWnfD_-vu1Nv2Q/s244/BK.jpg" style="clear: left; color: #2288bb; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="244" data-original-width="244" height="72" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgoRViR40CZmyfdlib8IRe9ZurvPS4jh9ko24-2fZh1SdQ6tP95iriOaHyzVhGj76pKpA2S2IlgEJ0DOu6u3cLlXJHO1HI9H-K09wtbKcpiA5i-JNSS6Em0IzN1kOxKtSxwqMzJKfmqjOFg194WBq9b0zjMrptUDeT2D79z82_96XUSbWnfD_-vu1Nv2Q/w72-h72/BK.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="72" /></a></div><span style="font-family: times;">ROBERTA KLINE, MD (Educational Dir. /Women's Diagnostic Group)</span></div><div><span style="font-family: times;">Dr. Kline is a board-certified ObGyn physician, Integrative Personalized Medicine expert, consultant, author, and educator whose mission is to change how we approach health and deliver healthcare. She helped to create the Integrative & Functional Medicine program for a family practice residency, has consulted with Sodexo to implement the first personalized nutrition menu for healthcare facilities, and serves as Education Director for several organizations including the Women’s Diagnostic Health Network, Mommies on a Mission. Learn more at <a href="https://bobbiklinemd.com/" style="color: #2288bb; text-decoration-line: none;">https://bobbiklinemd.com</a> <br /></span></div></div><div><span style="font-family: times;"><br /></span></div><div><span style="font-family: times;"><br /></span></div><div><span style="font-family: times;"><br /></span></div><div><span style="font-family: times;"><br /></span></div></i></div></span></div></div><p style="text-align: justify;"></p><hr /><p></p></div></div><ul style="background-color: white; color: #222222; line-height: 1.2; list-style: none; margin: 0px; padding: 0px 0px 0px 1.25em;"><li style="margin: 0px; padding: 0.7em 0px;"><div class="item-content"><div class="item-title" style="padding-bottom: 0.2em;"><a href="https://breastcancerblognews.blogspot.com/2023/01/dense-breast-news-2023.html" style="color: #0043ee; text-decoration-line: none;"><b><span style="font-family: arial;">DENSE BREAST NEWS: 2023</span></b></a></div><div class="item-snippet"><span style="font-family: arial;">1/19-2023- The ARE YOU DENSE ADVOCACY committee continued to pursue the public importance of patients receiving their own personal medical i...</span></div></div><div style="clear: both;"></div></li><li style="margin: 0px; padding: 0.7em 0px;"><div class="item-content"><div class="item-thumbnail" style="float: left; margin: 0px 5px 5px 0px;"><a href="https://breastcancerblognews.blogspot.com/2023/10/earlier-detection-reaching-generation.html" style="color: #0043ee; text-decoration-line: none;" target="_blank"><span style="font-family: arial;"><img alt="" border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBv2182EGB6jHc5n-ghsD0_nYqvRCRUL7Xa9XR7RanDvIIe0IvbD5X2jwoTK4OTtNyzrIywrascF2UEw7aboeVwrb_ZSOAzoEfG7jeS9O_rYYvz5AZrXu5XjKoSqGyWKefp3Tjt2zceeFuX2KPG5SmPk95hA_MQEHIsu7pd8B-w_ty5Y6KeAnze4EuMADl/w72-h72-p-k-no-nu/Untitled-1.jpg" style="border: none; padding-right: 0.4em; position: relative;" /></span></a></div><div class="item-title" style="padding-bottom: 0.2em;"><a href="https://breastcancerblognews.blogspot.com/2023/10/earlier-detection-reaching-generation.html" style="color: #0043ee; text-decoration-line: none;"><span style="font-family: arial;">"EARLIER DETECTION"- REACHING A GENERATION IN CRISIS</span></a></div><div class="item-snippet"><span style="font-family: arial;">WHAT ABOUT IF YOU'RE TOO YOUNG FOR A MAMMOGRAM? I went to my doctor for a lump I felt in my breast and she gave me a response that se...</span></div></div><div style="clear: both;"></div></li><li style="margin: 0px; padding: 0.7em 0px;"><div class="item-content"><div class="item-thumbnail" style="float: left; margin: 0px 5px 5px 0px;"><a href="https://breastcancerblognews.blogspot.com/2023/09/national-advocacy-honors-breast-cancer.html" style="color: #0043ee; text-decoration-line: none;" target="_blank"><span style="font-family: arial;"><img alt="" border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjuPeC05sfanRgWsluwNwQJvBjeBMsehtCHt2P8RMk-Hydn-_aXfHSjct9Ppi1eqJYy-SHLHd6QGTSrbig3zVTXeIGT3Uz2AHS0YMwX_LA4CTrubqEYVB4tYM3kbh8dord8kIl47TUyo5CQVO01EoFtnYmwsjmEHBvB6Kow7bGssfvJgw2KbfMU5Mkx6x4/w72-h72-p-k-no-nu/use1.jpg" style="border: none; padding-right: 0.4em; position: relative;" /></span></a></div><div class="item-title" style="padding-bottom: 0.2em;"><a href="https://breastcancerblognews.blogspot.com/2023/09/national-advocacy-honors-breast-cancer.html" style="color: #0043ee; text-decoration-line: none;"><span style="font-family: arial;">NATIONAL ADVOCACY HONORS BREAST CANCER IMAGING LEGEND</span></a></div><div class="item-snippet"><span style="font-family: arial;"> FOR IMMEDIATE RELEASE NATIONAL CANCER ADVOCACY GROUP RECOGNIZES BARD DIAGNOSTIC RESEARCH FOR ADVANCEMENTS IN DENSE BREAST IMAG</span></div></div></li></ul><p><span style="font-family: arial;"><br /></span></p><p><span style="font-family: arial;">Copyright © 2023- Robert L. Bard, MD & cancerscan.com. All rights reserved.</span></p><div><br /></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-4937789358054584122023-12-08T22:13:00.000-08:002024-02-01T06:51:19.860-08:00"EARLIER DETECTION"- REACHING A GENERATION IN CRISIS<p> <iframe allow="autoplay; fullscreen; picture-in-picture" frameborder="0" height="338" src="https://player.vimeo.com/video/881946464?h=3f51a4cb16&badge=0&autopause=0&quality_selector=1&player_id=0&app_id=58479" style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;" title="Allie (23) About Earlier Detection & Dense Breast/Cancer link" width="600"></iframe></p><div class="post-body entry-content" id="post-body-6095335838735548379" itemprop="description articleBody" style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; line-height: 1.4; position: relative; width: 660px;"><div style="text-align: justify;"><div style="font-size: 13.2px;"><div class="separator" style="clear: both; text-align: left;"><span style="text-align: justify;">By: Alexandra Fiederlein (23) | Edited by: </span><a href="https://robertaklinemd.com/" style="color: #0043ee; text-align: justify; text-decoration-line: none;">Dr. Roberta Kline</a><span style="text-align: justify;"> and the </span><a href="http://fightrecurrence.com/" style="color: #0043ee; text-align: justify; text-decoration-line: none;">ICRS Editorial Team</a></div><div class="separator" style="clear: both; text-align: center;"><p style="text-align: justify;"></p><div style="text-align: justify;"><div><div class="separator" style="clear: both; text-align: center;"><br /></div><div>I belong to the graduate-level age group that continues to witness the increasing numbers of breast cancer cases in our country. The women in this generation also happens to be the next group that falls prey to being UNDERDIAGNOSED. Insurance companies and the medical community have made little or no action to support or identify the need for women in their 20's and 30's to be approved for standardized early detection / breast cancer screening. </div></div><div><br /></div><div><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiei8P7QAh-W3Fnmb8H6EjdwslNaacXSuLJ6vUWjj-KSPSQQ6_d5jR1urr-mRlSToQh_R03jubSG-OqFTWXTNQgzSpWES7JiTt0xv2fBZBTISlehBS9ZdDC5i1wH7x-WkG7Pe7OumCyCblTt_27orhCKa9y0KAQVeZjpc6sAIzt6BemLFKt-m0jHOmKgu4D/s3096/34.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="3096" data-original-width="1956" height="157" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiei8P7QAh-W3Fnmb8H6EjdwslNaacXSuLJ6vUWjj-KSPSQQ6_d5jR1urr-mRlSToQh_R03jubSG-OqFTWXTNQgzSpWES7JiTt0xv2fBZBTISlehBS9ZdDC5i1wH7x-WkG7Pe7OumCyCblTt_27orhCKa9y0KAQVeZjpc6sAIzt6BemLFKt-m0jHOmKgu4D/w104-h157/34.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="104" /></a>From the front-row perspective, younger women are as much at risk of getting cancer. Reports show an uptick in genetic predisposition for breast cancer*, alongside a dangerous attitude of denial. Addressing this calls for widespread education and screening programs in our community as essentials to a life of wellness and prevention. To subscribe to a regular screening routine at the early stage of womanhood raises awareness and prevention for decades to come. Perhaps someday, installing breast cancer screening centers in college campuses may be commonplace and a powerful step toward a national prevention initiative.</div></div></div></div><div class="separator" style="clear: both; text-align: center;"><div style="font-size: 13.2px; text-align: justify;"><br /></div><div style="text-align: justify;"><table border="2" cellpadding="10" cellspacing="0" style="color: #444444; font-size: 13px;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both; text-align: center;"><b style="font-size: medium;">CURRENT DATA FROM PUBLIC SURVEY<br /></b><span style="font-size: x-small;">Assembled by Dr. Roberta Kline, OBGYN & Co-Editor of <a href="https://painhealersgroup.org/network.html" style="color: #0043ee; text-decoration-line: none;">Women's Health Digest</a></span></div><div class="separator" style="clear: both; text-align: center;"><br /></div><table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="background: rgb(255, 255, 255); border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; color: #222222; margin-bottom: 0.5em; margin-left: auto; margin-right: auto; padding: 5px; position: relative;"><tbody><tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhCCL_e_5bj9irV4o8JgADGWyfVsKvy6_6nb1ZgX5spT_AinLZPESA96mcrOKUFYpxqNMDqGLa-8qm8nXz4K1TleoDa9VjbFB3MyJ3Z6bJBVfxnrHNM-Sz3ktfnrvinBXQ8UjplMlmk9kMtqyYslCDAfG5TcqQ-Fs0co6WTvk9ZsK1qEzm7f_BipDPeocbC/s588/cdc.jpg" style="color: #0043ee; margin-left: auto; margin-right: auto; text-decoration-line: none;"><img border="0" data-original-height="203" data-original-width="588" height="216" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhCCL_e_5bj9irV4o8JgADGWyfVsKvy6_6nb1ZgX5spT_AinLZPESA96mcrOKUFYpxqNMDqGLa-8qm8nXz4K1TleoDa9VjbFB3MyJ3Z6bJBVfxnrHNM-Sz3ktfnrvinBXQ8UjplMlmk9kMtqyYslCDAfG5TcqQ-Fs0co6WTvk9ZsK1qEzm7f_BipDPeocbC/w628-h216/cdc.jpg" style="background: transparent; border: none; box-shadow: rgba(0, 0, 0, 0.1) 0px 0px 0px; padding: 0px; position: relative;" width="628" /></a></td></tr><tr><td class="tr-caption" style="font-size: 10.4px; text-align: center;"><a href="https://gis.cdc.gov/Cancer/USCS/#/Demographics/" style="color: #0043ee; font-family: arial; text-align: justify; text-decoration-line: none;"><span style="font-size: x-small;"><i>Source: CDC (link)</i></span></a></td></tr></tbody></table><br /><div class="separator" style="clear: both; text-align: center;"><br /></div><div><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; text-align: left;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: justify;"><span style="font-family: arial; font-size: small;">Enclosed is research-based public information by the CDC that widely supports the current reality about new cancers (including breast cancer) in women under 40. The data used by public health comes from a wide variety of places within our local communities: hospitals, laboratories, doctors' offices – anywhere that a person receives healthcare.</span></div><div class="separator" style="clear: both; text-align: justify;"><span style="font-family: arial; font-size: small;"><br /></span></div><div class="separator" style="clear: both; text-align: justify;"><span style="font-family: arial; font-size: small;"><div class="separator" style="clear: both;"><b>Age-specific rates breast cancer for 2020 (Total for ages 20-39)</b>: </div><div class="separator" style="clear: both;">•<span style="white-space: pre;"> </span>Rate of new breast cancers = 27/100,000</div><div class="separator" style="clear: both;">•<span style="white-space: pre;"> </span>Equals 11,368 new cases/42,765,288 women</div><div class="separator" style="clear: both;"><br /></div><div class="separator" style="clear: both;"><b>Details:</b></div><div class="separator" style="clear: both;"><20: numbers less than 16 cases for lower age categories, data suppressed</div><div class="separator" style="clear: both;">20-24: 1.7/100K; equals 174 new cases/10,239,813 women</div><div class="separator" style="clear: both;">25-29: 10.4/100K; equals 1,146 new cases/11,016,549 women</div><div class="separator" style="clear: both;">30-34: 30.5/100K; equals 3332 new cases/10,939,868 women</div><div class="separator" style="clear: both;">35-39: 63.5/100K; equals 6716 cases/10,569,058 women</div><div><br /></div></span></div><div class="separator" style="clear: both; text-align: justify;"><br /></div></div></div></div></div></div></td></tr></tbody></table><div style="color: #444444;"><div class="separator" style="clear: both; color: black; text-align: center;"><br /></div></div><p></p><div style="text-align: left;">(Continued)</div><div style="font-size: 13.2px;"><div><br /></div><div><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; color: #222222; float: right; margin-bottom: 0.5em; margin-left: 1em; padding: 5px; position: relative; text-align: justify;"><tbody><tr><td style="text-align: center;"><a href="https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2022-2024-breast-cancer-fact-figures-acs.pdf" style="clear: left; color: #0043ee; margin-bottom: 1em; margin-left: auto; margin-right: auto; text-decoration-line: none;"><img border="0" data-original-height="324" data-original-width="588" height="119" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj-XZK1ykl3Bsiw3JOAG819-2dt7uf7fsN0aTsjknXJpr6mOQI_fiUa9RavV5JfhHQjBGzs-_WJyY7WYRDD_I41aeaEVwRpe__mvPvh6oaPPN34jR7L5mVXSb0m2lSv-g6qYpax0HlPjcRacOa1WjfD7gxD3PJLzt2AGaToxEFdOzkkzQWIPqwwUTlvFSJg/w217-h119/2022-cover-wide-breast-cancer-facts-and-figures-588.jpg" style="background: transparent; border: none; box-shadow: rgba(0, 0, 0, 0.1) 0px 0px 0px; padding: 0px; position: relative;" width="217" /></a></td></tr><tr><td class="tr-caption" style="font-size: 10.56px; text-align: center;"><span style="font-size: x-small;"><i><a href="https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2022-2024-breast-cancer-fact-figures-acs.pdf" style="color: #0043ee; text-decoration-line: none;">Click to download</a> the latest ACS report</i></span></td></tr></tbody></table><div>Targeting the <b>young working PROFESSIONAL</b> is a major part of our population, where the vast majority tends to put off checkups and screenings because they are just "too busy". Professional women need to value their health above anything else, and therefore the narrative needs to be amplified in that area. We find this problem to be quite prevalent in urban areas with the constant on-the-go culture. Offering local resources and improved access for personal scanning are just some progress driven programs. </div></div><div><br /></div><div><div class="separator" style="clear: both; text-align: center;"><br /></div><div><b>GEN Z</b><b> </b>is a sensible focus group because these are the women who absolutely must receive routine scanning. We need to advocate for the narrative that age 40 is not the starting age where screening needs to begin- especially since we are now seeing cancer cases in younger ages are growing in numbers. Getting OB/GYN professionals on board is especially important because this is where women are getting their prescriptions. </div></div><div><br /></div><div>We need to educate on the benefits of ultrasound. People need to know HOW it works, WHY it works, and why it holds certain benefits over a mammogram. People need to know that it is SAFE and EFFECTIVE, and this technology can save lives. I think it is especially important to emphasize the option of ultrasound for younger women. Many younger women have dense breasts and don't even know it, putting them at a greater risk (I wouldn't have known if it weren't for all of you!). Ultrasound is obviously a safe and effective screening method for young women. It is also not linked with the stigma/fear of getting a mammogram like many women my age hold (X-Ray exposure, etc.). </div><div><br /></div><div><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiFrhBSFCb9_8DNfMJQaTsdNZmeKVdQt0cnE29bmcs5VAKjJlFSiaDiK2tSveLb5tZoKaxW-k4EPB9KoAcc_kTmqBRCUnFq4ZNWzyOwcH8sot8LDyP758qwKXDzMyRJi1PwhVOvOckmj9VkWzVCcm8hSIfucewSsLeVDMJP1xyJyf-BJi7lQZ3nX4skoyYV/s2432/22.jpg" style="clear: right; color: #0043ee; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="1080" data-original-width="2432" height="113" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiFrhBSFCb9_8DNfMJQaTsdNZmeKVdQt0cnE29bmcs5VAKjJlFSiaDiK2tSveLb5tZoKaxW-k4EPB9KoAcc_kTmqBRCUnFq4ZNWzyOwcH8sot8LDyP758qwKXDzMyRJi1PwhVOvOckmj9VkWzVCcm8hSIfucewSsLeVDMJP1xyJyf-BJi7lQZ3nX4skoyYV/w246-h113/22.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="246" /></a>If the drive for EARLIER DETECTION means proactive awareness, may this lead to turning social concern into clinical action. This includes clinicians joining hands with advocacy groups who recognize the many potential areas for at-risk women in my generation whose lives and safety continue to go unrecognized. And once the count of cancer cases and deaths rise exponentially due to inaction, perhaps then will the medical community find urgency in upgrading the required breast cancer screening age to (finally) include generations like mine. So say we all! </div></div><div style="font-size: 13.2px;"><br /></div><div style="font-size: 13.2px; text-align: left;"><span style="font-size: x-small;">Ref</span>:</div><div style="font-size: 13.2px;"><div style="text-align: left;"><span style="font-size: x-small;">*Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures, PMC9038417. (NIH)- <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038417/" style="color: #0043ee; text-decoration-line: none;">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038417/</a></span></div><div><br /></div><div></div><div><table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; color: #222222; margin-bottom: 0.5em; margin-left: auto; margin-right: auto; padding: 5px; position: relative;"><tbody><tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEixDSIuL_oA2Ec7Pw-3DbI9c3Kdvv4O-FePd2zvP65qDIR4V-78vc_yyTbJC9EYPByHhdV08cuyvrZ91-aBlhV6hMXLsNTn4eqixsQ_qbh677baZZxYw9q8moCW8wUuBnHumGkgiVcDYuWwwoenlwafeVHFu4ElvYwww_Q6GP7444PufxfaI5uVvPXwxYLe/s790/BANNAGH.jpg" style="color: #0043ee; margin-left: auto; margin-right: auto; text-decoration-line: none;"><span style="font-size: x-small;"><img border="0" data-original-height="148" data-original-width="790" height="100" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEixDSIuL_oA2Ec7Pw-3DbI9c3Kdvv4O-FePd2zvP65qDIR4V-78vc_yyTbJC9EYPByHhdV08cuyvrZ91-aBlhV6hMXLsNTn4eqixsQ_qbh677baZZxYw9q8moCW8wUuBnHumGkgiVcDYuWwwoenlwafeVHFu4ElvYwww_Q6GP7444PufxfaI5uVvPXwxYLe/w532-h100/BANNAGH.jpg" style="background: transparent; border: none; box-shadow: rgba(0, 0, 0, 0.1) 0px 0px 0px; padding: 0px; position: relative;" width="532" /></span></a></td></tr><tr><td class="tr-caption" style="font-size: 10.56px; text-align: center;"><span style="font-size: x-small;"><a href="https://bardcancercenter.com/diagnosis/breast-cancer/" style="color: #0043ee; text-decoration-line: none;">This article is sponsored by the educational program of Bard Diagnostic Imaging</a></span></td></tr></tbody></table><br /><div class="separator" style="clear: both; text-align: center;"><br /></div><div class="separator" style="clear: both; text-align: center;"><div style="text-align: justify;"><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhu3-y3VZJgIoOrstHM9t7MGXw6LhtBW993AoBQQjRsEEW2wJojdbEhkG8a5P6O40HwjLWtNtkx3PrLAfoP8SZcWMmMjebEqw_jyQE4r6VlhCPmcP_3pGz0WKBeIjWQwjjImJLpoZCqhtyqqU3C7XFwQDxhYE2hhQAxiEGNPFtT95XfCoP6x9Rp4h5HqHzF/s2248/headshot2.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="2248" data-original-width="1665" height="126" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhu3-y3VZJgIoOrstHM9t7MGXw6LhtBW993AoBQQjRsEEW2wJojdbEhkG8a5P6O40HwjLWtNtkx3PrLAfoP8SZcWMmMjebEqw_jyQE4r6VlhCPmcP_3pGz0WKBeIjWQwjjImJLpoZCqhtyqqU3C7XFwQDxhYE2hhQAxiEGNPFtT95XfCoP6x9Rp4h5HqHzF/w93-h126/headshot2.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="93" /></a></div>WHAT ABOUT IF YOU'RE TOO YOUNG FOR A MAMMOGRAM? I went to my doctor for a lump I felt in my breast and she gave me a response that set off red flags: "don't worry about it". Being a researcher involved in breast density and breast cancer, I knew that I had to take action; I was fortunate enough to have my breast ultrasound training with Dr. Robert Bard (cancer imaging specialist, NYC) upcoming in the next week. Dr. Bard showed me how to use the ultrasound to help me find two benign tumors in my breasts, and it was there that he reported that I have dense breasts. Had I not taken action in getting screened at the young age of 22, I would have never known that I should be getting screened via ultrasound every 6 months (because having dense breasts puts me at a higher risk for breast cancer), nor would I have known that I had benign breast tumors. </div><div><br /></div><div>- ALEXANDRA FIEDERLEIN, 22</div><div>Cancer Researcher/ Graduate- Molloy Univ.</div></div></div><div style="text-align: left;"><hr style="text-align: justify;" /></div></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiYDQ7yQEHDwmw5O7kOsa10UqU-hxssp9eL_Cg1ns2jf0oGr5xlQu3sNfbzc7RTs30GW5qtVRKb8C2VQn_GmsfAd7gG1ihVgEHZ3BcFeOJWKbkq6dCrhRXdcRXYFIwhqUoFoelOnVwh5Pk97vVkzryz3DSHTaHayTQOjZUD2XxWa0kjrtYV4nz_0KLArQ15/s203/EXTRA1.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="54" data-original-width="203" height="34" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiYDQ7yQEHDwmw5O7kOsa10UqU-hxssp9eL_Cg1ns2jf0oGr5xlQu3sNfbzc7RTs30GW5qtVRKb8C2VQn_GmsfAd7gG1ihVgEHZ3BcFeOJWKbkq6dCrhRXdcRXYFIwhqUoFoelOnVwh5Pk97vVkzryz3DSHTaHayTQOjZUD2XxWa0kjrtYV4nz_0KLArQ15/w128-h34/EXTRA1.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="128" /></a></div><br /><div><br /></div></div></div><div style="font-size: 13.2px;"><br /></div><div class="separator" style="clear: both; font-size: 13.2px; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhbyRVe9biDfDKdsUV_Ebn91tOheyT9qz86kxmXq9zz46Ga9K4Gck3UU2o5R6VS6DzLH_IRQM31G42UKZm-pJlQMtZkKS8SesiDXDBbQ3VaVIkeEBZbEhblb3QI6gw47B8sTc7mbdupVWhcxNS5EoMsyPikFndB8n0GBTVFNabH5of6bsbXfsG14hDbWOXQ/s480/bigger.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify; text-decoration-line: none;"><img border="0" data-original-height="320" data-original-width="480" height="125" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhbyRVe9biDfDKdsUV_Ebn91tOheyT9qz86kxmXq9zz46Ga9K4Gck3UU2o5R6VS6DzLH_IRQM31G42UKZm-pJlQMtZkKS8SesiDXDBbQ3VaVIkeEBZbEhblb3QI6gw47B8sTc7mbdupVWhcxNS5EoMsyPikFndB8n0GBTVFNabH5of6bsbXfsG14hDbWOXQ/w188-h125/bigger.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="188" /></a></div><div style="font-size: 13.2px;"><span style="font-family: times;">A major concern is the presence of breast cancer in underserved communities, including those TOO YOUNG FOR A MAMMOGRAM. Whereby the medical community touts the recommended (and legal/billable status) of getting a mammo scan should be between 40-50, what happens to the many women who do not fit this age criteria? How would they even know to get checked without the support of their clinicians or an alarm from family history? </span><span style="font-family: times;">Decades into the battle against breast cancer, clinicians and the public are much more educated about EARLY DETECTION, PREVENTION and the current protocols and modalities available to save lives. Recent headlines on DENSE BREAST and the advancements in ULTRASOUND SCANNING supports a major part of this battle. <a href="https://breastcancerblognews.blogspot.com/2023/10/early-detection-alert-risk-of-being-too_20.html" style="color: #0043ee; text-decoration-line: none;">SEE COMPLETE FEATURE</a></span></div><div style="font-size: 13.2px;"><br /></div><div style="font-size: 13.2px;"><br /></div><div style="font-size: 13.2px;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjoMpHEwDFYVP7fnA_k09h9x_zgwAP9xtwSrEk6CctfY8B_zNyd8vj_3tXZQlsSPF50KRtrSFmBx7NIp7bozNKbkqtCQJM3sRAxe4EgzFmjsFI4Z2X0O6PES9Aej55iK8ybDYb-Je0o8VLDT-R_DESZk3ufRq07VdhqFNMCUGyYpPg5Obu3e-WJZ8GSI9z7/s1713/image001.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="1218" data-original-width="1713" height="134" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjoMpHEwDFYVP7fnA_k09h9x_zgwAP9xtwSrEk6CctfY8B_zNyd8vj_3tXZQlsSPF50KRtrSFmBx7NIp7bozNKbkqtCQJM3sRAxe4EgzFmjsFI4Z2X0O6PES9Aej55iK8ybDYb-Je0o8VLDT-R_DESZk3ufRq07VdhqFNMCUGyYpPg5Obu3e-WJZ8GSI9z7/w188-h134/image001.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="188" /></a></div><a href="https://www.facebook.com/HispanicCoalitionofGreaterWaterbury" style="color: #0043ee; text-decoration-line: none;" target="_blank">WATERBURY, Conn. (October 12, 2023) JOE CAPPELLO/ARE YOU DENSE? FOUNDATION RECEIVES KEY TO THE CITY FROM MAYOR O'LEARY</a><br />Waterbury celebrated a citywide Pink Out on Thursday, October 26th! Saint Mary’s Hospital Foundation has once again partnered with the City of Waterbury to recognize Breast Cancer Awareness. Waterbury Mayor Neil O’Leary, Saint Mary’s Hospital President, Kim Kalajainen and special guest Joe Cappello will address organizers and volunteers from the Waterbury Police and Fire Departments as well as the Education Department, area students and others at 11:00 a.m. at Waterbury City Hall. </div><div style="font-size: 13.2px;"><br /></div><div style="font-size: 13.2px;"><br /></div><div style="font-size: 13.2px;"><table border="2" cellpadding="10" cellspacing="0" style="color: #444444; font-size: 13px;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both; text-align: center;"><b><span style="font-size: medium;">Video News Release: Innovations in Early Detection</span></b></div><div><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; text-align: left;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; font-family: times; font-size: small; text-align: center;"><br /></div></div><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: justify;"><div class="separator" style="clear: both; font-family: times; font-size: small; text-align: center;"><a href="https://youtu.be/L0pamDrNkcU" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="375" data-original-width="675" height="178" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjdEsrTrerDihfzSpphpy0m2C0Ul3pmQrrdQafS8K38mtCoL-qB2c6RP9I8Djy-q_uHKhwhRKbAIajiPz_9WqoW_wdkHZBWydN1QE6gzVYIEWWvMfoheQdrxw9stMaHDs9pcqoZ-yfqLTSMtDR7yG2F6gyaPHC6MUV4NULnjeXMuOy425oqVmw11hjceQ/s320/Screenshot%2001-19-2023%2009.11.06.png" style="background: rgb(255, 255, 255); border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="320" /></a></div><span style="font-family: arial; font-size: small;">"Are You Dense?" Foundation Co-founder Joe Cappello joins the medical diagnostic community to promote the "Get Checked Now!" campaign. Dr. Robert Bard from the Bard Cancer Center (NYC) supports supplemental imaging including the 3D Doppler Ultrasound scanner to offer dense breast detection. This video presents some of the latest advancements in ultrasound features to detect tumors through dense breast tissue- reportedly a significant challenge with mammograms. </span></div></div></div></div></div></div></td></tr></tbody></table><div style="color: #444444;"><div class="separator" style="clear: both; color: black; font-size: medium; text-align: center;"><br /></div></div></div><div style="font-size: 13.2px;"><div><hr /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgla5AUyEXvw-avcGwyolFNIllC9MgMEj4TJcKnhNsIm1-Vhc9mmBqiDCqn8G7NXN-DqbJzZAMnIZOL7BFsU_S8XdVTmNfDXxEuIfyIBMwAKO-61omxrZqb4AFrN4P6X6gsdk4AD_wE6BeR1GeXCjBYg0cOsIQEwXTEL5Uby1Lie0TfTt3fWpRpZ_2HT41b/s141/NEWS1.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="37" data-original-width="141" height="34" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgla5AUyEXvw-avcGwyolFNIllC9MgMEj4TJcKnhNsIm1-Vhc9mmBqiDCqn8G7NXN-DqbJzZAMnIZOL7BFsU_S8XdVTmNfDXxEuIfyIBMwAKO-61omxrZqb4AFrN4P6X6gsdk4AD_wE6BeR1GeXCjBYg0cOsIQEwXTEL5Uby1Lie0TfTt3fWpRpZ_2HT41b/w128-h34/NEWS1.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="128" /></a></div><br /><p><br /></p><p><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjSn_FI7-75v8RvFr7A6s7WsfMGuYGxgCJTUjk_T0p3RcD6krZAWg3r4-hZfmazWds9FaIFhqMzuSAFiPPWJDEIWtRNDG5s7bEdANC_r3XmcJQGFRpNhrB6hjLc0YRLwi5RF4rp_lEyr1Db6q3x0DngGUB2rodsaO5pIkLHICcrlcipSkm-R1v6FPX2BrmC/s2700/art1.jpg" style="clear: left; color: #0043ee; display: inline; margin-bottom: 1em; margin-right: 1em; text-align: center; text-decoration-line: none;"><img border="0" data-original-height="755" data-original-width="2700" height="183" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjSn_FI7-75v8RvFr7A6s7WsfMGuYGxgCJTUjk_T0p3RcD6krZAWg3r4-hZfmazWds9FaIFhqMzuSAFiPPWJDEIWtRNDG5s7bEdANC_r3XmcJQGFRpNhrB6hjLc0YRLwi5RF4rp_lEyr1Db6q3x0DngGUB2rodsaO5pIkLHICcrlcipSkm-R1v6FPX2BrmC/w659-h183/art1.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="659" /></a></p><span style="font-size: large;">GO "EARLIER" WITH EARLY DETECTION (FOR WOMEN AGES 20-40)</span></div><div style="font-size: 13.2px;">According to the American Cancer Society (ACS), women ages 45 to 54 and post-menopausal years are required to get mammograms every year.[1a] But for the underserved ages (20-40), the risk for breast cancer exists in growing numbers. In support of Breast Cancer Awareness month, <a href="http://fightrecurrence.com/" style="color: #0043ee; text-decoration-line: none;">the Integrative Cancer Resource Society</a>, the <a href="https://angiofoundation.org/" style="color: #0043ee; text-decoration-line: none;">AngioFoundation Institute</a> (501c3) and the <a href="https://www.areyoudense.org/" style="color: #0043ee; text-decoration-line: none;">"Are You Dense?" Foundation </a> addresses the continuing concerns for breast cancer in the New York area by recommending early detection screening programs for women over 20 (and not just anyone 40+ as standardized by the insurance companies.</div><div style="font-size: 13.2px;"><div><br /></div><div>The medical community has identified over 5% of all breast cancer cases occur in women over 20 and under the age of 40. The increased risk for breast cancer in dense tissue also exists and is identified by the medical community. Diagnostic Imaging specialist <a href="https://drrobertbard.com/" style="color: #0043ee; text-decoration-line: none;">Dr. Robert Bard</a> of NYC identifies the need for paying more attention to breast cancer screening to ages younger than the mandated 40+. "It's about time the (medical) community recognizes the growing rate of breast cancer in women of younger ages... from genetic predisposition to geography to having dense breast tissue, earlier detection should be our next national initiative."</div><p></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjq3C2mrXRrt-m_0PRiHy0P7spuhA2iwOhc_GgBGPoPlIfqa901VESrgrCCTqr_n-P2f4O8qRPOhiwi47u9RZEwsjaE1opRJF1Ij74loM3YQinepsEfcE45W4G-wwK3e09XCsMwuvcpMMTDzfCCiBz3_HGunWpJKU9kbQLNMBxIVMmWqvBvdbYbqeMzSqCk/s5120/shutterstock_1130966411.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify; text-decoration-line: none;"><img border="0" data-original-height="2880" data-original-width="5120" height="137" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjq3C2mrXRrt-m_0PRiHy0P7spuhA2iwOhc_GgBGPoPlIfqa901VESrgrCCTqr_n-P2f4O8qRPOhiwi47u9RZEwsjaE1opRJF1Ij74loM3YQinepsEfcE45W4G-wwK3e09XCsMwuvcpMMTDzfCCiBz3_HGunWpJKU9kbQLNMBxIVMmWqvBvdbYbqeMzSqCk/w243-h137/shutterstock_1130966411.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="243" /></a></div><div>•<span style="white-space: pre;"> </span>Breast cancer in younger women may be more aggressive and less likely to respond to treatment.</div><p></p><p>•<span style="white-space: pre;"> </span>Women who are diagnosed with breast cancer at a younger age are more likely to have genetic mutations predisposing them to breast and other cancers.</p><p>•<span style="white-space: pre;"> </span>Younger women who have breast cancer may ignore the warning signs—such as a breast lump or unusual discharge—because they believe they are too young to get breast cancer. This can lead to a delay in diagnosis and poorer outcomes.</p><p>•<span style="white-space: pre;"> </span>Some healthcare providers may also dismiss breast lumps or other symptoms in young women or adopt a "wait and see" approach.</p><p>•<span style="white-space: pre;"> </span>Breast cancer poses additional challenges for younger women as it can involve issues concerning sexuality, fertility, and pregnancy after breast cancer treatment. [1]</p><p><br /></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjH6p7P3-rlv16Tzb8wsW0Bf-Rfj_38_Ocp0bf6pNYDEzW__MRnSiSQtHscZL6gEnxIifUNlEWjmvxmvOJZQeXV3v4l-_ko5CvwqnSjNyHbNQZiCEAaUtP28XoQppdWfw4TJu4sBPSvVqYg8TsIjqcSFuv1EfuHGy6WKhprTPHLtZU030IR_RgOeW1wHLg9/s800/dreamstime_s_217376994.jpg" style="clear: right; color: #0043ee; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify; text-decoration-line: none;"><img border="0" data-original-height="533" data-original-width="800" height="124" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjH6p7P3-rlv16Tzb8wsW0Bf-Rfj_38_Ocp0bf6pNYDEzW__MRnSiSQtHscZL6gEnxIifUNlEWjmvxmvOJZQeXV3v4l-_ko5CvwqnSjNyHbNQZiCEAaUtP28XoQppdWfw4TJu4sBPSvVqYg8TsIjqcSFuv1EfuHGy6WKhprTPHLtZU030IR_RgOeW1wHLg9/w186-h124/dreamstime_s_217376994.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="186" /></a></div><div>2)<span style="white-space: pre;"> </span>INCLUDE SUPPLEMENTAL SCREENING FOR DENSE BREAST TISSUE (WITH HIGH RESOLUTION ULTRASOUND): Women diagnosed with dense breasts should continue to get regular screening mammograms. But there are additional screening tests that can help doctors detect tumors that may not be identified by conventional mammography or DBT. [2] Any woman who has dense breasts may want to consider supplemental screening, usually with breast ultrasound. Studies show that screening with ultrasound, in addition to mammography, improves detection of breast cancers in women with dense breasts. [3]</div><p></p><p>3)<span style="white-space: pre;"> </span>WHOLE BODY MRI (NO CONTRAST) FOR CANCER SCANNING: In simplistic terms, having a full-body access comports to the fact that everything is connected in one way or another. Our full-body MRI provides early diagnosis and the largest view of the body, where finding any cancers in the body and/or where they may spread can provide the best chance of treatment success. In suspected cases of early breast malignancy, the exclusion of metastatic disease is clinically vital and emotionally supportive.</p><p style="text-align: left;"><span style="font-size: x-small;"><i>1a) "Infographic: 7 Things to Know About Getting a Mammogram"- ACA/American Cancer Society: <a href="https://www.cancer.org/cancer/types/breast-cancer/mammogram-tips-infographic.html#:~:text=Women%20between%2040%20and%2044,choose%20to%20continue%20yearly%20mammograms." style="color: #0043ee; text-decoration-line: none;">https://www.cancer.org/cancer/types/breast-cancer/mammogram-tips-infographic.html#:~:text=Women%20between%2040%20and%2044,choose%20to%20continue%20yearly%20mammograms.</a></i></span></p><p style="text-align: left;"><i><span style="font-size: x-small;">1)<span style="white-space: pre;"> "</span></span></i><span style="font-size: x-small;"><span style="white-space: pre;"><i>Breast Cancer in Young Women"- Cleveland Clinic: </i></span></span><i><span style="font-size: x-small;"><a href="https://my.clevelandclinic.org/health/articles/16805-breast-cancer-in-young-women" style="color: #0043ee; text-decoration-line: none;">https://my.clevelandclinic.org/health/articles/16805-breast-cancer-in-young-women</a></span></i></p><p style="text-align: left;"><i><span style="font-size: x-small;">2) "</span></i><span style="font-size: x-small;"><i>What additional breast cancer screening tests are available for women who have dense breasts?"- Yale medicine- </i></span><i><span style="font-size: x-small;"><a href="https://www.yalemedicine.org/conditions/dense-breasts#:~:text=Women%20diagnosed%20with%20dense%20breasts,(whole%2Dbreast%20ultrasound)" style="color: #0043ee; text-decoration-line: none;">https://www.yalemedicine.org/conditions/dense-breasts#:~:text=Women%20diagnosed%20with%20dense%20breasts,(whole%2Dbreast%20ultrasound)</a>.</span></i></p><p style="text-align: left;"><i><span style="font-size: x-small;">3) Columbia Doctors/ "</span></i><span style="font-size: x-small;"><i>What Are Dense Breasts? </i></span><i style="font-size: small;">A radiologist offers guidance":-</i><span style="font-size: x-small;"><i>Health Insights: October 14, 2022</i></span><i><span style="font-size: x-small;"><span style="white-space: pre;"> </span><a href="https://www.columbiadoctors.org/news/what-are-dense-breasts#:~:text=Any%20woman%20who%20has%20dense,in%20women%20with%20dense%20breasts" style="color: #0043ee; text-decoration-line: none;">https://www.columbiadoctors.org/news/what-are-dense-breasts#:~:text=Any%20woman%20who%20has%20dense,in%20women%20with%20dense%20breasts</a>.</span></i></p><p style="text-align: left;"><i><span style="font-size: x-small;"><br /></span></i></p><div><hr /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg0Vevjps5FavoOlBO5I4HUKCVlLOCFHVntCRwqqWiw3anyPGzcmaLI_w-Hqnme09UsZTFzUCZ2NLz_sy7J9upxRBEFoF05U6glKxdoY3TEnNqhHc5OT_BGWmez2g8qcszxj9g3sZyKLcNQnzWnAASG2_xiE14orzEuGGsd8UUl8KVbDLxoM1t8Zi-oIGHU/s362/editorial.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify; text-decoration-line: none;"><img border="0" data-original-height="80" data-original-width="362" height="34" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg0Vevjps5FavoOlBO5I4HUKCVlLOCFHVntCRwqqWiw3anyPGzcmaLI_w-Hqnme09UsZTFzUCZ2NLz_sy7J9upxRBEFoF05U6glKxdoY3TEnNqhHc5OT_BGWmez2g8qcszxj9g3sZyKLcNQnzWnAASG2_xiE14orzEuGGsd8UUl8KVbDLxoM1t8Zi-oIGHU/w152-h34/editorial.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="152" /></a></div><div><br /></div><div><br /></div><div><br /></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjz1bTADyoWt839NqXl3FRIP-0J2H0C9UvqSgAKtiNsY7o-HsWhbDVT92kCNDmYlJuvEjdJf5VtDwqvM0WEKQ-D_4e7jiYgf7YRTqjtyUkSKKwad0ou5Qz-jo5YHhTSJt1e17YXewMffa-TnUeQhGWeXDXne9_5jem4P38B2RHpfxvUU4evjzJduFlPcowb/s108/NOELLE.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify; text-decoration-line: none;"><img border="0" data-original-height="108" data-original-width="99" height="90" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjz1bTADyoWt839NqXl3FRIP-0J2H0C9UvqSgAKtiNsY7o-HsWhbDVT92kCNDmYlJuvEjdJf5VtDwqvM0WEKQ-D_4e7jiYgf7YRTqjtyUkSKKwad0ou5Qz-jo5YHhTSJt1e17YXewMffa-TnUeQhGWeXDXne9_5jem4P38B2RHpfxvUU4evjzJduFlPcowb/w82-h90/NOELLE.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="82" /></a></div><i>"In order to catch cancer, you need to be able to detect it at an early stage so we can treat patients with the most effective mechanisms. Ultrasounds are an easy, cost-effective method for screening for early breast cancers, especially in women below the age of 45, who are likely to have dense breasts. When you are young and premenopausal your breasts are dense and we know that breast density is linked to cancer and which also makes it harder for cancers to be seen on a mammogram. Although breast cancer is rare in women under the age of 40, early detection is key. Public health campaigns are spending so much money on mammograms for this population of women who can easily and cost effectively be screened using an ultrasound."</i></div><div><br /></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgfQoHXfPmyEoqXRHAnSIwH2nFgrDN9a2OJJAcTkvtzf2AFZDMtpBoF61XTXzKbxGz7YPv1HzlrkJ6iL1DbZCAZrrMoSk9xJP8KikLTi8mw8Cn9eOiYfFazVScI342Y4S6C_bYS-WwP9-n64Hc-Zfdqsnnj41_ZkWhVe3L1sOHUbT4aTpl28zyDGH5MKGFv/s200/MARY.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify; text-decoration-line: none;"><img border="0" data-original-height="200" data-original-width="200" height="82" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgfQoHXfPmyEoqXRHAnSIwH2nFgrDN9a2OJJAcTkvtzf2AFZDMtpBoF61XTXzKbxGz7YPv1HzlrkJ6iL1DbZCAZrrMoSk9xJP8KikLTi8mw8Cn9eOiYfFazVScI342Y4S6C_bYS-WwP9-n64Hc-Zfdqsnnj41_ZkWhVe3L1sOHUbT4aTpl28zyDGH5MKGFv/w82-h82/MARY.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="82" /></a></div><i>"I LOVE this new program! Early detection is essential! There is a stigmatization around mammograms that they are painful and frightening. There is anxiety while you wait for the results. And, don't forget the appointment scheduling hassle. Women, particularly younger women with active lives, small children, careers don't want to have to fit one more thing into their hectic and demanding schedules. However, mammogram technology itself has advanced and it no longer has to be a painful experience. Clinics and imaging centers are offering untraditional scheduling opportunities, such as very early morning appointments to late evening appointments that are timed for very minimal wait times. And, clinicians are often prioritizing mammogram interpretations so the results are back within 24 hours. The Self Care message is trending right now. Mammograms should be a part of self care."</i></div></div></div></div></div></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-311660692143263452023-12-08T21:57:00.000-08:002023-12-08T21:57:46.740-08:00Epigenetic Research Notes: Profiling the Dense Breast Paradigm (part 1)<p> Coursework (Part 1) w<span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">ritten by: </span><a href="https://robertaklinemd.com/" style="background-color: white; color: #2288bb; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-decoration-line: none;">Dr. Roberta Kline</a><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">. </span></p><div class="post-body entry-content" id="post-body-5157246929809960258" itemprop="description articleBody" style="font-size: 13.2px; line-height: 1.4; position: relative; width: 660px;"><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"></p><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"></p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="background-color: white; color: #222222;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh9mXNAKFEd85vCObnWJ_JCE0i5e8qiH-8Kq-96togium3g4bI9Oe5vfTwIgg8iyRqQj0zp6ZNuoUdUAaiPOFhHoNBdxqR_JQ3_H8m8jq0TB2DslP_mKDfWePM4kwIwpID2cv9lj8Xa2ukWM7pqQ5Zr0xxiwy9BDomif56CKJ0Lki1Fk8JC1e58acJc6Ntf/s1222/book-kline.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="744" data-original-width="1222" height="265" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh9mXNAKFEd85vCObnWJ_JCE0i5e8qiH-8Kq-96togium3g4bI9Oe5vfTwIgg8iyRqQj0zp6ZNuoUdUAaiPOFhHoNBdxqR_JQ3_H8m8jq0TB2DslP_mKDfWePM4kwIwpID2cv9lj8Xa2ukWM7pqQ5Zr0xxiwy9BDomif56CKJ0Lki1Fk8JC1e58acJc6Ntf/w435-h265/book-kline.jpg" width="435" /></a></div><br />As an Ob-Gyn physician and genomics specialist, I have spent the better part of 10 years translating research in the genomic and gene expression areas into clinically usable information for healthcare professionals. One of the biggest challenges we face when connecting research with patient care is the long delay in the translation process and dissemination of the information. It often takes 10 to 20 years for information (validated findings) that comes out of research to be applied in clinical practice. These delays result in many lost opportunities to provide better care for our patients. This is one of the reasons why I'm really passionate about accelerating this process and making it easier for clinicians and their patients to take advantage of cutting-edge information and new technologies. </span></div><div class="post-body entry-content" id="post-body-5157246929809960258" itemprop="description articleBody" style="font-size: 13.2px; line-height: 1.4; position: relative; width: 660px;"><span style="color: #222222;"><br /></span></div><div class="post-body entry-content" id="post-body-5157246929809960258" itemprop="description articleBody" style="font-size: 13.2px; line-height: 1.4; position: relative; width: 660px;"><b style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">LINKING DENSE BREAST WITH BREAST CANCER</b><br style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;" /><span style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">We have known for a very long time that there is an increased risk of breast cancer for women who have dense breasts. Until recently, the research has been lagging in terms of what's the molecular mechanism, why do dense breasts present an increased risk of breast cancer? Without this knowledge, we can’t address the root causes, and are left with a lot of trial and error based on incomplete understanding. </span><span style="color: #222222;"><br /></span><div style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"><br /></div><div style="background-color: white;"><div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: center;"><iframe allow="autoplay; fullscreen; picture-in-picture" frameborder="0" height="338" src="https://player.vimeo.com/video/865202281?badge=0&autopause=0&player_id=0&app_id=58479" title="Dense Breast Review: R. Kline, MD" width="600"></iframe></div><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">It's very encouraging to know that currently there are 124 clinical trials ongoing looking at dense breasts and the relationship with breast cancer, anywhere from improved diagnostics, to treatment, to prevention, and, what’s close to my heart, to understanding the molecular mechanisms - what's happening at the cell level, at the genetic level that is causing different women to have an elevated risk of breast cancer. </p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">One of the striking features that we're learning about dense breasts and what is creating that density is the microenvironment, which means the environment in the supporting tissue surrounding the glands. This includes fibroblasts and collagen. It seems that rather than estrogen being the dominant factor, it is inflammation that is creating the increased density of breast tissue. </p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"><br /></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"><b></b></p><div class="separator" style="clear: both; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgXGi2K-8Cix2_cq0YV8JHgajcONpf_nfSaj8j7b-SAU8o-fdBkY2Pp24l_hBB3w9ZBFgUSDrVlUecKXQ6v4Jx2Jv4QzrvA0oYj4Ch5MrFeHJYPggt9CjWGxSfEqdLppVWXcxm4ZL-6jDo5_wwjCokH0n6nLZ-nh_kYB7YidBxoPNVBNCVznJsufm7p_OPh/s1280/11.jpg" style="clear: right; color: #2288bb; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="720" data-original-width="1280" height="126" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgXGi2K-8Cix2_cq0YV8JHgajcONpf_nfSaj8j7b-SAU8o-fdBkY2Pp24l_hBB3w9ZBFgUSDrVlUecKXQ6v4Jx2Jv4QzrvA0oYj4Ch5MrFeHJYPggt9CjWGxSfEqdLppVWXcxm4ZL-6jDo5_wwjCokH0n6nLZ-nh_kYB7YidBxoPNVBNCVznJsufm7p_OPh/w225-h126/11.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="225" /></a><b></b></div><b style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">ESTROGEN VS INFLAMMATION</b><br /><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;">What's fascinating to me is that even though we associate estrogen with the primary means by which women develop breast cancer, it may be a different process for breast cancers linked to breast density. Some of the research that has just come out in the last few years is showing us that rather than being hormonally driven, we think what's happening is there is an increase in these inflammatory markers in the tissue that is denser, and this is what can also lead to cancer.</span><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">There is clearly a genetic, or hereditary component, because having dense breasts is noted to run in families. But while having dense breasts increases a woman’s risk of breast cancer by up to 4-6x, not all of these women actually get cancer. That means there are other factors that can potentially increase as well as reduce a woman’s risk. This is where genomic research has been a gamechanger in identifying these other factors including for women with inherited genetic mutations, such as BRCA. </p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">We now know that there are multiple genes in multiple other pathways that can modify a woman’s risk of breast cancer even if she carries a BRCA mutation. [1]. Researchers have identified smaller changes in genes called SNPs (single nucleotide polymorphisms) that have a much lower individual impact than genetic mutations, but together can be additive.[2] In fact, women with specific patterns of SNPs had their risk of breast cancer significantly reduced. This can help explain why not all women with BRCA mutations get cancer, and provides insight into potential protective biological mechanisms.</p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">This is a really powerful paradigm shift, because now it opens the door for truly individualizing each woman’s risk – and potentially being able to change it through diet, lifestyle, or other modalities.</p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">We now are also learning that gene SNPs can also play a role in a woman’s risk for dense breasts and breast cancer. While there's much research that needs to be done, from my experience, there's a lot we can do already to potentially intervene and help women with dense breasts. As we wait for more definitive research, we can learn from the nutritional genomics and functional medicine realms. </p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"></p><div class="separator" style="clear: both; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhI3qB55gMGDcCcOr2YTcjmlW38HlrnjrXeLW2WrsbVoufN7zd71GhRKXpkFcUxgSf72DTNCxyk-HTYFt2o7IdFsTFsJFtRo693ECYMR4f_TDLdFTE5OPey9HFTydNL2ELeQ_56Jq2wAiFyTeM5YfbIFGgBT3FBH1uooox2v0jnR2IhXeLvE_h5wa_Pb1Fs/s800/dreamstime_s_176812483.jpg" style="clear: right; color: #2288bb; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="639" data-original-width="800" height="153" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhI3qB55gMGDcCcOr2YTcjmlW38HlrnjrXeLW2WrsbVoufN7zd71GhRKXpkFcUxgSf72DTNCxyk-HTYFt2o7IdFsTFsJFtRo693ECYMR4f_TDLdFTE5OPey9HFTydNL2ELeQ_56Jq2wAiFyTeM5YfbIFGgBT3FBH1uooox2v0jnR2IhXeLvE_h5wa_Pb1Fs/w191-h153/dreamstime_s_176812483.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="191" /></a></div><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;">We have long known that pro-inflammatory conditions are underlying drivers for so many of the chronic diseases we see today, from cancer to heart disease, diabetes, autoimmune disease, depression and more. The flip side of inflammation is oxidative stress. They go hand in hand. Some of the genes that drive these processes are now also being linked to dense breasts and potentially the increased breast cancer risk that women with dense breasts have. </span><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">My question is, why can't we use some of these dietary lifestyle and nutritional supplement interventions that we already know decrease many of these pro-inflammatory pathways? Why can't we start using those in clinical practice as we wait for research and clinical trials to better refine our knowledge? The fact is, we can! But it takes education, awareness and advocacy to implement these strategies more widely and make a difference now.</p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"><br /></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">Reference:</p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">1) link to polygenic model – breast cancer, Lynch syndrome etc <a href="https://healthresourcedigest.blogspot.com/2022/03/the-future-in-personalized-medicine.html" style="color: #2288bb; text-decoration-line: none;">https://healthresourcedigest.blogspot.com/2022/03/the-future-in-personalized-medicine.html</a></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;">2) Link to genetics/genomics <a href="https://modernhealing1.blogspot.com/2020/11/what-is-lynch-syndrome.html" style="color: #2288bb; text-decoration-line: none;">https://modernhealing1.blogspot.com/2020/11/what-is-lynch-syndrome.html</a></p><div class="separator" style="clear: both; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjl0WIYX3Z7Kzt_ox7ubDTIxgIhPMsBgRtXrA8ttKoJoPyzSBrmozGJFxiZL7bZV3ezKUQZphsLMtD9oLdvOVDKgahdkN-8CkIHV8VRp7Ytf7hbvedV_Ifs3sOnlxX76rjiOIjKVGM2Oxu3DRZT11JGe_yTh6X_uwihz1R5AAcNmkDJ1f_MaqSgen2wRhMx/s6840/V.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify; text-decoration-line: none;"><img border="0" data-original-height="3538" data-original-width="6840" height="68" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjl0WIYX3Z7Kzt_ox7ubDTIxgIhPMsBgRtXrA8ttKoJoPyzSBrmozGJFxiZL7bZV3ezKUQZphsLMtD9oLdvOVDKgahdkN-8CkIHV8VRp7Ytf7hbvedV_Ifs3sOnlxX76rjiOIjKVGM2Oxu3DRZT11JGe_yTh6X_uwihz1R5AAcNmkDJ1f_MaqSgen2wRhMx/w131-h68/V.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="131" /></a></div><div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;"><br /></div><div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;"><br /></div><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;"><br /></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"></p><div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;"><span style="font-family: arial; font-size: large;"><br /></span></div><div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"><span style="font-family: arial; font-size: large;">2024 CLINICAL PROFILE OF THE DENSE BREAST PARADIGM - </span><span style="font-family: arial; font-size: large; text-align: justify;">for the Obstetrics & Gynecology Society </span></div><div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;">Written by: <a href="https://robertaklinemd.com/" style="color: #0043ee; text-decoration-line: none;">Roberta Kline, MD</a></div><div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;">Published by ICRS Medical Press Ltd.</div><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"></p><div class="separator" style="clear: both; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh6yc61oHPGJNeKfER9BRMecasuvYIcXTeUtpzrj9yvjHAOEAnvGUdOpX7oInUxejVrfmCMoG6aiGMFlq7D7kH_NtTytSfbSp1rNy9PK2zBnFf2uRxW0CkYeXzK8KY5H7FIjPHk-x9lDykn6SMEy5z-9rHnGdZM4SZ_LC0E9vf-L9WY3ye8dXB59gkn57SH/s547/3D-book-on-white.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify; text-decoration-line: none;"><img border="0" data-original-height="547" data-original-width="346" height="190" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh6yc61oHPGJNeKfER9BRMecasuvYIcXTeUtpzrj9yvjHAOEAnvGUdOpX7oInUxejVrfmCMoG6aiGMFlq7D7kH_NtTytSfbSp1rNy9PK2zBnFf2uRxW0CkYeXzK8KY5H7FIjPHk-x9lDykn6SMEy5z-9rHnGdZM4SZ_LC0E9vf-L9WY3ye8dXB59gkn57SH/w123-h190/3D-book-on-white.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="123" /></a></div><div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;">Breast cancer affects the lives of hundreds of thousands of women every year and is a leading cause of death. While we have made great progress in advancing earlier diagnosis and more individualized treatments, we still need to improve our approach to achieve our ultimate goal - prevention. This requires a deeper understanding of the molecular mechanisms and the multitude of factors that contribute to the development of breast cancer. </div><div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: justify;"><br /></div><div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"><div style="text-align: justify;">Dr. Roberta Kline, recognized speaker and publishing crusader for women's health brings you a comprehensive review and a deep-dive analysis of the current research findings about breast density and its major risk factors for breast cancer. Her reports uncover current imaging practices and clinical protocols updated in great support of breast density detection and the means of addressing this growing condition that affects over 45% of the female population. "Knowing a woman has greater breast density is a critical first step, but it doesn’t end there... we need to go further by understanding the causes of breast density, and how they relate to breast cancer-- we now have another avenue to proactively intervene to reduce risk or even prevent breast cancer in the first place." This textbook is a champion in targeting the <b>Dense Breast Paradigm</b> as a blueprint and a clear course study for all clinical professionals who are dedicated to women's early detection and prevention programs. <a href="https://cancerresourcealliance.blogspot.com/2023/09/epigenetic-research-notes-profiling.html" style="color: #0043ee; text-decoration-line: none;">(More information)</a></div></div></div></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-6535344838749296612023-12-08T21:37:00.000-08:002023-12-12T04:11:51.009-08:009/27 Is World Dense Breast Tissue Day<p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"></p><div class="separator" style="clear: both; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; text-align: left;"><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="font-size: medium;"><b>FOR IMMEDIATE RELEASE</b></span></p><p style="font-size: 13.2px;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="font-size: medium;"></span></p><div class="separator" style="clear: both; font-size: 13.2px; text-align: center;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="font-size: medium;"></span></div><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="font-size: medium;"><div style="text-align: justify;"><b>PROCLAMATION: 9/27 Is World Dense Breast Tissue Day</b></div></span><p style="font-size: 13.2px;"></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiVKqLYMsFxG2yaKnZ60WHAqZBLJKI2r_byPhu5135qWQJ1CcNdWkSqsXJfTI4MNCW-DHMLxM-BNkTah5g2f2byLUDey4q-gQghGB-fIOHDY6OMJVTm8rEYOI-AlpAG8iiQ0wEzXfgDMiuKCXhKxc3XxKn0t2SJOoVe6rnt4SnrL4omeU7f8dtJbfgk2mku/s2091/SIMI-CAPP2.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="933" data-original-width="2091" height="177" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiVKqLYMsFxG2yaKnZ60WHAqZBLJKI2r_byPhu5135qWQJ1CcNdWkSqsXJfTI4MNCW-DHMLxM-BNkTah5g2f2byLUDey4q-gQghGB-fIOHDY6OMJVTm8rEYOI-AlpAG8iiQ0wEzXfgDMiuKCXhKxc3XxKn0t2SJOoVe6rnt4SnrL4omeU7f8dtJbfgk2mku/w397-h177/SIMI-CAPP2.jpg" width="397" /></a></span></p><div style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif">9/19/2023- Mr. Joe Cappello, co-founder of the "Are You Dense?" Foundation was invited to attend the Santa Clara County Board of Supervisors meeting at County Government Center to receive an official proclamation by Santa Clara County Supervisor (and former California State Senator) JOE SIMITIAN, officially confirming September 27 as World Dense Breast Tissue Day. According to Mr. Simitian, this proclamation was sparked by earlier discussions about the late Nancy Cappello who passed away of breast-cancer related complications from dense breast tissue. "(Nancy's) own life experience... said others should have more power, more knowledge, more ability to affect the decision making in their own healthcare. For this, we are a better state, a better county, and in fact a better nation by virtue of her work."</span></div><p></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif">To date, Joe Cappello continues to build and promote educational programs supporting research, clinical upgrades and improved scanning/monitoring programs. The "Are You Dense?" Foundation and "Are You Dense?" Advocacy are produced by the Cappellos in pursuit of saving lives through awareness through uniting with community leaders, clinical professionals and public recognition off the continued risks of having dense breast tissue.</span></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif">TRANSCRIPT OF PROCLAMATION: 9/19/2023</span></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif">County of Santa Clara Board of Supervisors</span></p><p style="color: black; font-family: "Times New Roman"; text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif"> <iframe allow="autoplay; fullscreen; picture-in-picture" frameborder="0" height="338" src="https://player.vimeo.com/video/866459937?badge=0&autopause=0&player_id=0&app_id=58479" style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: center;" title="proc-work1" width="600"></iframe></span></p><p style="color: black; font-family: "Times New Roman";"></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif"><br /></span></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif"><b>SPEAKER: Santa Clara County (CA) Supervisor Joe Simitian- District 5</b></span></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif">Thank you, Madam President. And I'm going to look to the clerk to see if we can bring Mr. Joe Cappello from “Are You Dense?” in Connecticut up on the screen. </span></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif">Colleagues and members of the public, you'll recall of course that just last week, we adjourned our meeting in memory of Nancy Cappello, who passed away almost five years ago now. And it provided an opportunity for our board to reflect on Nancy's extraordinary work over literally decades. We also took the opportunity at our last meeting to express our formal support for the Find It Early Act which is an effort at the national level congressional level to take the next step in terms of addressing the cancer risk of women with dense breast tissue. Today, we are calling out the formal acknowledgement of World Dense Breast Tissue Day. And the reason for that, Joe, and colleagues and members of the public is to ensure that we take advantage of this opportunity to identify September 27th as World Dense Breast Tissue Day, so that members of the public will have the information, the knowledge, the power that Nancy Cappello thought they were entitled to all those years ago.</span></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif">And as we have discussed previously (so I won't speak at quite substantial length today) this is information that patients need to have. They are now entitled to have it by law. That entitlement is in large measure, a function of the fact that Nancy Cappello took her own life experience and said others should have more power, more knowledge, more ability to affect the decision making in their own healthcare. For this, we are a better state, a better county, and in fact a better nation by virtue of her work. Joe, if you were here, I would have you up to the podium and I would hand you the physical commendation. But by virtue of our virtual connection today, I will virtually present it to you and we will send you the physical commendation and I hope it will find a place at “Are You Dense?”. </span></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif">I'm guessing that your screen-... It doesn't reveal it, but I am wearing on my lapel the “Are You Dense?” button which I wore all those years ago when I was privileged to work with Nancy and the organization on California law. With that, Madam President, I say thank you to our board, and to my colleagues for their support on this measure and through the chair. With your permission, I'd like to give Mr. Cappello an opportunity to say a brief word or two.</span></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif"><br /></span></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif"><b>Guest Speaker: JOE CAPPELLO</b></span></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif">Well, thank you, Supervisor Simitian. As I said before, it's a real pleasure. I finally got to meet the other Joe in Nancy's life. And believe me, she always had kind words to say about you, and you were always a standup guy. You were the one that she could count on for honesty and truthfulness when we were doing our legislative work in California. What we have now is a disclosure law, which is a national law, which will take effect a year from now. This is huge step for the health of women all over this nation. What it's going to do is standardize (diagnostic care) in the medical field for women with dense breasts. I thank you in the name of Nancy for the proclamation. She deserves it all. She worked hard and worked smart. She was not only prettier than me, <laugh>, but smarter than me. And, I thank you on her behalf. I appreciate that. Thank you.</span></p><p style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif">The Board of Supervisors of the County of Santa Clara, CA regularly meets in the Board of Supervisors’ Chambers, County Government Center, 70 West Hedding Street, San Jose. Regular meetings are held on designated Tuesdays at 9:30 a.m. The Board also holds regular meetings for the purpose of adjourning into Closed Session on Mondays at 2:00 p.m., which may be combined with meetings scheduled for the presentation of ceremonial items to be heard at 4:00 p.m.</span></p><div style="text-align: justify;"><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif"><br /></span></div></div><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif;"><b></b></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: justify;"><br /></p>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-44595088223630539912023-12-08T21:26:00.000-08:002023-12-08T21:27:11.254-08:00 NATIONAL CANCER ADVOCATE RECOGNIZES LEGEND IN DENSE BREAST IMAGING <p><span style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"></span></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiMzmBSCJsmPfKZQzg7kOCQEUsQNl3Xm7VIkq0OkFPA5W2L0W9j9qsC3bAAKhtgtjUm7zQXgvvXovVQ18H8ttAPh3Lun9_ihv0HTD_zHDMfDGBIAxXsatBC9B-XouG0TnS-tTDBqY0y8cwxwUzCeLWiR9F9aY7r-QjIaeVD90ObGbLFJNjhFcZoWv3YuIKT/s1222/joecapp.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="744" data-original-width="1222" height="296" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiMzmBSCJsmPfKZQzg7kOCQEUsQNl3Xm7VIkq0OkFPA5W2L0W9j9qsC3bAAKhtgtjUm7zQXgvvXovVQ18H8ttAPh3Lun9_ihv0HTD_zHDMfDGBIAxXsatBC9B-XouG0TnS-tTDBqY0y8cwxwUzCeLWiR9F9aY7r-QjIaeVD90ObGbLFJNjhFcZoWv3YuIKT/w485-h296/joecapp.jpg" width="485" /></a></div><br />8/28/2023- Joseph Cappello- Co-Founder of the 'Are You Dense?" Foundation and ICRA Sr. National Advisor for the Coalition for Women's Cancer Resources presented the first 2023 Cancer Research & Innovations award to cancer imaging specialist Dr. Robert Bard (NYC). <p></p><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">With over 200 nominations for the award, Dr. Bard was recognized for his lifetime of achievements in support of non-invasive screening of dense breast tissue. Mr. Cappello delivered the award with fellow executives Donna Johnson (Pres. Of Are You Dense Foundation) and Marion Bradley (Pres. Of Are You Dense Advocacy Foundation from Woodbury CT to personally honor Dr. Bard at his midtown NYC practice for his life's work. Since 2019, Mr. Cappello's Are You Dense Advocacy Foundation succeeded in helping to pass National legislation to federally mandate breast screening centers to address the dense breast crisis with the ultrasound complement. Mr Cappello's commitment to enforce this legislation nationally, started with his wife, the late Dr. Nancy M. Cappello who passed away due to complications with her late stage breast cancer treatment. </p><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">Since 1979, Dr. Bard's radiology practice clinically promoted and published the critical need for using ultrasound breast imaging as a supplemental scan alongside regularly scheduled mammograms. (It is noted that ultrasound scans are able to detect growths and tumors behind dense tissue, what mammograms tend to miss). At the time, no regulatory standard enforced the need for this 2nd scan, attributing to many undetected breast cancer tumors concealed by dense breast tissue. With the rise of breast cancer cases throughout the country, Dr. Bard's theories about dense breast imaging has taken root with a growing population of OB-GYNs and Imaging specialists. </p><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"></p><div class="separator" style="background-color: white; clear: both; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: center;"><br /></div><span style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">On a related note, in January of 2023- ARE YOU DENSE ADVOCACY continued to pursue the public importance of patients receiving their own personal medical information about the condition of their breast health. This initiative directs the Food and Drug Administration to ensure that mammography reports and summaries received by patients and their providers include appropriate information about breast density specified by the law. This also includes at a minimum, the effect of breast density in masking the presence of breast cancer on a mammogram. The qualitative assessment of the provider who interpreted the mammogram, and a reminder to patients that individuals with dense breast tissue should talk with their providers if they have any questions or concerns about their summary. From a prior report (3/28/2019) the Department of Health and Human Services and the FDA announced changes to the MQSA (Mammography Quality Standards Act) to include reporting of dense breast tissue to the patient- by and large, thanks to the Are You Dense Advocacy Foundation.</span><div style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"><br /></div><div class="separator" style="background-color: white; clear: both; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: center;"><a href="https://www.prnewswire.com/news-releases/are-you-dense-foundation-launches-national-recognition-for-clinical-advancements-in-dense-breast-imaging-301928711.html" imageanchor="1" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="64" data-original-width="168" height="48" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiFzpTDUGd3jlNfSY2YgaHD0QdLHLtSayVX6wYeXnNriAuKrXJABe85fO26-cg5lx-N1te5213Y_r6QCJF4gjJAG8afM6vcwJ5V7pJ1ZKxLuozIwTev3Ir3TATsh3gPIzdujcBzclPSdRpmPn1JYfzkRQ_rIfJadNAORN2h2M6DjqNuF5YeVMgIgff9yUxV/w127-h48/prn_cision_logo_desktop.png" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="127" /></a></div><br style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;" /><div style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"><br /><p></p><p><br /></p><p>"Decades since the advent of breast scanning technology, a growing list of real-time innovations in non-invasive diagnostic imaging provide new options in the field of early detection", states Dr. Bard. "These technologies directly align with breast density screening that can easily and affordably complement a woman's regular mammography appointment. By hybridizing the imaging process, we can safely combine diagnostic modalities and improve the assessment of disease and guide therapeutic procedures."</p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiAQlfkt45WLk2tGOVo9oOKqzA8eR08vMcdKayTeo5N19xlJ8KlugTO-v-cUVCD9-Mo6A1TRlvm_gPlURSC8CP_Fe8cnHtAwKCC8AW9sjjh29txNwA5Hj9QvK-w_677mT9vZLSJKTe54E8BhjsfO8VA5BzfcpPuuNTcfumuujUt3RHHQMurB5N-pHF0DBo/s1350/joe--capp-map.jpg" style="clear: right; color: #cc6611; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="842" data-original-width="1350" height="200" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiAQlfkt45WLk2tGOVo9oOKqzA8eR08vMcdKayTeo5N19xlJ8KlugTO-v-cUVCD9-Mo6A1TRlvm_gPlURSC8CP_Fe8cnHtAwKCC8AW9sjjh29txNwA5Hj9QvK-w_677mT9vZLSJKTe54E8BhjsfO8VA5BzfcpPuuNTcfumuujUt3RHHQMurB5N-pHF0DBo/s320/joe--capp-map.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="320" /></a></div>According to a 12/13/2022 press release, Congresswoman Rosa DeLauro (CT-03), Congressman Brian Fitzpatrick (PA-01), and award-winning journalist Katie Couric introduced their legislation, the Find It Early Act. This bill would ensure all health insurance plans cover screening and diagnostic mammograms and breast ultrasounds and MRIs with no cost-sharing. “It means a great deal to me to join Katie Couric, Congressman Fitzpatrick, and all of the breast cancer advocates here to talk about what we must do to detect breast cancer early and save women’s lives,” said Congresswoman Rosa DeLauro. (See complete feature)<p></p><p>"Dr. Bard will go down in medical history as one of the earliest change-makers in our crusade to improve women's early detection programs. His innovative approach to combine technologies makes him a true visionary for the next generation of cancer professionals... by standing his ground about the crisis and aiding in (what is now) a national legislation to save more lives!", states Mr. Cappello.</p><p><br /></p><table border="2" cellpadding="10" cellspacing="0" style="color: #444444; font-size: 13px;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both; text-align: center;"><b><span style="font-size: medium;">Video News Release: Innovations in Early Detection</span></b></div><div><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; text-align: left;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; font-family: times; font-size: small; text-align: center;"><br /></div></div><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: justify;"><div class="separator" style="clear: both; font-family: times; font-size: small; text-align: center;"><a href="https://youtu.be/L0pamDrNkcU" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="375" data-original-width="675" height="178" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjdEsrTrerDihfzSpphpy0m2C0Ul3pmQrrdQafS8K38mtCoL-qB2c6RP9I8Djy-q_uHKhwhRKbAIajiPz_9WqoW_wdkHZBWydN1QE6gzVYIEWWvMfoheQdrxw9stMaHDs9pcqoZ-yfqLTSMtDR7yG2F6gyaPHC6MUV4NULnjeXMuOy425oqVmw11hjceQ/s320/Screenshot%2001-19-2023%2009.11.06.png" style="background: rgb(255, 255, 255); border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="320" /></a></div><span style="font-family: arial; font-size: small;">"Are You Dense?" Foundation Co-founder Joe Cappello joins the medical diagnostic community to promote the "Get Checked Now!" campaign. Dr. Robert Bard from the Bard Cancer Center (NYC) supports supplemental imaging including the 3D Doppler Ultrasound scanner to offer dense breast detection. This video presents some of the latest advancements in ultrasound features to detect tumors through dense breast tissue- reportedly a significant challenge with mammograms. </span></div></div></div></div></div></div></td></tr></tbody></table><div style="color: #444444;"><div class="separator" style="clear: both; color: black; font-size: medium; text-align: center;"><br /></div></div><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhtLaGfFBBgSUBc0EZxyu5xzviEYRthf0ztuJUsi_NHHXew2vnGmeYS37A38DiDrizzVSXoea8VQsLL9yq00mRrsQuQVfBYean5Zq-0KgqVwuew9A_-MoSEeLn7fLYD7SESvGLyMp8dv7BLXtymmai08utvOx-VSxiBGy9B_oxyJHofGT4B1yBEhG84Mdw/s640/7-23-04_001.jpg" style="clear: right; color: #cc6611; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="416" data-original-width="640" height="208" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhtLaGfFBBgSUBc0EZxyu5xzviEYRthf0ztuJUsi_NHHXew2vnGmeYS37A38DiDrizzVSXoea8VQsLL9yq00mRrsQuQVfBYean5Zq-0KgqVwuew9A_-MoSEeLn7fLYD7SESvGLyMp8dv7BLXtymmai08utvOx-VSxiBGy9B_oxyJHofGT4B1yBEhG84Mdw/s320/7-23-04_001.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="320" /></a></div>THE LEGACY OF DR. NANCY CAPPELLO<br />In 2014, Imaging Technology News (ITN) introduced breast cancer survivor-turned-crusader Dr. Nancy Cappello and her story about having dense breast tissue leading to a late-stage cancer. A false negative mammography scan (diagnosed in 2004) concealed a large 2.5 cm suspicious lesion, which was later confirmed to be stage 3c breast cancer. This same cancer had metastasized to 13 lymph nodes. This sparked Dr. Cappello to create the "Are You Dense?" Foundation- an international awareness crusade to better support dense breast diagnostics and initiatives pass legislation to enact laws requiring mammography centers to inform patients about their breast density and the associated cancer risks. Dr. Cappello passed away on Nov 15, 2018, from secondary myelodysplastic syndrome (MDS), a bone marrow cancer that was a complication of her prior aggressive breast cancer treatments. But she ignited a legacy of fighting for improved policies, imaging technologies and advanced research to better address this health crisis that puts the est. 40% of the female population (women with dense breasts) at risk of a false negative reading.</div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-60953358387355483792023-10-31T07:35:00.026-07:002023-12-08T23:33:41.477-08:00"EARLIER DETECTION"- REACHING A GENERATION IN CRISIS<iframe allow="autoplay; fullscreen; picture-in-picture" frameborder="0" height="338" src="https://player.vimeo.com/video/881946464?h=3f51a4cb16&badge=0&autopause=0&quality_selector=1&player_id=0&app_id=58479" title="Allie (23) About Earlier Detection & Dense Breast/Cancer link" width="600"></iframe>
<div><div style="text-align: justify;"><div><div class="separator" style="clear: both; text-align: center;"><br /></div></div><div class="separator" style="clear: both; text-align: center;"><br /></div><div class="separator" style="clear: both; text-align: center;"><div><div style="text-align: justify;"><div><div class="separator" style="clear: both; text-align: center;"><br /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBv2182EGB6jHc5n-ghsD0_nYqvRCRUL7Xa9XR7RanDvIIe0IvbD5X2jwoTK4OTtNyzrIywrascF2UEw7aboeVwrb_ZSOAzoEfG7jeS9O_rYYvz5AZrXu5XjKoSqGyWKefp3Tjt2zceeFuX2KPG5SmPk95hA_MQEHIsu7pd8B-w_ty5Y6KeAnze4EuMADl/s932/Untitled-1.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="527" data-original-width="932" height="91" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBv2182EGB6jHc5n-ghsD0_nYqvRCRUL7Xa9XR7RanDvIIe0IvbD5X2jwoTK4OTtNyzrIywrascF2UEw7aboeVwrb_ZSOAzoEfG7jeS9O_rYYvz5AZrXu5XjKoSqGyWKefp3Tjt2zceeFuX2KPG5SmPk95hA_MQEHIsu7pd8B-w_ty5Y6KeAnze4EuMADl/w160-h91/Untitled-1.jpg" width="160" /></a></div>WHAT ABOUT IF YOU'RE TOO YOUNG FOR A MAMMOGRAM? I went to my doctor for a lump I felt in my breast and she gave me a response that set off red flags: "don't worry about it". Being a researcher involved in breast density and breast cancer, I knew that I had to take action; I was fortunate enough to have my breast ultrasound training with Dr. Robert Bard (cancer imaging specialist, NYC) upcoming in the next week. Dr. Bard showed me how to use the ultrasound to help me find two benign tumors in my breasts, and it was there that he reported that I have dense breasts. Had I not taken action in getting screened at the young age of 22, I would have never known that I should be getting screened via ultrasound every 6 months (because having dense breasts puts me at a higher risk for breast cancer), nor would I have known that I had benign breast tumors. </div><div><br /></div><div>- ALEXANDRA FIEDERLEIN, 22</div><div>Cancer Researcher/ Graduate- Molloy Univ.</div></div></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><table border="2" cellpadding="10" cellspacing="0" style="background-color: white; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both; text-align: center;"><b style="font-size: medium;">CURRENT DATA FROM PUBLIC SURVEY<br /></b><span style="font-size: x-small;">Assembled by Dr. Roberta Kline, OBGYN & Co-Editor of <a href="https://painhealersgroup.org/network.html">Women's Health Digest</a></span></div><div class="separator" style="clear: both; text-align: center;"><br /></div><table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto;"><tbody><tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhCCL_e_5bj9irV4o8JgADGWyfVsKvy6_6nb1ZgX5spT_AinLZPESA96mcrOKUFYpxqNMDqGLa-8qm8nXz4K1TleoDa9VjbFB3MyJ3Z6bJBVfxnrHNM-Sz3ktfnrvinBXQ8UjplMlmk9kMtqyYslCDAfG5TcqQ-Fs0co6WTvk9ZsK1qEzm7f_BipDPeocbC/s588/cdc.jpg" style="margin-left: auto; margin-right: auto;"><img border="0" data-original-height="203" data-original-width="588" height="216" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhCCL_e_5bj9irV4o8JgADGWyfVsKvy6_6nb1ZgX5spT_AinLZPESA96mcrOKUFYpxqNMDqGLa-8qm8nXz4K1TleoDa9VjbFB3MyJ3Z6bJBVfxnrHNM-Sz3ktfnrvinBXQ8UjplMlmk9kMtqyYslCDAfG5TcqQ-Fs0co6WTvk9ZsK1qEzm7f_BipDPeocbC/w628-h216/cdc.jpg" width="628" /></a></td></tr><tr><td class="tr-caption" style="text-align: center;"><a href="https://gis.cdc.gov/Cancer/USCS/#/Demographics/" style="font-family: arial; text-align: justify;"><span style="font-size: x-small;"><i>Source: CDC (link)</i></span></a></td></tr></tbody></table><br /><div class="separator" style="clear: both; text-align: center;"><br /></div><div><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; text-align: left;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: justify;"><span style="font-family: arial; font-size: small;">Enclosed is research-based public information by the CDC that widely supports the current reality about new cancers (including breast cancer) in women under 40. The data used by public health comes from a wide variety of places within our local communities: hospitals, laboratories, doctors' offices – anywhere that a person receives healthcare.</span></div><div class="separator" style="clear: both; text-align: justify;"><span style="font-family: arial; font-size: small;"><br /></span></div><div class="separator" style="clear: both; text-align: justify;"><span style="font-family: arial; font-size: small;"><div class="separator" style="clear: both;"><b>Age-specific rates breast cancer for 2020 (Total for ages 20-39)</b>: </div><div class="separator" style="clear: both;">•<span style="white-space: pre;"> </span>Rate of new breast cancers = 27/100,000</div><div class="separator" style="clear: both;">•<span style="white-space: pre;"> </span>Equals 11,368 new cases/42,765,288 women</div><div class="separator" style="clear: both;"><br /></div><div class="separator" style="clear: both;"><b>Details:</b></div><div class="separator" style="clear: both;"><20: numbers less than 16 cases for lower age categories, data suppressed</div><div class="separator" style="clear: both;">20-24: 1.7/100K; equals 174 new cases/10,239,813 women</div><div class="separator" style="clear: both;">25-29: 10.4/100K; equals 1,146 new cases/11,016,549 women</div><div class="separator" style="clear: both;">30-34: 30.5/100K; equals 3332 new cases/10,939,868 women</div><div class="separator" style="clear: both;">35-39: 63.5/100K; equals 6716 cases/10,569,058 women</div><div><br /></div></span></div><div class="separator" style="clear: both; text-align: justify;"><br /></div></div></div></div></div></div></td></tr></tbody></table><div style="background-color: white; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"><div class="separator" style="clear: both; color: black; font-size: medium; text-align: center;"><br /></div></div><p></p><div style="text-align: left;"><span style="font-size: x-large;">"EARLIER DETECTION"...<br />REACHING MY GENERATION IN CRISIS</span></div>By: Alexandra Fiederlein (23) | Edited by: <a href="https://robertaklinemd.com/">Dr. Roberta Kline</a> and the <a href="http://fightrecurrence.com/">ICRS Editorial Team</a><p></p><div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiFrhBSFCb9_8DNfMJQaTsdNZmeKVdQt0cnE29bmcs5VAKjJlFSiaDiK2tSveLb5tZoKaxW-k4EPB9KoAcc_kTmqBRCUnFq4ZNWzyOwcH8sot8LDyP758qwKXDzMyRJi1PwhVOvOckmj9VkWzVCcm8hSIfucewSsLeVDMJP1xyJyf-BJi7lQZ3nX4skoyYV/s2432/22.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="1080" data-original-width="2432" height="177" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiFrhBSFCb9_8DNfMJQaTsdNZmeKVdQt0cnE29bmcs5VAKjJlFSiaDiK2tSveLb5tZoKaxW-k4EPB9KoAcc_kTmqBRCUnFq4ZNWzyOwcH8sot8LDyP758qwKXDzMyRJi1PwhVOvOckmj9VkWzVCcm8hSIfucewSsLeVDMJP1xyJyf-BJi7lQZ3nX4skoyYV/w399-h177/22.jpg" width="399" /></a></div><div>I belong to the graduate-level age group that continues to witness the increasing numbers of breast cancer cases in our country. The women in this generation also happens to be the next group that falls prey to being UNDERDIAGNOSED. Insurance companies and the medical community have made little or no action to support or identify the need for women in their 20's and 30's to be approved for standardized early detection / breast cancer screening. </div></div><div><br /></div><div>From the front-row perspective, younger women are as much at risk of getting cancer. Reports show an uptick in genetic predisposition for breast cancer*, alongside a dangerous attitude of denial. Addressing this calls for widespread education and screening programs in our community as essentials to a life of wellness and prevention. To subscribe to a regular screening routine at the early stage of womanhood raises awareness and prevention for decades to come. Perhaps someday, installing breast cancer screening centers in college campuses may be commonplace and a powerful step toward a national prevention initiative.</div><div><br /></div><div><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: right; margin-left: 1em; text-align: justify;"><tbody><tr><td style="text-align: center;"><a href="https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2022-2024-breast-cancer-fact-figures-acs.pdf" style="clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><img border="0" data-original-height="324" data-original-width="588" height="119" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj-XZK1ykl3Bsiw3JOAG819-2dt7uf7fsN0aTsjknXJpr6mOQI_fiUa9RavV5JfhHQjBGzs-_WJyY7WYRDD_I41aeaEVwRpe__mvPvh6oaPPN34jR7L5mVXSb0m2lSv-g6qYpax0HlPjcRacOa1WjfD7gxD3PJLzt2AGaToxEFdOzkkzQWIPqwwUTlvFSJg/w217-h119/2022-cover-wide-breast-cancer-facts-and-figures-588.jpg" width="217" /></a></td></tr><tr><td class="tr-caption" style="text-align: center;"><span style="font-size: x-small;"><i><a href="https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2022-2024-breast-cancer-fact-figures-acs.pdf">Click to download</a> the latest ACS report</i></span></td></tr></tbody></table><div>Targeting the <b>young working PROFESSIONAL</b> is a major part of our population, where the vast majority tends to put off checkups and screenings because they are just "too busy". Professional women need to value their health above anything else, and therefore the narrative needs to be amplified in that area. We find this problem to be quite prevalent in urban areas with the constant on-the-go culture. Offering local resources and improved access for personal scanning are just some progress driven programs. </div></div><div><br /></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiei8P7QAh-W3Fnmb8H6EjdwslNaacXSuLJ6vUWjj-KSPSQQ6_d5jR1urr-mRlSToQh_R03jubSG-OqFTWXTNQgzSpWES7JiTt0xv2fBZBTISlehBS9ZdDC5i1wH7x-WkG7Pe7OumCyCblTt_27orhCKa9y0KAQVeZjpc6sAIzt6BemLFKt-m0jHOmKgu4D/s3096/34.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="3096" data-original-width="1956" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiei8P7QAh-W3Fnmb8H6EjdwslNaacXSuLJ6vUWjj-KSPSQQ6_d5jR1urr-mRlSToQh_R03jubSG-OqFTWXTNQgzSpWES7JiTt0xv2fBZBTISlehBS9ZdDC5i1wH7x-WkG7Pe7OumCyCblTt_27orhCKa9y0KAQVeZjpc6sAIzt6BemLFKt-m0jHOmKgu4D/s320/34.jpg" width="202" /></a></div><div><b>GEN Z</b><b> </b>is a sensible focus group because these are the women who absolutely must receive routine scanning. We need to advocate for the narrative that age 40 is not the starting age where screening needs to begin- especially since we are now seeing cancer cases in younger ages are growing in numbers. Getting OB/GYN professionals on board is especially important because this is where women are getting their prescriptions. </div></div><div><br /></div><div>We need to educate on the benefits of ultrasound. People need to know HOW it works, WHY it works, and why it holds certain benefits over a mammogram. People need to know that it is SAFE and EFFECTIVE, and this technology can save lives. I think it is especially important to emphasize the option of ultrasound for younger women. Many younger women have dense breasts and don't even know it, putting them at a greater risk (I wouldn't have known if it weren't for all of you!). Ultrasound is obviously a safe and effective screening method for young women. It is also not linked with the stigma/fear of getting a mammogram like many women my age hold (X-Ray exposure, etc.). </div><div><br /></div><div>If the drive for EARLIER DETECTION means proactive awareness, may this lead to turning social concern into clinical action. This includes clinicians joining hands with advocacy groups who recognize the many potential areas for at-risk women in my generation whose lives and safety continue to go unrecognized. And once the count of cancer cases and deaths rise exponentially due to inaction, perhaps then will the medical community find urgency in upgrading the required breast cancer screening age to (finally) include generations like mine. So say we all! </div></div><div><br /></div><div style="text-align: left;"><span style="font-size: x-small;">Ref</span>:</div><div><div style="text-align: left;"><span style="font-size: x-small;">*Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures, PMC9038417. (NIH)- <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038417/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038417/</a></span></div><div><br /></div><div></div><div><table align="center" cellpadding="0" cellspacing="0" class="tr-caption-container" style="margin-left: auto; margin-right: auto;"><tbody><tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEixDSIuL_oA2Ec7Pw-3DbI9c3Kdvv4O-FePd2zvP65qDIR4V-78vc_yyTbJC9EYPByHhdV08cuyvrZ91-aBlhV6hMXLsNTn4eqixsQ_qbh677baZZxYw9q8moCW8wUuBnHumGkgiVcDYuWwwoenlwafeVHFu4ElvYwww_Q6GP7444PufxfaI5uVvPXwxYLe/s790/BANNAGH.jpg" style="margin-left: auto; margin-right: auto;"><span style="font-size: x-small;"><img border="0" data-original-height="148" data-original-width="790" height="100" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEixDSIuL_oA2Ec7Pw-3DbI9c3Kdvv4O-FePd2zvP65qDIR4V-78vc_yyTbJC9EYPByHhdV08cuyvrZ91-aBlhV6hMXLsNTn4eqixsQ_qbh677baZZxYw9q8moCW8wUuBnHumGkgiVcDYuWwwoenlwafeVHFu4ElvYwww_Q6GP7444PufxfaI5uVvPXwxYLe/w532-h100/BANNAGH.jpg" width="532" /></span></a></td></tr><tr><td class="tr-caption" style="text-align: center;"><span style="font-size: x-small;"><a href="https://bardcancercenter.com/diagnosis/breast-cancer/">This article is sponsored by the educational program of Bard Diagnostic Imaging</a></span></td></tr></tbody></table><br /><div style="text-align: left;"><hr style="text-align: justify;" /></div></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiYDQ7yQEHDwmw5O7kOsa10UqU-hxssp9eL_Cg1ns2jf0oGr5xlQu3sNfbzc7RTs30GW5qtVRKb8C2VQn_GmsfAd7gG1ihVgEHZ3BcFeOJWKbkq6dCrhRXdcRXYFIwhqUoFoelOnVwh5Pk97vVkzryz3DSHTaHayTQOjZUD2XxWa0kjrtYV4nz_0KLArQ15/s203/EXTRA1.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="54" data-original-width="203" height="34" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiYDQ7yQEHDwmw5O7kOsa10UqU-hxssp9eL_Cg1ns2jf0oGr5xlQu3sNfbzc7RTs30GW5qtVRKb8C2VQn_GmsfAd7gG1ihVgEHZ3BcFeOJWKbkq6dCrhRXdcRXYFIwhqUoFoelOnVwh5Pk97vVkzryz3DSHTaHayTQOjZUD2XxWa0kjrtYV4nz_0KLArQ15/w128-h34/EXTRA1.jpg" width="128" /></a></div><br /><div><br /></div></div></div><div><br /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhbyRVe9biDfDKdsUV_Ebn91tOheyT9qz86kxmXq9zz46Ga9K4Gck3UU2o5R6VS6DzLH_IRQM31G42UKZm-pJlQMtZkKS8SesiDXDBbQ3VaVIkeEBZbEhblb3QI6gw47B8sTc7mbdupVWhcxNS5EoMsyPikFndB8n0GBTVFNabH5of6bsbXfsG14hDbWOXQ/s480/bigger.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="320" data-original-width="480" height="125" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhbyRVe9biDfDKdsUV_Ebn91tOheyT9qz86kxmXq9zz46Ga9K4Gck3UU2o5R6VS6DzLH_IRQM31G42UKZm-pJlQMtZkKS8SesiDXDBbQ3VaVIkeEBZbEhblb3QI6gw47B8sTc7mbdupVWhcxNS5EoMsyPikFndB8n0GBTVFNabH5of6bsbXfsG14hDbWOXQ/w188-h125/bigger.jpg" width="188" /></a></div><div><span style="background-color: white; color: #222222; font-family: times;">A major concern is the presence of breast cancer in underserved communities, including those TOO YOUNG FOR A MAMMOGRAM. Whereby the medical community touts the recommended (and legal/billable status) of getting a mammo scan should be between 40-50, what happens to the many women who do not fit this age criteria? How would they even know to get checked without the support of their clinicians or an alarm from family history? </span><span style="background-color: white; color: #222222; font-family: times;">Decades into the battle against breast cancer, clinicians and the public are much more educated about EARLY DETECTION, PREVENTION and the current protocols and modalities available to save lives. Recent headlines on DENSE BREAST and the advancements in ULTRASOUND SCANNING supports a major part of this battle. <a href="https://breastcancerblognews.blogspot.com/2023/10/early-detection-alert-risk-of-being-too_20.html">SEE COMPLETE FEATURE</a></span></div><div><br /></div><div><br /></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjoMpHEwDFYVP7fnA_k09h9x_zgwAP9xtwSrEk6CctfY8B_zNyd8vj_3tXZQlsSPF50KRtrSFmBx7NIp7bozNKbkqtCQJM3sRAxe4EgzFmjsFI4Z2X0O6PES9Aej55iK8ybDYb-Je0o8VLDT-R_DESZk3ufRq07VdhqFNMCUGyYpPg5Obu3e-WJZ8GSI9z7/s1713/image001.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1218" data-original-width="1713" height="134" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjoMpHEwDFYVP7fnA_k09h9x_zgwAP9xtwSrEk6CctfY8B_zNyd8vj_3tXZQlsSPF50KRtrSFmBx7NIp7bozNKbkqtCQJM3sRAxe4EgzFmjsFI4Z2X0O6PES9Aej55iK8ybDYb-Je0o8VLDT-R_DESZk3ufRq07VdhqFNMCUGyYpPg5Obu3e-WJZ8GSI9z7/w188-h134/image001.jpg" width="188" /></a></div><a href="https://www.facebook.com/HispanicCoalitionofGreaterWaterbury" target="_blank">WATERBURY, Conn. (October 12, 2023) JOE CAPPELLO/ARE YOU DENSE? FOUNDATION RECEIVES KEY TO THE CITY FROM MAYOR O'LEARY</a><br />Waterbury celebrated a citywide Pink Out on Thursday, October 26th! Saint Mary’s Hospital Foundation has once again partnered with the City of Waterbury to recognize Breast Cancer Awareness. Waterbury Mayor Neil O’Leary, Saint Mary’s Hospital President, Kim Kalajainen and special guest Joe Cappello will address organizers and volunteers from the Waterbury Police and Fire Departments as well as the Education Department, area students and others at 11:00 a.m. at Waterbury City Hall. </div><div><br /></div><div><br /></div><div><table border="2" cellpadding="10" cellspacing="0" style="background-color: white; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both; text-align: center;"><b><span style="font-size: medium;">Video News Release: Innovations in Early Detection</span></b></div><div><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; text-align: left;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; font-family: times; font-size: small; text-align: center;"><br /></div></div><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: justify;"><div class="separator" style="clear: both; font-family: times; font-size: small; text-align: center;"><a href="https://youtu.be/L0pamDrNkcU" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="375" data-original-width="675" height="178" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjdEsrTrerDihfzSpphpy0m2C0Ul3pmQrrdQafS8K38mtCoL-qB2c6RP9I8Djy-q_uHKhwhRKbAIajiPz_9WqoW_wdkHZBWydN1QE6gzVYIEWWvMfoheQdrxw9stMaHDs9pcqoZ-yfqLTSMtDR7yG2F6gyaPHC6MUV4NULnjeXMuOy425oqVmw11hjceQ/s320/Screenshot%2001-19-2023%2009.11.06.png" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="320" /></a></div><span style="font-family: arial; font-size: small;">"Are You Dense?" Foundation Co-founder Joe Cappello joins the medical diagnostic community to promote the "Get Checked Now!" campaign. Dr. Robert Bard from the Bard Cancer Center (NYC) supports supplemental imaging including the 3D Doppler Ultrasound scanner to offer dense breast detection. This video presents some of the latest advancements in ultrasound features to detect tumors through dense breast tissue- reportedly a significant challenge with mammograms. </span></div></div></div></div></div></div></td></tr></tbody></table><div style="background-color: white; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"><div class="separator" style="clear: both; color: black; font-size: medium; text-align: center;"><br /></div></div></div><div><div><hr /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgla5AUyEXvw-avcGwyolFNIllC9MgMEj4TJcKnhNsIm1-Vhc9mmBqiDCqn8G7NXN-DqbJzZAMnIZOL7BFsU_S8XdVTmNfDXxEuIfyIBMwAKO-61omxrZqb4AFrN4P6X6gsdk4AD_wE6BeR1GeXCjBYg0cOsIQEwXTEL5Uby1Lie0TfTt3fWpRpZ_2HT41b/s141/NEWS1.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="37" data-original-width="141" height="34" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgla5AUyEXvw-avcGwyolFNIllC9MgMEj4TJcKnhNsIm1-Vhc9mmBqiDCqn8G7NXN-DqbJzZAMnIZOL7BFsU_S8XdVTmNfDXxEuIfyIBMwAKO-61omxrZqb4AFrN4P6X6gsdk4AD_wE6BeR1GeXCjBYg0cOsIQEwXTEL5Uby1Lie0TfTt3fWpRpZ_2HT41b/w128-h34/NEWS1.jpg" width="128" /></a></div><br /><p><br /></p><p><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjSn_FI7-75v8RvFr7A6s7WsfMGuYGxgCJTUjk_T0p3RcD6krZAWg3r4-hZfmazWds9FaIFhqMzuSAFiPPWJDEIWtRNDG5s7bEdANC_r3XmcJQGFRpNhrB6hjLc0YRLwi5RF4rp_lEyr1Db6q3x0DngGUB2rodsaO5pIkLHICcrlcipSkm-R1v6FPX2BrmC/s2700/art1.jpg" style="clear: left; display: inline; margin-bottom: 1em; margin-right: 1em; text-align: center;"><img border="0" data-original-height="755" data-original-width="2700" height="183" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjSn_FI7-75v8RvFr7A6s7WsfMGuYGxgCJTUjk_T0p3RcD6krZAWg3r4-hZfmazWds9FaIFhqMzuSAFiPPWJDEIWtRNDG5s7bEdANC_r3XmcJQGFRpNhrB6hjLc0YRLwi5RF4rp_lEyr1Db6q3x0DngGUB2rodsaO5pIkLHICcrlcipSkm-R1v6FPX2BrmC/w659-h183/art1.jpg" width="659" /></a></p><span style="font-size: large;">GO "EARLIER" WITH EARLY DETECTION (FOR WOMEN AGES 20-40)</span></div><div>According to the American Cancer Society (ACS), women ages 45 to 54 and post-menopausal years are required to get mammograms every year.[1a] But for the underserved ages (20-40), the risk for breast cancer exists in growing numbers. In support of Breast Cancer Awareness month, <a href="http://fightrecurrence.com/">the Integrative Cancer Resource Society</a>, the <a href="https://angiofoundation.org/">AngioFoundation Institute</a> (501c3) and the <a href="https://www.areyoudense.org/">"Are You Dense?" Foundation </a> addresses the continuing concerns for breast cancer in the New York area by recommending early detection screening programs for women over 20 (and not just anyone 40+ as standardized by the insurance companies.</div><div><div><br /></div><div>The medical community has identified over 5% of all breast cancer cases occur in women over 20 and under the age of 40. The increased risk for breast cancer in dense tissue also exists and is identified by the medical community. Diagnostic Imaging specialist <a href="https://drrobertbard.com/">Dr. Robert Bard</a> of NYC identifies the need for paying more attention to breast cancer screening to ages younger than the mandated 40+. "It's about time the (medical) community recognizes the growing rate of breast cancer in women of younger ages... from genetic predisposition to geography to having dense breast tissue, earlier detection should be our next national initiative."</div><p></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjq3C2mrXRrt-m_0PRiHy0P7spuhA2iwOhc_GgBGPoPlIfqa901VESrgrCCTqr_n-P2f4O8qRPOhiwi47u9RZEwsjaE1opRJF1Ij74loM3YQinepsEfcE45W4G-wwK3e09XCsMwuvcpMMTDzfCCiBz3_HGunWpJKU9kbQLNMBxIVMmWqvBvdbYbqeMzSqCk/s5120/shutterstock_1130966411.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="2880" data-original-width="5120" height="137" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjq3C2mrXRrt-m_0PRiHy0P7spuhA2iwOhc_GgBGPoPlIfqa901VESrgrCCTqr_n-P2f4O8qRPOhiwi47u9RZEwsjaE1opRJF1Ij74loM3YQinepsEfcE45W4G-wwK3e09XCsMwuvcpMMTDzfCCiBz3_HGunWpJKU9kbQLNMBxIVMmWqvBvdbYbqeMzSqCk/w243-h137/shutterstock_1130966411.jpg" width="243" /></a></div><div>•<span style="white-space: pre;"> </span>Breast cancer in younger women may be more aggressive and less likely to respond to treatment.</div><p></p><p>•<span style="white-space: pre;"> </span>Women who are diagnosed with breast cancer at a younger age are more likely to have genetic mutations predisposing them to breast and other cancers.</p><p>•<span style="white-space: pre;"> </span>Younger women who have breast cancer may ignore the warning signs—such as a breast lump or unusual discharge—because they believe they are too young to get breast cancer. This can lead to a delay in diagnosis and poorer outcomes.</p><p>•<span style="white-space: pre;"> </span>Some healthcare providers may also dismiss breast lumps or other symptoms in young women or adopt a "wait and see" approach.</p><p>•<span style="white-space: pre;"> </span>Breast cancer poses additional challenges for younger women as it can involve issues concerning sexuality, fertility, and pregnancy after breast cancer treatment. [1]</p><p><br /></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjH6p7P3-rlv16Tzb8wsW0Bf-Rfj_38_Ocp0bf6pNYDEzW__MRnSiSQtHscZL6gEnxIifUNlEWjmvxmvOJZQeXV3v4l-_ko5CvwqnSjNyHbNQZiCEAaUtP28XoQppdWfw4TJu4sBPSvVqYg8TsIjqcSFuv1EfuHGy6WKhprTPHLtZU030IR_RgOeW1wHLg9/s800/dreamstime_s_217376994.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="533" data-original-width="800" height="124" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjH6p7P3-rlv16Tzb8wsW0Bf-Rfj_38_Ocp0bf6pNYDEzW__MRnSiSQtHscZL6gEnxIifUNlEWjmvxmvOJZQeXV3v4l-_ko5CvwqnSjNyHbNQZiCEAaUtP28XoQppdWfw4TJu4sBPSvVqYg8TsIjqcSFuv1EfuHGy6WKhprTPHLtZU030IR_RgOeW1wHLg9/w186-h124/dreamstime_s_217376994.jpg" width="186" /></a></div><div>2)<span style="white-space: pre;"> </span>INCLUDE SUPPLEMENTAL SCREENING FOR DENSE BREAST TISSUE (WITH HIGH RESOLUTION ULTRASOUND): Women diagnosed with dense breasts should continue to get regular screening mammograms. But there are additional screening tests that can help doctors detect tumors that may not be identified by conventional mammography or DBT. [2] Any woman who has dense breasts may want to consider supplemental screening, usually with breast ultrasound. Studies show that screening with ultrasound, in addition to mammography, improves detection of breast cancers in women with dense breasts. [3]</div><p></p><p>3)<span style="white-space: pre;"> </span>WHOLE BODY MRI (NO CONTRAST) FOR CANCER SCANNING: In simplistic terms, having a full-body access comports to the fact that everything is connected in one way or another. Our full-body MRI provides early diagnosis and the largest view of the body, where finding any cancers in the body and/or where they may spread can provide the best chance of treatment success. In suspected cases of early breast malignancy, the exclusion of metastatic disease is clinically vital and emotionally supportive.</p><p style="text-align: left;"><span style="font-size: x-small;"><i>1a) "Infographic: 7 Things to Know About Getting a Mammogram"- ACA/American Cancer Society: <a href="https://www.cancer.org/cancer/types/breast-cancer/mammogram-tips-infographic.html#:~:text=Women%20between%2040%20and%2044,choose%20to%20continue%20yearly%20mammograms.">https://www.cancer.org/cancer/types/breast-cancer/mammogram-tips-infographic.html#:~:text=Women%20between%2040%20and%2044,choose%20to%20continue%20yearly%20mammograms.</a></i></span></p><p style="text-align: left;"><i><span style="font-size: x-small;">1)<span style="white-space: pre;"> "</span></span></i><span style="font-size: x-small;"><span style="white-space: pre;"><i>Breast Cancer in Young Women"- Cleveland Clinic: </i></span></span><i><span style="font-size: x-small;"><a href="https://my.clevelandclinic.org/health/articles/16805-breast-cancer-in-young-women">https://my.clevelandclinic.org/health/articles/16805-breast-cancer-in-young-women</a></span></i></p><p style="text-align: left;"><i><span style="font-size: x-small;">2) "</span></i><span style="font-size: x-small;"><i>What additional breast cancer screening tests are available for women who have dense breasts?"- Yale medicine- </i></span><i><span style="font-size: x-small;"><a href="https://www.yalemedicine.org/conditions/dense-breasts#:~:text=Women%20diagnosed%20with%20dense%20breasts,(whole%2Dbreast%20ultrasound)">https://www.yalemedicine.org/conditions/dense-breasts#:~:text=Women%20diagnosed%20with%20dense%20breasts,(whole%2Dbreast%20ultrasound)</a>.</span></i></p><p style="text-align: left;"><i><span style="font-size: x-small;">3) Columbia Doctors/ "</span></i><span style="font-size: x-small;"><i>What Are Dense Breasts? </i></span><i style="font-size: small;">A radiologist offers guidance":-</i><span style="font-size: x-small;"><i>Health Insights: October 14, 2022</i></span><i><span style="font-size: x-small;"><span style="white-space: pre;"> </span><a href="https://www.columbiadoctors.org/news/what-are-dense-breasts#:~:text=Any%20woman%20who%20has%20dense,in%20women%20with%20dense%20breasts">https://www.columbiadoctors.org/news/what-are-dense-breasts#:~:text=Any%20woman%20who%20has%20dense,in%20women%20with%20dense%20breasts</a>.</span></i></p><p style="text-align: left;"><i><span style="font-size: x-small;"><br /></span></i></p><div><hr /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg0Vevjps5FavoOlBO5I4HUKCVlLOCFHVntCRwqqWiw3anyPGzcmaLI_w-Hqnme09UsZTFzUCZ2NLz_sy7J9upxRBEFoF05U6glKxdoY3TEnNqhHc5OT_BGWmez2g8qcszxj9g3sZyKLcNQnzWnAASG2_xiE14orzEuGGsd8UUl8KVbDLxoM1t8Zi-oIGHU/s362/editorial.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="80" data-original-width="362" height="34" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg0Vevjps5FavoOlBO5I4HUKCVlLOCFHVntCRwqqWiw3anyPGzcmaLI_w-Hqnme09UsZTFzUCZ2NLz_sy7J9upxRBEFoF05U6glKxdoY3TEnNqhHc5OT_BGWmez2g8qcszxj9g3sZyKLcNQnzWnAASG2_xiE14orzEuGGsd8UUl8KVbDLxoM1t8Zi-oIGHU/w152-h34/editorial.jpg" width="152" /></a></div><div><br /></div><div><br /></div><div><br /></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjz1bTADyoWt839NqXl3FRIP-0J2H0C9UvqSgAKtiNsY7o-HsWhbDVT92kCNDmYlJuvEjdJf5VtDwqvM0WEKQ-D_4e7jiYgf7YRTqjtyUkSKKwad0ou5Qz-jo5YHhTSJt1e17YXewMffa-TnUeQhGWeXDXne9_5jem4P38B2RHpfxvUU4evjzJduFlPcowb/s108/NOELLE.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="108" data-original-width="99" height="90" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjz1bTADyoWt839NqXl3FRIP-0J2H0C9UvqSgAKtiNsY7o-HsWhbDVT92kCNDmYlJuvEjdJf5VtDwqvM0WEKQ-D_4e7jiYgf7YRTqjtyUkSKKwad0ou5Qz-jo5YHhTSJt1e17YXewMffa-TnUeQhGWeXDXne9_5jem4P38B2RHpfxvUU4evjzJduFlPcowb/w82-h90/NOELLE.jpg" width="82" /></a></div><i>"In order to catch cancer, you need to be able to detect it at an early stage so we can treat patients with the most effective mechanisms. Ultrasounds are an easy, cost-effective method for screening for early breast cancers, especially in women below the age of 45, who are likely to have dense breasts. When you are young and premenopausal your breasts are dense and we know that breast density is linked to cancer and which also makes it harder for cancers to be seen on a mammogram. Although breast cancer is rare in women under the age of 40, early detection is key. Public health campaigns are spending so much money on mammograms for this population of women who can easily and cost effectively be screened using an ultrasound."</i></div><div><br /></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgfQoHXfPmyEoqXRHAnSIwH2nFgrDN9a2OJJAcTkvtzf2AFZDMtpBoF61XTXzKbxGz7YPv1HzlrkJ6iL1DbZCAZrrMoSk9xJP8KikLTi8mw8Cn9eOiYfFazVScI342Y4S6C_bYS-WwP9-n64Hc-Zfdqsnnj41_ZkWhVe3L1sOHUbT4aTpl28zyDGH5MKGFv/s200/MARY.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="200" data-original-width="200" height="82" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgfQoHXfPmyEoqXRHAnSIwH2nFgrDN9a2OJJAcTkvtzf2AFZDMtpBoF61XTXzKbxGz7YPv1HzlrkJ6iL1DbZCAZrrMoSk9xJP8KikLTi8mw8Cn9eOiYfFazVScI342Y4S6C_bYS-WwP9-n64Hc-Zfdqsnnj41_ZkWhVe3L1sOHUbT4aTpl28zyDGH5MKGFv/w82-h82/MARY.jpg" width="82" /></a></div><i>"I LOVE this new program! Early detection is essential! There is a stigmatization around mammograms that they are painful and frightening. There is anxiety while you wait for the results. And, don't forget the appointment scheduling hassle. Women, particularly younger women with active lives, small children, careers don't want to have to fit one more thing into their hectic and demanding schedules. However, mammogram technology itself has advanced and it no longer has to be a painful experience. Clinics and imaging centers are offering untraditional scheduling opportunities, such as very early morning appointments to late evening appointments that are timed for very minimal wait times. And, clinicians are often prioritizing mammogram interpretations so the results are back within 24 hours. The Self Care message is trending right now. Mammograms should be a part of self care."</i></div><div><br /></div></div></div></div></div></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-47699992510260627802023-10-28T20:25:00.016-07:002023-10-31T07:31:37.226-07:00THE RISK OF BREAST CANCER STARTS EARLIER THAN 40<p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjSn_FI7-75v8RvFr7A6s7WsfMGuYGxgCJTUjk_T0p3RcD6krZAWg3r4-hZfmazWds9FaIFhqMzuSAFiPPWJDEIWtRNDG5s7bEdANC_r3XmcJQGFRpNhrB6hjLc0YRLwi5RF4rp_lEyr1Db6q3x0DngGUB2rodsaO5pIkLHICcrlcipSkm-R1v6FPX2BrmC/s2700/art1.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="755" data-original-width="2700" height="183" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjSn_FI7-75v8RvFr7A6s7WsfMGuYGxgCJTUjk_T0p3RcD6krZAWg3r4-hZfmazWds9FaIFhqMzuSAFiPPWJDEIWtRNDG5s7bEdANC_r3XmcJQGFRpNhrB6hjLc0YRLwi5RF4rp_lEyr1Db6q3x0DngGUB2rodsaO5pIkLHICcrlcipSkm-R1v6FPX2BrmC/w659-h183/art1.jpg" width="659" /></a></div><br />According to the American Cancer Society (ACS), women ages 45 to 54 and post-menopausal years are required to get mammograms every year.[1a] But for the underserved ages (20-40), the risk for breast cancer exists in growing numbers. In support of Breast Cancer Awareness month, <a href="http://fightrecurrence.com/">the Integrative Cancer Resource Society</a>, the <a href="https://angiofoundation.org/">AngioFoundation Institute</a> (501c3) and the <a href="https://www.areyoudense.org/">"Are You Dense?" Foundation </a> addresses the continuing concerns for breast cancer in the New York area by recommending early detection screening programs for women over 20 (and not just anyone 40+ as standardized by the insurance companies.<p></p><p></p><span style="font-size: large;">MOVEMENT: "EARLIER DETECTION" FOR WOMEN AGES 20-40</span><br />The medical community has identified over 5% of all breast cancer cases occur in women over 20 and under the age of 40. The increased risk for breast cancer in dense tissue also exists and is identified by the medical community. Diagnostic Imaging specialist <a href="https://drrobertbard.com/">Dr. Robert Bard</a> of NYC identifies the need for paying more attention to breast cancer screening to ages younger than the mandated 40+. "It's about time the (medical) community recognizes the growing rate of breast cancer in women of younger ages... from genetic predisposition to geography to having dense breast tissue, earlier detection should be our next national initiative."<p></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjq3C2mrXRrt-m_0PRiHy0P7spuhA2iwOhc_GgBGPoPlIfqa901VESrgrCCTqr_n-P2f4O8qRPOhiwi47u9RZEwsjaE1opRJF1Ij74loM3YQinepsEfcE45W4G-wwK3e09XCsMwuvcpMMTDzfCCiBz3_HGunWpJKU9kbQLNMBxIVMmWqvBvdbYbqeMzSqCk/s5120/shutterstock_1130966411.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="2880" data-original-width="5120" height="137" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjq3C2mrXRrt-m_0PRiHy0P7spuhA2iwOhc_GgBGPoPlIfqa901VESrgrCCTqr_n-P2f4O8qRPOhiwi47u9RZEwsjaE1opRJF1Ij74loM3YQinepsEfcE45W4G-wwK3e09XCsMwuvcpMMTDzfCCiBz3_HGunWpJKU9kbQLNMBxIVMmWqvBvdbYbqeMzSqCk/w243-h137/shutterstock_1130966411.jpg" width="243" /></a></div>•<span style="white-space: pre;"> </span>Breast cancer in younger women may be more aggressive and less likely to respond to treatment.<p></p><p>•<span style="white-space: pre;"> </span>Women who are diagnosed with breast cancer at a younger age are more likely to have genetic mutations predisposing them to breast and other cancers.</p><p>•<span style="white-space: pre;"> </span>Younger women who have breast cancer may ignore the warning signs—such as a breast lump or unusual discharge—because they believe they are too young to get breast cancer. This can lead to a delay in diagnosis and poorer outcomes.</p><p>•<span style="white-space: pre;"> </span>Some healthcare providers may also dismiss breast lumps or other symptoms in young women or adopt a "wait and see" approach.</p><p>•<span style="white-space: pre;"> </span>Breast cancer poses additional challenges for younger women as it can involve issues concerning sexuality, fertility, and pregnancy after breast cancer treatment. [1]</p><p><br /></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjH6p7P3-rlv16Tzb8wsW0Bf-Rfj_38_Ocp0bf6pNYDEzW__MRnSiSQtHscZL6gEnxIifUNlEWjmvxmvOJZQeXV3v4l-_ko5CvwqnSjNyHbNQZiCEAaUtP28XoQppdWfw4TJu4sBPSvVqYg8TsIjqcSFuv1EfuHGy6WKhprTPHLtZU030IR_RgOeW1wHLg9/s800/dreamstime_s_217376994.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="533" data-original-width="800" height="124" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjH6p7P3-rlv16Tzb8wsW0Bf-Rfj_38_Ocp0bf6pNYDEzW__MRnSiSQtHscZL6gEnxIifUNlEWjmvxmvOJZQeXV3v4l-_ko5CvwqnSjNyHbNQZiCEAaUtP28XoQppdWfw4TJu4sBPSvVqYg8TsIjqcSFuv1EfuHGy6WKhprTPHLtZU030IR_RgOeW1wHLg9/w186-h124/dreamstime_s_217376994.jpg" width="186" /></a></div>2)<span style="white-space: pre;"> </span>INCLUDE SUPPLEMENTAL SCREENING FOR DENSE BREAST TISSUE (WITH HIGH RESOLUTION ULTRASOUND): Women diagnosed with dense breasts should continue to get regular screening mammograms. But there are additional screening tests that can help doctors detect tumors that may not be identified by conventional mammography or DBT. [2] Any woman who has dense breasts may want to consider supplemental screening, usually with breast ultrasound. Studies show that screening with ultrasound, in addition to mammography, improves detection of breast cancers in women with dense breasts. [3]<p></p><p>3)<span style="white-space: pre;"> </span>WHOLE BODY MRI (NO CONTRAST) FOR CANCER SCANNING: In simplistic terms, having a full-body access comports to the fact that everything is connected in one way or another. Our full-body MRI provides early diagnosis and the largest view of the body, where finding any cancers in the body and/or where they may spread can provide the best chance of treatment success. In suspected cases of early breast malignancy, the exclusion of metastatic disease is clinically vital and emotionally supportive.</p><p><span style="font-size: x-small;"><i>1a) "Infographic: 7 Things to Know About Getting a Mammogram"- ACA/American Cancer Society: <a href="https://www.cancer.org/cancer/types/breast-cancer/mammogram-tips-infographic.html#:~:text=Women%20between%2040%20and%2044,choose%20to%20continue%20yearly%20mammograms.">https://www.cancer.org/cancer/types/breast-cancer/mammogram-tips-infographic.html#:~:text=Women%20between%2040%20and%2044,choose%20to%20continue%20yearly%20mammograms.</a></i></span></p><p><i><span style="font-size: x-small;">1)<span style="white-space: pre;"> "</span></span></i><span style="font-size: x-small;"><span style="white-space: pre;"><i>Breast Cancer in Young Women"- Cleveland Clinic: </i></span></span><i><span style="font-size: x-small;"><a href="https://my.clevelandclinic.org/health/articles/16805-breast-cancer-in-young-women">https://my.clevelandclinic.org/health/articles/16805-breast-cancer-in-young-women</a></span></i></p><p><i><span style="font-size: x-small;">2) "</span></i><span style="font-size: x-small;"><i>What additional breast cancer screening tests are available for women who have dense breasts?"- Yale medicine- </i></span><i><span style="font-size: x-small;"><a href="https://www.yalemedicine.org/conditions/dense-breasts#:~:text=Women%20diagnosed%20with%20dense%20breasts,(whole%2Dbreast%20ultrasound)">https://www.yalemedicine.org/conditions/dense-breasts#:~:text=Women%20diagnosed%20with%20dense%20breasts,(whole%2Dbreast%20ultrasound)</a>.</span></i></p><p><i><span style="font-size: x-small;">3) Columbia Doctors/ "</span></i><span style="font-size: x-small;"><i>What Are Dense Breasts? </i></span><i style="font-size: small;">A radiologist offers guidance":-</i><span style="font-size: x-small;"><i>Health Insights: October 14, 2022</i></span><i><span style="font-size: x-small;"><span style="white-space: pre;"> </span><a href="https://www.columbiadoctors.org/news/what-are-dense-breasts#:~:text=Any%20woman%20who%20has%20dense,in%20women%20with%20dense%20breasts">https://www.columbiadoctors.org/news/what-are-dense-breasts#:~:text=Any%20woman%20who%20has%20dense,in%20women%20with%20dense%20breasts</a>.</span></i></p><p><i><span style="font-size: x-small;"><br /></span></i></p><div><hr /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg0Vevjps5FavoOlBO5I4HUKCVlLOCFHVntCRwqqWiw3anyPGzcmaLI_w-Hqnme09UsZTFzUCZ2NLz_sy7J9upxRBEFoF05U6glKxdoY3TEnNqhHc5OT_BGWmez2g8qcszxj9g3sZyKLcNQnzWnAASG2_xiE14orzEuGGsd8UUl8KVbDLxoM1t8Zi-oIGHU/s362/editorial.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="80" data-original-width="362" height="34" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg0Vevjps5FavoOlBO5I4HUKCVlLOCFHVntCRwqqWiw3anyPGzcmaLI_w-Hqnme09UsZTFzUCZ2NLz_sy7J9upxRBEFoF05U6glKxdoY3TEnNqhHc5OT_BGWmez2g8qcszxj9g3sZyKLcNQnzWnAASG2_xiE14orzEuGGsd8UUl8KVbDLxoM1t8Zi-oIGHU/w152-h34/editorial.jpg" width="152" /></a></div><br /><div><br /></div><div><br /></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjz1bTADyoWt839NqXl3FRIP-0J2H0C9UvqSgAKtiNsY7o-HsWhbDVT92kCNDmYlJuvEjdJf5VtDwqvM0WEKQ-D_4e7jiYgf7YRTqjtyUkSKKwad0ou5Qz-jo5YHhTSJt1e17YXewMffa-TnUeQhGWeXDXne9_5jem4P38B2RHpfxvUU4evjzJduFlPcowb/s108/NOELLE.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="108" data-original-width="99" height="108" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjz1bTADyoWt839NqXl3FRIP-0J2H0C9UvqSgAKtiNsY7o-HsWhbDVT92kCNDmYlJuvEjdJf5VtDwqvM0WEKQ-D_4e7jiYgf7YRTqjtyUkSKKwad0ou5Qz-jo5YHhTSJt1e17YXewMffa-TnUeQhGWeXDXne9_5jem4P38B2RHpfxvUU4evjzJduFlPcowb/s1600/NOELLE.jpg" width="99" /></a></div><i>"In order to catch cancer, you need to be able to detect it at an early stage so we can treat patients with the most effective mechanisms. Ultrasounds are an easy, cost-effective method for screening for early breast cancers, especially in women below the age of 45, who are likely to have dense breasts. When you are young and premenopausal your breasts are dense and we know that breast density is linked to cancer and which also makes it harder for cancers to be seen on a mammogram. Although breast cancer is rare in women under the age of 40, early detection is key. Public health campaigns are spending so much money on mammograms for this population of women who can easily and cost effectively be screened using an ultrasound."</i> - By: Noelle Cutter, PhD </div><div><br /></div><div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgfQoHXfPmyEoqXRHAnSIwH2nFgrDN9a2OJJAcTkvtzf2AFZDMtpBoF61XTXzKbxGz7YPv1HzlrkJ6iL1DbZCAZrrMoSk9xJP8KikLTi8mw8Cn9eOiYfFazVScI342Y4S6C_bYS-WwP9-n64Hc-Zfdqsnnj41_ZkWhVe3L1sOHUbT4aTpl28zyDGH5MKGFv/s200/MARY.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="200" data-original-width="200" height="94" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgfQoHXfPmyEoqXRHAnSIwH2nFgrDN9a2OJJAcTkvtzf2AFZDMtpBoF61XTXzKbxGz7YPv1HzlrkJ6iL1DbZCAZrrMoSk9xJP8KikLTi8mw8Cn9eOiYfFazVScI342Y4S6C_bYS-WwP9-n64Hc-Zfdqsnnj41_ZkWhVe3L1sOHUbT4aTpl28zyDGH5MKGFv/w94-h94/MARY.jpg" width="94" /></a></div><i>"I LOVE this new program! Early detection is essential! There is a stigmatization around mammograms that they are painful and frightening. There is anxiety while you wait for the results. And, don't forget the appointment scheduling hassle. Women, particularly younger women with active lives, small children, careers don't want to have to fit one more thing into their hectic and demanding schedules. However, mammogram technology itself has advanced and it no longer has to be a painful experience. Clinics and imaging centers are offering untraditional scheduling opportunities, such as very early morning appointments to late evening appointments that are timed for very minimal wait times. And, clinicians are often prioritizing mammogram interpretations so the results are back within 24 hours. The Self Care message is trending right now. Mammograms should be a part of self care."</i> - By: Mary Nielsen, Tigard, OR</div></div><div><br /></div><div><br /></div><div><hr /></div><div><span style="font-size: large;"><br /></span></div><div><div><span style="font-size: large;">"EARLIER DETECTION"- REACHING A GENERATION IN CRISIS </span>By: Alexandra Fiederlein (23)</div><div>Edited by: <a href="https://robertaklinemd.com/">Dr. Roberta Kline</a> and Carmen Regallo-Dewitt</div><div><br /></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiFrhBSFCb9_8DNfMJQaTsdNZmeKVdQt0cnE29bmcs5VAKjJlFSiaDiK2tSveLb5tZoKaxW-k4EPB9KoAcc_kTmqBRCUnFq4ZNWzyOwcH8sot8LDyP758qwKXDzMyRJi1PwhVOvOckmj9VkWzVCcm8hSIfucewSsLeVDMJP1xyJyf-BJi7lQZ3nX4skoyYV/s2432/22.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="1080" data-original-width="2432" height="177" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiFrhBSFCb9_8DNfMJQaTsdNZmeKVdQt0cnE29bmcs5VAKjJlFSiaDiK2tSveLb5tZoKaxW-k4EPB9KoAcc_kTmqBRCUnFq4ZNWzyOwcH8sot8LDyP758qwKXDzMyRJi1PwhVOvOckmj9VkWzVCcm8hSIfucewSsLeVDMJP1xyJyf-BJi7lQZ3nX4skoyYV/w399-h177/22.jpg" width="399" /></a></div>I belong to the graduate-level age group that continues to witness the increasing numbers of breast cancer cases in our country. The women in this generation also happens to be the next group that falls prey to being UNDERDIAGNOSED. Insurance companies and the medical community have made little or no action to support or identify the need for women in their 20's and 30's to be approved for standardized early detection / breast cancer screening. </div><div><br /></div><div>From the front-row perspective, younger women are as much at risk of getting cancer. Reports show an uptick in genetic predisposition for breast cancer*, alongside a dangerous attitude of denial. Addressing this calls for widespread education and screening programs in our community as essentials to a life of wellness and prevention. To subscribe to a regular screening routine at the early stage of womanhood raises awareness and prevention for decades to come. Perhaps someday, installing breast cancer screening centers in college campuses may be commonplace and a powerful step toward a national prevention initiative.</div><div><br /></div><div><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: right; margin-left: 1em; text-align: right;"><tbody><tr><td style="text-align: center;"><a href="https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2022-2024-breast-cancer-fact-figures-acs.pdf" style="clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><img border="0" data-original-height="324" data-original-width="588" height="119" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj-XZK1ykl3Bsiw3JOAG819-2dt7uf7fsN0aTsjknXJpr6mOQI_fiUa9RavV5JfhHQjBGzs-_WJyY7WYRDD_I41aeaEVwRpe__mvPvh6oaPPN34jR7L5mVXSb0m2lSv-g6qYpax0HlPjcRacOa1WjfD7gxD3PJLzt2AGaToxEFdOzkkzQWIPqwwUTlvFSJg/w217-h119/2022-cover-wide-breast-cancer-facts-and-figures-588.jpg" width="217" /></a></td></tr><tr><td class="tr-caption" style="text-align: center;"><span style="font-size: x-small;"><i><a href="https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2022-2024-breast-cancer-fact-figures-acs.pdf">Click to download</a> the latest ACS report</i></span></td></tr></tbody></table>Targeting the <b>young working PROFESSIONAL</b> is a major part of our population, where the vast majority tends to put off checkups and screenings because they are just "too busy". Professional women need to value their health above anything else, and therefore the narrative needs to be amplified in that area. We find this problem to be quite prevalent in urban areas with the constant on-the-go culture. Offering local resources and improved access for personal scanning are just some progress driven programs. </div><div><br /></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiei8P7QAh-W3Fnmb8H6EjdwslNaacXSuLJ6vUWjj-KSPSQQ6_d5jR1urr-mRlSToQh_R03jubSG-OqFTWXTNQgzSpWES7JiTt0xv2fBZBTISlehBS9ZdDC5i1wH7x-WkG7Pe7OumCyCblTt_27orhCKa9y0KAQVeZjpc6sAIzt6BemLFKt-m0jHOmKgu4D/s3096/34.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="3096" data-original-width="1956" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiei8P7QAh-W3Fnmb8H6EjdwslNaacXSuLJ6vUWjj-KSPSQQ6_d5jR1urr-mRlSToQh_R03jubSG-OqFTWXTNQgzSpWES7JiTt0xv2fBZBTISlehBS9ZdDC5i1wH7x-WkG7Pe7OumCyCblTt_27orhCKa9y0KAQVeZjpc6sAIzt6BemLFKt-m0jHOmKgu4D/s320/34.jpg" width="202" /></a></div><b>GEN Z</b> is a sensible focus group because these are the women who absolutely must receive routine scanning. We need to advocate for the narrative that age 40 is not the starting age where screening needs to begin- especially since we are now seeing cancer cases in younger ages are growing in numbers. Getting OB/GYN professionals on board is especially important because this is where women are getting their prescriptions. </div><div><br /></div><div>We need to educate on the benefits of ultrasound. People need to know HOW it works, WHY it works, and why it holds certain benefits over a mammogram. People need to know that it is SAFE and EFFECTIVE, and this technology can save lives. I think it is especially important to emphasize the option of ultrasound for younger women. Many younger women have dense breasts and don't even know it, putting them at a greater risk (I wouldn't have known if it weren't for all of you!). Ultrasound is obviously a safe and effective screening method for young women. It is also not linked with the stigma/fear of getting a mammogram like many women my age hold (X-Ray exposure, etc.). </div><div><br /></div><div>If the drive for EARLIER DETECTION means proactive awareness, may this lead to turning social concern into clinical action. This includes clinicians joining hands with advocacy groups who recognize the many potential areas for at-risk women in my generation whose lives and safety continue to go unrecognized. And once the count of cancer cases and deaths rise exponentially due to inaction, perhaps then will the medical community find urgency in upgrading the required breast cancer screening age to (finally) include generations like mine. So say we all! </div></div><div><br /></div><div>Ref:</div><div><div><span style="font-size: x-small;">*Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures, PMC9038417. (NIH)- <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038417/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038417/</a></span></div><div><br /></div><div><br /></div></div><div>ALSO SEE:</div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhbyRVe9biDfDKdsUV_Ebn91tOheyT9qz86kxmXq9zz46Ga9K4Gck3UU2o5R6VS6DzLH_IRQM31G42UKZm-pJlQMtZkKS8SesiDXDBbQ3VaVIkeEBZbEhblb3QI6gw47B8sTc7mbdupVWhcxNS5EoMsyPikFndB8n0GBTVFNabH5of6bsbXfsG14hDbWOXQ/s480/bigger.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="320" data-original-width="480" height="125" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhbyRVe9biDfDKdsUV_Ebn91tOheyT9qz86kxmXq9zz46Ga9K4Gck3UU2o5R6VS6DzLH_IRQM31G42UKZm-pJlQMtZkKS8SesiDXDBbQ3VaVIkeEBZbEhblb3QI6gw47B8sTc7mbdupVWhcxNS5EoMsyPikFndB8n0GBTVFNabH5of6bsbXfsG14hDbWOXQ/w188-h125/bigger.jpg" width="188" /></a></div><div><span style="background-color: white; color: #222222; font-family: times; font-size: 13.2px; text-align: justify;">A major concern is the presence of breast cancer in underserved communities, including those TOO YOUNG FOR A MAMMOGRAM. Whereby the medical community touts the recommended (and legal/billable status) of getting a mammo scan should be between 40-50, what happens to the many women who do not fit this age criteria? How would they even know to get checked without the support of their clinicians or an alarm from family history? </span><span style="background-color: white; color: #222222; font-family: times; font-size: 13.2px; text-align: justify;">Decades into the battle against breast cancer, clinicians and the public are much more educated about EARLY DETECTION, PREVENTION and the current protocols and modalities available to save lives. Recent headlines on DENSE BREAST and the advancements in ULTRASOUND SCANNING supports a major part of this battle. <a href="https://breastcancerblognews.blogspot.com/2023/10/early-detection-alert-risk-of-being-too_20.html">SEE COMPLETE FEATURE</a></span></div><div><br /></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-10612847330494140092023-10-24T05:46:00.033-07:002023-10-27T11:14:50.118-07:00NANCY'S LIST: The Power of Compassion and Loving Help<p></p><div class="separator" style="clear: both; text-align: center;"><br /></div><div style="text-align: center;"><iframe allow="autoplay; fullscreen; picture-in-picture" frameborder="0" height="338" src="https://player.vimeo.com/video/878768329?badge=0&autopause=0&quality_selector=1&player_id=0&app_id=58479" title="nancy-interview" width="600"></iframe></div><div style="text-align: center;"><br /></div><div style="text-align: left;">INTRODUCTION</div><div style="text-align: justify;">10/12/2023- For so many in the cancer community, it is rare to spot a bouquet of white roses and not think about the kindness and the giving spirit of <a href="http://Dr.">Dr.</a> <a href="https://nancyslist.org/">Nancy Novack</a>, founder and CEO of Nancy's List (<a href="http://NancysList.org">NancysList.org</a>). This year, Nancy (as she prefers to be addressed) was inducted unanimously by the collective board of the Integrative Cancer Resource Society (ICRS) as "the Top 2023 Cancer Crusader" during the Fall Women's Roundtable Powermeet Conference. </div><p></p><p style="text-align: justify;">This meeting, hosted by the Coalition for Women's Cancers aligned a special grouping of community leaders, clinicians and advocates working together to share information about the current state of cancer care. "It was such an honor to finally be connected with Nancy", starts Dr. Leslie Valle-Montoya- recently elected executive director of ICRS. "You couldn't be in the cancer awareness community and not hear about Nancy's List. To hear firsthand HER story (with that soft and genuinely loving voice) including how it all started truly hits you deep into your soul- and makes you want to be part of her mission!"</p><p></p><div style="text-align: justify;">Nancy's List is a free website that started in 2008, researching, organizing and publishing resources for cancer patients and survivors. According to the website, it's core beliefs "inspire community-wide support system for children, teens, and adults who are living with, through, and beyond cancer. Nancy's List is a compassionate grassroots effort committed to significantly improving the quality of life for these individuals, their families, and their caregivers. </div><div style="text-align: justify;"><br /></div><p></p><p></p><div style="text-align: justify;">INSPIRING OUR COMMUNITY "TO BE THE VERY BEST IT CAN BE" - From an interview by: Nancy Novack</div><p></p><p style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg6TbAuQeXLDN77S-XeOLd_q-0wf5-LThOQeq76jK2lLfCd-Sozhycogu_O4ORWVVY1Fa9IXGamX7F32_uCxdlU8AVFLMxwYlVKg7Ra3DAGZbmDf6-hwsPyn0Zz6SkNscKnZNSlUVWCPvoTBIZ62k_-9NatS6W0G3SMR0I0SEca5iiUUkwPQva_dEMV2et-/s645/fyi-cause.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="645" data-original-width="450" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg6TbAuQeXLDN77S-XeOLd_q-0wf5-LThOQeq76jK2lLfCd-Sozhycogu_O4ORWVVY1Fa9IXGamX7F32_uCxdlU8AVFLMxwYlVKg7Ra3DAGZbmDf6-hwsPyn0Zz6SkNscKnZNSlUVWCPvoTBIZ62k_-9NatS6W0G3SMR0I0SEca5iiUUkwPQva_dEMV2et-/s320/fyi-cause.jpg" width="223" /></a></div>I am a survivor of 20 years of stage four ovarian cancer. I knew nothing about cancer at that time, and just was complaining of what I thought was an appendicitis attack. (Of course) that didn't turn out that way. I was swept away to Stanford where I was treated pretty traditionally by a wonderful man whom I have a tremendous amount of respect and trust in- and I haven't had a recurrence in 20 years. I love being Stanford's poster poster child, but I think in the process I learned a great deal about the psychology (which I'm a psychologist) of cancer. I don't have the medical knowledge, but I certainly understand the psychology within my work with so many cancer patients.<p></p><p></p><div style="text-align: justify;">As it turned out, I spent a great deal of time in the infusion room with a ton of chemo. Because I'm a psychologist, I tend to ask a lot of questions and started talking to everybody in the room about what their experience was. I call it immediate intimacy that you have with another cancer patient. All of a sudden you cut through everything and you're everybody's best friend, and what I was struck by was the amount of fear that went into (not about dying, but) the fact that they didn't have enough money to have cancer. And that they feared that if they told their doctors they wouldn't be treated if they told their doctors that they couldn't afford their medications- and instead put food on the table for their families, they would be dismissed. So many stories of people telling me deep pain that they were suffering and a lot of stress about the money. </div><div style="text-align: justify;"><br /></div><p></p><p></p><div style="text-align: justify;">AFFORDING CANCER</div><div style="text-align: justify;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEixRLuuFr4z7wrqOcZXtarziFfgG2sEXvlgZGdCLUt26LeCtgsa5gN_feOssnHU5mjVcz_KXbNCmHsnQxF21B3etosfHfOTyufVESvZxzd-uMIBD3PXFKqSFAJTmsdsfzp1Lffg0nbT90-Z_AmWkLo5_Dq8C9LHSpq5KigufBHPrsVTLS-0zWDrw4oEMPdy/s5616/shutterstock_154905602.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="3744" data-original-width="5616" height="168" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEixRLuuFr4z7wrqOcZXtarziFfgG2sEXvlgZGdCLUt26LeCtgsa5gN_feOssnHU5mjVcz_KXbNCmHsnQxF21B3etosfHfOTyufVESvZxzd-uMIBD3PXFKqSFAJTmsdsfzp1Lffg0nbT90-Z_AmWkLo5_Dq8C9LHSpq5KigufBHPrsVTLS-0zWDrw4oEMPdy/w253-h168/shutterstock_154905602.jpg" width="253" /></a></div>They didn't get why they were so vulnerable but they all came to together and did a community action to adopt the families that were living in Marin. Most of this early group had prostate cancer and breast cancer. It was almost like an epidemic. It was huge numbers, and we just adopted them. And the little kids sent get well cards. The teenagers made food for the families. It was just an all out community action. And then that changed and it became a club for kids who were living with cancer where we went on adventures every weekend like going sailing. These were kids that had all kinds of brain cancer or leukemia. They're all alive today and I still hear from them, but during that time, they got to be kids. And that was important to me that they have that opportunity to be kids; they were supportive of each other, and they all ended up going to camps together for, for cancer kids and their families. It was a great project and it just kept changing a little bit when I see something that needs to happen. </div><p></p><p style="text-align: justify;">I'm still working on the financial resources every day. However, since the pandemic, I find cancer patients also have a lot of problems with Covid-- and again, people just don't have money to support themselves. Cancer survivors are so vulnerable as covid patients so finding out the foundations that can support people who have cancer AND have Covid. </p><p style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi7Kq4pvBN3JjC4qGoQjVUyFU62zsgfx0A4RJ1KJxbaUyGErWIH9ODAJiA7CaYyq0MJ2lfLaUES15gTD7w43G6liIx2I_yGK9x9uQXrBIeUIHzP6_FdxmZX_TV_GdyCn4ltLDDOBFipOFKOqGpb3BoO3aJbHXX-cCbrvdBjGBr3kgvWuvguxMDisoBV56ON/s3744/psoter1.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="3744" data-original-width="3306" height="307" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi7Kq4pvBN3JjC4qGoQjVUyFU62zsgfx0A4RJ1KJxbaUyGErWIH9ODAJiA7CaYyq0MJ2lfLaUES15gTD7w43G6liIx2I_yGK9x9uQXrBIeUIHzP6_FdxmZX_TV_GdyCn4ltLDDOBFipOFKOqGpb3BoO3aJbHXX-cCbrvdBjGBr3kgvWuvguxMDisoBV56ON/w271-h307/psoter1.jpg" width="271" /></a></div>When I moved to Texas, I lost my license to practice legally. I still help people by phone, but I don't have a legitimate license here. There's no reciprocity with California, which shouldn't surprise anybody. So I decided I could make a bigger network without a license and just kept identifying needs. And one was to make people much more aware of integrative oncology and how this could really support and deepen the healing process. <p></p><p></p><div style="text-align: justify;">We have a huge director, probably a thousand people all over the country of practitioners and healing centers that they can access. That's been very well received because they don't know this stuff on their own. It explains all the different modalities that are well connected with common will. I think my job (here) is to connect people with different resources that can help them focus on the real healing process at the same time. We have a real push for quality of life stuff that really gives them a free retreat or a free cancer camp, or a wish fulfillment project - something that really deepens their family connections and connects them emotionally to one another and to their bodies. I still talk about that a lot in many podcasts where we dive into financial resources and quality of life.</div><p></p><p></p><div style="text-align: justify;">THE DENSE BREAST PARADIGM</div><div style="text-align: justify;">Another panelist of the Cancer Powermeet was <a href="https://breastcancerblognews.blogspot.com/2023/09/national-advocacy-honors-breast-cancer.html">Joe Cappello of the "Are You Dense" Foundation</a>, who was astonished at how Nancy fully-related to his awareness mission about Dense Breasts and its links to cancer. "I actually have dense breasts", starts Nancy. "...and nobody has done a thing about it any different than the old fashioned mammogram. And every time I go in there and I say, "but wait a minute, what about sonogram?"... and they act like this is such an odd request. I'm very interested in this subject and I'd like to help you educate more women about this and what's available to them. I believe they can push for the same kind of techniques that we should all be having. I do worry about it because I've been following Dr. (Robert) Bard's work and that's a concern to me. And probably many of the women that I deal with-- 40% post-menopausal women, sign us up! My ultimate job is to educate people and give them opportunities and possibilities other than the leftovers that we've been doing for so long." </div><div style="text-align: justify;"><br /></div><p></p><p></p><div style="text-align: justify;"><div class="separator" style="clear: both; text-align: center;"><br /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgJX_fHkCRD_WGStjFgmx29gNWjdKLPN_VDAiLBYr6d-378Xkf-RHWbvDLMkhiM5wBsow7-cUp25MbmNqjk7dLLYkBtZRM8xzN93obqrILhJKW0Bs-qGIjFNEWdilSR6w5eB2OZgAgkfErOySExhdA4HjwhqVS9av6OdTkB827M6VrvlLCSNfOOzIsohGyD/s1824/6.jpg" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="783" data-original-width="1824" height="201" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgJX_fHkCRD_WGStjFgmx29gNWjdKLPN_VDAiLBYr6d-378Xkf-RHWbvDLMkhiM5wBsow7-cUp25MbmNqjk7dLLYkBtZRM8xzN93obqrILhJKW0Bs-qGIjFNEWdilSR6w5eB2OZgAgkfErOySExhdA4HjwhqVS9av6OdTkB827M6VrvlLCSNfOOzIsohGyD/w469-h201/6.jpg" width="469" /></a></div><br />A CONTAGIOUS LEGACY OF COMPASSION AND ANSWER-FINDING </div><div style="text-align: justify;">Dr. Leslie-Montoya underscores Nancy's monumental achievements by building what many call "the largest national cancer resource online... just about every support resource and cancer doc and healer from every type of modality is at Nancy's list!". Moderator <a href="http://lennardgettz.com/">Lennard Goetze</a> (founder of the now-national ICRS charter) admits in this forum that each time he produces a group and mentions the word 'resource', he thinks of Nancy every time. "To follow in her footsteps or even being in her shadow is goodness x10! I drive so many cancer patients and their families to her site, and I also find myself to reference it 'too often' either to get inspired and/or to find that kind of helpful information." He adds, "With great thanks to Nancy Novack, I have become a patient advocate (by profession), a publisher of cancer news and even a call-in center for many cancer cases (alongside my publishing partners "<a href="http://cousinsal.org/">Cousin Sal" Banchitta</a> and <a href="https://drrobertbard.com/">Dr. Robert Bard</a> in our "Get Checked Now!" program). Giving of ourselves in the form of education, advocacy and resource sharing has made us all a cancer resource ourselves... I guess being touched by Nancy is CONTAGIOUS!"</div><p></p><p style="text-align: justify;">The continuance of Nancy's inspiration also sparked the next ICRS development of the 2024 WOMEN'S HEALTH DIGEST- a collaborative free publication managed/edited by Dr. Roberta (Bobbi) Kline- offering field-based articles, videos and reports by clinical professionals and academic educators. WHD is collectively designed mostly "by women for women" in support of women's health, lifestyle and early detection, and a significant section covers the latest topics about women's cancers.</p><p></p><hr style="text-align: justify;" /><p></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjl0WIYX3Z7Kzt_ox7ubDTIxgIhPMsBgRtXrA8ttKoJoPyzSBrmozGJFxiZL7bZV3ezKUQZphsLMtD9oLdvOVDKgahdkN-8CkIHV8VRp7Ytf7hbvedV_Ifs3sOnlxX76rjiOIjKVGM2Oxu3DRZT11JGe_yTh6X_uwihz1R5AAcNmkDJ1f_MaqSgen2wRhMx/s6840/V.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="3538" data-original-width="6840" height="68" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjl0WIYX3Z7Kzt_ox7ubDTIxgIhPMsBgRtXrA8ttKoJoPyzSBrmozGJFxiZL7bZV3ezKUQZphsLMtD9oLdvOVDKgahdkN-8CkIHV8VRp7Ytf7hbvedV_Ifs3sOnlxX76rjiOIjKVGM2Oxu3DRZT11JGe_yTh6X_uwihz1R5AAcNmkDJ1f_MaqSgen2wRhMx/w131-h68/V.jpg" width="131" /></a></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><br /></div><p></p><p style="text-align: justify;"><br /></p><p></p><div style="text-align: justify;"><span style="font-family: arial; font-size: large;"><br /></span></div><div style="text-align: left;"><span style="font-family: arial; font-size: large;">2024 CLINICAL PROFILE OF THE DENSE BREAST PARADIGM - </span><span style="font-family: arial; font-size: large; text-align: justify;">for the Obstetrics & Gynecology Society </span></div><div style="text-align: justify;">Written by: <a href="https://robertaklinemd.com/">Roberta Kline, MD</a></div><div style="text-align: justify;">Published by ICRS Medical Press Ltd.</div><p></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh6yc61oHPGJNeKfER9BRMecasuvYIcXTeUtpzrj9yvjHAOEAnvGUdOpX7oInUxejVrfmCMoG6aiGMFlq7D7kH_NtTytSfbSp1rNy9PK2zBnFf2uRxW0CkYeXzK8KY5H7FIjPHk-x9lDykn6SMEy5z-9rHnGdZM4SZ_LC0E9vf-L9WY3ye8dXB59gkn57SH/s547/3D-book-on-white.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="547" data-original-width="346" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh6yc61oHPGJNeKfER9BRMecasuvYIcXTeUtpzrj9yvjHAOEAnvGUdOpX7oInUxejVrfmCMoG6aiGMFlq7D7kH_NtTytSfbSp1rNy9PK2zBnFf2uRxW0CkYeXzK8KY5H7FIjPHk-x9lDykn6SMEy5z-9rHnGdZM4SZ_LC0E9vf-L9WY3ye8dXB59gkn57SH/s320/3D-book-on-white.jpg" width="202" /></a></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">Breast cancer affects the lives of hundreds of thousands of women every year and is a leading cause of death. While we have made great progress in advancing earlier diagnosis and more individualized treatments, we still need to improve our approach to achieve our ultimate goal - prevention. This requires a deeper understanding of the molecular mechanisms and the multitude of factors that contribute to the development of breast cancer. </div><div style="text-align: justify;"><br /></div><div><div style="text-align: justify;">Dr. Roberta Kline, recognized speaker and publishing crusader for women's health brings you a comprehensive review and a deep-dive analysis of the current research findings about breast density and its major risk factors for breast cancer. Her reports uncover current imaging practices and clinical protocols updated in great support of breast density detection and the means of addressing this growing condition that affects over 45% of the female population. "Knowing a woman has greater breast density is a critical first step, but it doesn’t end there... we need to go further by understanding the causes of breast density, and how they relate to breast cancer-- we now have another avenue to proactively intervene to reduce risk or even prevent breast cancer in the first place." This textbook is a champion in targeting the <b>Dense Breast Paradigm</b> as a blueprint and a clear course study for all clinical professionals who are dedicated to women's early detection and prevention programs. <a href="https://cancerresourcealliance.blogspot.com/2023/09/epigenetic-research-notes-profiling.html">(More information)</a><br /><br /></div><hr /><br /><div style="text-align: justify;"><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEggL5beCQWkgijCP8Bex0Jvtgayn4rZfINwktSYXUxt3ySX9zfiyUl8pO0cJWLuvxx6OaChDxGHipfPqB5yJ4hgCEm8AsG_KPZFnkgq6bhvMfmbEBbh5dDzHPgqBOwWS9mq5E0PCW4_Zy78YwrE0qJ8rOt2ediwhEyRiURhB0eD2JdkXJKAFRqcAOqkTuPb/s297/blocc.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="195" data-original-width="297" height="195" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEggL5beCQWkgijCP8Bex0Jvtgayn4rZfINwktSYXUxt3ySX9zfiyUl8pO0cJWLuvxx6OaChDxGHipfPqB5yJ4hgCEm8AsG_KPZFnkgq6bhvMfmbEBbh5dDzHPgqBOwWS9mq5E0PCW4_Zy78YwrE0qJ8rOt2ediwhEyRiURhB0eD2JdkXJKAFRqcAOqkTuPb/s1600/blocc.jpg" width="297" /></a></div>LAUNCHING IN 2024: NATIONAL COALITION OF WOMEN'S HEALTH SUPPORT</div><div>Professional health orgs, foundations and advocates of women's health disorders (primarily cancers) is uniting to form a national alliance of collaborators. This collective group is focused on "doing more together" as far as exploring new resources, sharing current ideas and addressing a wide range of topics about women's issues. Meetings like our latest Women's Powermeet series discussed the latest in diagnostic and therapeutic solutions while introducing who's who in national crusadership in the advocacy realm. Clinicians are also welcome to discuss patient-dedicated road maps and a more thoughtful health analysis and research-based evaluation. It is this level of commitment to women's health that provides a deeper sense of care for the patient that lends itself to a more holistic and integrative strategy to therapeutics. It is also this philosophy that draws more intuitive and insightful awareness on a global scale to offer collaboration platforms too better share insights on a patient's disorders to seek out better solutions. (<a href="http://fightrecurrence.com/">See Women's Health Digest</a>)</div></div><div style="text-align: justify;"><br /></div><p></p><p style="text-align: justify;"></p><hr /><p></p><p style="text-align: justify;"><span style="font-family: arial; font-size: medium;"><b>WOMEN’S HEALTH DIGEST</b></span></p><p style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjP7yO5QXtk8KW2ElyXfL5p4-f6ANAMXY6T-FKZNdEz25-T7Npo5GzmxhUyo7S3QkIxMECU6MHZ9IFtcIqqeww8ArMZfI5QK15sX9tKQ0Yeg0XTBYY3ggV5deVfHs9ghP-02deeSVl0MuTYedqzza-6aZNGYb0dzYacRqagYCQcmeabPpF_GZsUDTjxKn76/s295/womenshealth_cover.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="295" data-original-width="228" height="181" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjP7yO5QXtk8KW2ElyXfL5p4-f6ANAMXY6T-FKZNdEz25-T7Npo5GzmxhUyo7S3QkIxMECU6MHZ9IFtcIqqeww8ArMZfI5QK15sX9tKQ0Yeg0XTBYY3ggV5deVfHs9ghP-02deeSVl0MuTYedqzza-6aZNGYb0dzYacRqagYCQcmeabPpF_GZsUDTjxKn76/w140-h181/womenshealth_cover.jpg" width="140" /></a></div>From the publishers of THE WELLNESS JOURNAL and the WOMEN'S DIAGNOSTIC NETWORK NEWS comes a consortium of IPHA'S top professional contributors in women's health & wellness advocacy. Subscribe to our latest community E-news forum and get the insiders news on pain therapeutics, diagnostics and lifestyle upgrades. We welcome special guest contributors from all modalities of healing - from practitioners, product innovators and researchers. Also, gain valuable insight from success stories of real people and their experience with WHAT WORKED for them! Get front row access to our latest headlines. Visit: <a href="http://WomensHealthDigest.org">WomensHealthDigest.org</a><p></p><br /><p style="text-align: justify;"><br /></p><p></p></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-2092161384349530492023-10-20T06:35:00.005-07:002023-10-20T06:35:37.679-07:00Early Detection Alert: The Risk of Being "Too Young for a Mammogram"<p><br /></p><div class="post-header" style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 10.8px; line-height: 1.6; margin: 0px 0px 1.5em;"><div class="post-header-line-1"></div></div><div class="post-body entry-content" id="post-body-7401616973675580816" itemprop="description articleBody" style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; line-height: 1.4; position: relative; width: 660px;"><div class="separator" style="clear: both; color: #444444; font-size: 13px; text-align: justify;"><span style="color: #222222; font-family: times; font-size: 13.2px;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh6E7oeDaC9zXLgnBZTw16Org48IIsGYkfhhKkf4t8Ztvk9v2lC_68cfEU8l1RmBwLWuBsj40eEQufIUa5IJ0_XRxFOd81Or-qDOtQ51ukBuj0pCmXmj8QyHuNVzRIS7l0oHxK2Uthydn3sTI8qrenMHJE8SvuOBKW2V3fCcQ7BLwvIs5nSyt-FU-JWu6DY/s480/bigger.jpg" imageanchor="1" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="320" data-original-width="480" height="213" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh6E7oeDaC9zXLgnBZTw16Org48IIsGYkfhhKkf4t8Ztvk9v2lC_68cfEU8l1RmBwLWuBsj40eEQufIUa5IJ0_XRxFOd81Or-qDOtQ51ukBuj0pCmXmj8QyHuNVzRIS7l0oHxK2Uthydn3sTI8qrenMHJE8SvuOBKW2V3fCcQ7BLwvIs5nSyt-FU-JWu6DY/s320/bigger.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="320" /></a></div>A major concern is the presence of breast cancer in underserved communities, including those TOO YOUNG FOR A MAMMOGRAM. Whereby the medical community touts the recommended (and legal/billable status) of getting a mammo scan should be between 40-50, what happens to the many women who do not fit this age criteria? How would they even know to get checked without the support of their clinicians or an alarm from family history?<br /><br /></span><span style="color: #222222; font-family: times; font-size: 13.2px;">Decades into the battle against breast cancer, clinicians and the public are much more educated about EARLY DETECTION, PREVENTION and the current protocols and modalities available to save lives. Recent headlines on DENSE BREAST and the advancements in ULTRASOUND SCANNING supports a major part of this battle.</span></div><div class="separator" style="clear: both; text-align: justify;"><span style="font-family: times;"><div class="separator" style="clear: both;"><br /></div><div class="separator" style="clear: both;"><div class="separator" style="clear: both; color: black; font-family: "Times New Roman"; font-size: medium;"><span style="color: #222222; font-family: times;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; color: #444444;"><br /></div><div class="separator" style="clear: both; color: #444444; text-align: left;"><div class="separator" style="clear: both; font-size: 13px; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgeGQhE2wd2kkljEDIjS7yodzEXHHS4yNSKFPBoaN95OrLp7D8BiLHW125KWGKzsfErnWMv3pIrE2nqkCZDj8LQPdGne8OxEekY7PW3HTkdK5wr0JqW1QOz1-JRFmjJEH3GcBk8oL3gNI__n_AV54iXXXCt0kHvJ4vySCesaxPb9tE-yQL-wwqtpDMaNA/s2248/headshot2.jpg" style="clear: left; color: #2288bb; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="2248" data-original-width="1665" height="104" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgeGQhE2wd2kkljEDIjS7yodzEXHHS4yNSKFPBoaN95OrLp7D8BiLHW125KWGKzsfErnWMv3pIrE2nqkCZDj8LQPdGne8OxEekY7PW3HTkdK5wr0JqW1QOz1-JRFmjJEH3GcBk8oL3gNI__n_AV54iXXXCt0kHvJ4vySCesaxPb9tE-yQL-wwqtpDMaNA/w77-h104/headshot2.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border-radius: 0px; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="77" /></a></div><span style="text-align: justify; text-indent: 24px;">WHAT ABOUT IF YOU'RE TOO YOUNG FOR A MAMMOGRAM? </span><span style="text-align: justify; text-indent: 24px;"><i>I went to my doctor for a lump I felt in my breast and she gave me a response that set off red flags: "don't worry about it". Being a researcher involved in breast density and breast cancer, I knew that I had to take action; I was fortunate enough to have my breast ultrasound training with Dr. Robert Bard (cancer imaging specialist, NYC) upcoming in the next week. Dr. Bard showed me how to use the ultrasound to help me find two benign tumors in my breasts, and it was there that he reported that I have dense breasts. Had I not taken action in getting screened at the young age of 22, I would have never known that I should be getting screened via ultrasound every 6 months (because having dense breasts puts me at a higher risk for breast cancer), nor would I have known that I had benign breast tumors. </i></span></div><div class="separator" style="clear: both; color: #444444; text-align: left;"><span style="text-align: justify; text-indent: 24px;"><br /></span></div><div class="separator" style="clear: both; color: #444444; text-align: right;"><span style="text-align: justify; text-indent: 24px;">- ALEXANDRA FIEDERLEIN, 22</span></div><div class="separator" style="clear: both; color: #444444; text-align: right;"><span style="text-align: justify; text-indent: 24px;">Cancer Researcher/ Graduate- Molloy Univ.</span></div></div><div class="separator" style="clear: both; text-align: center;"><div style="color: #444444; text-align: left;"><div class="separator" style="clear: both; color: black; text-align: center;"><br style="text-indent: 24px;" /></div><div class="separator" style="clear: both; color: black; text-align: center;"><hr /></div></div></div></div></span></div><div class="post-body entry-content" id="post-body-7436191054731063547" itemprop="description articleBody" style="color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 14.52px; line-height: 1.4; position: relative; text-align: left; width: 774px;"><div style="color: #222222;"><span style="font-family: "Times New Roman", serif; line-height: 19.5px;"></span></div></div></div><div class="separator" style="clear: both;"><span style="font-size: large;"><br /></span></div><div class="separator" style="clear: both;"><span style="font-size: large;">UNDERSERVED AGE FOR EARLY DETECTION</span></div><div class="separator" style="clear: both;">By <a href="https://drrobertbard.com/" style="color: #0043ee; text-decoration-line: none;">Dr. Robert L. Bard</a> and Joe Cappello of <a href="http://areyoudense.org/" style="color: #0043ee; text-decoration-line: none;">AreYouDense.org</a></div><div class="separator" style="clear: both;"><br /></div><div class="separator" style="clear: both;"><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; color: #222222; float: left; margin-bottom: 0.5em; padding: 5px; position: relative;"><tbody><tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhAEaUfyb9GSD7_SCc8n5BZYp7Ts-_tErduSriVtmfKxCnl5BcrBk6uvnpk_b2g9lpoiEHPI3e3Aa1cDTh_vX_G5sqevbIgHQVHcG_l06or0UBFHMLCOusggT1Gz_gQ1rarVzDH-RL9sr_QTi7NRyvG4fOwB5737mFa2ITmux5Mb6r3H5OrRQyMjXd6ClCX/s827/SCR%20(1).jpg" style="clear: left; color: #0043ee; margin-bottom: 1em; margin-left: auto; margin-right: auto; text-decoration-line: none;"><img border="0" data-original-height="570" data-original-width="827" height="221" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhAEaUfyb9GSD7_SCc8n5BZYp7Ts-_tErduSriVtmfKxCnl5BcrBk6uvnpk_b2g9lpoiEHPI3e3Aa1cDTh_vX_G5sqevbIgHQVHcG_l06or0UBFHMLCOusggT1Gz_gQ1rarVzDH-RL9sr_QTi7NRyvG4fOwB5737mFa2ITmux5Mb6r3H5OrRQyMjXd6ClCX/s320/SCR%20(1).jpg" style="background: transparent; border: none; box-shadow: rgba(0, 0, 0, 0.1) 0px 0px 0px; padding: 0px; position: relative;" width="320" /></a></td></tr><tr><td class="tr-caption" style="font-size: 10.56px; text-align: center;"><i style="font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: small;">Doppler Sonography offers clinical accuracy and access<br />to breast imaging evaluation (<a href="http://www.breastcancernyc.com/" style="color: #2288bb; text-decoration-line: none;">www.breastcancernyc.com</a></i><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="font-size: small;">)</span></td></tr></tbody></table><br />According to Breastcancer.org, "Where mammography is available, ultrasound should be seen as a supplemental test for women with dense breasts who do not meet high-risk criteria for screening [with] MRI and for high-risk women with dense breasts who are unable to tolerate MRI... but if mammography isn’t available, then ultrasound seems to be a good alternative for breast cancer screening."<br /><br />A recent cohort study is underway under a partnership between Molloy College and AreYouDense.org to publish new findings about low BMI patients and younger women about the presence of dense breast tissue. This same review also covers the advantages of ultrasound use where mammography is not available.<br /><br />Mammography is the current standard for breast cancer early detection for women 40 & older. Recent studies have shown nearly half of all women who get mammograms are found to have dense breasts, exposing this population to the risk that mammograms may miss potentially cancerous tumors concealed by dense breast tissue. Dr. Cutter's initial concepts to target LOW BMI (bet 12-22% body fat) was personally inspired. As an active TRIATHLETE, her own diagnosis sparked her survey and inquiry throughout the athletic community where she uncovered a significant trend that became the basis for this research. She wishes to target younger women, athletes and members of underserved communities. "Younger women may be more likely to have dense breasts... also I find athletes with LOWER BMI (body mass index) or those with less body fat are more likely to have more dense breast tissue compared with women who are obese." (See complete feature article)</div><div class="separator" style="clear: both;"><br /></div><div class="separator" style="clear: both;"><br /></div><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; color: #444444;"><br /></div></div><div><span style="font-size: 18px;"><table border="2" cellpadding="10" cellspacing="0" style="color: #444444; font-family: "Times New Roman", serif; font-size: 13px;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both; text-align: center;"><span style="font-family: times; font-size: x-large; text-indent: 0.25in;">NEWS FROM</span><span style="font-family: times; font-size: x-large; text-indent: 0.25in;"> THE FIELD </span></div><div class="separator" style="clear: both; text-align: justify;"><div style="text-align: left;"><span style="font-family: times; font-size: small; text-indent: 24px;"><br /></span></div><span style="text-indent: 0.25in;"><span style="font-family: times;"><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="background: rgb(255, 255, 255); border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; color: #222222; float: right; font-size: small; margin-bottom: 0.5em; margin-left: 1em; padding: 5px; position: relative; text-align: right;"><tbody><tr><td style="text-align: center;"><span style="clear: right; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><a href="https://thenationaldesk.com/news/spotlight-on-america/millions-of-women-have-this-breast-cancer-risk-factor-why-arent-they-being-informed-breast-cancer-awareness-month-dense-breast-tissue-xray-mammograms-cdc-dr-bard-suzanne-mcdonald" style="color: #2288bb; text-decoration-line: none;"><img border="0" data-original-height="338" data-original-width="484" height="223" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgdq3GVsqY_T_MSF8zTQtwDWLetgEl7F4JDDSZfpPM3BFaRYVyUPvpXi3kSyeodOp3cOnt4uU0lMe_8wmI0oHbnK499QPgCDCinaLDPWH7eGlWNMnYNRXcCPMKem7hjEJQ-1QzfwacuLD2QqRAtm3MWCsEgR_7-C4hzYKCygU42wR7IAiN4JX7expddYQ/s320/COLLAGE.jpg" style="background: transparent; border-radius: 0px; border: none; box-shadow: rgba(0, 0, 0, 0.1) 0px 0px 0px; padding: 0px; position: relative;" width="320" /></a></span></td></tr><tr><td class="tr-caption" style="font-size: 10.4px; text-align: center;"><a href="https://thenationaldesk.com/news/spotlight-on-america/millions-of-women-have-this-breast-cancer-risk-factor-why-arent-they-being-informed-breast-cancer-awareness-month-dense-breast-tissue-xray-mammograms-cdc-dr-bard-suzanne-mcdonald" style="color: #2288bb; text-decoration-line: none;">Click to see NEWS</a></td></tr></tbody></table></span></span><span style="text-align: left; text-indent: 0.25in;"></span><div style="text-align: left;"><span style="text-align: justify; text-indent: 0.25in;"><span style="font-family: times; font-size: small;">The DENSE BREAST TISSUE / CANCER CONNECTION is a topic that has finally achieved proper recognition in our community. Thanks to organizations like The 'ARE YOU DENSE?' Foundation, awareness of this health concern has now shed light to the risk to 40+% of the national women's population whereby more clinicians are now recognizing the need to state a patient's dense breast status. Research crusaders like Dr. Noelle Cutter and research associate Alexandra Fiederlein from Molloy University are underway the 2022 National Survey of Dense Breast Studies by bringing ultrasound access to underserved members of the women's community. </span></span></div><div style="text-align: left;"><span style="font-size: small;"><span style="font-family: times; text-indent: 0.25in;"><br /></span></span></div><div style="text-align: left;"><span style="font-size: small;"><span style="font-family: times; text-indent: 0.25in;">In a recent episode of SPOTLIGHT ON AMERICA, Dr. Bard spoke as the clinical expert in the report "Millions of women have this breast cancer risk factors... why aren't they being informed?" -- TND REPORT/</span><span style="text-indent: 0.25in;"><span style="font-family: times;">Spotlight on America is pressing to ensure women have access to a crucial health fact that could save their lives. According to the Centers for Disease Control and Prevention, 40% of women have dense breast tissue, which is a risk factor for cancer. The TND</span></span><span style="font-family: times; text-indent: 24px;"> team first highlighted this issue in October 2021, and more than a year later, we expose how some women are still being left in the dark about their density, and federal health bodies are failing to make sure they’re informed.</span></span></div></div></td></tr></tbody></table></span></div><div><span style="font-size: 18px;"><br /></span></div><div><span style="line-height: 19.5px;"><div><span style="line-height: 19.5px; text-indent: 0.25in;"><div class="separator" style="clear: both; text-align: left; text-indent: 0px;"><div class="separator" style="clear: both; text-align: center;"><br /></div><span style="font-size: x-large;"><br /></span></div><div class="separator" style="clear: both; text-align: left; text-indent: 0px;"><span style="font-size: medium;">REVIEW ON WOMEN'S EARLY DETECTION STANDARDS </span></div><div class="separator" style="clear: both; text-align: left; text-indent: 0px;"><i>Excerpt from the 2021 NYCRA Dense Breast Diagnostic Conference <span style="text-align: justify;">By: </span><a href="http://www.robertaklinemd.com/" style="color: #2288bb; text-align: justify; text-decoration-line: none;">Dr. Roberta Kline</a></i></div><div class="separator" style="clear: both; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; text-indent: 0px;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEip9KX7buVFs-Jdw1nzs2-6hkEJs5wsuu8jLQEOb2p_BoEGMoDznkeINOK5Dq0lIvbLPXNT1FMNJdUYmV0YnA7Ltd4qSMDKkJ9gfSBVr22sKZ5XBA72beT1WyLIEOiz2pqLZ_3bYyYcCoPiwDoy8ncysWl5vvtepQRMsySjf4HySE2rQzLI10gTPU0Crw/s800/dreamstime_s_104389297.jpg" style="clear: right; color: #2288bb; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="533" data-original-width="800" height="169" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEip9KX7buVFs-Jdw1nzs2-6hkEJs5wsuu8jLQEOb2p_BoEGMoDznkeINOK5Dq0lIvbLPXNT1FMNJdUYmV0YnA7Ltd4qSMDKkJ9gfSBVr22sKZ5XBA72beT1WyLIEOiz2pqLZ_3bYyYcCoPiwDoy8ncysWl5vvtepQRMsySjf4HySE2rQzLI10gTPU0Crw/w254-h169/dreamstime_s_104389297.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border-radius: 0px; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="254" /></a></div>Breast cancer is still one of the most common cancers in women, and the leading cause of cancer mortality. While mammography is considered the standard imaging for early detection, it falls short for many – including those with dense breasts. Approximately 40% of women have dense breasts, which we now know is associated with an increased risk of breast cancer. On top of this increased risk, mammogram is less sensitive for early detection – up to 50% less for women with the highest breast density. [1] As a result many women are not diagnosed until they have a much later stage cancer – and a worse prognosis. [2]</div><div class="separator" style="clear: both; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; text-indent: 0px;">The State of Connecticut passed legislation requiring notification of breast density in 2009, after having passed legislation requiring insurance coverage for ultrasound for dense breasts in 2005. As an ObGyn physician practicing in CT at the time, I remember the discussions with colleagues and patients around this issue although at the time there were no formal efforts to raise awareness or update guidelines from our national specialty organization, the American College of Obstetricians and Gynecologists (ACOG). </div><div class="separator" style="clear: both; text-indent: 0px;"><div class="separator" style="clear: both; text-align: center;"><br /></div><span style="font-size: medium;"><br />PERSPECTIVE: PERSONAL FINDINGS BY A CLINICAL PROFESSIONAL</span></div><div class="separator" style="clear: both; text-indent: 0px;">I was fortunate to have benefited personally from this effort when I had my first screening mammogram shortly after the law went into effect. The reading radiologist personally informed me of my high breast density immediately after the mammogram, and after recommending a breast ultrasound for further evaluation this was done right then and there. I walked away from my appointment feeling well informed, and any potential anxiety relieved by the prompt additional imaging and results. I also knew that I needed a different approach for my screenings going forward.</div><div class="separator" style="clear: both; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; text-indent: 0px;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjwTrzupAjpigNE2iV8Gf-Ek1hsTk98zY3fscLnC7m90USIo5z-KdFWtCpvbJh4DTsCcEcQKgZk_XL9qL-FN6K4g5x3Ol0c-675_OJqASMUbae2Zsfbi3WElTY0GHelX2_w6gB8GlFlJHtZpE6BwCXfg5x0uCDHU82pL8nEg9gJveAGXmjB2z8ewwqCQA/s800/dreamstime_s_34664571%20(1).jpg" style="clear: right; color: #2288bb; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="563" data-original-width="800" height="174" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjwTrzupAjpigNE2iV8Gf-Ek1hsTk98zY3fscLnC7m90USIo5z-KdFWtCpvbJh4DTsCcEcQKgZk_XL9qL-FN6K4g5x3Ol0c-675_OJqASMUbae2Zsfbi3WElTY0GHelX2_w6gB8GlFlJHtZpE6BwCXfg5x0uCDHU82pL8nEg9gJveAGXmjB2z8ewwqCQA/w248-h174/dreamstime_s_34664571%20(1).jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border-radius: 0px; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="248" /></a></div>Between 2009 and 2019, 37 other states and D.C. passed legislation requiring notification of breast density, one of the last being my new home state of New Mexico. In 2019 a federal law was passed to require both clinician and patient reports contain plain language around the woman’s breast density, and to discuss with her provider. The FDA then created standard language that has now been implemented, requiring reporting on a woman’s individual breast density, and recommendation to discuss with her provider.</div><div class="separator" style="clear: both; text-indent: 0px;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjRHi1nre-0dlXgJgOA6L5wL4mqFI2jHSAK3_sgdRu9dEVu6SS8VmoBv55_XgcRdBwP-pYiEsQBIwFS5UMMBeB0Izg33eCCmHrCz9wVqE9Gy0BiZ7WqOemiqViB6yjLfCb5YDbww3CvxVBNGqv_8COGKo76_FzVG0gVxKQiazjTYtqKonWeys0Tnrf6Lw/s1100/INSERT2.jpg" style="clear: right; color: #2288bb; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="706" data-original-width="1100" height="159" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjRHi1nre-0dlXgJgOA6L5wL4mqFI2jHSAK3_sgdRu9dEVu6SS8VmoBv55_XgcRdBwP-pYiEsQBIwFS5UMMBeB0Izg33eCCmHrCz9wVqE9Gy0BiZ7WqOemiqViB6yjLfCb5YDbww3CvxVBNGqv_8COGKo76_FzVG0gVxKQiazjTYtqKonWeys0Tnrf6Lw/w247-h159/INSERT2.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border-radius: 0px; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="247" /></a></div>There is still much to be learned about what causes dense breasts and why women with dense breasts have an increased risk of breast cancer, and our ongoing study is one of many that are seeking to answer these questions at the molecular and genetic level. But the evidence that supplementing mammograms with other imaging modalities can increase the rate of early detection is substantial, and provides us with tools we can use right now to make a difference. [3,4] Despite this progress, there are still significant hurdles in changing the standard of care. A recent experience with my routine breast cancer screening highlighted the ongoing challenges. When I had asked to schedule an ultrasound with my screening mammogram, I was informed that it was not done this way – I could only get a mammogram. After my mammogram, I had to wait to receive my letter in the mail approximately one week later to be able to take any additional steps. The interpretation included a description of breast density and recommended to discuss any additional care with my physician. </div><div class="separator" style="clear: both; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; text-indent: 0px;">When I called to schedule an ultrasound, I was told that since the radiologist did not recommend it in the report, I could not schedule it. I then had to speak with my primary care provider, educating her on dense breasts and why I needed an ultrasound. Luckily, she agreed to order one. While the radiology facility still questioned the order, eventually I was able to have this done. When the radiologist came in to discuss my results, she too was confused as to why I was having the ultrasound, and was not aware that this should be standard for women with dense breasts.</div><div class="separator" style="clear: both; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; text-indent: 0px;"><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; color: #222222; float: left; margin-bottom: 0.5em; margin-right: 1em; padding: 5px; position: relative;"><tbody><tr><td style="text-align: center;"><span style="clear: right; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><a href="https://360healthalert.blogspot.com/2022/02/ny-cancer-alliance-to-launch-first.html" style="color: #2288bb; text-decoration-line: none;"><img border="0" data-original-height="186" data-original-width="334" height="178" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEipJG_XJGSmBb3kgSRGxITh0Qw8atZPMnHmzeqmLuaIh6vwArzSq1NeXEpcxacL19aWKqU2SZ_JfvcwDpMsIUB1Eh6SieHsVAwAu2FkuHbKDKb23XPojZjYEyEg69LuvCgmE92EqYZkOu3MgWZ8XoWUHF9E-6OpiLcasCVm5Ojd-ufb6UpQ2oHue71EJg/s320/SCR-DENSE.jpg" style="background: transparent; border-radius: 0px; border: none; box-shadow: rgba(0, 0, 0, 0.1) 0px 0px 0px; padding: 0px; position: relative;" width="320" /></a></span></td></tr><tr><td class="tr-caption" style="font-size: 10.56px; text-align: center;"><span style="font-size: x-small;"><a href="https://360healthalert.blogspot.com/2022/02/ny-cancer-alliance-to-launch-first.html" style="color: #2288bb; text-decoration-line: none;">See 2022 Dense Breast Ultrasound Study</a></span></td></tr></tbody></table>Fortunately all was fine, but had I not been a physician that was fully aware of this issue, I would very likely have had only a mammogram and walked away with a dangerously false sense of security. This experience highlighted for me how much still needed to be done more than 20 years after my first experience. Legislation is only part of the solution. Clinician education and public awareness are the keys to changing how the intention behind these laws gets translated into actual change in health care.</div><div class="separator" style="clear: both; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; text-indent: 0px;">As I experienced, many clinicians are ill-informed about the nature of dense breasts, and options for adjunctive screening including ultrasound or MRI. This means that many of these reports end up being filed away with no further action being taken that could make a significant difference in early detection and saving lives.</div><div class="separator" style="clear: both; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; text-indent: 0px;">EPILOGUE: CURRENT STANDARDS VS NEEDS</div><div class="separator" style="clear: both; text-indent: 0px;">ACOG still officially does not recommend any further imaging for women with dense breasts on mammogram, despite the significant body of evidence suggesting that mammogram alone is insufficient and adjunctive imaging with ultrasound or MRI increases rate of early detection. [5] The U.S. Preventive Task Force [6] does not recommend routine adjunctive imaging for screening women with dense breasts. This leaves many healthcare practitioners, from ObGyns to other primary care providers, unprepared to discuss this with their patients or provide sound recommendations. </div><div class="separator" style="clear: both; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; text-indent: 0px;">The American College of Radiologists, who also publishes the BIRADS standards for breast cancer screening, acknowledges awareness of breast density detection issues with mammography but stops short of recommending routine adjunctive imaging. Instead, they list ultrasound and MRI as “may be appropriate”. [7] We have enough evidence to know how to better serve women with dense breasts, and we can do better. Now we need to push for better education of all primary health care providers, including ObGyns, and continue to raise awareness for women around current knowledge and best practices. </div><div class="separator" style="clear: both; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; text-indent: 0px;"><div class="separator" style="clear: both; text-align: center;"><div style="color: #444444; text-align: left;"><div class="separator" style="clear: both; color: black; font-family: "Times New Roman"; font-size: medium; text-align: center;"><br style="text-indent: 24px;" /></div></div></div></div><div class="separator" style="clear: both; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; text-indent: 0px;"><span style="font-size: x-small;">References</span></div><div class="separator" style="clear: both; text-indent: 0px;"><span style="font-size: x-small;"><i>1) Gordon PB. The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening. Curr Oncol. 2022 May 17;29(5):3595-3636.</i></span></div><div class="separator" style="clear: both; text-indent: 0px;"><span style="font-size: x-small;"><i>2) Chiu, S.Y.H.; Duffy, S.; Yen, A.M.F.; Tabár, L.; Smith, R.A.; Chen, H.H. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-Year follow-up of a Swedish mammographic screening. Cancer Epidemiol. Biomark. Prev. 2010, 19, 1219–1228</i></span></div><div class="separator" style="clear: both; text-indent: 0px;"><span style="font-size: x-small;"><i>3) Harada-Shoji N, Suzuki A, Ishida T, Zheng YF, Narikawa-Shiono Y, Sato-Tadano A, Ohta R, Ohuchi N. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2021 Aug 2;4(8):e2121505</i></span></div><div class="separator" style="clear: both; text-indent: 0px;"><span style="font-size: x-small;"><i>4) Mann, R.M., Athanasiou, A., Baltzer, P.A.T. et al. Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol 32, 4036–4045 (2022).</i></span></div><div class="separator" style="clear: both; text-indent: 0px;"><span style="font-size: x-small;"><i>5) Management of Women With Dense Breasts Diagnosed by Mammography. ACOG Committee Opinion. CO Number 625 March 2015</i></span></div><div class="separator" style="clear: both; text-indent: 0px;"><span style="font-size: x-small;"><i>6) https://uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening</i></span></div><div class="separator" style="clear: both; text-indent: 0px;"><span style="font-size: x-small;"><i>7) American College of Radiology ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density. 2021</i></span></div><div style="text-indent: 0px;"><br /></div><div style="text-indent: 0px;"><i style="font-size: x-small; text-align: left;">Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and The AngioFoundation). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.</i></div></span></div></span></div></div></span></div></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-74016169736755808162023-10-20T06:22:00.011-07:002023-10-23T06:25:21.846-07:00Early Detection Alert: The Risk of Being "Too Young for a Mammogram"<div class="separator" style="clear: both; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: justify;"><span style="color: #222222; font-family: times; font-size: 13.2px;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh6E7oeDaC9zXLgnBZTw16Org48IIsGYkfhhKkf4t8Ztvk9v2lC_68cfEU8l1RmBwLWuBsj40eEQufIUa5IJ0_XRxFOd81Or-qDOtQ51ukBuj0pCmXmj8QyHuNVzRIS7l0oHxK2Uthydn3sTI8qrenMHJE8SvuOBKW2V3fCcQ7BLwvIs5nSyt-FU-JWu6DY/s480/bigger.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="320" data-original-width="480" height="213" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh6E7oeDaC9zXLgnBZTw16Org48IIsGYkfhhKkf4t8Ztvk9v2lC_68cfEU8l1RmBwLWuBsj40eEQufIUa5IJ0_XRxFOd81Or-qDOtQ51ukBuj0pCmXmj8QyHuNVzRIS7l0oHxK2Uthydn3sTI8qrenMHJE8SvuOBKW2V3fCcQ7BLwvIs5nSyt-FU-JWu6DY/s320/bigger.jpg" width="320" /></a></div>A major concern is the presence of breast cancer in underserved communities, including those TOO YOUNG FOR A MAMMOGRAM. Whereby the medical community touts the recommended (and legal/billable status) of getting a mammo scan should be between 40-50, what happens to the many women who do not fit this age criteria? How would they even know to get checked without the support of their clinicians or an alarm from family history?<br /><br /></span><span style="color: #222222; font-family: times; font-size: 13.2px;">Decades into the battle against breast cancer, clinicians and the public are much more educated about EARLY DETECTION, PREVENTION and the current protocols and modalities available to save lives. Recent headlines on DENSE BREAST and the advancements in ULTRASOUND SCANNING supports a major part of this battle.</span></div><div class="separator" style="clear: both; text-align: justify;"><span style="color: #222222; font-family: times;"><div class="separator" style="clear: both;"><span style="font-size: 13.2px;"><br /></span></div><div class="separator" style="clear: both;"><span style="font-size: 13.2px;"><div class="separator" style="clear: both; color: black; font-family: "Times New Roman"; font-size: medium;"><span style="color: #222222; font-family: times;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; color: #444444;"><br /></div><div class="separator" style="clear: both; color: #444444; text-align: left;"><div class="separator" style="clear: both; font-size: 13px; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgeGQhE2wd2kkljEDIjS7yodzEXHHS4yNSKFPBoaN95OrLp7D8BiLHW125KWGKzsfErnWMv3pIrE2nqkCZDj8LQPdGne8OxEekY7PW3HTkdK5wr0JqW1QOz1-JRFmjJEH3GcBk8oL3gNI__n_AV54iXXXCt0kHvJ4vySCesaxPb9tE-yQL-wwqtpDMaNA/s2248/headshot2.jpg" style="clear: left; color: #2288bb; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="2248" data-original-width="1665" height="104" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgeGQhE2wd2kkljEDIjS7yodzEXHHS4yNSKFPBoaN95OrLp7D8BiLHW125KWGKzsfErnWMv3pIrE2nqkCZDj8LQPdGne8OxEekY7PW3HTkdK5wr0JqW1QOz1-JRFmjJEH3GcBk8oL3gNI__n_AV54iXXXCt0kHvJ4vySCesaxPb9tE-yQL-wwqtpDMaNA/w77-h104/headshot2.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border-radius: 0px; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="77" /></a></div><span style="text-align: justify; text-indent: 24px;">WHAT ABOUT IF YOU'RE TOO YOUNG FOR A MAMMOGRAM? </span><span style="text-align: justify; text-indent: 24px;"><i>I went to my doctor for a lump I felt in my breast and she gave me a response that set off red flags: "don't worry about it". Being a researcher involved in breast density and breast cancer, I knew that I had to take action; I was fortunate enough to have my breast ultrasound training with Dr. Robert Bard (cancer imaging specialist, NYC) upcoming in the next week. Dr. Bard showed me how to use the ultrasound to help me find two benign tumors in my breasts, and it was there that he reported that I have dense breasts. Had I not taken action in getting screened at the young age of 22, I would have never known that I should be getting screened via ultrasound every 6 months (because having dense breasts puts me at a higher risk for breast cancer), nor would I have known that I had benign breast tumors. </i></span></div><div class="separator" style="clear: both; color: #444444; text-align: left;"><span style="text-align: justify; text-indent: 24px;"><br /></span></div><div class="separator" style="clear: both; color: #444444; text-align: right;"><span style="text-align: justify; text-indent: 24px;">- ALEXANDRA FIEDERLEIN, 22</span></div><div class="separator" style="clear: both; color: #444444; text-align: right;"><span style="text-align: justify; text-indent: 24px;">Cancer Researcher/ Graduate- Molloy Univ.</span></div></div><div class="separator" style="clear: both; text-align: center;"><div style="color: #444444; text-align: left;"><div class="separator" style="clear: both; color: black; text-align: center;"><br style="text-indent: 24px;" /></div><div class="separator" style="clear: both; color: black; text-align: center;"><hr /></div></div></div></div></span></div><div class="post-body entry-content" id="post-body-7436191054731063547" itemprop="description articleBody" style="color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; line-height: 1.4; position: relative; text-align: left; width: 774px;"><div style="color: #222222;"><span style="font-family: "Times New Roman", serif; line-height: 19.5px;"></span></div></div></span></div><div class="separator" style="clear: both;"><span style="font-size: large;"><br /></span></div><div class="separator" style="clear: both;"><span style="font-size: large;">UNDERSERVED AGE FOR EARLY DETECTION</span></div><div class="separator" style="clear: both;"><span style="font-size: 13.2px;">By <a href="https://drrobertbard.com/">Dr. Robert L. Bard</a> and Joe Cappello of <a href="http://AreYouDense.org">AreYouDense.org</a></span></div><div class="separator" style="clear: both;"><span style="font-size: 13.2px;"><br /></span></div><div class="separator" style="clear: both;"><span style="font-size: 13.2px;"><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: left;"><tbody><tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhAEaUfyb9GSD7_SCc8n5BZYp7Ts-_tErduSriVtmfKxCnl5BcrBk6uvnpk_b2g9lpoiEHPI3e3Aa1cDTh_vX_G5sqevbIgHQVHcG_l06or0UBFHMLCOusggT1Gz_gQ1rarVzDH-RL9sr_QTi7NRyvG4fOwB5737mFa2ITmux5Mb6r3H5OrRQyMjXd6ClCX/s827/SCR%20(1).jpg" style="clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><img border="0" data-original-height="570" data-original-width="827" height="221" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhAEaUfyb9GSD7_SCc8n5BZYp7Ts-_tErduSriVtmfKxCnl5BcrBk6uvnpk_b2g9lpoiEHPI3e3Aa1cDTh_vX_G5sqevbIgHQVHcG_l06or0UBFHMLCOusggT1Gz_gQ1rarVzDH-RL9sr_QTi7NRyvG4fOwB5737mFa2ITmux5Mb6r3H5OrRQyMjXd6ClCX/s320/SCR%20(1).jpg" width="320" /></a></td></tr><tr><td class="tr-caption" style="text-align: center;"><i style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: small;">Doppler Sonography offers clinical accuracy and access<br />to breast imaging evaluation (<a href="http://www.breastcancernyc.com/" style="color: #2288bb; text-decoration-line: none;">www.breastcancernyc.com</a></i><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222; font-size: small;">)</span></td></tr></tbody></table><br />According to Breastcancer.org, "Where mammography is available, ultrasound should be seen as a supplemental test for women with dense breasts who do not meet high-risk criteria for screening [with] MRI and for high-risk women with dense breasts who are unable to tolerate MRI... but if mammography isn’t available, then ultrasound seems to be a good alternative for breast cancer screening." <br /><br /></span><span style="font-size: 13.2px;">A recent cohort study is underway under a partnership between Molloy College and AreYouDense.org to publish new findings about low BMI patients and younger women about the presence of dense breast tissue. This same review also covers the advantages of ultrasound use where mammography is not available.<br /><br /></span><span style="font-size: 13.2px;">Mammography is the current standard for breast cancer early detection for women 40 & older. Recent studies have shown nearly half of all women who get mammograms are found to have dense breasts, exposing this population to the risk that mammograms may miss potentially cancerous tumors concealed by dense breast tissue. Dr. Cutter's initial concepts to target LOW BMI (bet 12-22% body fat) was personally inspired. As an active TRIATHLETE, her own diagnosis sparked her survey and inquiry throughout the athletic community where she uncovered a significant trend that became the basis for this research. She wishes to target younger women, athletes and members of underserved communities. "Younger women may be more likely to have dense breasts... also I find athletes with LOWER BMI (body mass index) or those with less body fat are more likely to have more dense breast tissue compared with women who are obese." (See complete feature article)</span></div><div class="separator" style="clear: both;"><span style="font-size: 13.2px;"><br /></span></div><div class="separator" style="clear: both;"><br /></div><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; color: #444444;"><br /></div></div><div><span style="font-size: 18px;"><table border="2" cellpadding="10" cellspacing="0" style="color: #444444; font-family: "Times New Roman", serif; font-size: 13px;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both; text-align: left;"><span style="font-family: arial; font-size: large; text-indent: 0.25in;"><b>IN THE NEWS: DENSE BREAST PARADIGM</b></span></div><div class="separator" style="clear: both; text-align: left;"><span style="text-indent: 0.25in;"><div class="separator" style="clear: both; font-family: times; font-size: medium; text-align: center;"><br /></div><span style="font-family: arial; font-size: medium;">NEVER FORGET: NANCY CAPPELLO</span><br /><span style="font-family: times; font-size: small;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEisWuSMjBbhOJBItlc_1K8gruTxJsMf-Y26eTircGuqyPloLKS8O7ZVIlPMqNwXZRM0uTyNg1Miu9VIR5fB6RtfNkjGRUSNhK46vKaZ85ayC6TEJCsd9wJc-7yKktEIOvGX140XYrjCdi-ZWSWroSeFAp42Cx7TAv526Fpg3qs7vvmdGnivus86KqhAZ67P/s810/nancy_ahra2018.png" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="580" data-original-width="810" height="229" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEisWuSMjBbhOJBItlc_1K8gruTxJsMf-Y26eTircGuqyPloLKS8O7ZVIlPMqNwXZRM0uTyNg1Miu9VIR5fB6RtfNkjGRUSNhK46vKaZ85ayC6TEJCsd9wJc-7yKktEIOvGX140XYrjCdi-ZWSWroSeFAp42Cx7TAv526Fpg3qs7vvmdGnivus86KqhAZ67P/s320/nancy_ahra2018.png" width="320" /></a></div>10/23/2023 - In celebration of the upcoming birthday of the late Dr. Nancy Cappello (Oct. 30), the ICRS (Integrative Cancer resource Society) gives honor to her courage and life-saving pursuits to bring global awareness about the risks of Breast Cancer from the link to dense breast tissue. Dr. Cappello’s work to inform women about the risks of dense breast tissue led to density inform laws in 35 states. According to Dr. Roberta Kline (<a href="https://painhealersgroup.org/network.html">Women's Health Digest</a> medical publisher) and <a href="http://fightrecurrence.com/">Dr. Leslie Valle- Montoya</a> (ICRS exec. director), "...though we all know her passing to earmark a major movement in women's health, honoring the birthdate of such a figure posthumously (we feel) better resonates a more loving and eternal remembrance of message by breathing continued life to her legacy!"</span></span></div><div class="separator" style="clear: both; text-align: left;"><span style="font-family: times; font-size: small; text-indent: 0.25in;"><br /></span></div><div class="separator" style="clear: both; text-align: left;"><span style="font-size: small;"><span style="font-family: times; text-indent: 0.25in;">She was recognized throughout the women's cancer community as</span><span style="text-align: justify;"><span style="font-family: times;"> the founder of the breast density education movement in the U.S., on her passing on Nov. 15. A breast cancer survivor herself, Cappello passed away from secondary myelodyspastic syndrome (MDS), a bone marrow cancer that was a complication of her prior aggressive breast cancer treatments. </span></span><span style="font-family: times; text-align: justify; text-indent: 24px;">Cappello was diagnosed with stage 3C breast cancer in February 2004, just six weeks after her annual mammogram came up normal. Her doctor told her that the cancer was missed on the mammogram because she had dense fibroglandular breast tissue, a concept that was little-known among patients at that time. Dense breast tissue appears white on a traditional 2-D mammogram, which can mask cancers that also show up as white. Women with extremely dense breast tissue are five times more likely to have breast cancer compared to women with fatty breasts. <a href="https://www.itnonline.com/content/breast-density-advocate-nancy-m-cappello-passes-away">(See original source: ITN NEWS)</a></span></span></div><div class="separator" style="clear: both; text-align: left;"><span style="font-size: small;"><br /></span></div><div class="separator" style="clear: both; text-align: left;"><span style="font-size: small;"><br /></span></div><div class="separator" style="clear: both; text-align: center;"><div style="text-align: left;"><span style="font-size: small;">From the newsletter of:</span></div><div style="text-align: left;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh5vNJxDv6yk0TwBP28KNWWQxmL1iHJJuYmVEP4U757T3mqQZaW4W-XaRkp8QLnZ54lAl1tckmDe1lGgpptCWl26WdvVVjgr-uscGWpmbE5b1lrBKywhTDmxk5b98Owa1sd6AeXPGYvq8fNb7dzbxT-92F3PQOf8DEEj80Hw5oWZBvZ588ISTVGu7sS9hnA/s2846/logo-large.png" style="clear: left; margin-bottom: 1em; margin-right: 1em;"><span style="font-size: small;"><img border="0" data-original-height="1035" data-original-width="2846" height="49" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh5vNJxDv6yk0TwBP28KNWWQxmL1iHJJuYmVEP4U757T3mqQZaW4W-XaRkp8QLnZ54lAl1tckmDe1lGgpptCWl26WdvVVjgr-uscGWpmbE5b1lrBKywhTDmxk5b98Owa1sd6AeXPGYvq8fNb7dzbxT-92F3PQOf8DEEj80Hw5oWZBvZ588ISTVGu7sS9hnA/w136-h49/logo-large.png" width="136" /></span></a></div></div><div class="separator" style="clear: both; text-align: left;"><div class="separator" style="clear: both;"><span style="font-family: times; font-size: small; text-indent: 0.25in;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiI1OaSy2bLuLjIi4OWAESmDIBwMqkITb6z3a1sM06t24W_Sqx7v8KOD_7ZKougdEzVEgamC546IZYSnkReJ5YGm7llT8u1rFkxrcT58Kpt_I3-LwH4JykwxiC3eSIB8DlchCjT4BbH6UpkmMUY03c90wqlAkQVz_tG1OVkYzOni64rpcaYtS-6yzj8LPkZ/s1100/INSERT2.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="706" data-original-width="1100" height="205" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiI1OaSy2bLuLjIi4OWAESmDIBwMqkITb6z3a1sM06t24W_Sqx7v8KOD_7ZKougdEzVEgamC546IZYSnkReJ5YGm7llT8u1rFkxrcT58Kpt_I3-LwH4JykwxiC3eSIB8DlchCjT4BbH6UpkmMUY03c90wqlAkQVz_tG1OVkYzOni64rpcaYtS-6yzj8LPkZ/s320/INSERT2.jpg" width="320" /></a></div>The cancer research front and patient care community continues to pursue further awareness of dense breast diagnostic updates. This includes the sensible use of ultrasound imaging as a supplement to mammography. Dr, Cappello's mission included bringing change to the patient health care community by 'insisting' on the use of ultrasound as a supplement to mammogram because of its ability to detect cancer (tumor) presence by its ability to see through the cloudy obstruction of breast tissue density. "Hybrid imaging refers to combining diagnostic modalities to assess disease and monitor therapy. A useful combination of options is identifying the tumor vessel flow density to assess aggression and treatment progress. Similarly, tissue elastography is useful for border detection of malignant masses", says <a href="http://breastcancernyc.com/">Dr. Robert Bard</a> of the Bard Cancer Center, NYC.</span></div><div><span style="font-family: times; font-size: small; text-indent: 0.25in;"><br /></span></div></div><div class="separator" style="clear: both; text-align: center;"><span style="font-size: small;"><br /></span></div><div class="separator" style="clear: both; text-align: left;"><div class="separator" style="clear: both; text-align: center;"><span style="font-size: small;"><br /></span></div><span style="font-size: small;"><br /><span style="font-family: times; text-indent: 0.25in;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg_-Yd0xNcl9ZoS6b2Ew8ZvKq0950agpIzpA8fsRbuk78MzcWGsF6OPhvzMsKMoHMlGw2QZvYhvm6xxzBFmH7JEerRgNUa0-67-oqX_CK_j-_5g0fUAyovXFQ3ScBn7cl9i-08BIuHEkRoq2Jmn5mJjVL_x1iToXsIlbqa_bvi0ItdBypBSFmNVHpi03w9q/s181/EXTRA1.jpg" style="clear: left; font-family: "Times New Roman", serif; margin-bottom: 1em; margin-right: 1em; text-align: center; text-indent: 0px;"><img border="0" data-original-height="48" data-original-width="181" height="38" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg_-Yd0xNcl9ZoS6b2Ew8ZvKq0950agpIzpA8fsRbuk78MzcWGsF6OPhvzMsKMoHMlGw2QZvYhvm6xxzBFmH7JEerRgNUa0-67-oqX_CK_j-_5g0fUAyovXFQ3ScBn7cl9i-08BIuHEkRoq2Jmn5mJjVL_x1iToXsIlbqa_bvi0ItdBypBSFmNVHpi03w9q/w143-h38/EXTRA1.jpg" width="143" /></a></span></span></div><div class="separator" style="clear: both; text-align: justify;"><div style="text-align: left;"><span style="font-family: times; font-size: small; text-indent: 24px;"><br /></span></div><span style="font-size: small;"><span style="text-indent: 0.25in;"><span style="font-family: times;"><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="background: rgb(255, 255, 255); border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; color: #222222; float: right; margin-bottom: 0.5em; margin-left: 1em; padding: 5px; position: relative; text-align: right;"><tbody><tr><td style="text-align: center;"><span style="clear: right; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><a href="https://thenationaldesk.com/news/spotlight-on-america/millions-of-women-have-this-breast-cancer-risk-factor-why-arent-they-being-informed-breast-cancer-awareness-month-dense-breast-tissue-xray-mammograms-cdc-dr-bard-suzanne-mcdonald" style="color: #2288bb; text-decoration-line: none;"><img border="0" data-original-height="338" data-original-width="484" height="223" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgdq3GVsqY_T_MSF8zTQtwDWLetgEl7F4JDDSZfpPM3BFaRYVyUPvpXi3kSyeodOp3cOnt4uU0lMe_8wmI0oHbnK499QPgCDCinaLDPWH7eGlWNMnYNRXcCPMKem7hjEJQ-1QzfwacuLD2QqRAtm3MWCsEgR_7-C4hzYKCygU42wR7IAiN4JX7expddYQ/s320/COLLAGE.jpg" style="background: transparent; border-radius: 0px; border: none; box-shadow: rgba(0, 0, 0, 0.1) 0px 0px 0px; padding: 0px; position: relative;" width="320" /></a></span></td></tr><tr><td class="tr-caption" style="text-align: center;"><a href="https://thenationaldesk.com/news/spotlight-on-america/millions-of-women-have-this-breast-cancer-risk-factor-why-arent-they-being-informed-breast-cancer-awareness-month-dense-breast-tissue-xray-mammograms-cdc-dr-bard-suzanne-mcdonald" style="color: #2288bb; text-decoration-line: none;">Click to see NEWS</a></td></tr></tbody></table></span></span><span style="text-align: left; text-indent: 0.25in;"></span></span><div style="text-align: left;"><span style="text-align: justify; text-indent: 0.25in;"><span style="font-family: times; font-size: small;">The DENSE BREAST TISSUE / CANCER CONNECTION is a topic that has finally achieved proper recognition in our community. Thanks to organizations like The 'ARE YOU DENSE?' Foundation, awareness of this health concern has now shed light to the risk to 40+% of the national women's population whereby more clinicians are now recognizing the need to state a patient's dense breast status. Research crusaders like Dr. Noelle Cutter and research associate Alexandra Fiederlein from Molloy University are underway the 2022 National Survey of Dense Breast Studies by bringing ultrasound access to underserved members of the women's community. </span></span></div><div style="text-align: left;"><span style="font-size: small;"><span style="font-family: times; text-indent: 0.25in;"><br /></span></span></div><div style="text-align: left;"><span style="font-size: small;"><span style="font-family: times; text-indent: 0.25in;">In a recent episode of SPOTLIGHT ON AMERICA, Dr. Bard spoke as the clinical expert in the report "Millions of women have this breast cancer risk factors... why aren't they being informed?" -- TND REPORT/</span><span style="text-indent: 0.25in;"><span style="font-family: times;">Spotlight on America is pressing to ensure women have access to a crucial health fact that could save their lives. According to the Centers for Disease Control and Prevention, 40% of women have dense breast tissue, which is a risk factor for cancer. The TND</span></span><span style="font-family: times; text-indent: 24px;"> team first highlighted this issue in October 2021, and more than a year later, we expose how some women are still being left in the dark about their density, and federal health bodies are failing to make sure they’re informed.</span></span></div></div></td></tr></tbody></table></span></div><div><span style="font-size: 18px;"><br /></span></div><div><span style="line-height: 19.5px;"><span style="line-height: 19.5px; text-indent: 0.25in;"><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-align: left; text-indent: 0px;"><div class="separator" style="clear: both; text-align: center;"><br /></div><span style="font-size: x-large;"><br /></span></div><div class="separator" style="clear: both; text-align: left; text-indent: 0px;"><span style="font-size: medium;">REVIEW ON WOMEN'S EARLY DETECTION STANDARDS </span></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-align: left; text-indent: 0px;"><i>Excerpt from the 2021 NYCRA Dense Breast Diagnostic Conference <span style="text-align: justify;">By: </span><a href="http://www.robertaklinemd.com/" style="color: #2288bb; text-align: justify; text-decoration-line: none;">Dr. Roberta Kline</a></i></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEip9KX7buVFs-Jdw1nzs2-6hkEJs5wsuu8jLQEOb2p_BoEGMoDznkeINOK5Dq0lIvbLPXNT1FMNJdUYmV0YnA7Ltd4qSMDKkJ9gfSBVr22sKZ5XBA72beT1WyLIEOiz2pqLZ_3bYyYcCoPiwDoy8ncysWl5vvtepQRMsySjf4HySE2rQzLI10gTPU0Crw/s800/dreamstime_s_104389297.jpg" style="clear: right; color: #2288bb; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="533" data-original-width="800" height="169" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEip9KX7buVFs-Jdw1nzs2-6hkEJs5wsuu8jLQEOb2p_BoEGMoDznkeINOK5Dq0lIvbLPXNT1FMNJdUYmV0YnA7Ltd4qSMDKkJ9gfSBVr22sKZ5XBA72beT1WyLIEOiz2pqLZ_3bYyYcCoPiwDoy8ncysWl5vvtepQRMsySjf4HySE2rQzLI10gTPU0Crw/w254-h169/dreamstime_s_104389297.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border-radius: 0px; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="254" /></a></div>Breast cancer is still one of the most common cancers in women, and the leading cause of cancer mortality. While mammography is considered the standard imaging for early detection, it falls short for many – including those with dense breasts. Approximately 40% of women have dense breasts, which we now know is associated with an increased risk of breast cancer. On top of this increased risk, mammogram is less sensitive for early detection – up to 50% less for women with the highest breast density. [1] As a result many women are not diagnosed until they have a much later stage cancer – and a worse prognosis. [2]</div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;">The State of Connecticut passed legislation requiring notification of breast density in 2009, after having passed legislation requiring insurance coverage for ultrasound for dense breasts in 2005. As an ObGyn physician practicing in CT at the time, I remember the discussions with colleagues and patients around this issue although at the time there were no formal efforts to raise awareness or update guidelines from our national specialty organization, the American College of Obstetricians and Gynecologists (ACOG). </div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><div class="separator" style="clear: both; text-align: center;"><br /></div><span style="font-size: medium;"><br />PERSPECTIVE: PERSONAL FINDINGS BY A CLINICAL PROFESSIONAL</span></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;">I was fortunate to have benefited personally from this effort when I had my first screening mammogram shortly after the law went into effect. The reading radiologist personally informed me of my high breast density immediately after the mammogram, and after recommending a breast ultrasound for further evaluation this was done right then and there. I walked away from my appointment feeling well informed, and any potential anxiety relieved by the prompt additional imaging and results. I also knew that I needed a different approach for my screenings going forward.</div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjwTrzupAjpigNE2iV8Gf-Ek1hsTk98zY3fscLnC7m90USIo5z-KdFWtCpvbJh4DTsCcEcQKgZk_XL9qL-FN6K4g5x3Ol0c-675_OJqASMUbae2Zsfbi3WElTY0GHelX2_w6gB8GlFlJHtZpE6BwCXfg5x0uCDHU82pL8nEg9gJveAGXmjB2z8ewwqCQA/s800/dreamstime_s_34664571%20(1).jpg" style="clear: right; color: #2288bb; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="563" data-original-width="800" height="253" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjwTrzupAjpigNE2iV8Gf-Ek1hsTk98zY3fscLnC7m90USIo5z-KdFWtCpvbJh4DTsCcEcQKgZk_XL9qL-FN6K4g5x3Ol0c-675_OJqASMUbae2Zsfbi3WElTY0GHelX2_w6gB8GlFlJHtZpE6BwCXfg5x0uCDHU82pL8nEg9gJveAGXmjB2z8ewwqCQA/w353-h253/dreamstime_s_34664571%20(1).jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border-radius: 0px; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="353" /></a></div>Between 2009 and 2019, 37 other states and D.C. passed legislation requiring notification of breast density, one of the last being my new home state of New Mexico. In 2019 a federal law was passed to require both clinician and patient reports contain plain language around the woman’s breast density, and to discuss with her provider. The FDA then created standard language that has now been implemented, requiring reporting on a woman’s individual breast density, and recommendation to discuss with her provider.</div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;">There is still much to be learned about what causes dense breasts and why women with dense breasts have an increased risk of breast cancer, and our ongoing study is one of many that are seeking to answer these questions at the molecular and genetic level. But the evidence that supplementing mammograms with other imaging modalities can increase the rate of early detection is substantial, and provides us with tools we can use right now to make a difference. [3,4] Despite this progress, there are still significant hurdles in changing the standard of care. A recent experience with my routine breast cancer screening highlighted the ongoing challenges. When I had asked to schedule an ultrasound with my screening mammogram, I was informed that it was not done this way – I could only get a mammogram. After my mammogram, I had to wait to receive my letter in the mail approximately one week later to be able to take any additional steps. The interpretation included a description of breast density and recommended to discuss any additional care with my physician. </div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;">When I called to schedule an ultrasound, I was told that since the radiologist did not recommend it in the report, I could not schedule it. I then had to speak with my primary care provider, educating her on dense breasts and why I needed an ultrasound. Luckily, she agreed to order one. While the radiology facility still questioned the order, eventually I was able to have this done. When the radiologist came in to discuss my results, she too was confused as to why I was having the ultrasound, and was not aware that this should be standard for women with dense breasts.</div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; color: #222222; float: left; margin-bottom: 0.5em; margin-right: 1em; padding: 5px; position: relative;"><tbody><tr><td style="text-align: center;"><span style="clear: right; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><a href="https://360healthalert.blogspot.com/2022/02/ny-cancer-alliance-to-launch-first.html" style="color: #2288bb; text-decoration-line: none;"><img border="0" data-original-height="186" data-original-width="334" height="178" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEipJG_XJGSmBb3kgSRGxITh0Qw8atZPMnHmzeqmLuaIh6vwArzSq1NeXEpcxacL19aWKqU2SZ_JfvcwDpMsIUB1Eh6SieHsVAwAu2FkuHbKDKb23XPojZjYEyEg69LuvCgmE92EqYZkOu3MgWZ8XoWUHF9E-6OpiLcasCVm5Ojd-ufb6UpQ2oHue71EJg/s320/SCR-DENSE.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border-radius: 0px; border: none; box-shadow: rgba(0, 0, 0, 0.1) 0px 0px 0px; padding: 0px; position: relative;" width="320" /></a></span></td></tr><tr><td class="tr-caption" style="font-size: 10.56px; text-align: center;"><span style="font-size: x-small;"><a href="https://360healthalert.blogspot.com/2022/02/ny-cancer-alliance-to-launch-first.html" style="color: #2288bb; text-decoration-line: none;">See 2022 Dense Breast Ultrasound Study</a></span></td></tr></tbody></table>Fortunately all was fine, but had I not been a physician that was fully aware of this issue, I would very likely have had only a mammogram and walked away with a dangerously false sense of security. This experience highlighted for me how much still needed to be done more than 20 years after my first experience. Legislation is only part of the solution. Clinician education and public awareness are the keys to changing how the intention behind these laws gets translated into actual change in health care.</div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;">As I experienced, many clinicians are ill-informed about the nature of dense breasts, and options for adjunctive screening including ultrasound or MRI. This means that many of these reports end up being filed away with no further action being taken that could make a significant difference in early detection and saving lives.</div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;">EPILOGUE: CURRENT STANDARDS VS NEEDS</div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;">ACOG still officially does not recommend any further imaging for women with dense breasts on mammogram, despite the significant body of evidence suggesting that mammogram alone is insufficient and adjunctive imaging with ultrasound or MRI increases rate of early detection. [5] The U.S. Preventive Task Force [6] does not recommend routine adjunctive imaging for screening women with dense breasts. This leaves many healthcare practitioners, from ObGyns to other primary care providers, unprepared to discuss this with their patients or provide sound recommendations. </div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;">The American College of Radiologists, who also publishes the BIRADS standards for breast cancer screening, acknowledges awareness of breast density detection issues with mammography but stops short of recommending routine adjunctive imaging. Instead, they list ultrasound and MRI as “may be appropriate”. [7] We have enough evidence to know how to better serve women with dense breasts, and we can do better. Now we need to push for better education of all primary health care providers, including ObGyns, and continue to raise awareness for women around current knowledge and best practices. </div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><div class="separator" style="clear: both; text-align: center;"><div style="color: #444444; text-align: left;"><div class="separator" style="clear: both; color: black; font-family: "Times New Roman"; font-size: medium; text-align: center;"><br style="text-indent: 24px;" /></div></div></div></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><br /></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><span style="font-size: x-small;">References</span></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><span style="font-size: x-small;"><i>1) Gordon PB. The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening. Curr Oncol. 2022 May 17;29(5):3595-3636.</i></span></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><span style="font-size: x-small;"><i>2) Chiu, S.Y.H.; Duffy, S.; Yen, A.M.F.; Tabár, L.; Smith, R.A.; Chen, H.H. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-Year follow-up of a Swedish mammographic screening. Cancer Epidemiol. Biomark. Prev. 2010, 19, 1219–1228</i></span></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><span style="font-size: x-small;"><i>3) Harada-Shoji N, Suzuki A, Ishida T, Zheng YF, Narikawa-Shiono Y, Sato-Tadano A, Ohta R, Ohuchi N. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2021 Aug 2;4(8):e2121505</i></span></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><span style="font-size: x-small;"><i>4) Mann, R.M., Athanasiou, A., Baltzer, P.A.T. et al. Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol 32, 4036–4045 (2022).</i></span></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><span style="font-size: x-small;"><i>5) Management of Women With Dense Breasts Diagnosed by Mammography. ACOG Committee Opinion. CO Number 625 March 2015</i></span></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><span style="font-size: x-small;"><i>6) https://uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening</i></span></div><div class="separator" style="clear: both; font-family: times; font-size: 13.2px; text-indent: 0px;"><span style="font-size: x-small;"><i>7) American College of Radiology ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density. 2021</i></span></div><div style="font-family: times; font-size: 13.2px; text-indent: 0px;"><br /></div><div style="font-family: times; font-size: 13.2px; text-indent: 0px;"><i style="font-size: x-small; text-align: left;">Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and The AngioFoundation). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.</i></div></span></span></div></div><div class="separator" style="clear: both;"><span style="font-size: 13.2px;"><br /></span></div><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; color: #444444;"><br /></div></div></div></span></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-44115091428547531562023-09-27T04:39:00.005-07:002023-09-27T04:41:38.135-07:00NATIONAL ADVOCACY HONORS BREAST CANCER IMAGING LEGEND<p> FOR IMMEDIATE RELEASE</p><p></p><p>NATIONAL CANCER ADVOCACY GROUP RECOGNIZES BARD DIAGNOSTIC RESEARCH FOR ADVANCEMENTS IN DENSE BREAST IMAGING </p><p><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjuPeC05sfanRgWsluwNwQJvBjeBMsehtCHt2P8RMk-Hydn-_aXfHSjct9Ppi1eqJYy-SHLHd6QGTSrbig3zVTXeIGT3Uz2AHS0YMwX_LA4CTrubqEYVB4tYM3kbh8dord8kIl47TUyo5CQVO01EoFtnYmwsjmEHBvB6Kow7bGssfvJgw2KbfMU5Mkx6x4/s1650/use1.jpg" style="clear: left; color: #cc6611; float: left; margin-bottom: 1em; margin-right: 1em; text-align: center; text-decoration-line: none;"><img border="0" data-original-height="1650" data-original-width="1287" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjuPeC05sfanRgWsluwNwQJvBjeBMsehtCHt2P8RMk-Hydn-_aXfHSjct9Ppi1eqJYy-SHLHd6QGTSrbig3zVTXeIGT3Uz2AHS0YMwX_LA4CTrubqEYVB4tYM3kbh8dord8kIl47TUyo5CQVO01EoFtnYmwsjmEHBvB6Kow7bGssfvJgw2KbfMU5Mkx6x4/s320/use1.jpg" style="background: rgb(255, 255, 255); border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="250" /></a>8/28/2023- Joseph Cappello- Co-Founder of the 'Are You Dense?" Foundation and ICRA Sr. National Advisor for the Coalition for Women's Cancer Resources presented the first 2023 Cancer Research & Innovations award to cancer imaging specialist Dr. Robert Bard (NYC). </p><p>With over 200 nominations for the award, Dr. Bard was recognized for his lifetime of achievements in support of non-invasive screening of dense breast tissue. Mr. Cappello delivered the award with fellow executives Donna Johnson (Pres. Of Are You Dense Foundation) and Marion Bradley (Pres. Of Are You Dense Advocacy Foundation from Woodbury CT to personally honor Dr. Bard at his midtown NYC practice for his life's work. Since 2019, Mr. Cappello's Are You Dense Advocacy Foundation succeeded in helping to pass National legislation to federally mandate breast screening centers to address the dense breast crisis with the ultrasound complement. Mr Cappello's commitment to enforce this legislation nationally, started with his wife, the late Dr. Nancy M. Cappello who passed away due to complications with her late stage breast cancer treatment. </p><p>Since 1979, Dr. Bard's radiology practice clinically promoted and published the critical need for using ultrasound breast imaging as a supplemental scan alongside regularly scheduled mammograms. (It is noted that ultrasound scans are able to detect growths and tumors behind dense tissue, what mammograms tend to miss). At the time, no regulatory standard enforced the need for this 2nd scan, attributing to many undetected breast cancer tumors concealed by dense breast tissue. With the rise of breast cancer cases throughout the country, Dr. Bard's theories about dense breast imaging has taken root with a growing population of OB-GYNs and Imaging specialists. </p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiVB6OieXZ7wOuEPMbOOkjYBGnggwvqYVT0dOQNXD_NhQi_bMu5TBegoXOwmJxt4ylO8sHqMLXi268tJBTyHjxTQceL7k5J9tF0FvbOUIx-HmE0YP-vk59Igtja427I-ZCLP1O5AZKULsWow2xwbBQyRt8sMFPYk8zHjlb72qoK3wMaVGgGpgmBkl2oNrc/s480/best-art1.jpg" style="clear: right; color: #cc6611; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="432" data-original-width="480" height="288" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiVB6OieXZ7wOuEPMbOOkjYBGnggwvqYVT0dOQNXD_NhQi_bMu5TBegoXOwmJxt4ylO8sHqMLXi268tJBTyHjxTQceL7k5J9tF0FvbOUIx-HmE0YP-vk59Igtja427I-ZCLP1O5AZKULsWow2xwbBQyRt8sMFPYk8zHjlb72qoK3wMaVGgGpgmBkl2oNrc/s320/best-art1.jpg" style="background: rgb(255, 255, 255); border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="320" /></a></div>On a related note, in January of 2023- ARE YOU DENSE ADVOCACY continued to pursue the public importance of patients receiving their own personal medical information about the condition of their breast health. This initiative directs the Food and Drug Administration to ensure that mammography reports and summaries received by patients and their providers include appropriate information about breast density specified by the law. This also includes at a minimum, the effect of breast density in masking the presence of breast cancer on a mammogram. The qualitative assessment of the provider who interpreted the mammogram, and a reminder to patients that individuals with dense breast tissue should talk with their providers if they have any questions or concerns about their summary. From a prior report (3/28/2019) the Department of Health and Human Services and the FDA announced changes to the MQSA (Mammography Quality Standards Act) to include reporting of dense breast tissue to the patient- by and large, thanks to the Are You Dense Advocacy Foundation.<div><br /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://www.prnewswire.com/news-releases/are-you-dense-foundation-launches-national-recognition-for-clinical-advancements-in-dense-breast-imaging-301928711.html" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="64" data-original-width="168" height="48" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiFzpTDUGd3jlNfSY2YgaHD0QdLHLtSayVX6wYeXnNriAuKrXJABe85fO26-cg5lx-N1te5213Y_r6QCJF4gjJAG8afM6vcwJ5V7pJ1ZKxLuozIwTev3Ir3TATsh3gPIzdujcBzclPSdRpmPn1JYfzkRQ_rIfJadNAORN2h2M6DjqNuF5YeVMgIgff9yUxV/w127-h48/prn_cision_logo_desktop.png" width="127" /></a></div><br /><div><br /><p></p><p><br /></p><p>"Decades since the advent of breast scanning technology, a growing list of real-time innovations in non-invasive diagnostic imaging provide new options in the field of early detection", states Dr. Bard. "These technologies directly align with breast density screening that can easily and affordably complement a woman's regular mammography appointment. By hybridizing the imaging process, we can safely combine diagnostic modalities and improve the assessment of disease and guide therapeutic procedures."</p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiAQlfkt45WLk2tGOVo9oOKqzA8eR08vMcdKayTeo5N19xlJ8KlugTO-v-cUVCD9-Mo6A1TRlvm_gPlURSC8CP_Fe8cnHtAwKCC8AW9sjjh29txNwA5Hj9QvK-w_677mT9vZLSJKTe54E8BhjsfO8VA5BzfcpPuuNTcfumuujUt3RHHQMurB5N-pHF0DBo/s1350/joe--capp-map.jpg" style="clear: right; color: #cc6611; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="842" data-original-width="1350" height="200" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiAQlfkt45WLk2tGOVo9oOKqzA8eR08vMcdKayTeo5N19xlJ8KlugTO-v-cUVCD9-Mo6A1TRlvm_gPlURSC8CP_Fe8cnHtAwKCC8AW9sjjh29txNwA5Hj9QvK-w_677mT9vZLSJKTe54E8BhjsfO8VA5BzfcpPuuNTcfumuujUt3RHHQMurB5N-pHF0DBo/s320/joe--capp-map.jpg" style="background: rgb(255, 255, 255); border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="320" /></a></div>According to a 12/13/2022 press release, Congresswoman Rosa DeLauro (CT-03), Congressman Brian Fitzpatrick (PA-01), and award-winning journalist Katie Couric introduced their legislation, the Find It Early Act. This bill would ensure all health insurance plans cover screening and diagnostic mammograms and breast ultrasounds and MRIs with no cost-sharing. “It means a great deal to me to join Katie Couric, Congressman Fitzpatrick, and all of the breast cancer advocates here to talk about what we must do to detect breast cancer early and save women’s lives,” said Congresswoman Rosa DeLauro. (See complete feature)<p></p><p>"Dr. Bard will go down in medical history as one of the earliest change-makers in our crusade to improve women's early detection programs. His innovative approach to combine technologies makes him a true visionary for the next generation of cancer professionals... by standing his ground about the crisis and aiding in (what is now) a national legislation to save more lives!", states Mr. Cappello.</p><p><br /></p><table border="2" cellpadding="10" cellspacing="0" style="background-color: white; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both; text-align: center;"><b><span style="font-size: medium;">Video News Release: Innovations in Early Detection</span></b></div><div><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; text-align: left;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; font-family: times; font-size: small; text-align: center;"><br /></div></div><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: justify;"><div class="separator" style="clear: both; font-family: times; font-size: small; text-align: center;"><a href="https://youtu.be/L0pamDrNkcU" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="375" data-original-width="675" height="178" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjdEsrTrerDihfzSpphpy0m2C0Ul3pmQrrdQafS8K38mtCoL-qB2c6RP9I8Djy-q_uHKhwhRKbAIajiPz_9WqoW_wdkHZBWydN1QE6gzVYIEWWvMfoheQdrxw9stMaHDs9pcqoZ-yfqLTSMtDR7yG2F6gyaPHC6MUV4NULnjeXMuOy425oqVmw11hjceQ/s320/Screenshot%2001-19-2023%2009.11.06.png" style="background: rgb(255, 255, 255); border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="320" /></a></div><span style="font-family: arial; font-size: small;">"Are You Dense?" Foundation Co-founder Joe Cappello joins the medical diagnostic community to promote the "Get Checked Now!" campaign. Dr. Robert Bard from the Bard Cancer Center (NYC) supports supplemental imaging including the 3D Doppler Ultrasound scanner to offer dense breast detection. This video presents some of the latest advancements in ultrasound features to detect tumors through dense breast tissue- reportedly a significant challenge with mammograms. </span></div></div></div></div></div></div></td></tr></tbody></table><div style="background-color: white; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"><div class="separator" style="clear: both; color: black; font-size: medium; text-align: center;"><br /></div></div><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhtLaGfFBBgSUBc0EZxyu5xzviEYRthf0ztuJUsi_NHHXew2vnGmeYS37A38DiDrizzVSXoea8VQsLL9yq00mRrsQuQVfBYean5Zq-0KgqVwuew9A_-MoSEeLn7fLYD7SESvGLyMp8dv7BLXtymmai08utvOx-VSxiBGy9B_oxyJHofGT4B1yBEhG84Mdw/s640/7-23-04_001.jpg" style="clear: right; color: #cc6611; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="416" data-original-width="640" height="208" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhtLaGfFBBgSUBc0EZxyu5xzviEYRthf0ztuJUsi_NHHXew2vnGmeYS37A38DiDrizzVSXoea8VQsLL9yq00mRrsQuQVfBYean5Zq-0KgqVwuew9A_-MoSEeLn7fLYD7SESvGLyMp8dv7BLXtymmai08utvOx-VSxiBGy9B_oxyJHofGT4B1yBEhG84Mdw/s320/7-23-04_001.jpg" style="background: rgb(255, 255, 255); border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="320" /></a></div>THE LEGACY OF DR. NANCY CAPPELLO<br />In 2014, Imaging Technology News (ITN) introduced breast cancer survivor-turned-crusader Dr. Nancy Cappello and her story about having dense breast tissue leading to a late-stage cancer. A false negative mammography scan (diagnosed in 2004) concealed a large 2.5 cm suspicious lesion, which was later confirmed to be stage 3c breast cancer. This same cancer had metastasized to 13 lymph nodes. This sparked Dr. Cappello to create the "Are You Dense?" Foundation- an international awareness crusade to better support dense breast diagnostics and initiatives pass legislation to enact laws requiring mammography centers to inform patients about their breast density and the associated cancer risks. Dr. Cappello passed away on Nov 15, 2018, from secondary myelodysplastic syndrome (MDS), a bone marrow cancer that was a complication of her prior aggressive breast cancer treatments. But she ignited a legacy of fighting for improved policies, imaging technologies and advanced research to better address this health crisis that puts the est. 40% of the female population (women with dense breasts) at risk of a false negative reading.<p></p><p><br style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;" /></p></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-51572469298099602582023-09-24T18:46:00.003-07:002023-11-12T17:44:42.908-08:00Epigenetic Research Notes: Profiling the Dense Breast Paradigm (part 1)<p><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjIdpcCZfQeql6Mo2zunLSX57M419P48sznvRN7SBzQvwbh1S2_ZRRAtZ61Eh5eI5e704_KGiG6uGQfd7EY9Jw-S_8duted8-Hh9RK7c8-T8BqrJNB1UYaaHW7WjdSsX6HTUX8sBPrUqJzuPEX4zpU0b9yQHyO0e1kkJLDVHPuLbykDPWEMUKz7dbMTx_z2/s1280/poopa.jpg" style="clear: left; color: #2288bb; display: inline; float: left; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; margin-bottom: 1em; margin-right: 1em; text-align: center; text-decoration-line: none;"><img border="0" data-original-height="720" data-original-width="1280" height="213" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjIdpcCZfQeql6Mo2zunLSX57M419P48sznvRN7SBzQvwbh1S2_ZRRAtZ61Eh5eI5e704_KGiG6uGQfd7EY9Jw-S_8duted8-Hh9RK7c8-T8BqrJNB1UYaaHW7WjdSsX6HTUX8sBPrUqJzuPEX4zpU0b9yQHyO0e1kkJLDVHPuLbykDPWEMUKz7dbMTx_z2/w378-h213/poopa.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="378" /></a></p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="background-color: white; color: #222222; font-size: 13.2px;">Written by: </span><a href="https://robertaklinemd.com/" style="background-color: white; color: #2288bb; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-decoration-line: none;">Dr. Roberta Kline</a><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="background-color: white; color: #222222; font-size: 13.2px;">. </span><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"></p><p style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"></p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="background-color: white; color: #222222; font-size: 13.2px;">As an Ob-Gyn physician and genomics specialist, I have spent the better part of 10 years translating research in the genomic and gene expression areas into clinically usable information for healthcare professionals. One of the biggest challenges we face when connecting research with patient care is the long delay in the translation process and dissemination of the information. It often takes 10 to 20 years for information (validated findings) that comes out of research to be applied in clinical practice. These delays result in many lost opportunities to provide better care for our patients. This is one of the reasons why I'm really passionate about accelerating this process and making it easier for clinicians and their patients to take advantage of cutting-edge information and new technologies. </span><div style="background-color: white; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"><br /></div><div style="background-color: white;"><div style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: center;"><iframe allow="autoplay; fullscreen; picture-in-picture" frameborder="0" height="338" src="https://player.vimeo.com/video/865202281?badge=0&autopause=0&player_id=0&app_id=58479" title="Dense Breast Review: R. Kline, MD" width="600"></iframe></div><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"><b>LINKING DENSE BREAST WITH BREAST CANCER</b><br />We have known for a very long time that there is an increased risk of breast cancer for women who have dense breasts. Until recently, the research has been lagging in terms of what's the molecular mechanism, why do dense breasts present an increased risk of breast cancer? Without this knowledge, we can’t address the root causes, and are left with a lot of trial and error based on incomplete understanding. </p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">It's very encouraging to know that currently there are 124 clinical trials ongoing looking at dense breasts and the relationship with breast cancer, anywhere from improved diagnostics, to treatment, to prevention, and, what’s close to my heart, to understanding the molecular mechanisms - what's happening at the cell level, at the genetic level that is causing different women to have an elevated risk of breast cancer. </p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">One of the striking features that we're learning about dense breasts and what is creating that density is the microenvironment, which means the environment in the supporting tissue surrounding the glands. This includes fibroblasts and collagen. It seems that rather than estrogen being the dominant factor, it is inflammation that is creating the increased density of breast tissue. </p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"><br /></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"><b></b></p><div class="separator" style="clear: both; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgXGi2K-8Cix2_cq0YV8JHgajcONpf_nfSaj8j7b-SAU8o-fdBkY2Pp24l_hBB3w9ZBFgUSDrVlUecKXQ6v4Jx2Jv4QzrvA0oYj4Ch5MrFeHJYPggt9CjWGxSfEqdLppVWXcxm4ZL-6jDo5_wwjCokH0n6nLZ-nh_kYB7YidBxoPNVBNCVznJsufm7p_OPh/s1280/11.jpg" style="clear: right; color: #2288bb; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="720" data-original-width="1280" height="126" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgXGi2K-8Cix2_cq0YV8JHgajcONpf_nfSaj8j7b-SAU8o-fdBkY2Pp24l_hBB3w9ZBFgUSDrVlUecKXQ6v4Jx2Jv4QzrvA0oYj4Ch5MrFeHJYPggt9CjWGxSfEqdLppVWXcxm4ZL-6jDo5_wwjCokH0n6nLZ-nh_kYB7YidBxoPNVBNCVznJsufm7p_OPh/w225-h126/11.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="225" /></a><b></b></div><b style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">ESTROGEN VS INFLAMMATION</b><br /><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;">What's fascinating to me is that even though we associate estrogen with the primary means by which women develop breast cancer, it may be a different process for breast cancers linked to breast density. Some of the research that has just come out in the last few years is showing us that rather than being hormonally driven, we think what's happening is there is an increase in these inflammatory markers in the tissue that is denser, and this is what can also lead to cancer.</span></span><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">There is clearly a genetic, or hereditary component, because having dense breasts is noted to run in families. But while having dense breasts increases a woman’s risk of breast cancer by up to 4-6x, not all of these women actually get cancer. That means there are other factors that can potentially increase as well as reduce a woman’s risk. This is where genomic research has been a gamechanger in identifying these other factors including for women with inherited genetic mutations, such as BRCA. </p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">We now know that there are multiple genes in multiple other pathways that can modify a woman’s risk of breast cancer even if she carries a BRCA mutation. [1]. Researchers have identified smaller changes in genes called SNPs (single nucleotide polymorphisms) that have a much lower individual impact than genetic mutations, but together can be additive.[2] In fact, women with specific patterns of SNPs had their risk of breast cancer significantly reduced. This can help explain why not all women with BRCA mutations get cancer, and provides insight into potential protective biological mechanisms.</p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">This is a really powerful paradigm shift, because now it opens the door for truly individualizing each woman’s risk – and potentially being able to change it through diet, lifestyle, or other modalities.</p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">We now are also learning that gene SNPs can also play a role in a woman’s risk for dense breasts and breast cancer. While there's much research that needs to be done, from my experience, there's a lot we can do already to potentially intervene and help women with dense breasts. As we wait for more definitive research, we can learn from the nutritional genomics and functional medicine realms. </p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"></p><div class="separator" style="clear: both; color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhI3qB55gMGDcCcOr2YTcjmlW38HlrnjrXeLW2WrsbVoufN7zd71GhRKXpkFcUxgSf72DTNCxyk-HTYFt2o7IdFsTFsJFtRo693ECYMR4f_TDLdFTE5OPey9HFTydNL2ELeQ_56Jq2wAiFyTeM5YfbIFGgBT3FBH1uooox2v0jnR2IhXeLvE_h5wa_Pb1Fs/s800/dreamstime_s_176812483.jpg" style="clear: right; color: #2288bb; float: right; margin-bottom: 1em; margin-left: 1em; text-decoration-line: none;"><img border="0" data-original-height="639" data-original-width="800" height="153" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhI3qB55gMGDcCcOr2YTcjmlW38HlrnjrXeLW2WrsbVoufN7zd71GhRKXpkFcUxgSf72DTNCxyk-HTYFt2o7IdFsTFsJFtRo693ECYMR4f_TDLdFTE5OPey9HFTydNL2ELeQ_56Jq2wAiFyTeM5YfbIFGgBT3FBH1uooox2v0jnR2IhXeLvE_h5wa_Pb1Fs/w191-h153/dreamstime_s_176812483.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="191" /></a></div><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;">We have long known that pro-inflammatory conditions are underlying drivers for so many of the chronic diseases we see today, from cancer to heart disease, diabetes, autoimmune disease, depression and more. The flip side of inflammation is oxidative stress. They go hand in hand. Some of the genes that drive these processes are now also being linked to dense breasts and potentially the increased breast cancer risk that women with dense breasts have. </span></span><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">My question is, why can't we use some of these dietary lifestyle and nutritional supplement interventions that we already know decrease many of these pro-inflammatory pathways? Why can't we start using those in clinical practice as we wait for research and clinical trials to better refine our knowledge? The fact is, we can! But it takes education, awareness and advocacy to implement these strategies more widely and make a difference now.</p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"><br /></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">Reference:</p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">1) link to polygenic model – breast cancer, Lynch syndrome etc <a href="https://healthresourcedigest.blogspot.com/2022/03/the-future-in-personalized-medicine.html" style="color: #2288bb; text-decoration-line: none;">https://healthresourcedigest.blogspot.com/2022/03/the-future-in-personalized-medicine.html</a></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;">2) Link to genetics/genomics <a href="https://modernhealing1.blogspot.com/2020/11/what-is-lynch-syndrome.html" style="color: #2288bb; text-decoration-line: none;">https://modernhealing1.blogspot.com/2020/11/what-is-lynch-syndrome.html</a></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"><br /></p><hr style="text-align: justify;" /><p></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjl0WIYX3Z7Kzt_ox7ubDTIxgIhPMsBgRtXrA8ttKoJoPyzSBrmozGJFxiZL7bZV3ezKUQZphsLMtD9oLdvOVDKgahdkN-8CkIHV8VRp7Ytf7hbvedV_Ifs3sOnlxX76rjiOIjKVGM2Oxu3DRZT11JGe_yTh6X_uwihz1R5AAcNmkDJ1f_MaqSgen2wRhMx/s6840/V.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify; text-decoration-line: none;"><img border="0" data-original-height="3538" data-original-width="6840" height="68" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjl0WIYX3Z7Kzt_ox7ubDTIxgIhPMsBgRtXrA8ttKoJoPyzSBrmozGJFxiZL7bZV3ezKUQZphsLMtD9oLdvOVDKgahdkN-8CkIHV8VRp7Ytf7hbvedV_Ifs3sOnlxX76rjiOIjKVGM2Oxu3DRZT11JGe_yTh6X_uwihz1R5AAcNmkDJ1f_MaqSgen2wRhMx/w131-h68/V.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="131" /></a></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><br /></div><p></p><p style="text-align: justify;"><br /></p><p></p><div style="text-align: justify;"><span style="font-family: arial; font-size: large;"><br /></span></div><div><span style="font-family: arial; font-size: large;">2024 CLINICAL PROFILE OF THE DENSE BREAST PARADIGM - </span><span style="font-family: arial; font-size: large; text-align: justify;">for the Obstetrics & Gynecology Society </span></div><div style="text-align: justify;">Written by: <a href="https://robertaklinemd.com/" style="color: #0043ee; text-decoration-line: none;">Roberta Kline, MD</a></div><div style="text-align: justify;">Published by ICRS Medical Press Ltd.</div><p></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh6yc61oHPGJNeKfER9BRMecasuvYIcXTeUtpzrj9yvjHAOEAnvGUdOpX7oInUxejVrfmCMoG6aiGMFlq7D7kH_NtTytSfbSp1rNy9PK2zBnFf2uRxW0CkYeXzK8KY5H7FIjPHk-x9lDykn6SMEy5z-9rHnGdZM4SZ_LC0E9vf-L9WY3ye8dXB59gkn57SH/s547/3D-book-on-white.jpg" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify; text-decoration-line: none;"><img border="0" data-original-height="547" data-original-width="346" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh6yc61oHPGJNeKfER9BRMecasuvYIcXTeUtpzrj9yvjHAOEAnvGUdOpX7oInUxejVrfmCMoG6aiGMFlq7D7kH_NtTytSfbSp1rNy9PK2zBnFf2uRxW0CkYeXzK8KY5H7FIjPHk-x9lDykn6SMEy5z-9rHnGdZM4SZ_LC0E9vf-L9WY3ye8dXB59gkn57SH/s320/3D-book-on-white.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="202" /></a></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">Breast cancer affects the lives of hundreds of thousands of women every year and is a leading cause of death. While we have made great progress in advancing earlier diagnosis and more individualized treatments, we still need to improve our approach to achieve our ultimate goal - prevention. This requires a deeper understanding of the molecular mechanisms and the multitude of factors that contribute to the development of breast cancer. </div><div style="text-align: justify;"><br /></div><div><div style="text-align: justify;">Dr. Roberta Kline, recognized speaker and publishing crusader for women's health brings you a comprehensive review and a deep-dive analysis of the current research findings about breast density and its major risk factors for breast cancer. Her reports uncover current imaging practices and clinical protocols updated in great support of breast density detection and the means of addressing this growing condition that affects over 45% of the female population. "Knowing a woman has greater breast density is a critical first step, but it doesn’t end there... we need to go further by understanding the causes of breast density, and how they relate to breast cancer-- we now have another avenue to proactively intervene to reduce risk or even prevent breast cancer in the first place." This textbook is a champion in targeting the <b>Dense Breast Paradigm</b> as a blueprint and a clear course study for all clinical professionals who are dedicated to women's early detection and prevention programs. <a href="https://cancerresourcealliance.blogspot.com/2023/09/epigenetic-research-notes-profiling.html" style="color: #0043ee; text-decoration-line: none;">(More information)</a><br /><br /></div><hr /><br /><div style="text-align: justify;"><div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEggL5beCQWkgijCP8Bex0Jvtgayn4rZfINwktSYXUxt3ySX9zfiyUl8pO0cJWLuvxx6OaChDxGHipfPqB5yJ4hgCEm8AsG_KPZFnkgq6bhvMfmbEBbh5dDzHPgqBOwWS9mq5E0PCW4_Zy78YwrE0qJ8rOt2ediwhEyRiURhB0eD2JdkXJKAFRqcAOqkTuPb/s297/blocc.jpg" imageanchor="1" style="clear: left; color: #0043ee; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="195" data-original-width="297" height="195" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEggL5beCQWkgijCP8Bex0Jvtgayn4rZfINwktSYXUxt3ySX9zfiyUl8pO0cJWLuvxx6OaChDxGHipfPqB5yJ4hgCEm8AsG_KPZFnkgq6bhvMfmbEBbh5dDzHPgqBOwWS9mq5E0PCW4_Zy78YwrE0qJ8rOt2ediwhEyRiURhB0eD2JdkXJKAFRqcAOqkTuPb/s1600/blocc.jpg" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1px solid rgb(238, 238, 238); box-shadow: rgba(0, 0, 0, 0.1) 1px 1px 5px; padding: 5px; position: relative;" width="297" /></a></div>LAUNCHING IN 2024: NATIONAL COALITION OF WOMEN'S HEALTH SUPPORT</div><div>Professional health orgs, foundations and advocates of women's health disorders (primarily cancers) is uniting to form a national alliance of collaborators. This collective group is focused on "doing more together" as far as exploring new resources, sharing current ideas and addressing a wide range of topics about women's issues. Meetings like our latest Women's Powermeet series discussed the latest in diagnostic and therapeutic solutions while introducing who's who in national crusadership in the advocacy realm. Clinicians are also welcome to discuss patient-dedicated road maps and a more thoughtful health analysis and research-based evaluation. It is this level of commitment to women's health that provides a deeper sense of care for the patient that lends itself to a more holistic and integrative strategy to therapeutics. It is also this philosophy that draws more intuitive and insightful awareness on a global scale to offer collaboration platforms too better share insights on a patient's disorders to seek out better solutions. (<a href="http://fightrecurrence.com/" style="color: #0043ee; text-decoration-line: none;">See Women's Health Digest</a>)</div></div><div style="text-align: justify;"><br style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;" /></div></div><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"></p><hr style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;" /><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjhZCkF7pm2S5Av89sTgMjSMlSM27vGwCnqIzNTUvOS3qHDz0CW8Hxyza-m_con2BkzUAcD8Y_HZkbEa4myyLnlKXgqVWP9lIiEJjvuHGT5TlODkyyKNCb7lDxT06fAzGWuAPr7VikHHJo1G9LH6rkKSvZ-q0pNTS_fkxWiiw2dg2oRQCUaNYo5m0A0Zo7r/s2846/logo-large.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1035" data-original-width="2846" height="53" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjhZCkF7pm2S5Av89sTgMjSMlSM27vGwCnqIzNTUvOS3qHDz0CW8Hxyza-m_con2BkzUAcD8Y_HZkbEa4myyLnlKXgqVWP9lIiEJjvuHGT5TlODkyyKNCb7lDxT06fAzGWuAPr7VikHHJo1G9LH6rkKSvZ-q0pNTS_fkxWiiw2dg2oRQCUaNYo5m0A0Zo7r/w147-h53/logo-large.png" width="147" /></a></div><br /><p style="text-align: center;"><br /></p><p style="text-align: center;"><iframe allow="autoplay; fullscreen; picture-in-picture" frameborder="0" height="338" src="https://player.vimeo.com/video/866459937?badge=0&autopause=0&player_id=0&app_id=58479" title="proc-work1" width="600"></iframe></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"></p><div class="separator" style="clear: both; text-align: center;"><br /></div><p></p><p><b></b></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;"><b>FOR IMMEDIATE RELEASE</b></span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222; font-size: medium;">PROCLAMATION: 9/27 Is World Dense Breast Tissue Day</span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;">9/19/2023- Mr. Joe Cappello, co-founder of the "Are You Dense?" Foundation was invited to attend the Santa Clara County Board of Supervisors meeting at County Government Center to receive an official proclamation by Santa Clara County Supervisor (and former California State Senator) JOE SIMITIAN, officially confirming September 27 as World Dense Breast Tissue Day. According to Mr. Simitian, this proclamation was sparked by earlier discussions about the late Nancy Cappello who passed away of breast-cancer related complications from dense breast tissue. "(Nancy's) own life experience... said others should have more power, more knowledge, more ability to affect the decision making in their own healthcare. For this, we are a better state, a better county, and in fact a better nation by virtue of her work."</span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;">To date, Joe Cappello continues to build and promote educational programs supporting research, clinical upgrades and improved scanning/monitoring programs. The "Are You Dense?" Foundation and "Are You Dense?" Advocacy are produced by the Cappellos in pursuit of saving lives through awareness through uniting with community leaders, clinical professionals and public recognition off the continued risks of having dense breast tissue.</span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222; font-size: 13.2px;">TRANSCRIPT OF PROCLAMATION: 9/19/2023</span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;">County of Santa Clara Board of Supervisors</span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;"><br /></span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222; font-size: 13.2px;"><b>SPEAKER: Santa Clara County (CA) Supervisor Joe Simitian- District 5</b></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;">Thank you, Madam President. And I'm going to look to the clerk to see if we can bring Mr. Joe Cappello from “Are You Dense?” in Connecticut up on the screen. </span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222; font-size: 13.2px;">Colleagues and members of the public, you'll recall of course that just last week, we adjourned our meeting in memory of Nancy Cappello, who passed away almost five years ago now. And it provided an opportunity for our board to reflect on Nancy's extraordinary work over literally decades. We also took the opportunity at our last meeting to express our formal support for the Find It Early Act which is an effort at the national level congressional level to take the next step in terms of addressing the cancer risk of women with dense breast tissue. Today, we are calling out the formal acknowledgement of World Dense Breast Tissue Day. And the reason for that, Joe, and colleagues and members of the public is to ensure that we take advantage of this opportunity to identify September 27th as World Dense Breast Tissue Day, so that members of the public will have the information, the knowledge, the power that Nancy Cappello thought they were entitled to all those years ago.</span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222; font-size: 13.2px;">And as we have discussed previously (so I won't speak at quite substantial length today) this is information that patients need to have. They are now entitled to have it by law. That entitlement is in large measure, a function of the fact that Nancy Cappello took her own life experience and said others should have more power, more knowledge, more ability to affect the decision making in their own healthcare. For this, we are a better state, a better county, and in fact a better nation by virtue of her work. Joe, if you were here, I would have you up to the podium and I would hand you the physical commendation. But by virtue of our virtual connection today, I will virtually present it to you and we will send you the physical commendation and I hope it will find a place at “Are You Dense?”. </span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222; font-size: 13.2px;">I'm guessing that your screen-... It doesn't reveal it, but I am wearing on my lapel the “Are You Dense?” button which I wore all those years ago when I was privileged to work with Nancy and the organization on California law. With that, Madam President, I say thank you to our board, and to my colleagues for their support on this measure and through the chair. With your permission, I'd like to give Mr. Cappello an opportunity to say a brief word or two.</span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;"><br /></span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;"><b>Guest Speaker: JOE CAPPELLO</b></span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;">Well, thank you, Supervisor Simitian. As I said before, it's a real pleasure. I finally got to meet the other Joe in Nancy's life. And believe me, she always had kind words to say about you, and you were always a standup guy. You were the one that she could count on for honesty and truthfulness when we were doing our legislative work in California. What we have now is a disclosure law, which is a national law, which will take effect a year from now. This is huge step for the health of women all over this nation. What it's going to do is standardize (diagnostic care) in the medical field for women with dense breasts. I thank you in the name of Nancy for the proclamation. She deserves it all. She worked hard and worked smart. She was not only prettier than me, <laugh>, but smarter than me. And, I thank you on her behalf. I appreciate that. Thank you.</span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222; font-size: 13.2px;">The Board of Supervisors of the County of Santa Clara, CA regularly meets in the Board of Supervisors’ Chambers, County Government Center, 70 West Hedding Street, San Jose. Regular meetings are held on designated Tuesdays at 9:30 a.m. The Board also holds regular meetings for the purpose of adjourning into Closed Session on Mondays at 2:00 p.m., which may be combined with meetings scheduled for the presentation of ceremonial items to be heard at 4:00 p.m.</span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;"><br /></span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;"><br /></span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;"><br /></span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;"><br /></span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;"><br /></span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;"><br /></span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #222222;"><span style="font-size: 13.2px;"><br /></span></span></p><p style="color: #222222; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px;"><br /></p></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-78693996152714394492023-09-19T12:55:00.000-07:002023-09-20T08:10:38.927-07:00A NEED TO STANDARDIZE SCREENING WITH DENSE BREAST SCANNING<p style="text-align: center;"> <iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/BC-oHAi7m9A" title="YouTube video player" width="560"></iframe></p><div class="separator" style="background-color: white; clear: both; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: center;"><div class="separator" style="clear: both;"><b>RUNNING THE TORCH OF A DENSE BREAST CANCER CHAMPION</b></div><div class="separator" style="clear: both;">Dr. Noelle Cutter drives the spirit of Dr. Nancy Cappello's mission for early cancer detection for women with dense breasts alongside Dr. Robert Bard's dense breast screening pilot program (8/27-29) - and the global pursuit to expand current screening standards.</div></div><div class="separator" style="background-color: white; clear: both; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: center;"><div class="MsoNormalCxSpFirst" style="-webkit-text-stroke-width: 0px;"><div style="text-align: justify;"><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;"><h1 id="content" style="box-sizing: border-box; font-family: Merriweather, serif; font-size: 2.125rem; font-weight: 500; line-height: 1.3; margin-bottom: 0.75rem; margin-top: 1rem;">What Does It Mean to Have Dense Breasts?</h1></span></div><div style="text-align: justify;"><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;"><div><a href="https://www.cdc.gov/cancer/breast/basic_info/dense-breasts.htm">Source: CDC.gov</a></div><div><br /></div><div>A mammogram shows how dense your breasts are. When you get the results of your mammogram, you may also be told if your breasts have low or high density. Women with dense breasts have a higher risk of getting breast cancer.</div><div><br /></div><div><a href="file:///C:/Users/LEO/Desktop/NOW%202021/BARD/CAMPAIGN%203/DENSE%20BREASTS/GlobalInveniaABUS20DensityQuickFactsSheetDecember2018.pdf" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: center;"><img border="0" data-original-height="440" data-original-width="873" height="332" src="https://1.bp.blogspot.com/-PKC1iTUMvzk/YO8L2ROs3jI/AAAAAAAARQI/Rn3aRDzpqEc8sJMGZknCfsF_lFWEUEzewCLcBGAsYHQ/w659-h332/use.jpg" width="659" /></a><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div>PARTS OF THE BREAST</div><div>A woman’s breast has three kinds of tissue: FIBROUS TISSUE holds the breast tissue in place. GLANDULAR TISSUE is the part of the breast that makes milk, called the lobes, and the tubes that carry milk to the nipple, called ducts. Together, fibrous and glandular tissue are called fibroglandular tissue. FATTY TISSUE fills the space between the fibrous tissue, lobes, and ducts. It gives the breasts their size and shape.<span style="color: black; font-family: "Times New Roman"; font-size: medium;"></span></div><div><br /></div><div>BREAST CANCER RISK: Women with dense breasts have a higher chance of getting breast cancer. The more dense your breasts are, the higher your risk. Scientists don’t know for sure why this is true. Breast cancer patients who have dense breasts are not more likely to die from breast cancer than patients with non-dense (fatty) breasts.</div><div><br /></div><div><br /></div><div><br /></div><div><a href="https://1.bp.blogspot.com/-fbezYSvBljw/YOhLjOYazhI/AAAAAAAARNo/R09trNQcM4Eas9nQ50HPng6CvHqgoBo9gCLcBGAsYHQ/s646/ad.jpg" style="clear: right; float: right; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="516" data-original-width="646" src="https://1.bp.blogspot.com/-fbezYSvBljw/YOhLjOYazhI/AAAAAAAARNo/R09trNQcM4Eas9nQ50HPng6CvHqgoBo9gCLcBGAsYHQ/s320/ad.jpg" width="320" /></a>7/8/2021- A wave of recognized medical sites, journals and reports are now indicating that dense breast tissue increases the risk of developing breast cancer and often masks a tumor from being seen on the mammogram since dense tissue is white and cancerous tissue is also white. Mammograms are the standard screening test for breast cancer, however, in the 21st Century, ultrasound non invasive imaging is the preferred exam for dense “lumpy” mammary disease. </div></span><div><div class="separator" style="clear: both; text-align: center;"><div class="MsoNormalCxSpFirst" style="-webkit-text-stroke-width: 0px;"><div style="text-align: justify;"><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;"><br /></span></div><div style="text-align: justify;"><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;">The 1st World Conference of Breast Ultrasound in Philadelphia (1979) recognized ultrasound superiority in dense breast diagnostics but the density level was never quantified until recently. Mammography assessment of breast density is graded into four categories. Mammographers readily admit that these levels are subjective at best and technical factors such as mammary tissue compression and x-ray voltage/amperage dramatically influence the darkness or whiteness of the image.</span></div><div><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;"><br /></span></div></div></div></div><div><br /></div><div><div class="MsoNormalCxSpFirst" style="-webkit-text-stroke-width: 0px;"><div><hr /><p></p></div></div><p><span style="font-size: large;">URGENCY IN THE EVOLUTION OF TECHNOLOGY & IMAGING STRATEGIES FOR DENSE BREASTS</span></p><p>Written by: Dr. Robert L. Bard</p><div><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-nhYKSycK9HY/YPBBiz9kT4I/AAAAAAAARQ0/hZBcbRGgdpkeas9QODPtZnjsTHe8N7Q_gCLcBGAsYHQ/s1100/INSERT2.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="706" data-original-width="1100" height="258" src="https://1.bp.blogspot.com/-nhYKSycK9HY/YPBBiz9kT4I/AAAAAAAARQ0/hZBcbRGgdpkeas9QODPtZnjsTHe8N7Q_gCLcBGAsYHQ/w402-h258/INSERT2.jpg" width="402" /></a></div>Decades since the advent of breast scanning technology, innovations in non-invasive diagnostic imaging provide new options in the field of early detection. These technologies directly align with breast density screening (and are part of the Bard Breast Density Diagnostic Program) include:</div></div><div><p></p><p></p><div><span style="font-family: times;">• Doppler blood flow</span></div><span style="font-family: times;"><div><span>• Contrast enhanced ultrasound vascularity </span></div><span><div>• 3D Vessel Density Histogram </div></span><span><div>• 4D Volumetric Density Histogram</div><div>• Strain and shear wave tissue Elastography </div></span><span><div>• 3T MRI </div><div>• Optical Computed Tomography (OCT) for nipple lesions</div><div>• Reflectance Confocal Microscopy (RCM) for dermal invasion</div></span><span><div>• Hybrid <span style="background-color: transparent;">Mammo Imaging Fusion</span></div></span></span><div><span style="font-family: times;">•</span><span style="font-family: times;"> </span>Thermo-sensor</div><div><span style="font-family: times;">•</span><span style="font-family: times;"> </span>Trans Illumination</div><div><span style="font-family: times;">•</span><span style="font-family: times;"> </span>Near Infrared Specroscopy</div><p></p><p>Hybrid imaging refers to combining diagnostic modalities to assess disease and monitor therapy. A useful combination of options is the tumor vessel flow density to assess aggression and treatment progress. Similarly, tissue elastography is useful for border detection of malignant masses.</p><p><br /></p><p><a href="http://breastcancernyc.com/"><b>FOR COMPLETE DETAILS ON THIS PROGRAM, VISIT: http://breastcancernyc.com/</b></a></p></div></div></div></div></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-1861264802988032222023-01-19T05:11:00.024-08:002023-08-29T05:44:00.237-07:00DENSE BREAST NEWS: 2023<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg1hi7iEU5C61pA4STLifKOAPNs-_LKrjAPOETJNsxqj_HT5PAVl2UpQejYu4yUGWSaYpzLQOWukbuOt9QN7pDn_eObEAo1isifID27wHDxv70D_4Ik4OrFk_BQws4ZMBGl4Wz9GWqBDt84CvMAWvW3RVkJ__k7QjlEAd4utnAsFZ-EWVT43s2aEr-83Q/s1513/ayd-pinkmap-notext.png" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="1009" data-original-width="1513" height="213" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg1hi7iEU5C61pA4STLifKOAPNs-_LKrjAPOETJNsxqj_HT5PAVl2UpQejYu4yUGWSaYpzLQOWukbuOt9QN7pDn_eObEAo1isifID27wHDxv70D_4Ik4OrFk_BQws4ZMBGl4Wz9GWqBDt84CvMAWvW3RVkJ__k7QjlEAd4utnAsFZ-EWVT43s2aEr-83Q/s320/ayd-pinkmap-notext.png" width="320" /></a></div><div style="text-align: justify;">1/19-2023- The ARE YOU DENSE ADVOCACY committee continued to pursue the public importance of patients receiving their own personal medical information about the condition of their breast health. This initiative directs the Food and Drug Administration to ensure that mammography reports and summaries received by patients and their providers include appropriate information about breast density specified by the Secretary. This also includes at a minimum, the effect of breast density in masking the presence of breast cancer on a mammogram. The qualitative assessment of the provider who interpreted the mammogram, and a reminder to patients that individuals with dense breast tissue should talk with their providers if they have any questions or concerns about their summary. From a prior report (3/28/2019) the Department of Health and Human Services and the FDA announced changes to the MQSA (Mammography Quality Standards Act) to include reporting of dense breast tissue to the patient- by and large, thanks to the Are You Dense Advocacy, Inc. [1]</div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: right; margin-left: 1em; text-align: right;"><tbody><tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhYMj51r5mSn1Ikr6TDBR-9UfEodGqh_Xg1xYnoighw0pufOL4nAu04mC6x6UiByZQQS1yAYUfPySuHk9lBSkwZAu_y_ewrR13E8Zbz2gkFDwYl8cCDqVe0dEzdRwHS6z7XoiUONAfwAcHnXtiWwJY_J_zlIEHYQjIHJhvQ23e8HRCKsn3zRoBGiAo2ew/s842/20221019_102757.jpg" style="clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><span style="font-size: x-small;"><i><img border="0" data-original-height="842" data-original-width="710" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhYMj51r5mSn1Ikr6TDBR-9UfEodGqh_Xg1xYnoighw0pufOL4nAu04mC6x6UiByZQQS1yAYUfPySuHk9lBSkwZAu_y_ewrR13E8Zbz2gkFDwYl8cCDqVe0dEzdRwHS6z7XoiUONAfwAcHnXtiWwJY_J_zlIEHYQjIHJhvQ23e8HRCKsn3zRoBGiAo2ew/s320/20221019_102757.jpg" width="270" /></i></span></a></td></tr><tr><td class="tr-caption" style="text-align: center;"><span style="font-size: x-small;"><i>Joe Cappello / Are You Dense? Foundation</i></span></td></tr></tbody></table>According to a 12/13/2022 press release, Congresswoman Rosa DeLauro (CT-03), Congressman Brian Fitzpatrick (PA-01), and award-winning journalist Katie Couric introduced their legislation, the Find It Early Act. This bill would ensure all health insurance plans cover screening and diagnostic mammograms and breast ultrasounds and MRIs with no cost-sharing. “It means a great deal to me to join Katie Couric, Congressman Fitzpatrick, and all of the breast cancer advocates here to talk about what we must do to detect breast cancer early and save women’s lives,” said Congresswoman Rosa DeLauro. “As we all know, when it comes to surviving cancer, early detection is key – as 99 percent of women who receive an early diagnosis survive it. That is why today I am introducing the Find It Early Act, which would mandate all insurance providers to cover additional screenings including diagnostic mammograms, breast ultrasounds, and breast MRIs, with no cost-sharing.” “At DenseBreast-info we hear from women all the time who find out they have dense breasts and that they would benefit from additional screening, but then discover they have to navigate getting approvals from their insurance providers - and begina frustrating cycle of phone calls, denials, appeals and more phone calls,” said JoAnn Pushkin, Executive Director of DenseBreast-info, Inc. “The Find it Early Act will help ensure that when a woman is told that her mammogram might not be enough – she will not have to struggle to pay for additional imaging, orchoose between household bills and a recommended test, or spread the cost of an MRI over one year, and skip the next year because the cost of the exam has strained her budget.”</div><div style="text-align: justify;">“It is my pleasure to give a voice on behalf of many hundreds of dense breast cancer patients who have become advocates across this country to say THANK YOU Congresswoman DeLauro,” said Joseph J. Cappello, Executive Director and Co-Founder of Are You Dense Advocacy, Inc. “We thank you for taking the initiative as a leader in our 18-year battle, by demanding the FDA take action on the new MQSA rule by the end of this month. Your leadership will save many hundreds of lives across the nation.” [4]</div><div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><table border="2" cellpadding="10" cellspacing="0" style="background-color: white; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both; text-align: center;"><b><span style="font-size: medium;">Video News Release: Innovations in Early Detection</span></b></div><div><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; text-align: left;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; font-family: times; font-size: small; text-align: center;"><br /></div></div><div class="separator" style="clear: both;"><div class="separator" style="clear: both; text-align: justify;"><div class="separator" style="clear: both; font-family: times; font-size: small; text-align: center;"><a href="https://youtu.be/L0pamDrNkcU" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="375" data-original-width="675" height="178" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjdEsrTrerDihfzSpphpy0m2C0Ul3pmQrrdQafS8K38mtCoL-qB2c6RP9I8Djy-q_uHKhwhRKbAIajiPz_9WqoW_wdkHZBWydN1QE6gzVYIEWWvMfoheQdrxw9stMaHDs9pcqoZ-yfqLTSMtDR7yG2F6gyaPHC6MUV4NULnjeXMuOy425oqVmw11hjceQ/s320/Screenshot%2001-19-2023%2009.11.06.png" width="320" /></a></div><span style="font-family: times; font-size: x-small;">"Are You Dense?" Foundation Co-founder Joe Cappello joins the medical diagnostic community to promote the "Get Checked Now!" campaign. Dr. Robert Bard from the Bard Cancer Center (NYC) supports supplemental imaging including the 3D Doppler Ultrasound scanner to offer dense breast detection. This video presents some of the latest advancements in ultrasound features to detect tumors through dense breast tissue- reportedly a significant challenge with mammograms. </span></div></div></div></div></div></div></td></tr></tbody></table><div style="background-color: white; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13.2px; text-align: start;"><div class="separator" style="clear: both; color: black; font-size: medium; text-align: center;"><br /></div></div></div><p style="text-align: justify;"><b>WHAT'S NEW AT THE MQSA (NATIONAL STATISTICS)</b></p><p style="background-color: white; box-sizing: border-box; color: #333333; font-family: Georgia, Times; line-height: 1.5; margin: 0px auto 1rem; max-width: 45rem; text-align: justify;">Welcome to MQSA Insights. <span>These pages provide information pertaining to the Food and Drug Administration’s (FDA) Mammography Quality Standards Act’s (MQSA) program. </span>Our ultimate goal is to help facilities improve the quality of mammography by allowing them to see how facilities as an aggregate are doing across the nation as well as through exploring specific mammography topics.<span> Such information is designed to:</span></p><ul style="background-color: white; box-sizing: border-box; color: #333333; font-family: Georgia, Times; line-height: 1.5; margin: 0px auto 1rem; max-width: 45rem;"><li style="box-sizing: border-box; text-align: justify;">inform the public on how mammography facilities are doing overall complying with MQSA standards</li><li style="box-sizing: border-box; margin-bottom: 0px; margin-top: 0.5rem; text-align: justify;">highlight other important MQSA statistics and trends</li><li style="box-sizing: border-box; margin-bottom: 0px; margin-top: 0.5rem; text-align: justify;">allow facilities to compare how they are performing to the performance of facilities as a whole [2]</li></ul><p style="background-color: white; box-sizing: border-box; color: #333333; font-family: Georgia, Times; font-size: 1rem; line-height: 1.5; margin: 0px auto 1rem; max-width: 45rem; text-align: justify;"><a href="https://www.fda.gov/radiation-emitting-products/mqsa-insights/mqsa-national-statistics">SEE the latest MQSA Insights presenting the most commonly requested national statistics regarding the MQSA program. These statistics are updated on the first of each month. (LINK)</a></p><p style="background-color: white; box-sizing: border-box; color: #333333; font-family: Georgia, Times; font-size: 1rem; line-height: 1.5; margin: 0px auto 1rem; max-width: 45rem; text-align: justify;"><br /></p><hr style="text-align: justify;" /><div><span style="font-size: medium;"><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiD_2bQWXsBRglq4goVhTUdMoEsMfe8Ky9J_TcsWoG0cXAw_hAHwY-mp8_C6RjW4SG-ujwZ_TKjW-kD-QNa9Rj9cIvQmoRo5KU9q46QUxHn_GwzcORE4YfCFhEK8m1-qcnyCrrNxIrPlTK-c9Z81NCLvjoVfn6l-3V0uoo_T7x_SDAew_02paygwo5J5g/s203/EXTRA1.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="54" data-original-width="203" height="39" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiD_2bQWXsBRglq4goVhTUdMoEsMfe8Ky9J_TcsWoG0cXAw_hAHwY-mp8_C6RjW4SG-ujwZ_TKjW-kD-QNa9Rj9cIvQmoRo5KU9q46QUxHn_GwzcORE4YfCFhEK8m1-qcnyCrrNxIrPlTK-c9Z81NCLvjoVfn6l-3V0uoo_T7x_SDAew_02paygwo5J5g/w148-h39/EXTRA1.jpg" width="148" /></a></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">REPRISE: DR BARD IS CALLED AS MEDICAL EXPERT IN <a href="https://thenationaldesk.com/news/spotlight-on-america/millions-of-women-have-this-breast-cancer-risk-factor-why-arent-they-being-informed-breast-cancer-awareness-month-dense-breast-tissue-xray-mammograms-cdc-dr-bard-suzanne-mcdonald">'SPOTLIGHT ON AMERICA" FEATURE ON DENSE BREAST RESEARCH REPORT</a></div></span></div><div style="text-align: justify;"><br /></div><div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: left; margin-right: 1em; text-align: left;"><tbody><tr><td style="text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEirTYgtuSoY3z7OQNa_ipAW6RaHlDEbwwEi1gVjOMnCuTIIqp9lZ-lq7EjWx0KGYHhdcGXIFIIgWYEnrLtdKol4qA41hzqVppY8-JHhQot5SOBsGE7-vby5DmvENdRaOPGFqB8Q8lnqws-jMR9XaoHI7JVIiH2PRGVcbB5YYoo_BmBdYY-0Ur6MlirY-A/s648/fe7b1051-92aa-4a47-ab25-4e216b75ac64-medium16x9_8.png" style="clear: right; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><img border="0" data-original-height="365" data-original-width="648" height="180" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEirTYgtuSoY3z7OQNa_ipAW6RaHlDEbwwEi1gVjOMnCuTIIqp9lZ-lq7EjWx0KGYHhdcGXIFIIgWYEnrLtdKol4qA41hzqVppY8-JHhQot5SOBsGE7-vby5DmvENdRaOPGFqB8Q8lnqws-jMR9XaoHI7JVIiH2PRGVcbB5YYoo_BmBdYY-0Ur6MlirY-A/s320/fe7b1051-92aa-4a47-ab25-4e216b75ac64-medium16x9_8.png" width="320" /></a></td></tr><tr><td class="tr-caption" style="text-align: center;"><a href="https://www.areyoudense.org/" target="_blank"><span style="font-size: x-small;"><i>Courtesy: "Are You Dense?" Foundation</i></span></a></td></tr></tbody></table>Updated from a video feature originally launched on 10/14/2022, <a href="https://thenationaldesk.com/news/spotlight-on-america/millions-of-women-have-this-breast-cancer-risk-factor-why-arent-they-being-informed-breast-cancer-awareness-month-dense-breast-tissue-xray-mammograms-cdc-dr-bard-suzanne-mcdonald">Spotlight on America (TND)</a> presented an ongoing report: "A SHOCKING DIAGNOSIS". Suzanne McDonald was 48 years old when she got a routine mammogram in 2007. Like so many women, she received a letter telling her the X-ray was clear, and she breathed a sigh of relief. McDonald threw her letter in the garbage, trusting that it told her all she needed to know. She’d later find out that the mammogram had missed what was happening in her body: late-stage 3C cancer, which had been concealed by extremely dense breast tissue, which McDonald had never heard of. </div></div><div style="text-align: justify;"><br /></div><div><div style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><div class="separator" style="clear: both; text-align: center;"><a href="https://thenationaldesk.com/news/spotlight-on-america/millions-of-women-have-this-breast-cancer-risk-factor-why-arent-they-being-informed-breast-cancer-awareness-month-dense-breast-tissue-xray-mammograms-cdc-dr-bard-suzanne-mcdonald" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="338" data-original-width="484" height="177" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEilurUpFoBUbNWuXtGkyNXqZvnKdZ4CBS-G6EgStTEuCMrxqkj4KK7NmR6Pkss0VSeXPTcvJHRvCo4MoiZ10GmvjoxrNLwt64-uG7Qg73MwNCVVxItREyzyp8MrmPHe2qJTYbRDkRD6i7SNg4BywjI3CYGo7-bBA1nnea1EhD_YuF_RU2xKBnMzHXLyGw/w254-h177/COLLAGE.jpg" width="254" /></a></div>The image of a tumor in a dense breast (R) is like a polar bear in a snowstorm,” Dr. Robert Bard, a leading radiologist, told us. “It’s white against white, you can’t see it. So we’ve been missing tumors all the time.” Bard, the founder of the Bard Cancer Center, told us the lack of contrast in those crucial images means millions of women could miss their best chance at early detection. “Women with dense breasts are 5 to 7 times more likely to develop a breast tumor,” said Dr. Bard. “So given that you’re already at increased risk by having a high breast density, this is cause for making sure you get screened.”</div></div><div style="text-align: justify;"><br /></div><p style="background-color: white; box-sizing: border-box; line-height: 1.5; margin: 0px auto 1rem; max-width: 45rem; text-align: justify;"><span style="font-size: x-small;"><i><span style="color: #333333; font-family: Georgia, Times;">Special thanks to TND/ Andrea Nejman | National Investigative Producer & </span><span style="color: #333333; font-family: Georgia, Times;">Spotlight on America, Inside Your World Investigates</span></i></span></p><p></p><hr style="text-align: justify;" /><p></p><div class="separator"><p style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><span style="font-size: large;"></span></p><div class="separator" style="clear: both; text-align: center;"><span style="font-size: large;"><a href="https://direct.areyoudense.org/files/1915/0859/7060/ARE_YOU_DENSE_Handy_Guide_Dense_Breasts_10.17.17.pdf" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="530" data-original-width="289" height="136" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh3axlGwwmjilD3pZvpahMUPXFJhRdPdKsHI3ANQbQYpIm8JdNpV0KZ27DhLuQpnCrBtg0ah6NmB5oK8kMJpB0cxnOzdOq6CVhtmfxR33sd7mp0IcXi83SMaHJthNXqCkPhQGfp8jL5hYaUX5l-YCNK9FJ2sHK-NbZaA1630z2EgRK6pYS_Pd92qgMFMw/w74-h136/pdf1.jpg" width="74" /></a></span></div><span style="font-size: large;"><div style="text-align: justify;">HANDY PATIENT GUIDE TO SCREENING OPTIONS FOR DENSE BREASTS</div></span><div style="text-align: justify;">This patient-friendly guide outlines the benefits and harms of screening options for dense breasts. The two-page guide is based on current scientific and medical research on technology and dense breast tissue. The guide illustrates the approximate cancer detection rate for each exam. Bring this guide with you as you discuss your screening options with your health-care providers based on your risk, dense tissue and preferences. Keep in mind that all studies have limitations. The chart can be printed one page, back to back. (Special thanks to Julie S. Gershon, MD for her expert review). <a href="https://direct.areyoudense.org/files/1915/0859/7060/ARE_YOU_DENSE_Handy_Guide_Dense_Breasts_10.17.17.pdf">Download Chart in PDF here.</a> [3]</div><p></p></div><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgcrRxzF4MPKnXc0plqsICMFQc1Nyd0luVdvUVJZp8pXcbyBFdcLxuWkHfoZqxbO5JPtz1gCxvB6sFFDMCReCB8CNuBMA9yU3P8zPjlDo-SyMP0UDlOldYhfd326zbTZ4hSTv3MF6sfUKRTpbTPYb7bNQYJfJAUxkaLBjOe9AsFjzCOsEoVywNvMkvOQw/s2200/image.png" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="1700" data-original-width="2200" height="503" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgcrRxzF4MPKnXc0plqsICMFQc1Nyd0luVdvUVJZp8pXcbyBFdcLxuWkHfoZqxbO5JPtz1gCxvB6sFFDMCReCB8CNuBMA9yU3P8zPjlDo-SyMP0UDlOldYhfd326zbTZ4hSTv3MF6sfUKRTpbTPYb7bNQYJfJAUxkaLBjOe9AsFjzCOsEoVywNvMkvOQw/w651-h503/image.png" width="651" /></a></div><div style="text-align: justify;"><br /></div><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;">RESOURCES</p><p style="text-align: justify;"><span style="font-size: x-small;">1) <a href="https://www.areyoudenseadvocacy.org/news/map-all-pink">https://www.areyoudenseadvocacy.org/news/map-all-pink</a><br /></span><span style="font-size: small;">2) </span><a href="https://www.fda.gov/radiation-emitting-products/mammography-quality-standards-act-and-program/mqsa-insights" style="font-size: small;">https://www.fda.gov/radiation-emitting-products/mammography-quality-standards-act-and-program/mqsa-insights</a><br /><span style="font-size: small;">3) </span><a href="https://www.areyoudenseadvocacy.org/resources/handy-patient-guide-screening-options-dense-breasts" style="font-size: small;">https://www.areyoudenseadvocacy.org/resources/handy-patient-guide-screening-options-dense-breasts</a><br /><span style="font-size: small;">4) </span><a href="https://delauro.house.gov/media-center/press-releases/delauro-fitzpatrick-katie-couric-introduce-find-it-early-act-2022" style="font-size: small;">https://delauro.house.gov/media-center/press-releases/delauro-fitzpatrick-katie-couric-introduce-find-it-early-act-2022</a></p><p style="text-align: justify;"><span style="font-size: x-small;"><br /></span></p><p style="text-align: justify;"><span style="font-size: x-small;"><br /></span></p><p style="text-align: center;"><span>This feature article is brought to you in part by:</span></p><p style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEibEU3WCqmiZBK5pDvQMwwOA1OdhBMTYdiRSBdpwjFy-5szAvVs8jL6yjgf4iXIdZlZr0hBsM4uFsooMPaJuNifzQ-h7mw0f09Hl6XCAeqb1ByTtBGSvMsfGLwlPayvSPSGUSRNd-lpJ3uBJ8VEGdG4giNBfB6fZwZVOaIZy6gSz_esamSVs9V6G25hjA/s986/logos.jpg" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="282" data-original-width="986" height="164" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEibEU3WCqmiZBK5pDvQMwwOA1OdhBMTYdiRSBdpwjFy-5szAvVs8jL6yjgf4iXIdZlZr0hBsM4uFsooMPaJuNifzQ-h7mw0f09Hl6XCAeqb1ByTtBGSvMsfGLwlPayvSPSGUSRNd-lpJ3uBJ8VEGdG4giNBfB6fZwZVOaIZy6gSz_esamSVs9V6G25hjA/w571-h164/logos.jpg" width="571" /></a></div><br /><span style="font-size: x-small;"><br /></span><p></p><p style="text-align: justify;"><br /></p><p style="text-align: justify;"> </p></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-23552229892329098392021-10-14T21:22:00.011-07:002021-10-14T21:52:01.957-07:00DENSE BREAST DETECTION & IMAGE GUIDED ONCOLOGIC TREATMENT <p>By: Robert L. Bard, MD & Noelle Cutter, PhD | Edited by: Lennard M. Gettz, Ed.D</p><p><b>PROLOGUE</b></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/a/AVvXsEgj8j4Pd1MUBcifClFaozoVZEa4wRvgMwBoqFa17KO1uTAwQe7U-QMp1IdRi9fhOd7_wHuTwXEVjUB12WMsHkrWYa42Nf2EfAtEp7ht2v3Tn1Jc5859dGyWteOq5XQ2sk5fzmfmjt1On0f4yBc7EUhhXWaqk59MHyoPOa6t5_T7nWapIBZSHTPUBh5rTw=s640" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="416" data-original-width="640" height="136" src="https://blogger.googleusercontent.com/img/a/AVvXsEgj8j4Pd1MUBcifClFaozoVZEa4wRvgMwBoqFa17KO1uTAwQe7U-QMp1IdRi9fhOd7_wHuTwXEVjUB12WMsHkrWYa42Nf2EfAtEp7ht2v3Tn1Jc5859dGyWteOq5XQ2sk5fzmfmjt1On0f4yBc7EUhhXWaqk59MHyoPOa6t5_T7nWapIBZSHTPUBh5rTw=w209-h136" width="209" /></a></div>In 2014, Imaging Technology News (ITN) introduced breast cancer survivor-turned-crusader Dr. Nancy Cappello and her story about having dense breast tissue leading to a late-stage cancer. A false negative mammography scan (diagnosed in 2004) concealed a large 2.5 cm suspicious lesion, which was later confirmed to be stage 3c breast cancer. This same cancer had metastasized to 13 lymph nodes. This sparked Dr. Cappello to create the "Are You Dense?" Foundation- an international awareness crusade to better support dense breast diagnostics and initiatives pass legislation to enact laws requiring mammography centers to inform patients about their breast density and the associated cancer risks. Dr. Cappello passed away on Nov 15, 2018, from secondary myelodysplastic syndrome (MDS), a bone marrow cancer that was a complication of her prior aggressive breast cancer treatments. But she ignited a legacy of fighting for improved policies, imaging technologies and advanced research to better address this health crisis that puts the est. 40% of the female population (women with dense breasts) at risk of a false negative reading.<p></p><p><b><br /></b></p><p><b>PART 1: USE OF ULTRASOUND IN A 2021 RESEARCH STUDY OF BREAST DENSITY</b></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/a/AVvXsEhJCe5z44whX5y-EjrqZ5dZ8Iw5WG8gXKuK7PJx6BAGhspYVCIvE9ZTFfKYEOPYUFgq740_1B5w0tn5jjTvPVmfZ3-drbJwphjcWd-42dRTl1w7n08xq11DQwL5v5YSBEe8B0Sx_XwXoIPcK_JbToc9nWi6kC5mzZNhPXv8d-Tcl1NIte1ZtNpVPo-dnw=s480" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="432" data-original-width="480" height="200" src="https://blogger.googleusercontent.com/img/a/AVvXsEhJCe5z44whX5y-EjrqZ5dZ8Iw5WG8gXKuK7PJx6BAGhspYVCIvE9ZTFfKYEOPYUFgq740_1B5w0tn5jjTvPVmfZ3-drbJwphjcWd-42dRTl1w7n08xq11DQwL5v5YSBEe8B0Sx_XwXoIPcK_JbToc9nWi6kC5mzZNhPXv8d-Tcl1NIte1ZtNpVPo-dnw=w222-h200" width="222" /></a></div>In an ongoing clinical study co-investigated by Dr. Robert Bard (NYC) and Dr. Noelle Cutter (of Molloy College, Long Island, NY), data is collected from a cohort of women undergoing ultrasound density scans. Inspired by Dr. Cappello’s early surveys of specific demographic groups, this 2021 research explores dense breast predominance in the younger population or those with lower body mass index (including dancers and athletes), both are likely candidates to receive false negative readings on a mammogram. <p></p><p>In addition, breast density is also associated with breast cancer risk in women between ages 40-65, but there is limited evidence of its association with risk of breast cancer among women 18+. This estimated proportion of breast cancers are attributable to breast cancer risk factors commonly documented in clinical practice and used in breast cancer risk prediction models, including BI-RADS breast density and ultrasounds to confirm mammography readings. </p><p><br /></p><p><b>Target Objectives</b></p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/a/AVvXsEjM0M6LsAa-TBK2oeoJiWKM0fsaHzhY1LqJXNZeTDcqxqnmvciCh-97oYAHhjxaDXBkeFupSksM2InmMQDjYKH3RN1wxbdG8FrHVp7um-Pf3XlV0ShWgPAYFfB4R2DIMOQcCk4ZOPw9i2VRXYkn4ucA4FbxzJRhewGsMNdBJ_yycItDswVdTcIjkpB65w=s1882" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="1882" data-original-width="1523" height="320" src="https://blogger.googleusercontent.com/img/a/AVvXsEjM0M6LsAa-TBK2oeoJiWKM0fsaHzhY1LqJXNZeTDcqxqnmvciCh-97oYAHhjxaDXBkeFupSksM2InmMQDjYKH3RN1wxbdG8FrHVp7um-Pf3XlV0ShWgPAYFfB4R2DIMOQcCk4ZOPw9i2VRXYkn4ucA4FbxzJRhewGsMNdBJ_yycItDswVdTcIjkpB65w=s320" width="259" /></a></div>Endurance athletes are to be defined by those who participated in one or more endurance events (long course) in the year or as well as those who are (younger, low BMI cohort) MD and classification of “dense breasts” was heterogeneous and extremely dense as noted by the BIRADS code; (heterogeneously or extremely dense vs scattered fibroglandular densities). Data is collected as odds ratio (OR’s) and 95% confidence intervals included in research outcomes.<p></p><p>Although breast density is a well-established and prevalent breast cancer risk factor, it’s biological connection is not (yet) clearly understood. More research is needed to support the population associated risk proportion in athletic pre-menopausal women. The data gathered from this study reviews a cohort of women undergoing imaging ultrasound scans of pre-menopausal women with dense breasts. Anecdotally, 50 years ago one never saw a 35-year-old with breast cancer. Twenty years ago, it was common to see women in their 20s with cancer. Environmental factors and toxic substance carcinogenic effect may be a byproduct of the research outcome. </p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/a/AVvXsEgTdeIoggZWTycQwufBLkDKC_ezhgACJ6cZo75j7dpWe-7dLLvCErsSiB8oMg9K6gy7QFbPtyUunVajqvcsXwkItzIe77a3i17gn1NftDRWdBem5V0vVAude4q-p8bznk3qz8EFnKfJaWV4ljXZNcWP4-Tfq-CeS71nHWwVmHqySvYolI00u0aF7BnT_w=s2787" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1128" data-original-width="2787" height="250" src="https://blogger.googleusercontent.com/img/a/AVvXsEgTdeIoggZWTycQwufBLkDKC_ezhgACJ6cZo75j7dpWe-7dLLvCErsSiB8oMg9K6gy7QFbPtyUunVajqvcsXwkItzIe77a3i17gn1NftDRWdBem5V0vVAude4q-p8bznk3qz8EFnKfJaWV4ljXZNcWP4-Tfq-CeS71nHWwVmHqySvYolI00u0aF7BnT_w=w615-h250" width="615" /></a></div><br /><p><br /></p><p><b>Non-invasive Imaging options</b></p><p><b>1) Diagnostic Ultrasound</b> meets the scanning requirements and is performed in the office setting accurately and rapidly due to the high resolution and low cost of today’s sonographic equipment. Furthermore, advances in the computerization of the imaging, blood flow, and tumor measures of exact volume and vessel density are now less operator dependent- adding ease of use for this or any clinical research requiring the use of ultrasound technology. This provides a reliable and repeatable diagnosis, and a means to follow the individual’s unique pattern of cancer development, progress, and response to treatment. </p><p>Recent technological advances also make these procedures available to much broader clinical application, without requiring years of very unique training and clinical experience, for example, with diagnoses of cystic versus solid lesions. Accuracy in assessing breast [1] tumors and metastatic foci has been documented. It must be emphasized that the beginner will find many confusing artifacts and findings should be confirmed with all pertinent imaging modalities.</p><p><b>2) 3D Doppler Ultrasound with Dynamic Contrast Enhanced MRI</b> are the gold standards by which cancers are initially diagnosed or confirmed and serially followed after treatment. The percentage of malignant vessels can be quantified and re-evaluated in the identical tumor volume as serial follow ups to the standard treatments using radiation, surgery, hormones, chemotherapy, cryotherapy, watchful waiting and the non-standard regenerative treatments: ablation using focal laser, focal ultrasound, photodynamic, radiofrequency and microwave technologies. Since vessel mapping is possible, embolic treatments may be considered.</p><p><b>3) 3D Sonography</b> can demonstrate the tumor volume and marginal capsule of locally affected lymph nodes more accurately than the MRI since the resolution is 100 microns at 18 MHz. The exam takes about 10 minutes, and the probes are automated meaning that this is less operator dependent than other sonographic procedures. Vessel density index (VI) imaging is performed on the data set at an independent workstation and comparison made with prior exams if available.</p><p><b>4) 3D Power Doppler </b>indices vary according to the tumor stage, the histologic grade, capsular disruption, and lymph node metastases. Histologic grade has been studied with this technology and the following approximation has proven useful in prostate tumor staging. This quantitative measure of neovascularity was initially applied to prostate cancer. [2] While it does not exactly correlate with histologic Gleason grading since this is a current functional measure while the microscopy is purely anatomical and may not represent current aggressive potential. It’s predictive value of aggression could be studied in the context of breast and other cancers [3,4]</p><p>Medical imaging can map the arteries, veins and nerves providing preoperative landmarks reducing postoperative bleeding and avoiding nerve damage. Tumors of low aggressive potential may be treated medically and followed by interval scans or locally reduced by radiation or laser ablation. Biopsies of certain abnormalities may be averted or postponed. (FIG 1)</p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/a/AVvXsEiVgeoQg3iABpVcO6eiygkjPEb24ZRzBIpHoCMdB7Y2RMc0wjybXNuTVgvsVngCClzxhA7qBhe_BJypM8PkkCFhfNULeg3zdDaIOyy1vKFdz-4XNPfO__zrkm7e_iOkDXGWJqxvgMV_aT9mBOyUBaVgQYArj9NiefM-nb1hep1Tz-ngXUJtJsx62dHNGw=s960" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="606" data-original-width="960" height="299" src="https://blogger.googleusercontent.com/img/a/AVvXsEiVgeoQg3iABpVcO6eiygkjPEb24ZRzBIpHoCMdB7Y2RMc0wjybXNuTVgvsVngCClzxhA7qBhe_BJypM8PkkCFhfNULeg3zdDaIOyy1vKFdz-4XNPfO__zrkm7e_iOkDXGWJqxvgMV_aT9mBOyUBaVgQYArj9NiefM-nb1hep1Tz-ngXUJtJsx62dHNGw=w473-h299" width="473" /></a></div><div class="separator" style="clear: both; text-align: center;"><i>Fig. 1 - Left black and white coronal ultrasound shows irregular “donut” periphery corresponding to desmoplastic tissue while the right colored elastography demonstrates the fibrotic elements creating the “crater” interior </i></div><div class="separator" style="clear: both; text-align: center;"><p><br /></p></div><p><br /></p><p><a href="https://blogger.googleusercontent.com/img/a/AVvXsEhYnYBW05KZVy-a_RqwltOsFCKCFhoGeSMR2QDSPnSnkatpUq862rPzSXB35JLOLcmiFRH_TX2eVURtSRiJPabndnAQuh-PiivVHUZxMR9NCOSN-hQb7F3fcAt0-a5QfUBrX6X-fMZo17ps5pfNuoM0vNfQj7hzG5tRi5SibrZ6v1aDRHzjyonCRpccmw=s688" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: center;"><img border="0" data-original-height="688" data-original-width="674" height="136" src="https://blogger.googleusercontent.com/img/a/AVvXsEhYnYBW05KZVy-a_RqwltOsFCKCFhoGeSMR2QDSPnSnkatpUq862rPzSXB35JLOLcmiFRH_TX2eVURtSRiJPabndnAQuh-PiivVHUZxMR9NCOSN-hQb7F3fcAt0-a5QfUBrX6X-fMZo17ps5pfNuoM0vNfQj7hzG5tRi5SibrZ6v1aDRHzjyonCRpccmw=w133-h136" width="133" /></a><b>Part 2: TRACKING BREAST CANCERS AND TUMORS</b></p><p>High tumor vessel density correlates with greater aggression. Axillary and mediastinal imaging can document lymphadenopathy. Abdominal scans simultaneously performed may detect ascites and metastases to the liver, periaortic nodes and pelvic organs. Response to neoadjuvant chemotherapy may be assessed MRI, CT, mammography, PET/CT and ultrasound. The new technology of ultrasound elastography, assessing tumor stiffness, predicts response to treatment accurately and may indicate better therapeutic strategies on a timelier basis. [5] Residual cancer burden scoring could provide better treatment options since the treatment response for evaluation of neoadjuvant chemotherapy needs a more comprehensive and authoritative standard than is currently available. </p><p><br /></p><p><b>Lymph Node Disease </b></p><p>Lymph node assessment is possible at the same time. Under sonographic guidance, biopsies may be obtained. Sonographic criteria for malignancy are published elsewhere. Image guidance of enlarged node can distinguish between active tumor and necrotic areas diminishing necessity of repeated aspirations for indeterminate findings. (Fig 2) Pathologic assessment of a large postoperative specimen may be facilitated by high frequency scanning to re-localize the suspect region for targeted study that has been removed from its previous anatomic position. [6] Elastography is useful in targeting sub-centimeter foci in large nodal masses</p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/a/AVvXsEg5M_rJQy2SV-Hn-F3lhR4EAy_WRmuj3grrUiMdKN51lsHthViZosE8zwHBotIirKlxPjB0zuAYFTjDjBMgfrWzlE-oj9Y1lylPL7HgvBDvMNMmDPlhKrEb4OkMvvht283L5mvjsW0EFNr0dG5HMCfbbQYbUYNB2rf_CvM1eu26ar0HNqTS_ydo5b-BIQ=s875" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="655" data-original-width="875" height="327" src="https://blogger.googleusercontent.com/img/a/AVvXsEg5M_rJQy2SV-Hn-F3lhR4EAy_WRmuj3grrUiMdKN51lsHthViZosE8zwHBotIirKlxPjB0zuAYFTjDjBMgfrWzlE-oj9Y1lylPL7HgvBDvMNMmDPlhKrEb4OkMvvht283L5mvjsW0EFNr0dG5HMCfbbQYbUYNB2rf_CvM1eu26ar0HNqTS_ydo5b-BIQ=w436-h327" width="436" /></a></div><div class="separator" style="clear: both; text-align: center;"><span style="text-align: left;"><i>Fig. 2 - Vessel mapping preoperative</i></span></div><p><b><br /></b></p><p><b>Part 3: IMAGE GUIDED BIOPSY AND TREATMENT</b></p><p>New computer programs use nanotechnology and cybernetic modalities for accurate image guided biopsy and treatment options. Lesions as small as 3 mm have been successfully imaged at frequencies above 14 MHz. Employing 3D sonography with Doppler, the physician manually targets the area of highest tumor neovascularity. This is critical since only part of a mass may be cancerous and missed on non targeted punch biopsies. The marriage with fusion of MRI with ultrasound permits image guided biopsies that spare the adjacent vascular channels. The same technology allows customized ultrasound or MRI guided biopsies to be performed under local anesthesia. Immediate cytologic confirmation of tumor cells permits the withdrawal of the biopsy needle and insertion of a LASER fiber or cryogenic probe immediately treating the proven tumor. MRI thermocoupled sensors prevent overheating of the adjacent nerves and sensitive tissues. Following ablation, the zone of destruction is confirmed with Doppler, contrast ultrasound or DCE-MRI. Inflammatory lesions that are deeply seated may be approached by robotic image guided subdermal injections or targeted biopsies if necessary. This outpatient procedure allows the patient to return to work immediately. RF thermoprobes with temperature auto cutoffs prevent thermal skin damage.[7] Similar user friendly and cost-effective modalities may replace other therapies in the near future. At the 2016 AMERICAN SOCIETY OF LASERS IN MEDICINE meeting in Boston, cutaneous melanoma with in-transit metastases was successively treated by laser technologies [8] MRI Fusion Biopsies with CT and/or ultrasound are routine adding further to the accuracy of image guided biopsies and focal treatment procedures. [9]</p><p>Advances in ultrasound elastography progressed from simple strain imaging to shear wave sonography to 3D coronal shear wave elastography where the plane of the image corresponds to the surgical field as the tumor is dissected in the most superficial plane. The tumor desmoplasia in the coronal plane creates a sawtooth irregular border with a central echo pattern simulating a “donut” and is termed the “crater” sign in this increasingly popular imaging paradigm. Elastography is used worldwide primarily in the diagnostic workup of breast, thyroid and prostate tumors and has reduced the number of biopsies on false positive findings from mammography, b-mode ultrasound and MRI.[10]</p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/a/AVvXsEgePY7Yif_3yIDYhrcNTfa0qW6pytmOAeCmfONN9E7LEYkSyrh6M9y2Fe6Ku8RFjwmdDjnY3s7CY8VwWL5b5N3iPhJJECPma7Uo-TdMRDPfpYJhakpYRnOAA8YMTVQygIWlExLQqAlSwZZHTLk0gqklglI3OFYKsbsRX8rg3MOvaD_UdvYTAT-LucDh8A=s972" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="752" data-original-width="972" height="294" src="https://blogger.googleusercontent.com/img/a/AVvXsEgePY7Yif_3yIDYhrcNTfa0qW6pytmOAeCmfONN9E7LEYkSyrh6M9y2Fe6Ku8RFjwmdDjnY3s7CY8VwWL5b5N3iPhJJECPma7Uo-TdMRDPfpYJhakpYRnOAA8YMTVQygIWlExLQqAlSwZZHTLk0gqklglI3OFYKsbsRX8rg3MOvaD_UdvYTAT-LucDh8A=w379-h294" width="379" /></a></div><br /><p><br /></p><p><br /></p><p><i>Fig. 3 - Mixed solid/necrotic axillary lymph node-vessel density allows targeting of active disease</i></p><p><br /></p><p><br /></p><p><br /></p><p><br /></p><p><br /></p><p><br /></p><p><i>References</i></p><p><i>1.<span style="white-space: pre;"> </span>Bard R. Vascular imaging of cancer in the dense breast. 60th Journees Francaises de Radiologie 2012, Paris</i></p><p><i>2.<span style="white-space: pre;"> </span>https://www.breastcancer.org/symptoms/understand_bc/statistics </i></p><p><i>3.<span style="white-space: pre;"> </span>Cruwys, Cheryl, and JoAnn Pushkin. “Breast density and impacts on health.” ecancermedicalscience 11 (2017).</i></p><p><i>4.<span style="white-space: pre;"> </span>Nazari, Shayan Shaghayeq, and Pinku Mukherjee. “An overview of mammographic density and its association with breast cancer.” Breast cancer 25.3 (2018): 259-267.</i></p><p><i>5.<span style="white-space: pre;"> </span>Boyd, Norman F., et al. “Mammographic density: a heritable risk factor for breast cancer.” Cancer epidemiology. Humana Press, 2009. 343-360.</i></p><p><i>6.<span style="white-space: pre;"> </span>Burton, Anya, et al. “Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide.” PLoS medicine 14.6 (2017): e1002335.</i></p><p><i>7.<span style="white-space: pre;"> </span>Azam, Shadi, et al. “Determinants of mammographic density change.” JNCI Cancer Spectrum 3.1 (2019): pkz004.</i></p><p><i>8.<span style="white-space: pre;"> </span>Boyd, Norman F., et al. “Body size, mammographic density, and breast cancer risk.” Cancer Epidemiology and Prevention Biomarkers 15.11 (2006): 2086-2092.</i></p><p><i>9.<span style="white-space: pre;"> </span>Bard R. Image guided cancer treatment. Advances in Medical and Surgical Dermatology, 15th Annual Mt Sinai Winter Symposium New York 2015.</i></p><p><i>10.<span style="white-space: pre;"> </span>Merce L, Alcazar J, Lopez C et al. Clinical usefulness of 3-dimensional sonography and power Doppler angiography for diagnosis of endometrial carcinoma. J Ultrasound Med 2007; 26:1279-1289.</i></p><p><i><span style="font-family: times; font-size: x-small;"><br /></span></i></p><p><span style="background-color: white; color: #222222;"><span style="font-family: times; font-size: x-small;">Disclaimer & Copyright Notice: The materials provided on this website/web-based article are copyrighted 2021 and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and Bard Diagnostic Research & Educational Programs). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.</span></span></p><div><br /></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-30287217202185687492021-09-28T10:30:00.023-07:002021-10-10T07:34:52.664-07:00 Dense Breast Research: Code name IRON-WOMAN<p><span style="font-size: large;">Research overview: MAMMOGRAPHIC DENSITY, PHYSICAL ACTIVITY AND BREAST CANCER</span></p><p></p><p>Written by: Dr. Noelle Cutter / Sept. 12, 2021 <br />Edited by: the publishing team @ NYCRANEWS.com</p><p>Mammography, as the primary screening modality, has facilitated a substantial decrease in breast cancer-related mortality in the general population. However, the sensitivity of mammography for breast cancer detection is decreased in women with higher breast densities, which is an independent risk factor for breast cancer. With increasing public awareness of the implications of a high breast density, there is an increasing demand for supplemental screening in these patients. Yet, improvements in breast cancer detection with supplemental screening methods come at the expense of increased false-positives, recall rates, patient anxiety, and costs. Therefore, breast cancer screening practice must change from a general one-size-fits-all approach to a more personalized, risk-based one that is tailored to the individual woman's risk, personal beliefs, and preferences, while accounting for cost, potential harm, and benefits.</p><p style="text-align: center;"><iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/ceSkfYpivJs" title="YouTube video player" width="560"></iframe></p><p><b><br /></b></p><p><b>FACTOIDS & FIGURES-</b> The Inspiration behind our research initiative <a href="https://www.breastcancer.org/symptoms/understand_bc/statistics"><span style="font-size: x-small;">[1]</span></a>: </p><p>▪ Breast cancer is the second most common cancer among women in the United States and about 1 in 8 U.S. women (about 13%) will develop invasive breast cancer over the course of her lifetime.</p><p>▪ In 2021, it is estimated that over 280,000 new cases of invasive breast cancer will be diagnosed in women in the U.S., </p><p>▪ Over 40,000 women in the U.S. are expected to die in 2021 from breast cancer. Unfortunately, death rates have been steady in women under 50 since 2007, despite advancements in treatment options.</p><p>▪ For women in the U.S., breast cancer death rates are higher than those for any other cancer, besides lung cancer.</p><p>▪ As of January 2021, there are more than 3.8 million women with a history of breast cancer in the U.S. This includes women currently being treated and women who have finished treatment.</p><p>▪ Breast cancer is the most commonly diagnosed cancer among American women. In 2021, it's estimated that about 30% of newly diagnosed cancers in women will be breast cancers.</p><p>▪ Breast cancer became the most common cancer globally as of 2021, accounting for 12% of all new annual cancer cases worldwide, according to the World Health Organization.</p><p>▪ A woman’s risk of breast cancer nearly doubles if she has a first-degree relative (mother, sister, daughter) who has been diagnosed with breast cancer.</p><p></p><table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: left; margin-right: 1em; text-align: left;"><tbody><tr><td style="text-align: center;"><span style="clear: right; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><a href="https://vimeo.com/604149015/10a65d37f1"><img border="0" data-original-height="444" data-original-width="900" height="158" src="https://1.bp.blogspot.com/-YMYm27ZCMEI/YVNfPvQxVeI/AAAAAAAARpM/4eOnFyJ3lFon-bJZu2wslIJYiJ0zFLz3ACLcBGAsYHQ/s320/poster-use.jpg" width="320" /></a></span></td></tr><tr><td class="tr-caption" style="text-align: center;"><i><span style="font-size: x-small;"><a href="https://vimeo.com/604149015/10a65d37f1">Click for full lecture</a> with Dr. N. Cutter & Dr. L. Bard</span></i></td></tr></tbody></table>▪ About 5-10% of breast cancers can be linked to known gene mutations inherited from one’s mother or father. Mutations in the BRCA1 and BRCA2genes are the most common. On average, women with a BRCA1 mutation have up to a 72% lifetime risk of developing breast cancer. For women with a BRCA2 mutation, the risk is 69%. Breast cancer that is positive for the BRCA1 or BRCA2 mutations tends to develop more often in younger women. <p></p><p>▪ About 85% of breast cancers occur in women who have no family history of breast cancer. </p><p>The most significant risk factors for breast cancer are sex (being a woman) and age. But recent research is beginning to clarify additional risk factors associate with BC</p><p><br /></p><p><b>PHYSICAL ACTIVITY </b><br />Physical activity is considered a significant modifiable factor in breast cancer risk, and since exercise reduces fatty tissue and BMI, it has been thought to increase breast density. However, studies into the relationship between physical activity and breast density have been inconclusive. Other factors such as alteration in metabolism of endogenous hormones, are suggested to influence mammographic density (MD) as well. Therefore, it is evident that the links between physical activity and breast cancer risk need to be clarified.</p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/a/AVvXsEjG0pMHJ5dqPaEwWwbG3atc6RJI8kqE4SyUAN078BpPmjEd5lcU2NAuNu6YYJ3OGh099uVPReH22scoviTE1WZnd3TJkJe5BqD4FgH9ae9tRzicQXnoNq5CJhCPHF3ND2lblp_wasEsuEJADCgOHBDlv6T1uLZQjBia_pQCc0G0wsnH69yU97W9xz6YmA=s1080" imageanchor="1" style="margin-left: 1em; margin-right: 1em; text-align: center;"><img border="0" data-original-height="517" data-original-width="1080" height="281" src="https://blogger.googleusercontent.com/img/a/AVvXsEjG0pMHJ5dqPaEwWwbG3atc6RJI8kqE4SyUAN078BpPmjEd5lcU2NAuNu6YYJ3OGh099uVPReH22scoviTE1WZnd3TJkJe5BqD4FgH9ae9tRzicQXnoNq5CJhCPHF3ND2lblp_wasEsuEJADCgOHBDlv6T1uLZQjBia_pQCc0G0wsnH69yU97W9xz6YmA=w589-h281" width="589" /></a></div><p></p><p><b></b></p><b>BREAST TISSUE DENSITY </b><br />Breast density levels refer to the appearance of the breast tissue on a mammogram. Breast density is part of the supportive or connective tissue that makes up the breast tissue. As you can see in this image, breast tissue is white to gray and transparent against a dark background. Denser breast tissue appears more white whereas fatty/non-dense tissue appears grapy and transparent. <p></p><p>Levels of density are described using a results reporting system called Breast Imaging Reporting and Data System (BI-RADS). The levels of density are often recorded in your mammogram report using letters. The levels of density are:</p><p>A: Almost entirely fatty indicates that the breasts are almost entirely composed of fat. About 1 in 10 women has this result.</p><p>B: Scattered areas of fibroglandular density indicates there are some scattered areas of density, but the majority of the breast tissue is non-dense. About 4 in 10 women have this result.</p><p>C: Heterogeneously dense indicates that there are some areas of non-dense tissue, but that the majority of the breast tissue is dense. About 4 in 10 women have this result.</p><p>D: Extremely dense indicates that nearly all of the breast tissue is dense. About 1 in 10 women has this result.</p><p>In general, women with breasts that are classified as heterogeneously dense or extremely dense are considered to have dense breasts. Almost half of women undergoing mammograms have dense breasts.</p><div class="separator" style="clear: both; text-align: center;"><br /></div><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/a/AVvXsEhJuq_QT_EJzL_n6q8J17WzAzeMk7l4aKENSjxcN7Pl78rcUQicXjyLftxf-IRCVau6xVawXxyD1Ls46HBwtXpq4xhDxKYU8Q2Trm1Qd3KgcazDIcYNBe89fYnEPne7vqdeqZ101kkrg6W6o2EepxaaSMwGT6uvs98xgVIvTv4kzAqv5XNF6___1r7qPQ=s480" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="432" data-original-width="480" height="288" src="https://blogger.googleusercontent.com/img/a/AVvXsEhJuq_QT_EJzL_n6q8J17WzAzeMk7l4aKENSjxcN7Pl78rcUQicXjyLftxf-IRCVau6xVawXxyD1Ls46HBwtXpq4xhDxKYU8Q2Trm1Qd3KgcazDIcYNBe89fYnEPne7vqdeqZ101kkrg6W6o2EepxaaSMwGT6uvs98xgVIvTv4kzAqv5XNF6___1r7qPQ=s320" width="320" /></a></div><b>FATTY TISSUE vs. DENSE TISSUE </b><br />A close up here shows the difference in imaging for a breast tumor on non-dense vs dense breast tissue using a mammogram. Breast density has been widely considered a strong risk factor for breast cancer, with statistics suggesting as much as a six times higher likelihood of the disease in breasts, compared with those with a less dense breast tissue. Not only does dense breast tissue make it harder for a mammogram to pick up small tumors, but dense breasts themselves have been associated with a higher chance of cellular abnormality.<p></p><p><br /></p><p><br /></p><p> </p><p><b></b></p><div class="separator" style="clear: both; text-align: center;"><b><a href="https://1.bp.blogspot.com/-RD9ZOc6wm7E/YVNZ-0pnVhI/AAAAAAAARo8/lKw8ZtXQsyw0reCZYceuLuKs6BE3tn-XQCLcBGAsYHQ/s294/ULTRA.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="283" data-original-width="294" height="283" src="https://1.bp.blogspot.com/-RD9ZOc6wm7E/YVNZ-0pnVhI/AAAAAAAARo8/lKw8ZtXQsyw0reCZYceuLuKs6BE3tn-XQCLcBGAsYHQ/s0/ULTRA.jpg" width="294" /></a></b></div><b>WHY IT MATTERS? </b><br />Women who have dense breast tissue have a higher risk of breast cancer compared to women with less dense breast tissue. It’s unclear at this time why dense breast tissue is linked to a higher lifetime risk of breast cancer. Understanding that link is extremely important.<p></p><p>Dense breast tissue also makes it harder for radiologists to see cancer. On mammograms, dense breast tissue looks white. Breast masses or tumors also look white, so the dense tissue can hide tumors. But fatty tissue looks almost black. On a black background it’s easier to see a tumor that looks white. So, mammograms can be less accurate in women with dense breasts.</p><p>One of the challenges in promoting the widespread utility of breast cancer risk prediction models has been the assertion that most women with a diagnosis of breast cancer have no established clinical breast cancer risk factors or are not considered to be high risk. <span style="font-size: x-small;">[1][2]</span> Although it is impossible to determine the cause of breast cancer in any individual case <span style="font-size: x-small;">[3]</span> easily assessed risk factors that explain a substantial proportion of incident breast cancers can be used to stratify breast cancer risk for targeted screening <span style="font-size: x-small;">[4]</span> and primary prevention <span style="font-size: x-small;">[5]</span> and improve public health interventions to reduce breast cancer risk.</p><p>Recent research has suggested that for women with dense breasts, a screening strategy that also takes into account a woman’s risk factors and protective factors may be the best predictor of whether a woman will develop breast cancer after a normal mammogram and before her next scheduled mammogram.</p><p><br /></p><p><b></b></p><div class="separator" style="clear: both; text-align: center;"><b><a href="https://1.bp.blogspot.com/-AMTVffQZu0A/YVNZXRruUEI/AAAAAAAARo0/soWCF-m6HfgvcrUVddKBljgzghlh5urGwCLcBGAsYHQ/s480/dreamstime_xs_130820427%2B%25281%2529.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="320" data-original-width="480" height="118" src="https://1.bp.blogspot.com/-AMTVffQZu0A/YVNZXRruUEI/AAAAAAAARo0/soWCF-m6HfgvcrUVddKBljgzghlh5urGwCLcBGAsYHQ/w178-h118/dreamstime_xs_130820427%2B%25281%2529.jpg" width="178" /></a></b></div><b>MAMMOGRAPHIC DENSITY </b><br />Breasts contain glandular, connective, and fat tissue. Breast density is a term that describes the relative amount of these different types of breast tissue as seen on a mammogram. Dense breasts have relatively high amounts of glandular tissue and fibrous connective tissue and relatively low amounts of fatty breast tissue.<p></p><p><br /></p><p><b>HOW COMMON ARE DENSE BREASTS? </b><br />Nearly half of all women age 40 and older who get mammograms are found to have dense breasts. Breast density is often inherited, but other factors can influence it. Factors associated with lower breast density include increasing age, having children, and using tamoxifen. Factors associated with higher breast density include using postmenopausal hormone replacement therapy and having a low body mass index.</p><p>Women with dense breasts have a higher risk of breast cancer than women with fatty breasts, and the risk increases with increasing breast density. This increased risk is separate from the effect of dense breasts on the ability to read a mammogram. MD one of the strongest risk factors. And because individuals with denser breasts tend to develop more serious types of breast cancer, understanding the connection is important.</p><p><br /></p><p><b></b></p><div class="separator" style="clear: both; text-align: center;"><b><a href="https://1.bp.blogspot.com/-KHB4g98vXZw/YVNX07SCu3I/AAAAAAAARoc/GrKqfUO2_5o0SPIj8TXOTFnsOwHg0nW9gCLcBGAsYHQ/s1895/Bike2.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1895" data-original-width="1259" height="320" src="https://1.bp.blogspot.com/-KHB4g98vXZw/YVNX07SCu3I/AAAAAAAARoc/GrKqfUO2_5o0SPIj8TXOTFnsOwHg0nW9gCLcBGAsYHQ/s320/Bike2.jpg" width="213" /></a></b></div><b>ATHLETES </b><br />A common question that invariably comes up when discussing breast density relates to breast density in athletes. As an athlete myself who has dense breasts, I was struck by the number of individuals in my athletic community who also have dense breasts. A shocking trend was seen in the overwhelming amount of young women with dense breasts who subsequently had received false negative mammogram reports.<p></p><p>What we do know is that your breast tissue tends to become less dense as you age, though some women may have dense breast tissue at any age. Women with less body fat are more likely to have more dense breast tissue compared with women who are obese. From observation (thus far), athletic women are also more likely to have dense breast tissue. One of the main goals of our study is to really try to understand the biological connection of breast density in athletes as well as run a retrospective study on how common this trend is.</p><p><br /></p><p><b>RESEARCH OBJECTIVES </b><br />It's not clear why some women have a lot of dense breast tissue and others do not. You may be more likely to have dense breasts if you:</p><p>▪ ARE YOUNGER; your breast tissue tends to become less dense as you age, though some women may have dense breast tissue at any age.</p><p>▪ HAVE LOWER BMI (body mass index); women with less body fat are more likely to have more dense breast tissue compared with women who are obese.</p><p></p><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-crBrfK-tL2c/YVNYorVN9KI/AAAAAAAARos/G1ouQ2gKlbgQgt0qoS-rUvw4OTVGITBDgCLcBGAsYHQ/s800/dreamstime_s_176812483.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="639" data-original-width="800" height="152" src="https://1.bp.blogspot.com/-crBrfK-tL2c/YVNYorVN9KI/AAAAAAAARos/G1ouQ2gKlbgQgt0qoS-rUvw4OTVGITBDgCLcBGAsYHQ/w190-h152/dreamstime_s_176812483.jpg" width="190" /></a></div>Breast density is shown to be associated with breast cancer risk in women aged 40 to 65 years, but there is limited evidence thus far of its association with risk of breast cancer among women 18+. Furthermore, a high proportion of women with low BMI present with dense breasts, making them likely candidates to receive false negative readings on a mammogram. We aimed to estimate the proportion of breast cancers attributable to breast cancer risk factors commonly documented in clinical practice and used in breast cancer risk prediction models, including BI-RADS breast density and ultrasounds to confirm mammography readings. Our data will be collected from a cohort of women undergoing ultrasound density scans at the Bard Cancer Center (NYC).<p></p><p>Although breast density is a well-established, strong, and prevalent breast cancer risk factor it’s biological connection is not clearly understood. More research is needed to support the population associated risk proportion in athletic pre-menoposal women. Our data will start with a cohort of women undergoing imaging ultrasounds at the Bard Cancer Diagnostic Center. Our population will include pre-menoposal women with dense breasts.</p><p><br /></p><p><b>METHODS </b><br />Endurance athletes are defined those who participated in one or more endurance events (long course) in the year or as well as those who are (younger, low BMI cohort). MD and classification of “dense breasts” was heterogeneous and extremely dense as noted by the BI_RADS code; (heterogeneously or extremely dense vs scattered fibroglandular densities). Data will be collected as odds ratio (OR’s) and 95% confidence intervals included in our outcomes</p><p>
</p><table border="0" cellpadding="10" cellspacing="10">
<tbody><tr>
<td bgcolor="#CCFFFF" valign="top" width="369"><p><span style="font-family: arial;"><b>Cross-sectional Analysis</b></span></p></td>
<td bgcolor="#CCFFFF" valign="top" width="369"><p><span style="font-family: arial;"><b>1000+ pre-menopausal women aged 18+</b></span></p></td>
</tr>
<tr>
<td bgcolor="#CCFFFF" valign="top" width="369"><p><span style="font-family: arial;"><b>Collect information on height, weight, BMI and history of disease</b></span></p></td>
<td bgcolor="#CCFFFF" valign="top" width="369"><p><span style="font-family: arial;"><b>Physical activity assessment</b></span></p></td>
</tr>
<tr>
<td bgcolor="#CCFFFF" valign="top" width="369"><p><span style="font-family: arial;"><b>MD measurement performed by radiologist and confirmed by ultrasound</b></span></p></td>
<td bgcolor="#CCFFFF" valign="top" width="369"><p><span style="font-family: arial;"><b>Logistic regression used to estimate the association of MD within participation in physical activity</b></span></p></td>
</tr>
</tbody></table><p></p><p><br /></p><p><a href="https://1.bp.blogspot.com/-iT8ebMkLz8w/YVNUpeZDdEI/AAAAAAAARoM/TlENF1eUsdAe-MVckeNFN8ol_apQuyrKQCLcBGAsYHQ/s881/Slide12.JPG" style="clear: left; float: left; font-size: x-large; margin-bottom: 1em; margin-right: 1em; text-align: center;"><img border="0" data-original-height="681" data-original-width="881" height="379" src="https://1.bp.blogspot.com/-iT8ebMkLz8w/YVNUpeZDdEI/AAAAAAAARoM/TlENF1eUsdAe-MVckeNFN8ol_apQuyrKQCLcBGAsYHQ/w491-h379/Slide12.JPG" width="491" /></a></p><p>JAMA STUDY: <br />A recent report in Journal of the American Medical Association found that first-degree family history of breast cancer dense breasts were associated with an increased population associated risk proportion of breast cancer. Among premenopausal women, the largest individual population associated risk proportion was for breast density, with 28.9% (95% CI, 25.3%-32.5%) of breast cancers potentially removed by reducing breast density from BI-RADS heterogeneously or extremely dense breasts to scattered fibroglandular densities. The population associated risk proportion for breast density increased to 65.5% (95% CI, 60.4%-70.6%) if all premenopausal women reduced their breast density to the lowest category of almost entirely fat tissue. </p><p><b>SUMMARY/ WRAP-UP </b><br />Given that greater breast density as categorized by the BI-RADS remains a factor associated with breast cancer for all ages of women, information about breast density together with life expectancy may benefit clinical decision-making regarding screening. In March 2019, the US Food and Drug Administration recommended changes to the Mammography Quality Standards Act to make it mandatory to report breast density information to both patients and their physicians. However, how women and their physicians should use this information to inform screening recommendations is unclear. Very dense breasts may increase the risk that cancer won't be detected on a mammogram.</p><p>What is clear is that additional research is needed to elucidate the mechanisms underlying the observed associations between breast density and risk of breast cancer. As newer and more advanced breast density assessment techniques are developed, evaluation of the diffusion of such innovations with an aim of developing individualized screening strategies will be important, particularly among athletic women, for whom dense breast are more likely seen.</p><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-Ks6N8Dbggro/YVNeKtMsQzI/AAAAAAAARpE/Lqfulss1INkV11aeEn3QNWV542bHMVJjgCLcBGAsYHQ/s1614/5-LOGOS.jpg" style="margin-left: 1em; margin-right: 1em; text-align: center;"><img border="0" data-original-height="319" data-original-width="1614" height="98" src="https://1.bp.blogspot.com/-Ks6N8Dbggro/YVNeKtMsQzI/AAAAAAAARpE/Lqfulss1INkV11aeEn3QNWV542bHMVJjgCLcBGAsYHQ/w498-h98/5-LOGOS.jpg" width="498" /></a></div><div class="separator" style="clear: both; text-align: center;"><br /></div><p></p><hr /><p><b>EPILOGUE </b></p><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-9eW4vD3mp3M/YVNW-QuYCnI/AAAAAAAARoU/HzXIdDnJdwQT1uiF84bL5Agk8KAazYI0QCLcBGAsYHQ/s209/NOELLE.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="209" data-original-width="192" height="78" src="https://1.bp.blogspot.com/-9eW4vD3mp3M/YVNW-QuYCnI/AAAAAAAARoU/HzXIdDnJdwQT1uiF84bL5Agk8KAazYI0QCLcBGAsYHQ/w72-h78/NOELLE.jpg" width="72" /></a></div><i>Dr. Noelle Cutter is a professor of biology, ironman finisher, and advocate for dense breast screening. United with an expanding research team dedicated to collecting data on women with dense breasts and screening options for these patients, her initiative aims to investigate and gather conclusive information about dense breasts in specific groups- including age, body mass index, and amount of physical activity and the underlying diagnostics of breast cancer tumors. This research program is under a partnership with Molloy College and Dr. Robert Bard, expert diagnostic cancer imaging specialist in NYC and other colleagues from the NY Cancer Resource Alliance. </i><p></p><p><i>With your support, we are able to implement this screening program for women's health as well as help fund this clinical research. Our work will advance technology, change legislation and most importantly save lives through awareness.</i></p><p><i><br /></i></p><hr /><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-Ox6U_NUGDK0/YVNjMUjozLI/AAAAAAAARpU/3CuQomlG2vEi6z9rPyinEeGgCEolWK1ngCLcBGAsYHQ/s203/EXTRA1.jpg" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="54" data-original-width="203" height="48" src="https://1.bp.blogspot.com/-Ox6U_NUGDK0/YVNjMUjozLI/AAAAAAAARpU/3CuQomlG2vEi6z9rPyinEeGgCEolWK1ngCLcBGAsYHQ/w182-h48/EXTRA1.jpg" width="182" /></a></div><p></p><div class="separator" style="clear: both; text-align: center;"><a href="http://breastcancernyc.com/dense.html" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="449" data-original-width="799" height="180" src="https://1.bp.blogspot.com/-oMhwjDGkYLs/YVNqb0RoSVI/AAAAAAAARpc/8ntfMrE6nZAQnH8U54c1hiOozuu2l0aAgCLcBGAsYHQ/s320/rlb-abus.jpg" width="320" /></a></div><p></p><p>On July 27-29, Bard Diagnostic Imaging is offering a comprehensive <a href="http://breastcancernyc.com/dense.html">DENSE BREAST SCREENING DAY</a>, employing an array of imaging advancements dedicated to the visibility of dense breast tissue and cancer early detection. This special program is dedicated to supporting dense breasted patients by first identifying one's actual breast density (through a density assessment scan) to establish a base line for the full diagnostic study (est. 15-20 minutes per patient).</p><p>Dr. Bard has formulated a comprehensive early detection program specific for dense breasted women. This includes the latest technologies in breast ultrasound, scanning. "We need screening technology for dense breasts because the mammography misses too many cancers in dense breast. So patients are happy to know that this technology is here. If there is a problem, you focus in on it in three dimensions, you find out where it is, and then you, uh, address it with a biopsy or an MRI or a specialized ultrasound." For decades. The ultrasound has advanced greatly in accuracy and reliability to scan quickly. In real time, patients are attracted to its safety aspect, eliminating concerns for radiation and other physical after effects.</p><div><br /></div><div class="separator" style="clear: both; text-align: center;"><br /></div><p><b><br /></b></p><p><b>REFERENCES</b></p><p><span style="font-size: x-small;"><i>1) <a href="https://www.breastcancer.org/symptoms/understand_bc/statistics">https://www.breastcancer.org/symptoms/understand_bc/statistics</a> </i></span></p><p><span style="font-size: x-small;"><i>2) Cruwys, Cheryl, and JoAnn Pushkin. “Breast density and impacts on health.” ecancermedicalscience 11 (2017).</i></span></p><p><span style="font-size: x-small;"><i>3) Nazari, Shayan Shaghayeq, and Pinku Mukherjee. “An overview of mammographic density and its association with breast cancer.” Breast cancer 25.3 (2018): 259-267.</i></span></p><p><span style="font-size: x-small;"><i>4) Boyd, Norman F., et al. “Mammographic density: a heritable risk factor for breast cancer.” Cancer epidemiology. Humana Press, 2009. 343-360.</i></span></p><p><span style="font-size: x-small;"><i>5) Burton, Anya, et al. “Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide.” PLoS medicine 14.6 (2017): e1002335.</i></span></p><p><span style="font-size: x-small;"><i>6) Azam, Shadi, et al. “Determinants of mammographic density change.” JNCI Cancer Spectrum 3.1 (2019): pkz004.</i></span></p><p><span style="font-size: x-small;"><i>7) Boyd, Norman F., et al. “Body size, mammographic density, and breast cancer risk.” Cancer Epidemiology and Prevention Biomarkers 15.11 (2006): 2086-2092.</i></span></p><p><span style="font-size: x-small;"><i>8) Masala, Giovanna, et al. “Can Dietary and Physical Activity Modifications Reduce Breast Density in Postmenopausal Women? The DAMA Study, a Randomized Intervention Trial in Italy.” Cancer Epidemiology and Prevention Biomarkers 28.1 (2019): 41-50.</i></span></p><p><span style="font-size: x-small;"><i>9) Wyshak, Grace, and Rose E. Frisch. “Breast cancer among former college athletes compared to non-athletes: a 15-year follow-up.” British journal of cancer 82.3 (2000): 726.</i></span></p><p><span style="font-size: x-small;"><i>10) McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1159-1169.</i></span></p><p><br /></p><p><i>Disclaimer & Copyright Notice: The materials provided on this website/web-based article are copyrighted 2021 and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and Bard Diagnostic Research & Educational Programs). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.</i></p><p><br /></p><p> </p><div><br /></div>
<div class="separator" style="clear: both; text-align: center;"><a href="https://blogger.googleusercontent.com/img/a/AVvXsEh4RTJiqoVpvfqUJ-JmBUSqmF-7d8FkJid4EcAitDMqipvUetBjfD8JLAZQUqsj7LImSy8FGci2DS-1v1HKOOGcA8ThcNvm4cAsT1DBa7N0ElTTUUkBWxEVyouOBLa2TZ1M3yMZ6YQuE6KQCh92BA8L-8HdCOelMQgMaNYlycl4aPMWNYKsOthydaT3Jw=s2563" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="1227" data-original-width="2563" height="153" src="https://blogger.googleusercontent.com/img/a/AVvXsEh4RTJiqoVpvfqUJ-JmBUSqmF-7d8FkJid4EcAitDMqipvUetBjfD8JLAZQUqsj7LImSy8FGci2DS-1v1HKOOGcA8ThcNvm4cAsT1DBa7N0ElTTUUkBWxEVyouOBLa2TZ1M3yMZ6YQuE6KQCh92BA8L-8HdCOelMQgMaNYlycl4aPMWNYKsOthydaT3Jw=s320" width="320" /></a></div><br />NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-43057680091915317932021-07-26T04:39:00.008-07:002022-01-31T10:11:17.520-08:00TUMOR DETECTION FOR DENSE BREASTS<p style="text-align: justify;"><span style="letter-spacing: -0.2px;">BREAST CANCER DECODED By: </span><span style="letter-spacing: -0.15pt; text-align: justify;">Robert L. Bard, MD</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"><o:p> </o:p></span><span style="letter-spacing: -0.15pt;"> </span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">CONCEPT
AND APPROACH</span></p><p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Drastic
changes in the incidence, diagnosis and treatment of breast cancer and benign
breast disease highlight a singular need for an up to date source on the early
detection and proper therapy of breast tumors.</span><span style="letter-spacing: -0.15pt;">
</span><span style="letter-spacing: -0.15pt;">The age of occurrence of breast cancer, formerly only a problem of older
women, is now at a median age of 45 years.</span><span style="letter-spacing: -0.15pt;">
</span><span style="letter-spacing: -0.15pt;">This means that women in their twenties are developing breast
cancer.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Although risk factors have been
identified, the jeopardy to life is unchanged.</span><span style="letter-spacing: -0.15pt;">
</span><span style="letter-spacing: -0.15pt;">The increasing use of estrogen for osteoporosis and other female disorders
may elevate the risk of breast cancer.</span><span style="letter-spacing: -0.15pt;">
</span><span style="letter-spacing: -0.15pt;">One out of every eight women will develop breast cancer.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Fortunately, the vast majority of tumors in
younger women are benign and can be diagnosed by simple, safe non surgical
tests.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Jewish women, prone to breast
cancer, are further plagued by the concomitant presence of fibrocystic breasts
that are lumpy and mask a growing breast cancer.</span></p><span style="letter-spacing: -0.15pt;">The incidence of miss by mammography
increases markedly in younger patients and those with "mastitis" or
"cystic" breasts.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">A paper from
the University of Indiana Medical Center on the mammographic diagnosis of
fibroadenomas (benign tumor of young women) demonstrated that in 35 surgically
proven biopsies, the mammogram missed every mass. A non x ray exam, called the
sonogram, was able to diagnose every tumor in this study. Another non-x ray
test, called Doppler ultrasound, according to DIAGNOSTIC IMAGING (1988) and
CLINICAL RADIOLOGY (1990) may detect breast tumors not seen by all other tests.
Light scanning is another procedure that uses computers and fiberoptics to
visualize tumors.</span><p></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">The
latest text book on Breast Disease, BREAST ULTRASOUND by Thomas Stavros (Lippincott,
2002) mentioned that most abnormalities of the breast may be better
characterized or even detected only by diagnostic ultrasound procedures. JAMA
(May 1993) noted mammography readings were highly variable with many false
positives.<b> Moreover, one expert missed 67% of cancers on high quality
mammograms.</b> <b>Indeed, top mammographers disagreed clinically in 1/3 of
readings.</b><o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"><o:p> </o:p></span><span style="letter-spacing: -0.15pt;">Since
cancers may lie dormant for up to ten years and that mammography is less
accurate in younger women, one realizes that sonography becomes necessary for a
complete workup in the detection of invasive. </span><b style="letter-spacing: -0.15pt;">Mayo Clinic computer program
shows sonograms capable of 99% accuracy. </b><span style="letter-spacing: -0.15pt;">The latest malpractice newsletters
warn physicians that they are liable if they miss a breast cancer because they
have not performed a sonogram. In fact, the PIAA Data Sharing Report shows that
the patient found the tumor in 69% of cases, mammography missed or was
equivocal in 49% and the median age of breast cancer was 43 years of age. False
negatives were highest in the under age 40 group comprising 40% of claims.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"><o:p> </o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">BREAST
IMPLANTS<span style="mso-spacerun: yes;"> </span><o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"></span></p><div class="separator" style="clear: both; text-align: center;"><span style="letter-spacing: -0.15pt;"><a href="https://1.bp.blogspot.com/-iRhX8VxxcCg/YP6iNWEMGBI/AAAAAAAARUs/GrBAZ55AV0MBCvC3TYPwRgI4n503_Rb2ACPcBGAYYCw/s2048/shutterstock_764133022.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="1367" data-original-width="2048" height="129" src="https://1.bp.blogspot.com/-iRhX8VxxcCg/YP6iNWEMGBI/AAAAAAAARUs/GrBAZ55AV0MBCvC3TYPwRgI4n503_Rb2ACPcBGAYYCw/w193-h129/shutterstock_764133022.jpg" width="193" /></a></span></div><span style="letter-spacing: -0.15pt;">Every
year over 150,000 women have breast implants. Recent press has pointed to the
problem of breast cancer development in the augmented breast and the inability
of mammography to see it.</span><p></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Mammography
has also long been used as the primary diagnostic imaging study for
complications of breast augmentation in the over one million women who
currently have breast implants. However, lack of accuracy of both mammographic
information and clinical interpretation have necessitated the application of
the non x ray imaging modalities of light scanning, sonography and duplex
Doppler ultrasound. <o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Every
plastic surgeon has received a radiologist's mammogram report on a patient in
whom a long standing implant has been removed for various complications that
referred to the ovoid shaped density as a "prosthesis in
position."</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Radiographically, the
hard capsule that forms after a year cannot be differentiated from certain
implant devices. Also, a leakage of silicone gel that is restricted to the
fibrous capsule is not separately distinguishable. Thus, x rays are inadequate
for the diagnosis of implant rupture except where the silicone has extruded
physically through the capsule. Even then, the routine views may not
demonstrate leakage that is close to the surface of the capsule so that it will
only be identified by a tangential x ray beam. An irregular outline of an
implant may be positional, caused by adjacent breast pathology, resultant of
fibrous septation or actually due to implant rupture.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">A sonogram identifies an implant much the same as a cyst. Thus the size, shape, position, peripheral
envelope, wall contour and internal echo pattern are readily demonstrable.
Rupture of an implant, whether from structural failure, interoperative damage,
penetrating trauma or blunt trauma such as closed capsulotomy, is quickly and
accurately diagnosed by routine high frequency sonography.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Sonography
is also important in breast cancer diagnosis since the implant masks most of
the breast from the x ray. Dr. Levine, in the 1990 article: DEFINITIVE
DIAGNOSIS OF BREAST IMPLANT RUPTURE BY ULTRASONOGRAPHY in "Plastic and
Reconstructive Surgery" states that sonography is the best imaging
modality for the augmented breast.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Perhaps
more interesting are the roles of light scanning and duplex Doppler imaging in
the diagnosis of the cause of the implant rupture. Spontaneous failure of the
envelope will be accompanied by fluid extravasation. If recent and localized,
light scanning and Doppler flows will be unremarkable. A long standing leakage
may become secondarily infected, thus producing unilateral light absorption.
Similarly, trauma, intraoperative or external, may be associated with bleeding
which will also absorb light rays. Thus, a normal light scan exam in
transillumination suggests the probability of structure failure of the implant.
Duplex Doppler may shows linear fluid filled structures to be adjacent arteries
or veins. Additionally, this procedure may detect cancers adjacent to the
implant.<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"><o:p> </o:p></span><span style="letter-spacing: -0.15pt;">The
treatment of breast disease has also changed from the days of deforming radical
mastectomies.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Simple removal of the
tumor followed by mastectomy, chemotherapy and radiation therapy are now
available.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Post mastectomy
reconstructive surgery will often restore a woman to her former natural
shape.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">In </span><st1:country-region style="letter-spacing: -0.15pt;" w:st="on">England</st1:country-region><span style="letter-spacing: -0.15pt;">
and </span><st1:country-region style="letter-spacing: -0.15pt;" w:st="on"><st1:place w:st="on">Australia</st1:place></st1:country-region><span style="letter-spacing: -0.15pt;">,
where breast ultrasound and Doppler analysis are routinely used, exploratory
surgery has decreased 90%.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">The American
Cancer Society stresses self examination and mammography.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Unfortunately, the survival rate of breast
cancer has not changed in the past 25 years.</span><span style="letter-spacing: -0.15pt;">
</span><span style="letter-spacing: -0.15pt;">Clearly, other diagnostic exams are needed, since the cure rate is
related to the early detection of the disease. Alarmingly, despite many years
of ongoing, improved and massive breast cancer screening, the US National
Center for Health Statistics now sates that the incidence of number of cases of
this disease is actually increasing.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"><o:p> </o:p></span><span style="letter-spacing: -0.15pt;">Many
women are overwhelmed with the variety of medical tests and their safety.
Recent articles in the NY Times stated that the female patient is
psychologically ill equipped to deal with the emotional trauma of breast cancer
at the time of diagnosis. These reports suggest that women be well informed
prior to the discovery of a tumor, so that they may make a better informed
decision.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">The book addresses the
specific type of exam for both early detection of breast disease as well as the
optimal test for specific disorders for each individual woman in an orderly,
sequential and safe format.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">The pro's
and con's of treatment protocols are also formatted.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">The author, a radiologist specializing in new
methods of breast imaging, has been lecturing for the Ultrasonic Institute on
new methods of breast cancer detection since 1973 at medical centers around the
nation and at international conferences and mentions in this book all types of
exams and therapies.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">The reader chooses
for herself what modality may be most suitable.</span><span style="letter-spacing: -0.15pt;">
</span><span style="letter-spacing: -0.15pt;">Methods used in </span><st1:place style="letter-spacing: -0.15pt;" w:st="on">Europe</st1:place><span style="letter-spacing: -0.15pt;">, for example,
find acceptance in American medicine twenty or thirty years later.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Some medical regimens may be generally
unsuitable for patients, yet may be ideal or the only possibility for an
individual woman.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Diagrams of the
various exams are available for better appreciation of the visually oriented
test.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">As a ready reference format, each
chapter is preceded by a one page summary for quick review.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">The overall aim of the work is to be a health
"bible" for breast disorders for the 1990's woman.</span><span style="letter-spacing: -0.15pt;"> </span></p><p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">It is obvious that too few women are getting
the message about the importance of early breast cancer detection since they
fear that it will be too late or the therapy will be too deforming.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">The purpose of the book is to show that CHANCES
ARE ITS BENIGN, AND, PROPER TREATMENT CAN SAVE YOUR LIFE AND NOT
DISFIGURE.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">The work reaches out to the
reader to reassure her with dramatic evidence that taking control of her
breasts' health in a planned, stepwise manner can mean the difference between
the words:</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">"The scan shows it's a
cyst.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Don't worry" and the chilling
sentence, "we could have helped you if you come in earlier."</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Women walk out of my office, knowing that
their lump is benign and that their fears are nothing, looking ten years younger.</span><span style="letter-spacing: -0.15pt;"> </span></p><p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"></span></p><div class="separator" style="clear: both; text-align: center;"><span style="letter-spacing: -0.15pt;"><a href="https://1.bp.blogspot.com/-RlYZn65LViM/YP6iLATbbDI/AAAAAAAARUc/PnxKEFej6KY0ErOz4JhZNWChYm5_6X4gQCPcBGAYYCw/s480/dreamstime_xs_130820427%2B%25281%2529.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="320" data-original-width="480" height="133" src="https://1.bp.blogspot.com/-RlYZn65LViM/YP6iLATbbDI/AAAAAAAARUc/PnxKEFej6KY0ErOz4JhZNWChYm5_6X4gQCPcBGAYYCw/w200-h133/dreamstime_xs_130820427%2B%25281%2529.jpg" width="200" /></a></span></div><span style="letter-spacing: -0.15pt;">Women with cancer can be helped because of
the simple techniques used when tumors are small.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Even men develop breast cancer at a rate approximately
1% that of women. Most women do need to know that CHANCES ARE ITS BENIGN.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Since the age range of breast cancer is now
from the teens to the hundred's, women of all ages need to become actively
involved in managing their health just as they do their finances. Since all
women are at risk of breast cancer, all families must know the facts and the
choices involved. Jewish women, successful women, women on hormones, women with
breast implants and the growing number of health conscious people of all ages
will want to know thee available regimens so they have the data necessary to
knowledgeably take charge of the their own lives.</span><p></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"><o:p> </o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">REVIEW
OF CURRENT MEDICAL LITERATURE</span><span style="letter-spacing: -0.15pt;"> </span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Fleisher's
DIAGNOSTIC SONOGRAPHY (Saunders 1989) states that a sonogram is the best method
for diagnosing benign disorders and that a mammogram is the better tool for
diagnosing malignant diseases. He quotes the sensitivity of sonograms in cancer
detection at 69% as compared to the mammographic detection rate at 74%. The
author's own series using a hand held real time unit (same as Dr. Bard's) shows
an accuracy in detecting palpable lesions of 85% for sonograms and 70% for
mammograms. Both modalities yield a rate of 89% and he recommends both tests be
used in combination.<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Hagen-Ansert's
TEXTBOOK OF DIAGNOSTIC ULTRASOUND (Mosby 1989) states sonogram is clinically
useful in a) dense breasts</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">b) younger
patients</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">c) uncertain mammographic
findings</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">d) pregnant patients</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">e) implants</span><span style="letter-spacing: -0.15pt;">
</span><span style="letter-spacing: -0.15pt;">f) differentiation of cystic from solid in a known mass</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Kopan's
BREAST IMAGING (Lipincott 1989) states that sonography should not be used for
cancer screening. However, he quotes studies by Sickle's, Cole, and Egan
showing respectively that sonogram detects cancers at the following rates: 58%,
78% and 79% in the general population</span><span style="letter-spacing: -0.15pt;"> </span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Britton's
article in CLINICAL RADIOLOGY (1990) demonstrates duplex doppler having a sensitivity
of 91% and specificity of 89%.<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Levin's
paper in PLASTIC AND RECONSTRUCTIVE SURGERY (1991) mentions that mammography is
unreliable in the post augmented breast and that ultrasonography is the test of
choice for evaluation of breast prostheses.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><st1:city w:st="on"><st1:place w:st="on"><span style="letter-spacing: -0.15pt;">Dixon</span></st1:place></st1:city><span style="letter-spacing: -0.15pt;">'s paper in BRITISH J SURGERY (1992) showed 78%
sensitivity and 100% specificity for carcinoma using duplex Doppler.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Adler’s
abstract in ULTRASOUND MED BIOL (1990) has 82% detection rate of malignant
neovascularity with duplex Doppler.<span style="mso-tab-count: 1;"> </span></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Scatarige's
note in THORACIC RADIOLOGY (1989) shows high accuracy of staging internal
mammary lymphadenopathy.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Jones
review in CLINICAL ONCOLOGY (1990) had sonograms picking up axillary nodes
missed by other methods in 27% of cases.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Levin's
paper in PLASTIC AND RECONSTRUCTIVE SURGERY (1991) mentions that mammography is
unreliable in the post augmented breast and that ultrasonography is the test of
choice for evaluation of breast prostheses.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Parker's
lecture at the NYU BREAST CANCER UPDATE (1993) showed sonography's ability to
detect unsuspected cancers as small as 0.4 cm and determine whether the
associated lymphadenopathy was malignant or benign. Mendellson's 1992 talk at
DOWNSTATE MEDICAL CONFERENCE showed sonograms to be able to discover occult
lesions.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Barth's
1993 study showing sonograms detected more than twice as much multicentric
breast cancer than mammography.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Stavro's
1997 paper shows accuracy in detecting benign disease solely by ultrasound at
99.7 %.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Bard's
paper in 1993 NY STATE JOURNAL OF MEDICINE revealing mammographic misses in
breast implant imaging.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Bard's
1994 lecture at the MAYO CLINIC highlighted the accuracy of multimodality
imaging.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Bard's
1996 FEMALE PATIENT paper showed 99% accuracy in benign disease diagnosis<span style="mso-tab-count: 6;"> </span><o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"><o:p> </o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">CONCLUSION<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"></span></p><div class="separator" style="clear: both; text-align: center;"><span style="letter-spacing: -0.15pt;"><a href="https://1.bp.blogspot.com/-_Dc8sfateEk/YP6iLOmuMaI/AAAAAAAARUg/7jS-ZJkbOpAtiWl8d2GWpsmesHPGQ9aGgCPcBGAYYCw/s480/dreamstime_xs_104011977.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="386" data-original-width="480" height="199" src="https://1.bp.blogspot.com/-_Dc8sfateEk/YP6iLOmuMaI/AAAAAAAARUg/7jS-ZJkbOpAtiWl8d2GWpsmesHPGQ9aGgCPcBGAYYCw/w248-h199/dreamstime_xs_104011977.jpg" width="248" /></a></span></div><span style="letter-spacing: -0.15pt;">As
breast cancer strikes younger women due to lowering of the median age of
occurrence, screening procedures become imperative.</span><p></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Although
mammography is the only generally accepted screening modality, it is clearly of
limited use in younger patients or those with fibrocystic breasts.<span style="mso-spacerun: yes;"> </span>The inaccuracy of sonograms is true if one
considers the total population to be screened will predominate in older age
groups. Kopan's, in his textbook, admits that he chooses to do sonograms on
women under 28 because of anecdotal evidence that it works best. Dr. Bard's
suggestion is that sonograms be the screening procedure of choice in younger
women and those with fibrocystic breasts. Mammography should remain the gold
standard in women over 40 or those with fatty breasts of any age. The
combination of light scanning, Doppler ultrasound and standard sonograms of the
breast often mean the difference between delayed diagnosis and immediate
surgery. Multimodality imaging, the emphasis of this book, offers the patient
the difference between weeks of worry for the mammogram to be repeated for
"interval change" or for an immediate answer that the problem is
benign.<o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"><o:p> </o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"><o:p> </o:p></span><span style="letter-spacing: -0.15pt;">COMPETITION</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Aside
from a few books on cancer and women's diseases, there are no non-medical books
on the spectrum of new tests and therapies for breast disease.</span><span style="letter-spacing: -0.15pt;"> </span><span style="letter-spacing: -0.15pt;">Given the epidemic proportions of breast
cancer, the time is right for a new and comprehensive manual for today's
concerned and aware women.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Books
on personal health include THE DOCTOR BOOK, by Wesley Smith (Price Stern Sloan,
L.A. 1987) which has one paragraph on breast exam by a physician and one
paragraph on mammography.<span style="mso-spacerun: yes;"> </span><o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"><o:p> </o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">The
NY TIMES GUIDE TO PERSONAL HEALTH by Jane Brody (<st1:place w:st="on">Avon</st1:place>,
1982) has 7 pages on breast cancer with 2 paragraphs on diagnostic tests.<span style="mso-spacerun: yes;"> </span><o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">HORMONES,
by Lois Jovanovic, MD (Fawcett, 1987) includes 26 pages on breast disease,
mentioning the fact that 90% of breast cancers are detected by women
themselves, leaving the reader to wonder at the value of the
"gold-standard" exams<span style="mso-spacerun: yes;"> </span>of
mammography and 2 pages on hormone therapy for breast cancer.<span style="mso-spacerun: yes;"> </span><o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"><o:p> </o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">CHOICES,
by Marion Morra and Eve Potts (Avon 1987) also titled:<span style="mso-spacerun: yes;"> </span>Realistic alternatives in cancer therapy, has
one chapter on breast cancer, with 6 pages on mammography, one paragraph each
on ultrasound, computed tomography, transillumination and thermography.<span style="mso-spacerun: yes;"> </span>There are 16 pages on surgery and
radiotherapy and 29 pages on post operative care. <o:p></o:p></span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;"><o:p> </o:p></span><span style="letter-spacing: -0.15pt;">Lauersen's
IT'S YOUR BODY (Berkely 1983) on p.418 states that sonograms will be effective
in the future. Indeed, Dr. Lauersen routinely now performs sonography on his
patients semiannually or more often in his private office.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Gross's
WOMEN TALK ABOUT BREAST SURGERY (Harper 1991) has 2 pages mentioning a
particular cancer was missed by mammogram and sonogram.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Levy's
YOUR BREASTS (Noonday 1990) says one 1 page that benign cysts that are not
palpable or show on x ray may be imaged with sonograms.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Thompson's
EVERY WOMAN'S HEALTH (Prentice Hall 1990) says on one page that sonograms are
useful in cyst detection.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Better
Homes and Garden's FAMILY MEDICAL GUIDE (1989) mentions that </span><span style="letter-spacing: -0.15pt;">sonogram
is useful if mammography is unclear.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Harvard's
YOUR GOOD HEALTH (HARVARD 1987) says on one page that sonogram is good for cyst
detection.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Love's
DR. SUSAN LOVE'S BREAST BOOK (ADDISON WESLEY 1990) has one half page each on
sonogram and transillumination.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Hirshaut's
BREAST CANCER: THE COMPLETE GUIDE (BANTAM 1992) has one half page each on
sonogram and transillumination.</span></p>
<p class="MsoNormal" style="line-height: 12pt; mso-hyphenate: none; text-align: justify; text-justify: inter-ideograph;"><span style="letter-spacing: -0.15pt;">Many
private practice radiologists are currently routinely screening women with cystic
breasts or those under fifty with sonograms even though the <st1:place w:st="on"><st1:placename w:st="on">American</st1:placename> <st1:placetype w:st="on">College</st1:placetype></st1:place>
of Radiology does not recognize this as a screening tool. However, there is no
other acceptable alternative choice for the patient or better diagnostic tool
for the physician other than the non specific MRI exam. Every finding (30%
specificity) must be biopsied to be verified.<o:p></o:p></span></p>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-73930312424346892652021-07-07T22:42:00.034-07:002022-01-31T10:13:05.795-08:00Ultrasound Significantly Reduces False Readings of DENSE BREASTS<p></p><div class="MsoNormalCxSpFirst" style="-webkit-text-stroke-width: 0px;"><div class="separator" style="clear: both; text-align: center;"><a href="https://www.youtube.com/watch?v=BC-oHAi7m9A&ab_channel=Awareness4acure" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="350" data-original-width="628" height="214" src="https://1.bp.blogspot.com/-ABcIuY1ea-w/YVyHl3bLuOI/AAAAAAAARx8/iV-j4Z2x3SAmbIf48cVIV2ii3nyZL0pkQCLcBGAsYHQ/w384-h214/video1.jpg" width="384" /></a></div><div class="separator" style="background-color: white; clear: both; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: center;"><br /></div><div class="separator" style="background-color: white; clear: both; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: center;"><div class="separator" style="clear: both;"><b><a href="https://www.youtube.com/watch?v=BC-oHAi7m9A&ab_channel=Awareness4acure">RUNNING THE TORCH OF A DENSE BREAST CANCER CHAMPION</a></b></div><div class="separator" style="clear: both;">Dr. Noelle Cutter drives the spirit of Dr. Nancy Cappello's mission for early cancer detection for women with dense breasts alongside Dr. Robert Bard's dense breast screening pilot program (8/27-29) - and the global pursuit to expand current screening standards.</div><div class="separator" style="clear: both;"><br /></div></div><div class="separator" style="background-color: white; clear: both; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: center;"><div class="MsoNormalCxSpFirst" style="-webkit-text-stroke-width: 0px;"><div style="text-align: justify;"><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;"><h1 id="content" style="box-sizing: border-box; font-family: Merriweather, serif; font-size: 2.125rem; font-weight: 500; line-height: 1.3; margin-bottom: 0.75rem; margin-top: 1rem;">What Does It Mean to Have Dense Breasts?</h1></span></div><div style="text-align: justify;"><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;"><div><a href="https://www.cdc.gov/cancer/breast/basic_info/dense-breasts.htm">Source: CDC.gov</a></div><div><br /></div><div>A mammogram shows how dense your breasts are. When you get the results of your mammogram, you may also be told if your breasts have low or high density. Women with dense breasts have a higher risk of getting breast cancer.</div><div><br /></div><div><a href="file:///C:/Users/LEO/Desktop/NOW%202021/BARD/CAMPAIGN%203/DENSE%20BREASTS/GlobalInveniaABUS20DensityQuickFactsSheetDecember2018.pdf" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: center;"><img border="0" data-original-height="440" data-original-width="873" height="332" src="https://1.bp.blogspot.com/-PKC1iTUMvzk/YO8L2ROs3jI/AAAAAAAARQI/Rn3aRDzpqEc8sJMGZknCfsF_lFWEUEzewCLcBGAsYHQ/w659-h332/use.jpg" width="659" /></a><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div>PARTS OF THE BREAST</div><div>A woman’s breast has three kinds of tissue: FIBROUS TISSUE holds the breast tissue in place. GLANDULAR TISSUE is the part of the breast that makes milk, called the lobes, and the tubes that carry milk to the nipple, called ducts. Together, fibrous and glandular tissue are called fibroglandular tissue. FATTY TISSUE fills the space between the fibrous tissue, lobes, and ducts. It gives the breasts their size and shape.<span style="color: black; font-family: "Times New Roman"; font-size: medium;"></span></div><div><br /></div><div>BREAST CANCER RISK: Women with dense breasts have a higher chance of getting breast cancer. The more dense your breasts are, the higher your risk. Scientists don’t know for sure why this is true. Breast cancer patients who have dense breasts are not more likely to die from breast cancer than patients with non-dense (fatty) breasts.</div><div><br /></div><div><br /></div><div><div class="separator" style="clear: both; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: center;"><br /></div><div class="separator" style="clear: both; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: center;"><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><div class="MsoNormalCxSpFirst" style="-webkit-text-stroke-width: 0px;"><table border="2" cellpadding="10" cellspacing="0" style="text-align: justify;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; color: #444444; font-family: arial; font-weight: bold; text-align: center;"><br /></div></div><div><span style="color: #444444; font-family: times;"><div><b style="font-family: arial;"><div style="text-align: left;"><b style="font-size: 13px;"><span style="font-size: medium;">TRIBUTE TO A GLOBAL CRUSADER</span></b><div class="separator" style="clear: both; text-align: center;"><a href="https://www.youtube.com/watch?v=ht4UpoY-BnQ" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="544" data-original-width="974" height="157" src="https://1.bp.blogspot.com/-jbm88Nc3MbU/YPpd0QALrfI/AAAAAAAARTM/96r_xNR5WT8vPYKUAfLaZ6dEjVntTTBIgCLcBGAsYHQ/w281-h157/7b03b9f1-ea1d-4885-b14d-923629c94c54.jpg" width="281" /></a></div></div></b>(<a href="https://www.youtube.com/watch?v=ht4UpoY-BnQ">Play Video-L)</a> The NY Cancer Resource Alliance gives loving tribute to Dr. Nancy Cappello, co-founder of "Are You Dense" and chief crusader of the mission to bring change to the protocols and standards of Early Detection. Her organization embarked in a global advocacy project to win legislation for dense breast scanning and to bring awareness to the need for better technologies and imaging interpretation. Today, her loving husband Joe continues her unending fight to save more lives through awareness, advocacy and her crusade for change. (Also see below to read her full story in our ORG SPOTLIGHT section)</div><div><br /></div></span></div></td></tr></tbody></table></div><div class="MsoNormalCxSpFirst" style="-webkit-text-stroke-width: 0px; text-align: left;"></div></div></div><div class="separator" style="clear: both; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: center;"><br /></div><div class="separator" style="clear: both; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: center;"><div class="MsoNormalCxSpFirst" style="-webkit-text-stroke-width: 0px;"><div class="separator" style="clear: both;"><a href="https://1.bp.blogspot.com/-fbezYSvBljw/YOhLjOYazhI/AAAAAAAARNo/R09trNQcM4Eas9nQ50HPng6CvHqgoBo9gCLcBGAsYHQ/s646/ad.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="516" data-original-width="646" src="https://1.bp.blogspot.com/-fbezYSvBljw/YOhLjOYazhI/AAAAAAAARNo/R09trNQcM4Eas9nQ50HPng6CvHqgoBo9gCLcBGAsYHQ/s320/ad.jpg" width="320" /></a></div><div style="text-align: justify;"><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;">7/8/2021- A wave of recognized medical sites, journals and reports are now indicating that dense breast tissue increases the risk of developing breast cancer and often masks a tumor from being seen on the mammogram since dense tissue is white and cancerous tissue is also white. Mammograms are the standard screening test for breast cancer, however, in the 21st Century, ultrasound non invasive imaging is the preferred exam for dense “lumpy” mammary disease. </span></div><div style="text-align: justify;"><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;"><br /></span></div><div style="text-align: justify;"><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;">The 1st World Conference of Breast Ultrasound in Philadelphia (1979) recognized ultrasound superiority in dense breast diagnostics but the density level was never quantified until recently. Mammography assessment of breast density is graded into four categories. Mammographers readily admit that these levels are subjective at best and technical factors such as mammary tissue compression and x-ray voltage/amperage dramatically influence the darkness or whiteness of the image.</span></div><div><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;"><br /></span></div></div></div></div><div><br /></div><div><div class="MsoNormalCxSpFirst" style="-webkit-text-stroke-width: 0px;"><div style="text-align: justify;"><hr /><p></p></div></div><p style="text-align: justify;"><span style="font-size: large;">URGENCY IN THE EVOLUTION OF TECHNOLOGY & IMAGING STRATEGIES FOR DENSE BREASTS</span></p><p style="text-align: justify;">Written by: Dr. Robert L. Bard</p><div><div class="separator" style="clear: both; text-align: justify;"><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-nhYKSycK9HY/YPBBiz9kT4I/AAAAAAAARQ0/hZBcbRGgdpkeas9QODPtZnjsTHe8N7Q_gCLcBGAsYHQ/s1100/INSERT2.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="706" data-original-width="1100" height="300" src="https://1.bp.blogspot.com/-nhYKSycK9HY/YPBBiz9kT4I/AAAAAAAARQ0/hZBcbRGgdpkeas9QODPtZnjsTHe8N7Q_gCLcBGAsYHQ/w468-h300/INSERT2.jpg" width="468" /></a></div>Decades since the advent of breast scanning technology, innovations in non-invasive diagnostic imaging provide new options in the field of early detection. These technologies directly align with breast density screening (and are part of the Bard Breast Density Diagnostic Program) include:</div></div><div><p></p><p></p><div style="text-align: justify;"><span style="font-family: times;">• Doppler blood flow</span></div><span style="font-family: times;"><div style="text-align: justify;"><span>• Contrast enhanced ultrasound vascularity </span></div><span><div style="text-align: justify;">• 3D Vessel Density Histogram </div></span><span><div style="text-align: justify;">• 4D Volumetric Density Histogram</div><div style="text-align: justify;">• Strain and shear wave tissue Elastography </div></span><span><div style="text-align: justify;">• 3 T MRI </div><div style="text-align: justify;">• Optical Computed Tomography (OCT) for nipple lesions</div><div style="text-align: justify;">• Reflectance Confocal Microscopy (RCM) for dermal invasion</div></span><span><div style="text-align: justify;">• Hybrid <span style="background-color: transparent;">Mammo Imaging Fusion</span></div></span></span><div style="text-align: justify;"><span style="font-family: times;">•</span><span style="font-family: times;"> </span>Thermo-sensor</div><div style="text-align: justify;"><span style="font-family: times;">•</span><span style="font-family: times;"> </span>Trans Illumination</div><div style="text-align: justify;"><span style="font-family: times;">•</span><span style="font-family: times;"> </span>Near Infrared Specroscopy</div><p></p><p style="text-align: justify;">Hybrid imaging refers to combining diagnostic modalities to assess disease and monitor therapy. A useful combination of options is the tumor vessel flow density to assess aggression and treatment progress. Similarly, tissue elastography is useful for border detection of malignant masses.</p><p style="text-align: justify;"><br /></p><div style="color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: justify;"><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;"><hr /></span></div><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-kvOMQqeQQmk/YPBB7WAYAJI/AAAAAAAARQ8/tQiPqoRz228qZMOT4P7Fc0Mw4klpThLPwCLcBGAsYHQ/s185/MEDTECH1.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><br /></a><a href="https://1.bp.blogspot.com/-kvOMQqeQQmk/YPBB7WAYAJI/AAAAAAAARQ8/tQiPqoRz228qZMOT4P7Fc0Mw4klpThLPwCLcBGAsYHQ/s185/MEDTECH1.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="61" data-original-width="185" height="47" src="https://1.bp.blogspot.com/-kvOMQqeQQmk/YPBB7WAYAJI/AAAAAAAARQ8/tQiPqoRz228qZMOT4P7Fc0Mw4klpThLPwCLcBGAsYHQ/w143-h47/MEDTECH1.jpg" width="143" /></a></div><div style="color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: justify;"><br /></div></div><div style="color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: justify;"><br /></div><div style="color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: justify;"><br /></div><div style="color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: justify;"><br /></div><div style="color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px; text-align: justify;"><br /></div></div></span></div><div style="text-align: justify;"></div><div style="text-align: justify;"><span style="color: black; font-family: "Times New Roman"; text-align: left;"><div style="text-align: justify;"><span style="font-size: large;">4D VOLUMETRIC DENSITY HISTOGRAM</span></div><div style="font-size: medium; text-align: justify;">This new variation of the 4D ultrasound imaging involves real time scanning of the entire breast and focusing of the greatest density tissue with 3D volumetric capture of the tissue. The computer searches the gray level of the images under study and provides a percentage (%) number of the whiteness of the volume under study.</div><p style="font-size: medium;"></p><p style="font-size: medium;"></p><div class="separator" style="clear: both; font-size: medium; text-align: center;"><br /></div><div style="font-size: medium; text-align: justify;">This investigative process began in 2017 under a study of scar tissue and presented at the 2018 ASLMS meeting using elastography and volumetric sonogram density analysis. Breast cancers, like scar tissue, are dark while fibrocystic abnormal tissues is more white.</div><p style="font-size: medium;"></p><p style="font-size: medium; text-align: justify;">The clinical utility of 4D image acquisition is:</p><p style="font-size: medium; text-align: justify;">1. Automated electronics sampling of the tissue volume in real time</p><p style="font-size: medium; text-align: justify;">2. 200-300 images of a data set are generated in 5-15 seconds</p><p style="font-size: medium; text-align: justify;">3. The process is User-INDEPENDENT unlike standard 2D ultrasound which is highly user dependent</p><p style="font-size: medium; text-align: justify;">4. The data set for serial studies uses fixed parameters so that treatment efficacy may be rapidly compared </p></span></div><div style="text-align: justify;"><span style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;"><hr /></span></div><div style="text-align: justify;"><br /></div><div style="text-align: left;"><span style="font-size: large;"><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-v65qqbkVEdw/YO8KjuroYQI/AAAAAAAARQA/OSE2U-MZv3A_2fMq2DVENaKMxpLC_099QCLcBGAsYHQ/s360/use1.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="276" data-original-width="360" src="https://1.bp.blogspot.com/-v65qqbkVEdw/YO8KjuroYQI/AAAAAAAARQA/OSE2U-MZv3A_2fMq2DVENaKMxpLC_099QCLcBGAsYHQ/s320/use1.jpg" width="320" /></a></div><div>INNOVATIONS REFLECTING A NEW IMAGING STRATEGY: MEET THE ABUS</div></span></div><div style="text-align: left;"><span style="font-size: medium;"><div style="text-align: justify;">The medical imaging and cancer communities are now taking strides toward the dedicated scanning of Dense Breasts. As mammograms have been known to have difficulty seeing tumors through dense breast tissue, the demand to upgrade imaging standards is at its highest. Dense breasted patients carry the risk of a mis-read which may miss advanced cases of breast cancer. </div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">According to GE Healthcare, "Approximately 40% of women have dense breasts, one of the strongest common risk factors for developing breast cancer. Having dense breasts increases a woman's chance of developing breast cancer by four to six times, and seventy-one percent of breast cancers are found in dense breasts.</div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">Clinical evidence is growing about the effectiveness of ultrasound for finding small, node-negative, invasive cancers missed by mammography. In 2018, GE Healthcare launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the U.S. This FDA Approveed ultrasound supplemental breast screening technology specifically designed for detecting cancer in dense breast tissue. When used in addition to mammography, Invenia ABUS can improve breast cancer detection by 55 percent over mammography alone. Invenia ABUS 2.0 supplemental imaging is designed for the screening environment, specifically for dense breast imaging. Invenia ABUS 2.0 diminishes operator variability and creates 3D ultrasound volumes to enable comprehensive analysis and comparison to multimodality exams. <a href="https://www.ge.com/news/press-releases/setting-new-standard-breast-care-ge-healthcare-introduces-invenia-abus-20#_ftn1">[1]</a></div><div class="separator" style="clear: both; text-align: center;"><br /></div><div style="text-align: justify;">“We believe ABUS can help clinicians find significantly more cancers than mammography alone, especially in women with dense breasts,” said Luke Delaney, general manager of Automated Breast Ultrasound at GE Healthcare. “As breast ultrasound technology continues to advance, we are investing to continually improve image quality, workflow and patient comfort - all of which contribute to early detection and improved outcomes.” <a href="https://www.ge.com/news/press-releases/setting-new-standard-breast-care-ge-healthcare-introduces-invenia-abus-20#_ftn1">[1]</a></div></span><span style="font-size: medium;"><div style="text-align: justify;"><br /></div></span></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><div class="MsoNormalCxSpFirst" style="-webkit-text-stroke-width: 0px;"><table border="2" cellpadding="10" cellspacing="0" style="text-align: justify;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; color: #444444; font-family: arial; font-weight: bold; text-align: center;"><b style="text-align: justify;"><span style="font-size: medium;">Dense Breasts: Answers to Commonly Asked Questions </span></b></div></div><div class="separator" style="clear: both;"><span style="color: #444444; font-family: arial;"><b><br /></b></span></div><div><span style="color: #444444; font-family: times;"><div><b><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-E9vcYOq9jL8/YOaF3v9TZiI/AAAAAAAARNI/ecprnr1D45cRwCH6HA5LY5Xd5XY5kenCACPcBGAYYCw/s480/dreamstime_xs_18837816.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="480" data-original-width="320" height="320" src="https://1.bp.blogspot.com/-E9vcYOq9jL8/YOaF3v9TZiI/AAAAAAAARNI/ecprnr1D45cRwCH6HA5LY5Xd5XY5kenCACPcBGAYYCw/s320/dreamstime_xs_18837816.jpg" /></a></div>Q: How common are Dense Breasts?</b></div><div><b>A: </b>Nearly half of all women age 40 and older who get mammograms are found to have dense breasts. Breast density is often inherited, but other factors can influence it. Factors associated with lower breast density include increasing age, having children, and using tamoxifen. Factors associated with higher breast density include using postmenopausal hormone replacement therapy and having a low body mass index.</div><div><br /></div><div><div><b>Q: Are dense breasts a risk factor for breast cancer?</b></div><div><b>A: </b>Yes, women with dense breasts have a higher risk of breast cancer than women with fatty breasts, and the risk increases with increasing breast density. This increased risk is separate from the effect (false negatives) of dense breasts on the ability to read a mammogram.</div></div></span></div><div><span style="color: #444444; font-family: times;"><br /></span></div><div style="text-align: right;"><a href="https://www.gofundme.com/f/stromski-family" style="color: #cd3778; text-decoration-line: none;"><i><span style="color: #444444;"><span style="font-family: times;">* </span></span><span style="color: #444444; font-family: times;">S</span></i></a>ource: <a href="https://www.cancer.gov/types/breast/breast-changes/dense-breasts">NIH: National Cancer Institute</a></div></td></tr></tbody></table></div><p><br style="color: black; font-family: "Times New Roman"; font-size: medium; text-align: left;" /></p><div class="MsoNormalCxSpFirst" style="-webkit-text-stroke-width: 0px; text-align: left;"><div style="text-align: justify;"><hr /><p></p></div></div><p><b style="background-color: #3d85c6;"><span style="color: white; font-size: medium;">ORG SPOTLIGHT:</span></b></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #444444;"><span style="font-size: large;">“ARE YOU DENSE”- FORGING A SMART, NEW PROTOCOL IN BREAST CANCER SCREENING</span></span></p><p><span face="Arial, Tahoma, Helvetica, FreeSans, sans-serif" style="color: #444444;">By: Joe Cappello of “Are You Dense” (<a href="http://areyoudense.org">areyoudense.org</a> & <a href="http://areyoudenseadvocacy.org">areyoudenseadvocacy.org</a>) | Edited by: Carmen R. DeWitt</span></p><p><span style="color: #444444;"></span></p><div class="separator" style="clear: both; text-align: center;"><span style="color: #444444;"><a href="https://1.bp.blogspot.com/-sYlEry1Yyv0/YOibyiKzV7I/AAAAAAAARN0/u3WOBDhzdkID-MhDDFC-wfCXCSpu3jxIgCLcBGAsYHQ/s640/7-23-04_001.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="416" data-original-width="640" src="https://1.bp.blogspot.com/-sYlEry1Yyv0/YOibyiKzV7I/AAAAAAAARN0/u3WOBDhzdkID-MhDDFC-wfCXCSpu3jxIgCLcBGAsYHQ/s320/7-23-04_001.jpg" width="320" /></a></span></div><span style="color: #444444;"><div><span style="color: #444444;"><span face="Sintony, sans-serif" style="color: #231f20; font-weight: 700; text-align: start;">Dr. Nancy Cappello's Story:</span><span face="Sintony, sans-serif" style="color: #231f20; font-weight: 700; text-align: start;"> "</span>I have dense breast tissue – and women like me (2/3 of pre-menopausal and 1/4 of post menopausal) have less than a 48% chance of having breast cancer detected by a mammogram. In November 2003 I had my yearly mammogram and my "Happy Gram" report that I received stated that my mammogram was "NORMAL" and that there were "no significant findings." Six weeks later at my annual exam in January, my doctor felt a ridge in my right breast and sent me for another mammogram and an ultrasound. The mammogram revealed "nothing" yet the ultrasound detected a large 2.5 cm suspicious lesion, which was later confirmed to be stage 3c breast cancer, as the cancer had metastasized to 13 lymph nodes.... Since then, I learned that there are many women like me with recent normal mammogram reports with a hidden intruder stealing their life. I am on a quest to expose this best-kept secret of dense breast tissue to ensure that women with dense breast tissue receive screening and diagnostic measures to find cancer at its earliest stage - isn't that the purpose of Screening Programs?"</span></div><div><span style="color: #444444;"><br /></span></div><div><b>Nancy's story is a widely common one, and demands to be recognized to change the current standards. </b>We established an advocacy group to help create a new standard protocol for diagnosis because the current standard is clearly an injustice to ALL women. This includes public education and awareness for the many women who get side swiped because of a lack of understanding and clinical information. </div></span><p></p><p><span style="color: #444444;">Our advocacy work led us to reach out to our legislators, explore the current insurance coverages and eventually got our first win with a disclosure law in 2009, making Connecticut the first state in the nation to pass legislation making it a law for Docs to disclose to the patient if they have dense breast tissue. This says that if a woman has dense breasts, she'd must be told by her physician that she's got dense breast there's alternative screening. This includes options like an ultrasound or an MRI. Also, two years ago, ‘<a href="https://www.areyoudenseadvocacy.org/about">Are You Dense Advocacy, Inc</a>.’ was instrumental in passing the first national dense breast disclosure law. We are now working with Sen. Feinstein to enact this legislation. </span></p><p><span style="color: #444444;"><b>FORGING A NATIONAL MOVEMENT<br /> </b></span><span style="color: #444444;">It used to be that when you Googled ‘dense breast’, there was next to NO information available. But over time, as we started making ‘noise’ about this issue, more and more interest began coming our way. </span><span style="color: #444444;">As news broke of our ‘touchdown’ with our state, it wasn’t long before other states started asking how we did it. Before long, Nancy started helping women across the country and the next state was Texas. She helped the girl down in Texas to get legislation passed – and next came our public educational website for the many others who definitely need this.</span></p><div class="separator" style="clear: both;"><a href="https://www.areyoudenseadvocacy.org/donate" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1035" data-original-width="2846" height="87" src="https://1.bp.blogspot.com/-SxIuDoq7Pk8/YOib0HF3DoI/AAAAAAAARN4/CyIywOCsnqU_akwQbPhZHGB59scxlL45gCLcBGAsYHQ/w240-h87/logo-large.png" width="240" /></a></div><p></p><p><span style="color: #444444;">Nancy quit her job with the state of Connecticut and started doing “<a href="http://areyoudense.org">Are You Dense”</a> full-time and she helped pass 38 different laws in 38 states. It's a tremendous amount of work to pass laws on a state by state basis, but she was really the catalyst. Nancy was the person behind and the voice and the face behind dense breast tissue. As outreach work goes, we created a major effort around what we've done now. Manufacturers are supporting our interest as far as the expansion of full breast automated ultrasound and others came into existence (and are doing quite well) because of our efforts.</span></p><p>* For more information about Nancy and Joe Cappello's national mission, visit: <a href="http://areyoudense.org">areyoudense.org</a> and <a href="http://areyoudenseadvocacy.org">areyoudenseadvocacy.org</a></p><p></p></div></div><p style="text-align: justify;"><br /></p><div><div class="MsoNormalCxSpFirst" style="-webkit-text-stroke-width: 0px;"><div style="text-align: justify;"><table border="2" cellpadding="10" cellspacing="0" style="text-align: justify;"><tbody><tr><td bgcolor="#E1F3DA"><div class="separator" style="clear: both;"><div class="separator" style="clear: both; color: #444444; font-family: arial; font-weight: bold; text-align: left;"><b style="text-align: justify;"><span style="font-size: medium;">From the Surgical Side...</span></b></div><div class="separator" style="clear: both; color: #444444; font-family: arial; font-weight: bold; text-align: left;"><b style="text-align: justify;"><span style="font-size: medium;">"THEY MADE A LAW REQUIRING DENSE BREAST SCANNING"</span></b></div></div><div><span style="color: #444444; font-family: times;"><b><div class="separator" style="clear: both; text-align: center;"><br /></div></b></span><div><span style="color: #444444; font-family: times;"><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-zXh2IO6yjyo/YOaVxGZunQI/AAAAAAAARNc/ZAPa5hXy-Ng3vCnL7yiEM2rOk73U-KStQCLcBGAsYHQ/s100/chaga.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="100" data-original-width="71" src="https://1.bp.blogspot.com/-zXh2IO6yjyo/YOaVxGZunQI/AAAAAAAARNc/ZAPa5hXy-Ng3vCnL7yiEM2rOk73U-KStQCLcBGAsYHQ/s0/chaga.jpg" /></a></div>In New Jersey, we have the Breast Density Law that literally says women with very dense breasts should be getting more than just screening mammography and the insurance companies have to cover. And that can either be an ultrasound or an MRI, but women over 40 do not usually like the idea of getting an MRI and gadolinium IV each year. Instead, adding ultrasound allows you to scan the whole breast and see through the very dense breast tissue. Ultrasounds will also work to the full depth of the breath straight down to the chest wall, so that if there are any masses, it will see right through the fibers and thick tissue- not limited like mammogram. </span></div><div><span style="color: #444444; font-family: times;"><br /></span></div><div><span style="color: #444444; font-family: times;">Even extremely dense breast patients should get a mammogram because it also shows things like calcifications-- something that the average ultrasound tech may find harder to capture. Women with extremely dense breast definitely can benefit from added surveillance because as your breasts get more dense, mammography can miss things. Due to a higher volume of dense tissue, a little tumor can hide underneath fibercystic tissue making it very hard to see in mammography, even with tomosynthesis or the 3d mammo. </span></div><div><br /></div></div><div style="text-align: right;"><span style="color: #444444; font-family: times;"><i>By: Dr. Stephen Chagares | </i></span><span style="text-align: justify;"><span style="color: #444444; font-family: times;"><i>https://www.drchagares.com</i></span></span></div></td></tr></tbody></table></div></div><p style="text-align: justify;"><span style="font-size: medium;"><br /></span></p><p></p><div style="text-align: justify;"><span style="font-size: large;">TREATMENT OPTIONS</span></div><div style="text-align: justify;">Risk stratification is important since the cost/benefit of any therapy must be weighed against the likelihood of health consequences. Hormone treatments have been controversial for 50 years and remains so to date. Since Dr. Selig Strax (my late partner) developed the “lumpectomy” for conservative therapy of breast cancer at Mt Sinai Medical Center in the 1960’s, advances in limiting tissue damage have yielded progress in chemotherapy, radiation therapy and immunotherapy. Similarly focal treatment options that began with prostate cancer in 2000 with HIFU (High Intensity Focused Ultrasound) are now found in thyroid and breast treatment centers and Laser Ablation and Cryo Ablation are now available alternatives. </div><p></p><p style="text-align: justify;">Elastography is used worldwide since 2010 for cancer detection because cancer is hard (inelastic) and benign tissue is soft (elastic). This quantitative technology for cancer detection has not been adapted for breast density analysis to date.</p><p style="text-align: justify;"><br /></p><p style="text-align: justify;">REFERENCES</p><p style="text-align: justify;">1) GE.com/ Setting A New Standard for Breast Care: GE Healthcare Introduces Invenia ABUS 2.0 <a href="https://www.ge.com/news/press-releases/setting-new-standard-breast-care-ge-healthcare-introduces-invenia-abus-20#_ftn1">https://www.ge.com/news/press-releases/setting-new-standard-breast-care-ge-healthcare-introduces-invenia-abus-20#_ftn1</a></p><p style="text-align: justify;"><i><span style="font-size: x-small;">1) Breast density and risk- European Radiology 31:4839-4847, 2021</span></i></p><p></p><div style="text-align: justify;"><i><span style="font-size: x-small;">2) 4D histogram analysis of malignancy- Mt Sinai Surgical Symposium 2020- 3D/4D breast density histogram</span></i></div><i><div style="text-align: justify;"><i><span style="font-size: x-small;">3) Proceedings: Male Breast Cancer Coalition 2019</span></i></div><span style="font-size: x-small;"><div style="text-align: justify;"><i><span style="font-size: x-small;">4) Ultrasound imaging of subdermal pathology /Springer Heidelberg 2018</span></i></div><div style="text-align: justify;"><i><span style="font-size: x-small;">5) 3D Doppler imaging of malignant melanoma- Intl Dermatologic Surgery Symposium 2016</span></i></div><div style="text-align: justify;"><i><span style="font-size: x-small;">6) 3D Doppler imaging in dense breasts Proceedings: 2012 Societe Francaises de Radiologie</span></i></div></span></i><p></p><p style="text-align: justify;"><br /></p><p></p><hr style="text-align: justify;" /><div style="text-align: justify;">CONTRIBUTORS</div><div style="text-align: justify;"><span style="font-size: x-small;"><br /></span></div><div class="separator" style="clear: both;"><b style="color: #222222; text-align: justify;"><a href="https://drrobertbard.com/" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><span style="font-size: x-small;"><img border="0" data-original-height="140" data-original-width="110" height="121" src="https://1.bp.blogspot.com/-rSwPJCkNGwU/YPA5K-2NgiI/AAAAAAAARQk/ZCCi5J8drqo6QmvFl340bmr10qJjirfBACLcBGAsYHQ/w95-h121/bard1.jpg" width="95" /></span></a></b></div><span style="font-size: x-small;"><b style="color: #222222; text-align: justify;"><span style="font-family: times;">DR. ROBERT L. BARD</span></b><span style="color: #222222; font-family: times; text-align: justify;"> has paved the way for the diagnostic study of various cancers both clinically and academically. He runs an active NYC practice (Bard Diagnostic Imaging) using the latest in digital Imaging technology which has been also used to help guide biopsies and, even replicate much of the same reports of a clinical invasive biopsy. Imaging solutions such as high-powered Sonograms, Spectral Doppler, sonofluoroscopy, 3D/4D Image Reconstruction and the Spectral Doppler are safe, noninvasive, and does not use ionizing radiation. His commitment to lead the community of cancer imaging and diagnostic experts has led to the establishment of the "Get Checked Now!" campaign.</span></span><p></p><p style="text-align: justify;"><span style="font-family: times; font-size: x-small;"></span></p><div class="separator" style="clear: both;"><span style="font-family: times; font-size: x-small;"><a href="https://www.areyoudense.org/" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="140" data-original-width="110" height="123" src="https://1.bp.blogspot.com/-ix7ldKe_dRg/YPA6SJopxuI/AAAAAAAARQs/ftVjV7OJ6boNgsu8RcYbsrShuwxbKnPxACLcBGAsYHQ/w97-h123/joe.jpg" width="97" /></a></span></div><span style="font-family: times; font-size: x-small;"><b><span style="color: #3d85c6;"><a href="https://www.areyoudense.org/">JOSEPH J. CAPPELLO</a></span></b> married Nancy Marcucci, in 1974 and the story began. Joe is the co-founder and executive director of Are You Dense, and Are You Dense Advocacy- in January of 2019 after Nancy’s passing from treatment related bone marrow cancer (MDS). His passion is to continue Nancy’s legacy by pursuing the goal that they set in 2004; that not one woman would die from a late stage breast cancer due to dense breast tissue. In 2009, Joe and Nancy championed the first in the nation breast density inform law in the State of Connecticut (and now, 36 States have breast density legislation).</span><p></p><p style="text-align: justify;"><br /></p><p><i style="color: #222222; font-family: Arial, Helvetica, sans-serif; font-size: xx-small; text-align: justify;">Disclaimer & Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and Bard Diagnostic Research & Educational Programs). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.</i></p><p style="text-align: justify;"> </p><p style="text-align: justify;"><br style="color: black; font-family: "Times New Roman"; font-size: medium;" /></p></div></div></div>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-35957739136668155792021-05-21T00:59:00.012-07:002021-06-09T10:06:55.333-07:00How this MICRO IMPLANT RADAR revolutionized breast cancer surgeries<p> INTRODUCTION</p><div style="text-align: justify;"><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-Zb7_jF_mnxU/YKdmq1QSA4I/AAAAAAAAQ58/DvI9gQXaGBgHYWGEGeV7lqtJf6Ux1H_UgCLcBGAsYHQ/s1417/merit.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="920" data-original-width="1417" height="231" src="https://1.bp.blogspot.com/-Zb7_jF_mnxU/YKdmq1QSA4I/AAAAAAAAQ58/DvI9gQXaGBgHYWGEGeV7lqtJf6Ux1H_UgCLcBGAsYHQ/w356-h231/merit.jpg" width="356" /></a></div><span>For surgical procedures of breast cancer, NYCRANEWS explores wire-free Radar Localization - a pre-surgical procedure to locate and mark the exact breast abnormality through the use of a small, 12×1.6 mm implanted radar reflector device, roughly the size of a grain of rice.</span><span style="mso-spacerun: yes;"> </span><span>This micro-electronic implant communicates with the scanning handpiece, allowing the surgeon to identify the exact tissue (and how much of it) to extract during </span><span>a lumpectomy [<a href="https://myhealth.alberta.ca/Alberta/Pages/Breast-needle-localization.aspx#:~:text=Needle%20localization%20(also%20called%20wire,by%20mammogram%20or%20ultrasound%20guidance.">1</a>]. The early process of localization came in the form of a guide wire insert but later advancements offered other solutions including a wireless radioactive seed and (then) a non-radioactive version called SCOUT®- f</span>ormerly called<a href="https://www.merit.com/wp-content/uploads/2020/07/SCOUT-Report-2019-July-Changes-for-SCOUT-Radar-Localization.pdf"> SAVI-SCOUT (until July, 2019</a><a href="https://www.merit.com/wp-content/uploads/2020/09/201812-SCOUTReport-IntroducingTheNewSCOUTUltrasoundDeliverySystem.pdf">)</a> [<a href="https://www.merit.com/wp-content/uploads/2020/07/SCOUT-Report-2019-July-Changes-for-SCOUT-Radar-Localization.pdf">2</a>]<span>. It was</span><span style="mso-spacerun: yes;"> </span><span>developed by Cianna Medical and then acquired in 2018 by</span><span style="mso-spacerun: yes;"> </span><span><a href="https://www.merit.com/">Merit Medical</a>, an American medical technology company.</span><span style="mso-spacerun: yes;"> </span></div><p></p><p></p><p class="MsoNormal" style="text-align: justify;"></p><div style="text-align: justify;">Publishers of FightRecurrence.com and PinkSmart News dedicated a review of this surgical solution in support of improvements in the preservation of the breast during surgery. In this feature article, we present <a href="https://www.paradisecoastbreastspecialists.com/about">Dr. TroyShell-Masouras</a> of Paradise Coast Breast Specialists in <st1:place w:st="on"><st1:city w:st="on">Naples</st1:city> <st1:state w:st="on">Fla.</st1:state></st1:place> - and David Gilstrap, Director & Global Product Management of Merit Medical. Together, we explored technical perspectives and design strategies behind radar localization and the SCOUT® technology. They shared the procedural advantages provided by the wire-free upgrade as well as its overall improvements to the patient's well-being in the pre and post-surgical phases.</div><p></p><p class="MsoNormal" style="text-align: justify;"><o:p> </o:p></p><div><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-pRLnSt_Dgys/YKLzWeWZoXI/AAAAAAAAQ4k/HrzwV6v642AU7dXu7cBhNhNBuB9xtkywgCLcBGAsYHQ/s1324/dime1.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="641" data-original-width="1324" height="138" src="https://1.bp.blogspot.com/-pRLnSt_Dgys/YKLzWeWZoXI/AAAAAAAAQ4k/HrzwV6v642AU7dXu7cBhNhNBuB9xtkywgCLcBGAsYHQ/w285-h138/dime1.jpg" width="285" /></a></div><span style="font-size: medium;">WIRE-FREE UPGRADE IN LOCALIZED IMPLANTS</span></div><span><div style="text-align: justify;"><i><span>This segment is from </span>Mr. David Gilstrap's 5/2021 interview.</i></div><div style="text-align: justify;"><span><br /></span></div><div style="text-align: justify;"><span>The concept of</span><span style="mso-spacerun: yes;"> </span><span>SCOUT® wire-free radar localization</span><span style="mso-spacerun: yes;"> </span><span>was developed by Cianna</span><span style="mso-spacerun: yes;"> </span><span>Medical in 2010 and was an alternative to the predominant guide wire concept.</span><span style="mso-spacerun: yes;"> The launch of the </span><span>SCOUT® introduced "going wire free" for the patient, providing a huge impact on patient satisfaction. Prior to this, the original process included placing a wire in the patient the day of</span><span style="mso-spacerun: yes;"> </span><span>surgery, and the patient maintains this wire sticking out of their breast until surgery time, which could be up to several hours.</span></div></span><p></p><p></p><p class="MsoNormal" style="text-align: justify;"></p>The genesis of the non-radioactive reflector came about in 2010 as the company started re-evaluating the breast surgery localization space, because at the time there were only two other options available;<span style="mso-spacerun: yes;"> </span>the guide wire solution (standard for 50+ years) and the<span style="mso-spacerun: yes;"> </span>radioactive seed alternative.<span style="mso-spacerun: yes;"> </span>Despite its advantages, the radioactive seed<span style="mso-spacerun: yes;"> </span>solution showed its own set of limitations and regulatory issues, limiting its public acceptance.<span style="mso-spacerun: yes;"> </span>"It needed a lot of training and tracking and was restricted to a limited time where you can actually place it."<p></p><p class="MsoNormal" style="text-align: justify;"></p><div style="text-align: justify;">By December 2014, Cianna Medical<span style="mso-spacerun: yes;"> </span>received FDA Clearance for the first generation of SCOUT®<span style="mso-spacerun: yes;"> </span>allowing full commercialization in the U.S, and CE Mark for <st1:place w:st="on">Europe</st1:place> would follow. The implant is technically called the reflector. It doesn't transmit a signal, but actually reflects a signal that's being sent to it. It has its own electronic circuitry, an antenna and it is sealed with a bio-compatible coating called APTEK. There's no power source or moving parts in the reflector- it's inert. With FDA long-term implant status, when it's placed into a patient,<span style="mso-spacerun: yes;"> </span>there are no limitations on removal and it can remain in the patient forever. It doesn't have to be removed again. There's no risk to the patient or the area of interest.<div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-KpkS3TaLqfk/YKLzx3t1sxI/AAAAAAAAQ4s/_RnxvNO9PV4cG3nv5Shre3oiN6k1krfmQCLcBGAsYHQ/s1080/dev1.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="606" data-original-width="1080" src="https://1.bp.blogspot.com/-KpkS3TaLqfk/YKLzx3t1sxI/AAAAAAAAQ4s/_RnxvNO9PV4cG3nv5Shre3oiN6k1krfmQCLcBGAsYHQ/s320/dev1.jpg" width="320" /></a></div></div><p></p><p class="MsoNormal" style="text-align: justify;">Once placed into the region for surgery, the surgeon uses the SCOUT®<span style="mso-spacerun: yes;"> </span>surgical guide which transmits pulsating infrared light and a pulsating radar signal (at 50 million pulses/sec). This infrared light activates the reflector which bounces the radar signal<span style="mso-spacerun: yes;"> </span>back to the system, giving an audible cadence when detected as well as distance measurements from the end of that guide, accurate to one millimeter. To simplify, the technology is very similar to the micro power impulse radar used in your backup sensors in automobiles. So it is very accurate in detecting things over very short distances.</p><p class="MsoNormal" style="text-align: justify;">Merit attributes their success in tech feature upgrades to collected end user data from the surgical community. Prototypes are underway for a reduced reflector size, advanced image guidance, customized targeting cadence and improved ease of use in installation<span style="mso-spacerun: yes;"> </span>Since SCOUT® is approved for soft tissues it is rapidly expanding into other surgical sites such as pulmonary nodules and soft tissue sarcomas.</p><div class="separator" style="clear: both; text-align: center;"><div class="separator" style="clear: both; text-align: left;"><span style="text-align: center;"><table align="left" border="0" cellpadding="6" cellspacing="0" style="width: 592px;">
<tbody><tr>
<td bgcolor="#F2FFFF" valign="top" width="364"><iframe allowfullscreen='allowfullscreen' webkitallowfullscreen='webkitallowfullscreen' mozallowfullscreen='mozallowfullscreen' width='363' height='266' src='https://www.blogger.com/video.g?token=AD6v5dwRrmGV_-i8AgPx-mHWobfMfS27nilnHP0IzrZ1VxjFPem73WpGwFcsaocWsNfsl6uXiTe3_xRpwtGwnFO3HA' class='b-hbp-video b-uploaded' frameborder='0'></iframe></td>
<td bgcolor="#F2FFFF" valign="top" width="204"><br /><br />Dr. Barry Rosen, breast surgeon at Good Sheppard Hospital (Chicago, IL) describes the many advantages of wire-free localization technology in oncoplastic surgery. For the patient, this innovation adds a new level of ease and adaptability over the traditional (pain and stress of) the wired version. </td>
</tr>
<tr>
<td bgcolor="#F2FFFF"><p class="WEES"><br /></p></td><td bgcolor="#F2FFFF"><br /></td>
</tr>
</tbody></table>
<p> </p>
<p> </p>
<p> </p>
<p> </p></span></div><div><br /></div></div><hr /><p></p><p class="MsoNormal" style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><div><br /></div></div><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-lP5Nlffc3e8/YKLyoHKCGpI/AAAAAAAAQ4c/aMyPSHz9NSYiY4D8jdjEfo380ONS8k0DQCLcBGAsYHQ/s566/scout-breast-mammo.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><br /><img border="0" data-original-height="566" data-original-width="403" height="247" src="https://1.bp.blogspot.com/-lP5Nlffc3e8/YKLyoHKCGpI/AAAAAAAAQ4c/aMyPSHz9NSYiY4D8jdjEfo380ONS8k0DQCLcBGAsYHQ/w176-h247/scout-breast-mammo.jpg" width="176" /></a></div><span style="font-size: medium;"><div style="text-align: justify;">FROM THE SURGICAL FIELD</div></span><div style="text-align: justify;"><i>Breast surgeon Dr. Troy Shell-Masouras expands on the benefits of the wire-free (non-radioactive) radar<span style="mso-spacerun: yes;"> </span>in comparison to the former solutions like the localization wire and radioactive seed. This segment is excerpted from Dr. Shell-Masouras' direct interview in 5/2021.</i></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">Initially, the first breakthrough into a wireless approach<span style="mso-spacerun: yes;"> </span>was the radioactive seed - technology that was well-known in prostate cancer. These pellets can be placed into the breast in a similar fashion where the SCOUT reflector<span style="mso-spacerun: yes;"> w</span>ould be placed. Once installed, you would use a probe that detects the signal of the seeds. The issue here is that because it is radioactive, there are very strict monitoring and nuclear medicine guidelines on this process as far as its retrieval. To describe this a different way, imagine inserting this radioactive seed in a patient before their surgery-- then if that patient gets into a car accident or disappeared in some way, your entire radioactive seed program could be shut down because you have to be able to retrieve that seed.</div><p></p><p class="MsoNormal" style="text-align: justify;">There are limitations on how long that seed is active and detectable. Because of these issues, products like SCOUT<span style="mso-spacerun: yes;"> </span>were developed where there are no limitations on the activity of the device. Time is of no concern if your patient grows ill and their procedure is postponed a month or so down the road. There's no urgency to retrieve the product at any time. These real-life situations are really why products like this are developed.</p><p class="MsoNormal" style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-DqTLfl4aQM8/YKLDCGLFUgI/AAAAAAAAQ4U/wOfXYOsWyaQggC-HUt1oOzaHtcRkcNuNgCLcBGAsYHQ/s336/troy1.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="210" data-original-width="336" height="221" src="https://1.bp.blogspot.com/-DqTLfl4aQM8/YKLDCGLFUgI/AAAAAAAAQ4U/wOfXYOsWyaQggC-HUt1oOzaHtcRkcNuNgCLcBGAsYHQ/w355-h221/troy1.jpg" width="355" /></a></div>Comparatively speaking, there appears to be no difference in accuracy between the wired solution, the radioactive seed and the SCOUT. The radioactive seed is significantly smaller than the SCOUT<span style="mso-spacerun: yes;"> </span>but this size difference is a non-issue to surgeons. Statements about SCOUT’s (minor) limitations however mention a slight adjustment in work parameters around the distance between the skin and the device particularly with large breasts or very dense breasts. The SCOUT technology is something that continues to evolve... they are trying to develop where you have a different signal if you have more than one lesion from multiple markers within the breast. Merit is also leading to a lot of competition because everybody wants a piece of that wire free action- but the SCOUT developers set the bar pretty high and a lot of institutions have embraced it... I think it's going to be tough for them to break in since SCOUT has already made their mark.<p></p><p class="MsoNormal" style="text-align: justify;">It is noted that programs using radioactive seeds continue to exist, but the market appears to reflect a transition to non-radioactive devices for reasons described.</p><p class="MsoNormal" style="text-align: justify;"><a href="https://www.linkedin.com/company/paradise-coast-breast-specialists/">Dr. TroyShell-Masouras</a> conducts life saving Breast Cancer Surgery at <a href="https://www.paradisecoastbreastspecialists.com/" target="_blank">Paradise Coast Breast Specialists in </a><st1:place w:st="on"><a href="https://www.paradisecoastbreastspecialists.com/" target="_blank"><st1:city w:st="on">Naples</st1:city> </a><st1:state w:st="on"><a href="https://www.paradisecoastbreastspecialists.com/" target="_blank">Fla</a>.</st1:state></st1:place><span style="mso-spacerun: yes;"> </span>Dr. Shell-Masouras specializes in the diagnosis and treatment of breast cancer and benign breast disease, and provides high risk breast cancer assessments, breast ultrasounds, ultrasound-guided breast procedures to include biopsies and aspiration, partial mastectomy and lumpectomy, total mastectomy to include Hidden Scar™ Breast Conserving Surgery and Hidden Scar™ Nipple Sparing Mastectomy, sentinel lymph node biopsy, axillary lymph node dissection, and radar localization for lumpectomies.</p><div style="text-align: justify;"><div class="separator" style="clear: both; text-align: center;"><div><br /></div><div><div class="MsoNormalCxSpFirst" style="background-color: white; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><div style="text-align: justify;"><table border="2" cellpadding="10" cellspacing="0"><tbody><tr><td bgcolor="#E1F3DA"><span style="font-family: times; font-size: x-large;">VIEWPOINTS</span><p></p><p class="MsoNormalCxSpFirst"><span style="font-family: times;"></span></p><div class="separator" style="clear: both; text-align: center;"><span style="font-family: times;"><a href="https://1.bp.blogspot.com/-QQMdgRiJrJ8/YE7PxUcImfI/AAAAAAAAQH0/O3JFBQzKjosZHPTByPqx2OgbK9JxDbazQCLcBGAsYHQ/s458/chagares-headshot-2.jpg" style="clear: left; color: #cd3778; float: left; margin-bottom: 1em; margin-right: 1em; text-decoration-line: none;"><img border="0" data-original-height="458" data-original-width="458" height="95" src="https://1.bp.blogspot.com/-QQMdgRiJrJ8/YE7PxUcImfI/AAAAAAAAQH0/O3JFBQzKjosZHPTByPqx2OgbK9JxDbazQCLcBGAsYHQ/w95-h95/chagares-headshot-2.jpg" style="background: transparent; border-radius: 0px; border: 1px solid transparent; box-shadow: rgba(0, 0, 0, 0.2) 0px 0px 0px; padding: 8px; position: relative;" width="95" /></a></span></div><span style="font-family: times;">STEPHEN A. CHAGARES, MD FACS- <a href="https://www.drchagares.com/" style="color: #cd3778; text-decoration-line: none;">Cancer Surgeon/ General,Laparoscopic, Robotic Surgery</a> - </span><span style="font-family: times;"><span style="color: #444444; text-align: justify;">“</span>Yes, the Scout technology is a great progression of technology. It allows accurate localization with site of incision at the Surgeon’s discretion allowing for significantly increased cosmetic appearance of a lumpectomy. Also, it’s placed days earlier so no radiology delays on OR days waiting for patients to return after being sent down for guidewire placement." </span><div class="separator" style="clear: both; text-align: center;"><p></p><p style="text-align: start;"><span style="font-family: times;"></span></p><p style="text-align: start;"><i style="color: #444444; font-size: 13px;">* Opinions expressed in this VIEWPOINTS section are supportive comments about the contents of this article and are solely those from the contributors credited.</i></p></div></td></tr></tbody></table></div></div><div style="background-color: white; color: #444444; font-family: Arial, Tahoma, Helvetica, FreeSans, sans-serif; font-size: 13px;"><div class="separator" style="clear: both;"><div style="text-align: start;"><span style="font-family: times; font-size: large;"><div style="font-family: "Times New Roman"; font-size: medium;"><span style="font-size: x-large;"></span></div></span></div></div></div></div></div></div><div style="text-align: justify;"></div><p></p><p class="MsoNormal" style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-VFAGQ_Drbaw/YKUOQCCH1SI/AAAAAAAAQ5Q/LJB9Fj4F7BQq-JUcZYPit4VGDWoE5qQfACLcBGAsYHQ/s181/EXTRA1.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><br /></a><a href="https://1.bp.blogspot.com/-VFAGQ_Drbaw/YKUOQCCH1SI/AAAAAAAAQ5Q/LJB9Fj4F7BQq-JUcZYPit4VGDWoE5qQfACLcBGAsYHQ/s181/EXTRA1.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="48" data-original-width="181" height="37" src="https://1.bp.blogspot.com/-VFAGQ_Drbaw/YKUOQCCH1SI/AAAAAAAAQ5Q/LJB9Fj4F7BQq-JUcZYPit4VGDWoE5qQfACLcBGAsYHQ/w138-h37/EXTRA1.jpg" width="138" /></a></div><div><br /></div><div><br /></div><div><br /></div><div><br /></div><div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><a href="http://breastcancernyc.com/index_open_tamox.html" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: center;" target="_blank"><img border="0" data-original-height="1073" data-original-width="2048" height="133" src="https://1.bp.blogspot.com/-De_nvAppuKs/YLfz1Ci0WSI/AAAAAAAAQ-4/WwwNlwjGjakybYMoToK2iVv3nfdSI0AEACLcBGAsYHQ/w254-h133/tamox-work2a-use.jpg" width="254" /></a><b><a href="http://breastcancernyc.com/">TAMOXIFEN vs. AROMATASE INHIBITORS FOR MALE BREAST CANCER</a></b></div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><a href="https://malebreastcancercoalition.org/">The Male Breast Cancer Coalition </a>presented the work of <a href="https://www.dana-farber.org/find-a-doctor/jose-pablo-leone/">Dr. Jose Pablo Leone</a>, medical oncologist and researcher at the Dana-Farber Cancer Institute about his research plans covering tamoxifen and aromatase inhibitors for the treatment of male breast cancer. While women have the benefits of switching to AI should they contract side effects from Tamoxifen, men are in a harder situation when making this decision because not enough data about the efficacy of aromatase inhibitors (AI) are available for men. </div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-0O8IqXxmWBw/YLf1pI7Q8UI/AAAAAAAAQ_A/wPT3aByOFkEy9qiZJr8s5xMJ0zptjj7xgCLcBGAsYHQ/s100/Jose-Pablo-Leone-IMOJ.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="100" data-original-width="100" src="https://1.bp.blogspot.com/-0O8IqXxmWBw/YLf1pI7Q8UI/AAAAAAAAQ_A/wPT3aByOFkEy9qiZJr8s5xMJ0zptjj7xgCLcBGAsYHQ/s0/Jose-Pablo-Leone-IMOJ.jpg" /></a></div>"Currently, only retrospective studies are available out there, which are prone to selection bias. We need to do more research to get scientific validity to dictate treatment for patients. Due to the physiological differences in the endocrine system between men and women, there may be differences in the efficacy of aromatase inhibitors, leaving men with only Tamoxifen as their primary option. Tamoxifen for men is the standard recommended drug for men with metastatic breast cancer. If there is progression of disease after Tamoxifen, then other endocrine therapies can be used in the metastatic setting. This is why we need prospective studies evaluating AI in men." <a href="http://breastcancernyc.com/index_open_tamox.html">(See complete article) </a></div></div><div><br /></div><div><hr /><p></p><p class="MsoNormal" style="text-align: justify;"></p><div class="separator" style="clear: both; text-align: center;"><br /></div></div><div><div class="separator" style="clear: both; text-align: center;"><a href="https://www.youtube.com/watch?v=wxSoIAFsUYc" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="428" data-original-width="768" height="151" src="https://1.bp.blogspot.com/-7nGrSeOQI78/YKUP3xGFyMI/AAAAAAAAQ5g/vDpfllc1X78Qg6OLxqvUaf-KpsuEA7Z-ACLcBGAsYHQ/w272-h151/yout.jpg" width="272" /></a></div><div style="text-align: left;"><a href="http://breastcancernyc.com/"><b></b></a><b><a href="http://breastcancernyc.com/">BREAST CANCERSCAN NEWS</a>:</b> From the International Oncology Community (Comunità Oncologica Internazionale)</div></div><div style="text-align: justify;"><br /></div><div><div style="text-align: justify;">4/30/2021 Dr. Robert Bard has been elected as the Sr. Medical Advisor of the Integrative Cancer Resource Alliance- an international community of diagnostic imaging specialists. His educational presentation has been translated in over 5 different languages for the world stage, supporting partners in The Netherlands, <a href="https://www.youtube.com/watch?v=wxSoIAFsUYc">Italy, </a>France and Germany. This 2021 report recognizes the advancements in non-invasive, real-time diagnostic imaging of cancer tumors for tracking, monitoring, screening and dual diagnosing as well as preop and image guiding intervention during procedures. Dr. Bard identifies the global movement and demand for virtualization- a medical innovation for remote multi-disciplinary collaboration (<a href="https://telemedscans.com/NEWS.html">ie, TeleRad, Tele-Health and Virtual Conferences</a>) to support the expansion of data sharing as a modern paradigm of problem-solving in cancer care. </div><div style="text-align: justify;"><br /></div><div style="text-align: justify;">In an earlier feature, Dr. Bard celebrates the global solidarity of cancer imaging scientists including the work of some of his most respected research colleagues including <a href="https://modernhealing1.blogspot.com/2019/05/italian-contributions-to-advanced.html">Professors Luigi Solbiati, Carlo Martinoli, Rodolfo Campani</a>. These are just some of the many highly regarded members of the pioneering community who helped pave the movement for a much improved detection of cancer tumors and other subdermal disorders. </div><div style="text-align: justify;"><br /></div><div class="separator" style="clear: both; text-align: center;"><a href="https://1.bp.blogspot.com/-ubNus-a5bpA/YKnKy2m12zI/AAAAAAAAQ6o/t3R0h7Y7Hz03bjQjFiaJ7Cf8wmN50_bfwCLcBGAsYHQ/s417/ultra-breast.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: justify;"><img border="0" data-original-height="248" data-original-width="417" height="141" src="https://1.bp.blogspot.com/-ubNus-a5bpA/YKnKy2m12zI/AAAAAAAAQ6o/t3R0h7Y7Hz03bjQjFiaJ7Cf8wmN50_bfwCLcBGAsYHQ/w237-h141/ultra-breast.jpg" width="237" /></a></div><div style="text-align: justify;">(Image-L) Once you have a vascular map of the cancer, we have the initial vessel density of 4.5%. Successful treatment over weeks or months will bring it down. In this case, it's down to one quarter of the initial treatment so this is treatment success. This is quantitative mapping of treatment follow-up because if it's working, it's better to change treatment, to avoid the side effects of chemo or other immunotherapies. The first circle on top shows the red tumor vessels. The 4D Instagram computer reconstruction gives you a quantitative measure of how many tumor vessels are present. Once you have a number, you can follow the number up or down to verify treatment success or failure to adequately adjust treatment that's needed up or down. (For complete review of CLINICAL IMAGING OF BREAST CANCER Explained, visit: <a href="http://breastcancernyc.com">breastcancernyc.com</a>)</div><div style="text-align: justify;"><br /></div><div style="text-align: justify;"><br /></div><p class="wee" style="background-color: #ffffcc; line-height: 24px;"><strong style="font-family: Oswald; font-size: 28px; line-height: 34px;">GET CHECKED NOW! : EARLY DETECTION SAVES LIVES</strong><br /></p><div style="text-align: justify;"><span style="color: #333333; font-family: times;"><div class="separator" style="clear: both; text-align: center;"><a href="http://fightrecurrence.com/" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="560" data-original-width="450" height="138" src="https://1.bp.blogspot.com/-8BZVQz63_MA/YKUaAM7m6-I/AAAAAAAAQ5s/cHFV6m7S4R8M3G2v642utrTVSl6wpo3tACPcBGAYYCw/w111-h138/button-sally2.jpg" width="111" /></a></div>According to the </span><a href="http://www.who.int/cancer/detection/en/" style="font-family: times;">World Health Organization</a><span style="color: #333333; font-family: times;">, early detection of cancer greatly increases the chances for successful treatment. In the ongoing battle against cancer, it is common knowledge that most cancers in their early stages are far more likely to be treated with positive results. Moreover, a thorough checkup of one's physiological analyses, heredity review and personal data gathering are all strong info-gatherings for early warning signs that someone may be a candidate for cancer. PROACTIVE tasking starts from AWARENESS, EDUCATION & REGULAR SCREENINGS. The right attitude of self-preservation and an appreciation for longevity is lesson #1. Pursuing a balanced lifestyle covering all the bases of </span><a href="http://rejuvenatesolutions.com/index_diag.html" style="font-family: times;">nutrition, exercise, sleep, detoxing and de-stressing is also part of an overall plan for better quality of life.</a> Also visit: <a href="http://www.FightRecurrence.com">www.FightRecurrence.com</a></div><p></p><p class="wee" style="background-color: #ffffcc; font-family: Verdana, Geneva, sans-serif; font-size: 18px; line-height: 24px;"> </p><br /><div style="text-align: justify;">References:</div><p class="MsoNormal"><span style="font-size: small;">1) "What is Breast Needle Localization?"</span><span style="font-size: small; mso-tab-count: 1;"> </span><a href="https://myhealth.alberta.ca/Alberta/Pages/Breast-needle-localization.aspx#:~:text=Needle%20localization%20(also%20called%20wire,by%20mammogram%20or%20ultrasound%20guidance" style="font-size: small;">https://myhealth.alberta.ca/Alberta/Pages/Breast-needle-localization.aspx#:~:text=Needle%20localization%20(also%20called%20wire,by%20mammogram%20or%20ultrasound%20guidance</a><span style="font-size: small;">.</span></p><p class="MsoNormal"><span style="font-size: x-small;">2) July 2019: "Exciting Changes are Here for SCOUT Radar Localization: Merit medical is excited to announce that SAVI SCOUT will now be known as SCOUT radar localization... </span><span style="font-size: small;">": </span><a href="https://www.merit.com/wp-content/uploads/2020/07/SCOUT-Report-2019-July-Changes-for-SCOUT-Radar-Localization.pdf" style="font-size: small;">https://www.merit.com/wp-content/uploads/2020/07/SCOUT-Report-2019-July-Changes-for-SCOUT-Radar-Localization.pdf</a></p><div><span style="font-size: small;">3) Savi Scout- a Surgeon's Perspective (SAVI SCOUT News/ CiannaMedical Newsletter)- </span><a href="https://www.merit.com/wp-content/uploads/2020/09/201808-SCOUTReport-ASurgeonsPerspective.pdf" style="font-size: small;">https://www.merit.com/wp-content/uploads/2020/09/201808-SCOUTReport-ASurgeonsPerspective.pdf</a></div><p class="MsoNormal"><span style="font-size: x-small;">4) Introducing the New SCOUT Ultrasound Delivery System (SAVI SCOUT News/ CiannaMedical Newsletter)-: <a href="https://www.merit.com/wp-content/uploads/2020/09/201812-SCOUTReport-IntroducingTheNewSCOUTUltrasoundDeliverySystem.pdf">https://www.merit.com/wp-content/uploads/2020/09/201812-SCOUTReport-IntroducingTheNewSCOUTUltrasoundDeliverySystem.pdf</a></span></p><p class="MsoNormal"><span style="font-size: x-small;">5) Seasoned Leader Appointed to Guide / Merit’s Cianna Medical Franchise (SCOUT REPORT-News) <a href="https://www.merit.com/wp-content/uploads/2020/07/SCOUT-Report-2019-February-Seasoned-Leader-Appointed-to-Guide.pdf">https://www.merit.com/wp-content/uploads/2020/07/SCOUT-Report-2019-February-Seasoned-Leader-Appointed-to-Guide.pdf</a></span></p><p class="MsoNormal"><br /></p><div><div><span face="arial, helvetica, sans-serif" style="color: #444444; font-size: xx-small;">Disclaimer & Copyright Notice: The materials provided on this website are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and Bard Diagnostic Research & Educational Programs). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.</span></div></div><div><span face="arial, helvetica, sans-serif" style="color: #444444; font-size: xx-small;"><br /></span></div><p class="MsoNormal"><br /></p></div><div class="separator" style="clear: both; text-align: center;"><br /></div><br />NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-53085480110251308012019-08-08T05:47:00.002-07:002021-10-09T13:30:13.967-07:00FROM CANCER LINK SUSPICION TO GLOBAL RECALL: BREAST IMPLANT ALCL REVIEW - THEN AND NOW<div class="separator" style="clear: both; text-align: center;">
<a href="http://angiofoundation.org/prog_Implantscan.html" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;" target="_blank"><img border="0" data-original-height="936" data-original-width="1062" height="352" src="https://1.bp.blogspot.com/-sBjVLfj9kRE/XUwZYbiu7NI/AAAAAAAAD2Y/YwsBV44vvzw-eSGThkFBiU-xAQ8gzfNYACLcBGAs/s400/graphic-headlines.jpg" width="400" /></a></div>
<div style="text-align: justify;">
<span face=""arial" , "helvetica" , sans-serif" style="font-size: x-small;">Edited by: <a href="http://drrobertbard.com/" target="_blank">Dr. Robert Bard</a></span></div>
<div style="text-align: justify;">
<b><br /></b></div>
<div style="text-align: justify;">
<b>Introduction</b></div>
<div style="text-align: justify;">
The FDA (US Food & Drug Administration) first identified a possible association between certain breast implants and the development of Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) in 2011 [1]. On July 24, 2019, ALCL advocacy groups and the global community of implant users finally achieved the long awaited recognition about this emergent disorder when the FDA announced Allergan's voluntary recall of their textured implants. Such a recall raises a level of urgency about the public health risks behind BIA-ALCL with the hopes that other manufacturers would soon follow this lead. "Whenever a company accepts responsibility to pull a risky product from the market, they usually aim to correct product flaws to eliminate public health risks. Recalls also set a great precedence for new research that can add to our scientific understanding about preventing the disorder and other paradigms like it", states <a href="http://implantscan.org/">implantscan.org</a>.<br />
<br />
Note that ALCL is not breast cancer - it is a type of non-Hodgkin’s lymphoma (cancer of the immune system) that in most cases is found in the scar tissue and fluid near the implant, but in some cases, it can spread throughout the body [1]. A significant number of cases are recorded to appear within 8-10 years after implantation but new reports are showing symptoms earlier. A recent report from the American Society for Aesthetic Plastic Surgery states that the first symptom of BIA-ALCL is usually a swelling of the breast between 2 to 28 years after the insertion of breast implants, with an average of about 8 years after implantation. A theory that the increased surface area of textured implants allows a higher number of bacteria around the implant, which forms a biofilm in some patients, and can result in chronic inflammation, ultimately leading to a proliferation of lymphocytes. [2]</div>
<div style="text-align: justify;">
<br />
<b>A SURGEON'S REVIEW</b><br />
Feat. <a href="https://drclarkmd.com/patricia-clark-md/" target="_blank">Dr. Patricia Clark</a></div>
<div style="text-align: justify;">
<a href="https://1.bp.blogspot.com/-IjDTeVfK57s/XUwWaEU8kKI/AAAAAAAAD2M/eI9xAiQ3gOAifJbSETI_FDSy7Yoq2q2QgCLcBGAs/s1600/implant1.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em; text-align: justify;"><img border="0" data-original-height="532" data-original-width="641" height="165" src="https://1.bp.blogspot.com/-IjDTeVfK57s/XUwWaEU8kKI/AAAAAAAAD2M/eI9xAiQ3gOAifJbSETI_FDSy7Yoq2q2QgCLcBGAs/s200/implant1.jpg" width="200" /></a>PinkSmart News conducted an interview by late 2018 with Dr. Patricia Clark of Ironwood Women's Centers and the Ironwood Cancer and Research Centers in Scottsdale, AZ. She provided great insight on various breast-related cancer topics, and she also helped clarify many areas of the BIA-ALCL associated Lymphoma crisis. Dr Clark is a respected nationally recognized onco-plastic (reconstructive) surgeon. These surgeries plastic surgery techniques like breast lifts or breast reductions with cancer surgeries to conserve the breast and reconstruct the defects without implants. Hence, if she performs a lumpectomy for breast cancer, rather than leave a lumpectomy defect or a deformity in the breast, she can modify techniques used during cosmetic breast lifts and reductions to fill the hole, repair the defect and prevent deformity. She might even operate on the other side so that the two match. She teams with leading board certified plastic surgeons to ensure patients have access to the full range of both mastectomy and partial mastectomy reconstructive options. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Dr. Clark and others speculate the true number is of BIA-ALCL cases is likely under-reported to the FDA registry. Incidence estimates range from 1:3817 patients to 1:30,000. The treatment of BIA-ALCL that has not spread beyond the capsule of the implant is simply to remove the capsule and replace the implant. Because it forms in a different manner than other primary non-Hodgkin lymphomas that arise in lymph nodes, chemotherapy and radiation therapy are rarely necessary unless diagnosis is delayed and the disease has spread beyond the capsule. There are likely patients with implant problems who have had the implant and capsule removed, and for which a thorough pathologic examination may not have been done, but for whom the patient’s surgery was curative. Because of increased awareness, this is less likely to happen now than in early years. A quick raise of hands to see who had treated a case by the hundreds of reconstructive plastic surgeons attending the 2018 BC3 meeting sponsored by Georgetown University resulted in more than 20 surgeons who had personally seen or worked with ALCL cases. At that time, records showed less than 500 cases being reported internationally with 16 deaths from over 30,000,000 implant placements. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: center;">
<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/_7-7FN_2kI0" width="560"></iframe><br />
<br />
<div style="text-align: justify;">
A capsule is tissue laid down around the implant that is part of the body's normal process of walling off any foreign body. In addition, the formation or buildup of seroma fluid doesn't mean a patient is going to get cancer. That clear fluid that appears during injury or infection, or in the case if implants, is the body’s reaction to a foreign matter and to large, raw, cut areas of tissue. Hence, every single breast implant, whether it's smooth or textured, forms this capsule. When capsule become too thick, contract, develop persistent seromas, or start to deform the implants, plastic surgeons remove and replace the implants and perform a capsulectomy- the surgical removal of scar tissue and capsule. In doing so, this complete removal procedure inadvertently treats the disease successfully since the lymphoma is usually confined to just the capsule.<br />
<br />
<b>THE TEXTURED IMPLANT DILLEMMA</b></div>
Manufacturers developed textured implants as an upgrade to the smoother counterpart. Smooth implants would result in the shrinking of collagen and the fibers, leading to shrinkage and eventually causing the implants to become hard as a rock and painful. Textured implants were designed to prevent this while accommodating many shaped implants from rotating or shifting over time. Some shapes are thicker on the bottom, thinner on the top, and more teardrop-shaped like a breast. With textured implants, one Because of the texture, a leading theory of cause of BIA- ALCL is the high amount of surface area with more little nooks and crannies can trap more bacteria, which causes more immune cells to move in (lymphocytes) which are subjected to prolonged inflammation and can become cancerous. Other theories include allergic reactions associated with textured implants, and genetic factors.<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://1.bp.blogspot.com/-5HLYqE2BMPE/XVRBxJm-UzI/AAAAAAAAD9Y/n57DO-2CKIQjk90qrowyYcF8XZavznlIQCLcBGAs/s1600/Dr-Clark-300x200.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="200" data-original-width="300" src="https://1.bp.blogspot.com/-5HLYqE2BMPE/XVRBxJm-UzI/AAAAAAAAD9Y/n57DO-2CKIQjk90qrowyYcF8XZavznlIQCLcBGAs/s1600/Dr-Clark-300x200.jpg" /></a></div>
BIA-ALCL may occur in all implants, smooth as well as textured, but most are associated with Allergan Biocell textured implants. These have now been recalled from the market. Since the risk of development of BIA-ALCL is so low, the FDA does not recommend removal of these implants if there is no swelling or pain. If a patient develops a seroma or fluid around the implant, this should be sampled and sent for pathology evaluation.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
A current update of an estimated 1 in 30,000 textured implant risk has been reported and 573 unique and pathologically confirmed BIA-ALCL cases worldwide related to breast implants [3]- according to Dr. Clemens at the July 2019 review with the American Society of Plastic Surgeons. But prior to this year’s recall, the use of textured implants remained prevalent and the risk figures showed an inconclusively low number and did not warrant any public safety action or manufacturer’s recall. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
“BIA-ALCL is not the same disease as the lymphomas that you see spontaneously arise in lymph nodes in the general public. It's not a disease that you treat with chemotherapy or radiation. This is somewhat limited to the implant capsule in most cases. Proportionately speaking, it is very rare … it can invade the local tissues you can have wide-spread disseminated disease or, but that's stunningly rare.”<br />
<br /></div>
<div style="text-align: justify;">
Dr. Clark’s most recent experience with an ALCL case emphasizes the multidisciplinary care patients receive. This included radiology, pathology, medical and radiation oncology and plastic surgery. Capsules must be completely removed and are often densely adherent to the chest wall and even the periosteum (lining) of the bone of the rib. This increases complexity and difficulty in removing every single piece of it. She recently collaborated with Scottsdale plastic surgeon Dr. Joe Berardi due to his previous experience with BIA-ALCL and meticulous approach to capsulectomies.</div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
In summary, it is believed that the two strongest factors that provoke breast implant related lymphomas included formation of a BIOFILM; an infectious coating of bacteria embedding themselves in the surface of the implant. This biofilm recruits the immune cells, which develop the cancer. Also, research have found immune-mediated or allergy-like eosinophils, indicating there could be an allergic component to development of ALCL. </div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
Biofilms are not penetrated by antibiotics and are poorly penetrated by immune cells which can result in chronic, sub-clinical infection that the body and antibiotics can’t clear. The capsule is a physical barrier between the implant and the normal breast tissue within which it has been inserted.<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://angiofoundation.org/prog_Implantscan.html" target="_blank"><img border="0" data-original-height="346" data-original-width="936" height="235" src="https://1.bp.blogspot.com/-CXA1Sk5TI7M/XUwr8opUruI/AAAAAAAAD3M/yNgnJZBb-YkyBizkMGvh20osOl7qufnSACLcBGAs/s640/PSA2.jpg" width="640" /></a></div>
<br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<b>THE RECALL: LANDMARKING A GAME-CHANGER</b></div>
<div style="text-align: justify;">
<a href="https://1.bp.blogspot.com/-TyGizQalwJo/XVRHjAzk3cI/AAAAAAAAD9k/96NIa7pDExgnGSj7WkV4-I54VJt1eeCmwCLcBGAs/s1600/fda.jpg" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="429" data-original-width="484" height="176" src="https://1.bp.blogspot.com/-TyGizQalwJo/XVRHjAzk3cI/AAAAAAAAD9k/96NIa7pDExgnGSj7WkV4-I54VJt1eeCmwCLcBGAs/s200/fda.jpg" width="200" /></a>Each time a product is recalled, it reflects upon the manufacturer’s aim to rectify a known issue that could cause eventual harm to the consumer. The community of implant users and medical professionals have viewed enough cases (and fatalities) of BIA-ALCL historically that the July 24 recall marks a significant touchdown toward the industry’s recognition and global restitution of the possible disaster that this product has yet to face. “It validates the seriousness of the situation, because the layperson can understand that a company doesn't do that… (unless) there's a serious problem”, says Jennifer Cook of <a href="http://biaalcl.com/">BIAALCL.com</a>.<br />
<br />
“I’m grateful for the chance that future women will develop this lymphoma has been greatly reduced. Its not only Allergan implants that create the risk, but it does appear from current data that their implants create the highest risk, and so with those implants being removed from the market, its going to greatly reduce the number of new cases of this disease being created. There's obviously a lot more work to be done but it is the first step, and an additional part of that equation for me was just awareness because all the women out there with this lymphoma, or the implants that can create it, still in their bodies right now, may have no idea about this lymphoma because no one is obligated to warn them. So any immediate attention potentially can reach them and so the withdrawal created more media attention and then hopefully, more awareness.”<br />
<br />
<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" style="background: rgb(255, 242, 204); border-collapse: collapse; border: none; mso-background-themecolor: accent4; mso-background-themetint: 51; mso-border-alt: solid windowtext .5pt; mso-padding-alt: 0in 5.4pt 0in 5.4pt; mso-yfti-tbllook: 1200;">
<tbody>
<tr>
<td style="border: 1pt solid windowtext; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt; width: 467.5pt;" valign="top" width="700"><div class="MsoNormalCxSpFirst" style="line-height: normal; margin-bottom: 0in; mso-add-space: auto; mso-margin-top-alt: auto;">
<br /></div>
<div class="MsoNormalCxSpMiddle" style="line-height: normal; margin-bottom: 0in; mso-add-space: auto; mso-margin-top-alt: auto;">
<a href="https://1.bp.blogspot.com/-fQMyV99fB6s/XVRYWZgGBrI/AAAAAAAAD9w/mSZQ1tiGUVUNe9PC1Q55VVwnC_c_guI-ACLcBGAs/s1600/jen1.jpg" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="417" data-original-width="578" height="230" src="https://1.bp.blogspot.com/-fQMyV99fB6s/XVRYWZgGBrI/AAAAAAAAD9w/mSZQ1tiGUVUNe9PC1Q55VVwnC_c_guI-ACLcBGAs/s320/jen1.jpg" width="320" /></a><b><span style="font-size: large;">BREAKING NEWS!</span><o:p></o:p></b></div>
<div class="MsoNormalCxSpMiddle" style="line-height: normal; margin-bottom: 0in; mso-add-space: auto; mso-margin-top-alt: auto;">
By: Jennifer Cook (<a href="http://biaalcl.com/">BIAALCL.com</a>)<b><o:p></o:p></b><br />
<br /></div>
<div class="MsoNormalCxSpMiddle" style="line-height: normal; margin-bottom: 0in; mso-add-space: auto; mso-margin-top-alt: auto;">
August 8, 2019 –
A new article has been published out of <a href="https://www.nature.com/articles/s41379-019-0337-2" target="_blank">MD ANDERSON in a Modern Pathology Journal</a> addressing the proper way to evaluate and sample an implant capsule
that has been removed from a patient suspected of Breast Implant Associated ALCL. The article indicates that the disease can
often be missed if proper and thorough evaluation of the capsule is not
done. Not only can the disease be
missed but often positive margins of lymphoma on the implant capsule can be
missed and this can create a risk of incomplete resection of the disease w/c
increases the risk of recurrence and worsens the patient's prognosis. Therefore, a person who is suspected of having
BIA-ALCL should have their surgeon and pathologist become aware of these
latest new recommendations on proper pathology protocols so they can benefit
from the state of the art information on how to diagnose and treat this
disease. (See complete report: <o:p></o:p><a href="https://www.nature.com/articles/s41379-019-0337-2" style="text-align: justify;">https://www.nature.com/articles/s41379-019-0337-2</a>)<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://biaalcl.com/" target="_blank"><img border="0" data-original-height="49" data-original-width="210" height="46" src="https://1.bp.blogspot.com/-J17fDeuhyj4/XUw4rr_ghXI/AAAAAAAAD3Y/-VoM1gUjTt47ALfBEAinXQxgFIlVoZIwQCLcBGAs/s200/cropped-210x49-BIA-ALCL-color-w-Ribbon.png" width="200" /></a></div>
<div class="separator" style="clear: both; text-align: center;">
source</div>
</div>
<div class="MsoNormalCxSpMiddle" style="line-height: normal; margin-bottom: 0in; mso-add-space: auto; mso-margin-top-alt: auto;">
<br /></div>
</td>
</tr>
</tbody></table>
<br />
..................................................................................................................................................................<br />
<br />
<b>CONTRIBUTORS </b><b>/ TECHNICAL ADVISORS</b><br />
<a href="https://www.ironwoodwomenscenters.com/" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;" target="_blank"><img border="0" data-original-height="110" data-original-width="80" height="105" src="https://1.bp.blogspot.com/-2s0wBLkdOrk/XUwdIYzCPCI/AAAAAAAAD2s/gMV9KZLkx8ECz8Hfpy60f4bxB3B42n6JgCLcBGAs/s200/patr_clark.jpg" width="80" /></a><a href="https://www.ironwoodwomenscenters.com/doctors/patricia-clark-md-facs-2/" target="_blank"><b>Patricia Clark</b>, <b>MD, FACS</b></a> is a board-certified general surgeon with a passion for treating breast cancer and for using oncoplastic surgery to improve outcomes. Additional plastic surgery training led her to become nationally recognized as a teacher of oncoplastic surgery at national and international conferences. These techniques reduce the need for mastectomy in patients with complex breast disease and they minimize deformity. She is an active member of the American Society of Breast Surgeons, the Society of Surgical Oncology, the American College of Surgeons, the National Consortium of Breast Centers and the American Society of Breast Disease. She currently practices at the Ironwood Women's Centers in Avondale AZ. (<a href="https://www.ironwoodwomenscenters.com/doctors/patricia-clark-md-facs-2/">www.ironwoodwomenscenters.com</a>)<br />
<br />
<a href="https://biaalcl.com/" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;" target="_blank"><img border="0" data-original-height="100" data-original-width="80" height="105" src="https://1.bp.blogspot.com/-G80TSqVJAKc/XUwc40UVeNI/AAAAAAAAD2k/qlO6n9np2mY65EOIp4O4skjhO2g5k7bAQCLcBGAs/s200/SFSF.jpg" width="80" /></a><b><a href="https://biaalcl.com/" target="_blank">Jennifer Cook</a></b> was diagnosed with Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) in August of 2017- which started her on a road to major research to collect all information about the disorder as well as seek out an international social media group of fellow survivors and a supportive community (<a href="http://www.biaalcl.com/">www.BIAALCL.com</a>). Today, Jennifer stands as one of the top advocates of the group, conducting outreach efforts to seek out other victims of this health issue. She is also an active voice in many leadership circles dedicated in the fight to bring public recognition and corporate accountability to this crisis. (<a href="http://survivorstories1.blogspot.com/2018/11/the-obstacles-of-getting-rare-new.html" target="_blank">See Jennifer's interview on Survivor Stories</a>)<br />
<br />
<b>EDITORIAL TEAM </b><br />
<a href="https://bardcancercenter.com/" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;" target="_blank"><img border="0" data-original-height="110" data-original-width="80" height="110" src="https://1.bp.blogspot.com/-Hx6eX2p7C7A/XUwjSqTSAdI/AAAAAAAAD28/V-YYxeviXyYrpq3L7DKnyVmKyWAIVV76ACLcBGAs/s200/bard1.jpg" width="80" /></a><b><a href="https://bardcancercenter.com/" target="_blank">Robert Bard, MD, PC, DABR, FASLMS</a></b> has paved the way for the diagnostic study of various cancers both clinically and academically. His main practice in midtown, NYC (Bard Diagnostic Imaging) uses the latest in digital Imaging technology which has been also used to help guide biopsies and in many cases, even replicate much of the same reports of a clinical invasive biopsy. Imaging solutions such as high-powered Sonograms, Spectral Doppler, sonofluoroscopy, 3D/4D Image Reconstruction and the Spectral Doppler are safe, noninvasive, and does not use ionizing radiation. His commitment to lead the community of cancer imaging and diagnostic experts has led to the establishment of the "Get Checked Now!" campaign.<br /><br /></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<div style="text-align: left;">
1)<span style="white-space: pre;"> </span><a href="https://www.fda.gov/medical-devices/breast-implants/questions-and-answers-about-breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alcl">https://www.fda.gov/medical-devices/breast-implants/questions-and-answers-about-breast-implant-associated-anaplastic-large-cell-lymphoma-bia-alcl</a></div>
</div>
<div style="text-align: justify;">
<div style="text-align: left;">
2)<span style="white-space: pre;"> </span><a href="https://www.surgery.org/sites/default/files/BIA-ALCL-Talking-Points-2-13-19.pdf">https://www.surgery.org/sites/default/files/BIA-ALCL-Talking-Points-2-13-19.pdf</a></div>
</div>
<div style="text-align: justify;">
<div style="text-align: left;">
3)<span style="white-space: pre;"> </span>American Society of Plastic Surgeons: BIA-ALCL Resources | By the numbers, and what they mean. By Mark Clemens, MD <a href="https://www.plasticsurgery.org/for-medical-professionals/health-policy/bia-alcl-physician-resources/by-the-numbers">https://www.plasticsurgery.org/for-medical-professionals/health-policy/bia-alcl-physician-resources/by-the-numbers</a><br />
4) Modern Pathology: <a href="https://www.nature.com/articles/s41379-019-0337-2">https://www.nature.com/articles/s41379-019-0337-2</a></div>
</div>
<div style="text-align: justify;">
<br />
<span face="Arial, Helvetica, sans-serif" style="font-size: xx-small;"><i>Disclaimer & Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and Bard Diagnostic Research & Educational Programs). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.</i></span></div>
NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-85533364535234347992018-09-22T08:46:00.001-07:002020-04-23T06:33:17.502-07:00CANCER 101: The Essentials of How Cancer Happens (and Doesn't)<b style="font-family: calibri, sans-serif; font-size: 14.6667px;">CANCER MADE EASY: GENETICS & MUTATIONS</b><br />
<div class="MsoNormalCxSpMiddle" style="mso-add-space: auto; mso-margin-top-alt: auto;">
<span style="color: black; font-family: "calibri" , sans-serif; font-size: 11.0pt;">By Dr.
Patricia Clark<o:p></o:p></span></div>
<div class="MsoNormalCxSpMiddle" style="mso-add-space: auto; mso-margin-top-alt: auto;">
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://2.bp.blogspot.com/-jNoPx3wZ8DI/W6Zjxv9rVLI/AAAAAAAABWM/VwqNRcqIgRkvrgwfTza1tznFNkCsog-agCLcBGAs/s1600/CLARK-shutterstock_1008942907.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="1040" data-original-width="1600" height="416" src="https://2.bp.blogspot.com/-jNoPx3wZ8DI/W6Zjxv9rVLI/AAAAAAAABWM/VwqNRcqIgRkvrgwfTza1tznFNkCsog-agCLcBGAs/s640/CLARK-shutterstock_1008942907.jpg" width="640" /></a></div>
<div class="MsoNormalCxSpMiddle" style="mso-add-space: auto; mso-margin-top-alt: auto;">
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;">Our DNA and our genetic material is breaking and being damaged every single day. That's just the wear and tear of life. Our bodies have genes and mechanisms to repair broken DNA, and our immune systems have mechanisms to identify and destroy cancerous cells. With breast cancer, 5% to 10% of people have a genetic predisposition that raises their risk of development of breast cancer.</span></span><br />
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;"><br /></span></span>
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;">If we have a cell that can't be repaired, our immune system can recognize it and our natural killer cells can destroy it. So that's how things ought to work. Eventually, you accumulate MUTATIONS over a lifetime as more genes and genetic information are damaged and break down. Somebody like Angelina Jolie had a gene that predisposed her to get breast cancer. She had a gene called BRCA which is a DNA repair mechanism gene. She had one copy of that gene that did not work causing an 87% chance she was going to get breast cancer. She decided with a risk this high for the particular genetic mutation she had, she was going to get mastectomies and remove her ovaries, which were also at risk.</span></span><br />
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;"><br /></span></span>
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;">Genes are like a paragraph of instructions that tell a cell what it is supposed to do, such as what proteins it should make. If all the letters in the instructions are in the correct order, or the gene is “spelled’ correctly, the gene can be read by the cell and everything works. Pathologic mutations in genes have to occur in very specific locations for a cell to no longer be able to understand the instructions it carries. We have all read paragraphs where letters or words are left out, but we can understand the meaning of the paragraph. </span></span><br />
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;"><br /></span></span>
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;">Changing the letters at a key location though, can change the entire meaning of the paragraph of instructions. For instance, If I have a sentence in that paragraph with the word CAR, and I change that "R" to a "T" it now reads CAT. That might change the entire meaning of the message to the cell, and it will no longer be able to carry out it’s functions. That would be a pathological mutation and raise the risk of inheriting cancer or of a cell becoming cancerous. Had I changed the C to a K, and made the word 'KAR', the cell may have still been able to read and understood the word carrying that mutation and can happily continue making the proteins it was supposed to manufacture. This is why some mutations may cause no harm to the cell as long as the cell can still read and understand it’s instructions while other mutations can stop a gene in its tracks, being rendered pathologic. </span></span><br />
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;"><br /></span></span>
<b style="font-family: calibri, sans-serif; font-size: 14.6667px;">This is the simplest way to describe mutations.</b><br />
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;"><br /></span></span>
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;">A lot of mutations aren't going to matter. You have to mutate them in very specific spots before a cell cant read it. To get a cancer, it's not enough to have one mutation. You have to have one or more specific mutations to enable cells to divide uncontrollably. Then you've got to have a mutation that allows it to get out of the organ that it's in (such as a milk duct) and escape into the nearby adjacent tissues, forming a tumor. That's a whole other gene that has to be bad. You have to have a gene in there that allows those cells to bring in their own blood supply so they can keep the tumor fed and alive.. So that's yet another genetic mutation.</span></span><br />
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;"><br /></span></span>
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;">Like with breast cancer, people don’t die of the breast cancer in their breast. They die if it traveled into their entered their bloodstream and lodged in their lungs, it lodged in their liver, it lodged in their bones it lodged in their brain... if it had the mutations it needed to escape the breast and lodge in an organ system that you need. In order to do that it that takes a whole other set of genetic mutations. We can test the tumors for these mutations. Putting a garden variety breast cancer cell in the lung (per se), may be sort of like putting a Palm tree in Alberta, Canada. You can put a Palm tree up there, unless it has a set of very specific genetic mutations, it's not going to survive the winter up there.</span></span><br />
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;"><br /></span></span>
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;"><b>“IT’S NOT THAT EASY TO GET CANCER”</b>:</span></span><br />
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;">So that's why all of us aren't running around with cancers. 1 in 8 women will develop breast cancer over their lifetimes. We have genetic mutations that we accumulate, a lot of them meaningless. Then the other thing is you've got to have the exact right mutations all lined up in a row for something to become cancerous. For the same reason not all firefighters in 9/11 die of cancer, it also depends on genetic predisposition and a person’s ability to protect from and heal environmental insults. We see families where it seems everybody's getting cancer but we can't find a nice single smoking gun or a silver bullet that “caused” it. If cancer were a single process or silver bullet, we’d have it cured already. We're going to have cancer forever because you can't stop the body from mutating or accumulating genetic damage. If you could, we would all be immortal.</span></span><br />
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;"><br /></span></span>
<a href="https://3.bp.blogspot.com/-HCxXYhRmFRg/W6ZnS1PkilI/AAAAAAAABWo/70ezaTyb22MugTLRdhpKmUCY6454UqhIwCLcBGAs/s1600/Dr-Clark-300x200.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="200" data-original-width="300" height="133" src="https://3.bp.blogspot.com/-HCxXYhRmFRg/W6ZnS1PkilI/AAAAAAAABWo/70ezaTyb22MugTLRdhpKmUCY6454UqhIwCLcBGAs/s200/Dr-Clark-300x200.jpg" style="cursor: move;" width="200" /></a><span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;">So that's the briefest of the basics. Understanding cancer from the angle of genetic mutation and predisposition helps you see why some people get it, some people don't. Some people may not have the robust repair mechanisms or the lifestyle to fight it off. Many are sedentary-- they don't exercise, they drink alcohol, or have other lifestyle risks that are another part of it. </span></span><br />
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;"><br /></span></span>
<span style="font-family: "calibri" , sans-serif;"><span style="font-size: 14.6667px;">There are also a lot of environmental factors that can turn genes on and turn genes off. That’s a whole other layer. You can be predisposed because you carry a unique malfunctioning gene ... which carries a variable increase in somebody's risk. They may have a 40% risk they're going to get cancer- or you can see it as that there's 60% risk they never will. We have proto-oncogenes that must be turned on to cause a tumor to form, and tumor suppressor genes that must be turned off to allow a cancer to form. We may or may not be exposed to the environment inside or outside the body that's going to turn it on - or off.</span></span><br />
<div>
<br /></div>
</div>
<div class="MsoNormalCxSpMiddle" style="mso-add-space: auto; mso-margin-top-alt: auto;">
<br /></div>
<div class="MsoNormalCxSpMiddle" style="mso-add-space: auto; mso-margin-top-alt: auto;">
<br /></div>
<div class="MsoNormalCxSpMiddle" style="mso-add-space: auto; mso-margin-top-alt: auto;">
<span style="color: black; font-family: "calibri" , sans-serif; font-size: 11.0pt;">………………………………………………………………………………………………………………………………………………………………..<o:p></o:p></span></div>
<div class="MsoNormalCxSpMiddle" style="mso-add-space: auto; mso-margin-top-alt: auto;">
<br /></div>
<div class="MsoNormalCxSpMiddle" style="mso-add-space: auto; mso-margin-top-alt: auto;">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://1.bp.blogspot.com/-KCoWco9WBe4/W6ZnLhWseKI/AAAAAAAABWk/ta-gn9_YzD4_dznrp7lJX9hwTv63OTofQCLcBGAs/s1600/0.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="500" data-original-width="500" height="200" src="https://1.bp.blogspot.com/-KCoWco9WBe4/W6ZnLhWseKI/AAAAAAAABWk/ta-gn9_YzD4_dznrp7lJX9hwTv63OTofQCLcBGAs/s200/0.jpg" width="200" /></a></div>
<b style="mso-bidi-font-weight: normal;"><span style="color: black; font-family: "calibri" , sans-serif; font-size: 11.0pt;">ABOUT THE AUTHOR:<o:p></o:p></span></b></div>
<div class="MsoNormalCxSpMiddle" style="mso-add-space: auto; mso-margin-top-alt: auto;">
<span style="color: black; font-family: "calibri" , sans-serif; font-size: 11.0pt;">Awareness
for a Cure welcomes our newest cancer expert, <b style="mso-bidi-font-weight: normal;">Dr. Patricia Clark</b>- Breast and Oncoplastic Surgeon. Dr. Clark is a
renowned speaker at the BC3 (National Breast Cancer Conferences) and is
currently the medical director and surgical oncologist at the Ironwood Breast Cancer
and Research Centers in Scottsdale, AZ. You can learn more about Dr. Clark at: <a href="http://www.drclarkmd.com/">www.drclarkmd.com</a> <o:p></o:p></span></div>
<div class="MsoNormalCxSpMiddle" style="mso-add-space: auto; mso-margin-top-alt: auto;">
<br /></div>
<div class="MsoNormalCxSpMiddle" style="mso-add-space: auto; mso-margin-top-alt: auto;">
<br /></div>
<div class="MsoNormalCxSpMiddle">
<b style="mso-bidi-font-weight: normal;"><span style="font-family: "calibri" , sans-serif; font-size: 11.0pt;">Eliminating Cancer is not enough:<o:p></o:p></span></b></div>
<div class="MsoNormalCxSpMiddle">
<span style="font-family: "calibri" , sans-serif; font-size: 11.0pt;">A woman’s
function and body image matter. For most women, there is no survival advantage
to mastectomy. By using oncoplastic techniques such as breast reduction or
mastopexy at the time of lumpectomy, selected women with larger tumors or more
complex disease can now have complete removal of their cancer and still have a
good cosmetic result. </span><span style="font-family: "calibri" , sans-serif; font-size: 11pt;">While Dr
Clark personally performs oncoplastic procedures, high quality plastic surgery
consultation is available for all women requiring reconstruction from
mastectomy, and to optimize outcomes in selected women undergoing oncoplastic
procedures.</span><span style="font-family: "calibri" , sans-serif; font-size: 11pt;"> </span><span style="font-family: "calibri" , sans-serif; font-size: 11pt;">Surgery can be performed on
the other breast to provide symmetry. We don’t want the breast to be a reminder
of cancer in years to come. </span><a href="http://www.drclarkmd.com/" style="font-family: calibri, sans-serif; font-size: 14.6667px;">www.drclarkmd.com</a></div>
<div class="MsoNormalCxSpMiddle">
<br /></div>
<div class="MsoNormalCxSpMiddle">
<br />
<span style="text-align: justify;"><span style="font-family: Arial, Helvetica, sans-serif; font-size: xx-small;"><i>Disclaimer & Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and Bard Diagnostic Research & Educational Programs). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.</i></span></span></div>
NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.comtag:blogger.com,1999:blog-5686896224759267446.post-40733724592870755622018-09-10T15:41:00.002-07:002020-04-23T06:33:24.742-07:00Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): "Where we are, and aren’t"<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";"><b>By: Constantine Kaniklidis</b> Medical Research (<a href="https://cancerkn.com/breast-cancer-screening-series-constantine-kaniklidis/" target="_blank">Cancer Knowledge network</a>) & Director of <a href="http://nosurrenderbreastcancerhelp.org/" target="_blank">No Surrender Breast Cancer Foundation (NSBCF)</a>-- circa 2018, </span><span style="font-family: "vollkorn medium"; text-align: right;">September</span><br />
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<br /></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<table cellpadding="0" cellspacing="0" class="tr-caption-container" style="float: right; margin-left: 1em; text-align: right;"><tbody>
<tr><td style="text-align: center;"><a href="https://2.bp.blogspot.com/-uUTEWPHHbG4/W5bymhVLahI/AAAAAAAABNQ/91Ym7-lRQ5c3Yh8IhBBvz6OZ8uk1vXOjACLcBGAs/s1600/implant-blog.jpg" imageanchor="1" style="clear: right; margin-bottom: 1em; margin-left: auto; margin-right: auto;"><img border="0" data-original-height="226" data-original-width="400" height="225" src="https://2.bp.blogspot.com/-uUTEWPHHbG4/W5bymhVLahI/AAAAAAAABNQ/91Ym7-lRQ5c3Yh8IhBBvz6OZ8uk1vXOjACLcBGAs/s400/implant-blog.jpg" width="400" /></a></td></tr>
<tr><td class="tr-caption" style="text-align: center;">SEE <a href="http://breastcancerblognews.blogspot.com/2018/07/hazardous-implant-alert-anaplastic.html" target="_blank">BIA-ALCL FEATURE @ NEWS1</a></td></tr>
</tbody></table>
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">Here some reflections, and a plea for further, more systematized
and coordinated action and consensus:</span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<br /></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">First, the just published LYSA Registry data from the French
Cancer Agency </span><span style="color: teal; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">[reported at ASCO 2018]</span><span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";"> has shed some further light on two prognostically distinct
classes of BIA-ALCLs (based on effusion, breast tumor mass, and lymph node
involvement), with <i>in situ BIA-ALCLs</i> exhibiting an indolent clinical
course that enables complete remission typically after implant removal, in
contrast to <i>infiltrative BIA-ALCLs</i> exhibiting a more aggressive clinical
course, with in fact a prognosis virtually identical to systemic anaplastic
large cell lymphoma (ALCL), despite real differences. Further clarification was
provided in AU-NZ studies </span><span style="color: teal; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">[especially Loch-Wilkinson,
Plast Reconstr Surg. 2017 Oct]</span><span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">, higher-surface-area (HAS)
textured implants significantly increased the risk of BIA-ALCL (over 14 times
higher with Biocell textured implants and almost 11 times higher with
polyurethane (Silimed) textured implants compared with Siltex textured
implants, so there clearly is a risk hierarchy at play here.</span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<br /></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">Second, being mindful of overtreatment (always a concern),
nonetheless given that BIA-ALCL related death, although rare, is predominantly
due to uncontrolled local disease progression, there is a role in patients with
more advanced local disease – particularly in the minority of patients whose
disease extends beyond the capsule – for chemotherapeutic intervention, and at
this time the best evidenced first-line therapy apart from the strongly toxic
CHOP family of regimens is the monoclonal antibody <i>brentuximab vedotin
(Adcetris)</i> based on its role in refractory in ALCL, despite the limited but
still positive data of its off-label use in BIA-ALCL; and I have seen some
cases of patients progressing on CHOP therapy but achieving pathological
complete response (pCR) with brentuximab vedotin in the second line. Given its
comparatively favorable side effect profile and higher tolerability over
traditional chemotherapies, it retains some considerable appeal.</span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<br /></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";"><b>Third, for myself, given that: </b></span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<span style="font-family: "vollkorn medium";">(1) the NF-kB) pathway is commonly deregulated in lymphomas, and
that</span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">(2) curcumin can inhibit growth of these cell lines and increase
their chemosensitivity to cisplatin, and given also that</span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">(3) it (curcumin) increases apoptosis and differentiation of
vitamin D-treated tumor cells, with direct binding of curcumin to the vitamin D
receptor (VDR), and that</span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">(4) curcumin modulates the well-known overexpression of EZH2 in
anaplastic lymphomas and can down-regulate the JAK/STAT pathway that is
also incriminated in BIA-ALCL, </span><span style="font-family: "vollkorn medium";">then I have (strictly ad hoc-ly and off-label) counseled the
deployment, with provisional but promising success, of a regimen of
high-penetrance </span><i style="font-family: "vollkorn medium";">curcuminoids</i><span style="font-family: "vollkorn medium";"> (either phytosomal or nanoparticulate) and
optimal-dosed </span><i style="font-family: "vollkorn medium";">Vitamin D3</i><span style="font-family: "vollkorn medium";"> (achieving 25(OH)D assay levels of at least 66
ng/ml and above), in the small number of BIA-ALCL cases I have consulted on,
but clearly this requires validation in clinical trial. And Mark Clemens'
recent findings suggesting that some BIA-ALCL are associated with a </span><i style="font-family: "vollkorn medium";">chronic
allergic immune response</i><span style="font-family: "vollkorn medium";"> to currently undetermined antigen(s) - with IL-13
activity (associated with allergic inflammation) as well as eosinophils and
mast cells surrounding the BIA-ALCL tumors plus the presence of IgE – is
tantalizing in this connection of anti-inflammatory interventions.</span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<br /></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://3.bp.blogspot.com/-3N8E9kAJDss/W5qJG-QYUwI/AAAAAAAABRI/sAQyWJrSyT4XzS6j4cnpHY8xtxS_CbYJwCLcBGAs/s1600/shutterstock_1024292428.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" data-original-height="876" data-original-width="1600" height="218" src="https://3.bp.blogspot.com/-3N8E9kAJDss/W5qJG-QYUwI/AAAAAAAABRI/sAQyWJrSyT4XzS6j4cnpHY8xtxS_CbYJwCLcBGAs/s400/shutterstock_1024292428.jpg" width="400" /></a></div>
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";"><b>Going Forward, Work Still To Do:</b></span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in; margin-left: .5in; margin-right: 0in; margin-top: 0in; mso-list: l0 level1 lfo1; tab-stops: list .5in; text-indent: -.25in;">
<span style="font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium"; mso-fareast-font-family: "Vollkorn Medium";"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">I am also looking to press
for the expansion of the European Commission Medical Device Expert Group
(VMDEC) Task Force with respect to collection and analysis of EU-based BIA-ALCL
cases, but VMDEC registry data must be coordinated with other non-EU entities –
like the PROFILE Registry maintained by the The Plastic Surgery Foundation here
in the States, the Australian Breast Device Registry, among many others –
if we are to establish a larger and more comprehensive cross-boundary collaborative
BIA-ALCL surveillance initiatives to advance our knowledge and better serve the
many women affected (and often overlooked and sometimes misdiagnosed as Hodgkin
lymphoma or other entities). </span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in; margin-left: .5in; margin-right: 0in; margin-top: 0in; mso-list: l0 level1 lfo1; tab-stops: list .5in; text-indent: -.25in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";"><br /></span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in; margin-left: .5in; margin-right: 0in; margin-top: 0in; mso-list: l0 level1 lfo1; tab-stops: list .5in; text-indent: -.25in;">
<!--[if !supportLists]--><span style="font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium"; mso-fareast-font-family: "Vollkorn Medium";"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">It is disconcerting that we
still, even in 2018, lack consistent standardization and reporting regarding
pathological examination of mammary implants (most institutions often continue
to recommend gross examination alone). </span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in; margin-left: .5in; margin-right: 0in; margin-top: 0in; mso-list: l0 level1 lfo1; tab-stops: list .5in; text-indent: -.25in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";"><br /></span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in; margin-left: .5in; margin-right: 0in; margin-top: 0in; mso-list: l0 level1 lfo1; tab-stops: list .5in; text-indent: -.25in;">
<!--[if !supportLists]--><span style="font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium"; mso-fareast-font-family: "Vollkorn Medium";"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">Furthermore, we are not
doing enough to educate patients and their health professionals on the
importance of routine surveillance after implantation. </span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in; margin-left: .5in; margin-right: 0in; margin-top: 0in; mso-list: l0 level1 lfo1; tab-stops: list .5in; text-indent: -.25in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";"><br /></span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in; margin-left: .5in; margin-right: 0in; margin-top: 0in; mso-list: l0 level1 lfo1; tab-stops: list .5in; text-indent: -.25in;">
<!--[if !supportLists]--><span style="font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium"; mso-fareast-font-family: "Vollkorn Medium";"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt "Times New Roman";">
</span></span></span><!--[endif]--><span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">And we must finally – long
overdue -bring explicit consent issues to the fore to assure fairness to
patients. It would appear that most breast-focused plastic surgeons in the U.S.
and the UK fail to consistently include risk of BIA-ALCL and that uniform
informed-consent documents lack widespread adoption and use, so a model
BIA-ALCL informed consent is required and effective efforts made to assure that
the patient is not simply “allowed” to read and decipher the information as it
is found in the informed consent agreement as is all too commonly the case, but
that health professionals first openly and candidly discuss not only the risk
of BIA-ALCL but also the <b>common presenting symptoms</b> (a mass, breast
swelling/pain, or delayed-presentation seroma / effusion) of BIA-ALCL the
patient should be on guard for which would trigger a mandated evaluation. I
call this the need for “<i>informed discussion</i>” in addition to mere “<i>informed
consent</i>”, and that need was best put by the UK High Court (Judgement in
Montgomery ‘v’ Lanarkshire Health Board) that stated that “<i>risk shouldn't be
a numbers game, it should be part of <u>dialogue</u></i>”.</span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<br />
...............................................................................................................................................................</div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";"><b>Constantine Kaniklidis </b>of <a href="http://evidencewatch.com/">evidencewatch.com</a></span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">Director, Medical Research, No Surrender Breast Cancer Foundation
(NSBCF)</span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">Oncology Reviewer, Current Oncology</span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">Member, Society for Integrative Oncology (SIO)</span></div>
<div class="MsoBodyText" style="margin-bottom: .0001pt; margin-bottom: 0in;">
<span style="color: black; font-family: "vollkorn medium"; mso-bidi-font-family: "Vollkorn Medium";">European Association for Cancer Research (EACR) </span></div>
<div class="MsoBodyText">
<br /></div>
<div class="MsoNormal">
<br /></div>
<i style="font-family: Arial, Helvetica, sans-serif; font-size: x-small; text-align: justify;">Disclaimer & Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (The NY Cancer Resource Alliance/IntermediaWorx inc. and Bard Diagnostic Research & Educational Programs). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers. Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately. This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.</i>NYCRA NEWShttp://www.blogger.com/profile/11403509705833243721noreply@blogger.com